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Summary		
1.	 The	 visualized	 whole-cell	 patch-clamp	 technique	 was	 used	 to	 record	 from	renilla-green	fluorescent	protein	tagged	neuropeptide-Y	(NPY-GFP)	neurons	of	the	murine	 arcuate	 nucleus	 of	 the	 hypothalamus	 (ARH).	 Here,	 passive	 and	 active	membrane	properties	were	quantified	and	the	effects	of	energy	status	and	ambient	glucose	concentration	were	 investigated.	Key	findings	here	are	that	NPY	neurons	of	the	ARH	have	a	significantly	shorter	action	potential	duration	in	the	fasted	state,	with	brain	slices	incubated	in	artificial	cerebrospinal	fluid	(aCSF)	containing	1	mM	glucose,	 compared	 to	 neurons	 of	 fed	 animals,	 incubated	 in	 1	 mM	 glucose-containing	aCSF.		Also	 observed	 was	 a	 redistribution	 in	 the	 profile	 of	 active	 conductances	expressed	 by	 NPY	 neurons,	 when	 comparing	 ‘fed’	 and	 ‘fasted’	 populations.	 A	 T-type	 calcium	 conductance	 was	 associated	 with	 more	 positive	 energy	 states,	whereas	 a	hyperpolarization-activated	non-selective	 cation	 conductance	 (IT)	was	associated	with	 negative	 energy	 states,	 in	 these	 neurons.	Herein	 this	 thesis	 uses	the	 term	 ‘positive	 energy	 state’	 to	 describe	 neurons	 recorded	 in	 vitro,	 the	environmental	condition	of	which	replicating	a	 fed,	sated,	high	blood	and	central	glucose	 concentration	 state	 in	 vivo.	 Furthermore	 this	 thesis	 will	 use	 the	 term	“negative	 energy	 state’	 to	 describe	 neurons	 recorded	 in	vitro,	 the	 environmental	condition	 of	 which	 replicating	 a	 fasted,	 hungry,	 low	 blood	 and	 central	 glucose	concentration	state	in	vivo.	
2.	The	visualized	whole-cell	patch-clamp	technique	was	used	to	record	from	NPY-eGFP	neurons	of	 the	murine	ARH.	NPY	neuron	 sensitivity	 to	 glucose	and	ghrelin	was	quantified,	both	 in	neurons	of	brain	slices	taken	from	animals	 fed	ad	libitum	prior	to	culling,	and	in	neurons	of	brain	slices	taken	from	mice	subjected	to	an	18-
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hour	 fast	 prior	 to	 culling.	 A	 major	 finding	 of	 this	 study	 was	 that	 an	 increased	proportion	 of	 NPY-eGFP	 neurons	 are	 glucose	 responsive	 (GR)	 following	 an	 18-hour	fast.	 	Glucose	inhibited	(GI)	and	glucose	excited	(GE)	NPY	eGFP	neurons	are	recruited	by	fasting.		Another	major	finding	in	this	study	was	that	fasting	increases	the	excitatory	effects	 of	 ghrelin	 on	 NPY	 eGFP	 neurons.	 NPY	 neuron	 depolarization	 induced	 by	both	 glucose	 and	 ghrelin	 is	 via	 KATP	 channels,	 therefore	 the	 effect	 of	 one	 factor	upon	the	channel	can	impact	the	ability	of	other	KATP	modulators	to	effect	neuronal	excitability.		
3.	 The	 visualized	 whole-cell	 patch-clamp	 technique	 was	 used	 to	 record	 from	murine	 proopiomelanocortin	 enhanced-green	 fluorescent	 protein	 (POMC-eGFP)	neurons	 of	 the	 ARH.	 The	 contribution	 of	 T-cell	 protein	 tyrosine	 phosphatase	(TCPTP)	and	phosphoinositide-3	kinase	(PI3K)	to	ARH	POMC	neuron	insulin	signal	transduction	was	 investigated.	Here	we	 found	 insulin	 to	exert	differential	 effects	on	POMC	neurons,	with	some	excited,	some	inhibited,	whilst	some	neurons	were	insensitive	to	bath	application	insulin.		A	 major	 finding	 of	 this	 study	 was	 that	 the	 insulin-induced	 excitation	 of	POMC	 neurons	 in	 the	 presence	 of	 a	 TCPTP	 inhibitor	 was	 significantly	 larger	 in	magnitude	 than	 the	excitation	observed	 in	 the	presence	of	a	PI3K	 inhibitor.	This	result	 indicates	 that	TCPTP	exerts	an	 inhibitory	 tone	upon	 insulin-induced	PI3K-dependent	POMC	neuron	excitation.	Also	 observed	were	 considerable	 differences	 in	 the	proportion	 of	 insulin-induced	excitations	and	insulin-induced	inhibitions,	when	comparing	experimental	groups.	 Groups	 included	 a	 population	 of	 control	 POMC	 neurons,	 a	 population	 of	POMC	neurons	incubated	in	a	TCPTP	inhibitor,	and	a	population	of	POMC	neurons	
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incubated	 in	 a	 PI3K	 inhibitor.	 Under	 control	 conditions	 around	 half	 of	 POMC	neurons	 were	 inhibited	 by	 insulin,	 approximately	 10%	 were	 excited	 and	 the	remaining	40%	did	not	respond	to	insulin.	Inhibition	of	neuronal	TCPTP	decreased	the	proportion	of	insulin-inhibited,	and	increased	the	proportion	of	insulin-excited	POMC	 neurons,	 compared	 to	 control.	 Neuronal	 inhibition	 of	 PI3K	 resulted	 in	 an	insulin	 response	 distribution,	 similar	 to	 that	 observed	 in	 the	 TCPTP	 inhibitor	group,	with	an	increased	proportion	of	insulin-induced	excitations,	and	a	reduced	proportion	 of	 insulin-induced	 inhibitions,	 relative	 to	 control.	 This	 result	 is	somewhat	 paradoxical,	 as	 ostensibly	 both	 inhibition	 and	 disinhibition	 of	 PI3K	signaling	in	POMC	neurons,	drives	an	increased	excitatory	response	to	insulin.	
4.	 The	 visualized	 whole-cell	 patch-clamp	 technique	 was	 used	 to	 record	 from	murine	 yellow	 fluorescent	 protein-tagged	 leptin	 receptor-expressing	 (LepR)	neurons	 of	 the	 murine	 dorsomedial	 hypothalamus	 (DMH).	 The	electrophysiological	 effects	 of	 leptin	 on	 LepR	 neurons	 of	 the	 mouse	 DMH	 were	investigated.	 Leptin	 depolarized	 38.2%	 of	 DMH	 LepR	 neurons,	 hyperpolarized	14.7%	of	DMH	LepR	neurons,	whilst	the	remaining	47.1%	did	not	respond.	Leptin-induced	 membrane	 excitation	 was	 via	 the	 activation	 of	 a	 non-selective	 cation	conductance.	Leptin-induced	membrane	hyperpolarization	was	via	 the	activation	of	 a	 potassium	 conductance.	 Leptin-induced	 excitation	 measured	 in	 whole-cell	patch	clamp	experiments	in	vitro	was	associated	with	obesity-related	increases	in	blood	 pressure	 and	 heart	 rate	measured	 in	 vivo	by	 Dr.	 Stephanie	 Simonds.	 This	work	formed	part	of	her	PhD	research	and	is	now	published	(see	above).	
5.	The	visualized	whole-cell	patch-clamp	 technique	was	used	 to	 characterize	 the	electrophysiological	 and	 pharmacological	 properties	 of	 rat	 DMH	 gonadotropin	inhibitory	hormone	(GnIH)	neurons.	Major	 findings	of	 these	experiments	 include	
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the	identification	of	glutamatergic	and	GABAergic	synaptic	inputs	to	GnIH	neurons.	Additionally	 I	 identify	 a	 number	 of	 voltage-sensitive	 active	 conductances	expressed	 in	 rat	 GnIH	 neurons.	 There	 include	 a	 time-	 and	 voltage-dependent	inward	 rectification	 (IH)	 and	 a	 transient	 outwardly	 rectifying	 potassium	conductance	(ITR).	GnIH	neurons	were	depolarized	by	noradrenaline,	via	activation	of	a	non-selective	cation	conductance.	5-HT	induced	a	complex	profile	of	responses	in	 GnIH	 neurons.	 15.8%	 were	 inhibited	 by	 5-HT,	 42.1%	 were	 excited	 by	 5-HT,	whilst	 the	 remaining	 42.1%	 responded	 to	 5-HT	 with	 a	 biphasic,	 inhibitory-excitatory	membrane	 potential	 response.	 Thyrotropin	 releasing	 hormone	 (TRH)	depolarized	GnIH	neurons	 via	 a	 non-selective	 cation	 conductance,	whilst	 ghrelin	depolarized	GnIH	neurons	through	the	inhibition	of	a	potassium	conductance.	
6.	 The	 visualized	 whole-cell	 patch-clamp	 technique	 was	 used	 to	 investigate	 the	electrophysiological	properties	of	electrotonically-coupled	interneurons	located	in	layers	1	and	2	of	 the	murine	prefrontal	cortex	(PFC).	The	properties	of	electrical	synapses	between	fast	spiking	(FS)	and	non-fast	spiking	(NFS)	interneurons	were	investigated.	Major	findings	of	these	studies	were	that	layer	2	FS	interneurons	are	depolarized	 by	 5-HT,	 via	 the	 activation	 of	 a	 non-selective	 cation	 conductance,	consistent	with	5-HT3	 receptor	activation.	Furthermore,	 the	gap	 junction	blocker	carbenoxolone	 decoupled	 synchronized	 epileptiform	 activity,	 whilst	 the	anticonvulsant	benzoylamino-benzopyran	compounds	Tonabersat	and	Carabersat	significantly	inhibited	gap	junctional	intercellular	communication	(GJIC).				
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Chapter	1:	General	Introduction	
1.1	 Energy	homeostasis	Energy	homeostasis	 is	 the	regulation	of	caloric	 intake	and	energy	expenditure	 in	order	 to	 maintain	 a	 consistent	 internal	 environment.	 A	 key	 regulator	 of	 energy	homeostasis	 is	 the	 autonomic	 nervous	 system	 (ANS),	 which	 modulates	 the	innervation	of	 the	 internal	organs	through	both	 its	subdivisions;	 the	sympathetic	nervous	system	(SNS)	and	parasympathetic	nervous	system	(PNS).	Both	of	 these	arms	of	 the	ANS	are	comprised	of	pre-ganglionic	neurons	 in	 the	spinal	cord,	and	post	ganglionic	neurons	in	the	periphery.	The	pre-ganglionic	neurons	have	afferent	connections	 within	 the	 hypothalamus,	 and	 along	 with	 brainstem	 nuclei	 the	hypothalamus	is	one	of	the	key	control	centers	for	energy	homeostasis,	integrating	both	central	and	peripheral	signals,	 formulating	functional	outputs	in	the	form	of	electrical	 codes,	neurotransmitter	and	neuropeptide	 release	 to	drive	appropriate	target	innervation.		
1.2	 Obesity	Obesity	and	 its	associated	co-morbidities	are	 immense	health	and	socioeconomic	burdens,	especially	in	western	societies	where	high	calorie	foods	are	increasingly	available	 and	 sedentary	 lifestyles	 are	 more	 commonplace.	 The	 most	 common	method	of	 quantifying	 obesity	 is	 the	 body	mass	 index	 (BMI)	 calculated	 as:	 Body	weight	(Kg)/	height	(m)2	(Gray	and	Fujioka,	1991).	The	world	health	organization	(WHO)	defines	a	value	>	25	as	overweight,	and	>30	as	obese.	In	2005	23.2%	of	the	global	adult	population	was	overweight	(24.0%	men,	22.4%	women)	(Kelly	et	al.,	
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2008).	 Finkelstein	 et	 al	 project	 obesity	 rates	 in	 the	 USA	 to	 reach	 42%	 by	 2030	(Finkelstein	et	al.,	2012).	Excess	body	fat	is	associated	with	a	number	of	secondary	diseases	including	type-II	diabetes,	cardiovascular	disease	and	cancer	and	as	such	obesity	 is	 an	avoidable	drain	on	healthcare	 resources	 (Dixon,	2010).	Of	 the	USA,	estimates	from	2008	put	the	healthcare	costs	of	obese	individuals	at	41.5%	higher	than	healthy	weight	 individuals,	and	the	total	obesity-associated	healthcare	costs	are	 estimated	 to	 be	 $86	 billion	 USD	 (Finkelstein	 et	 al.,	 2009).	 Prevention	 and	intervention	strategies	aimed	at	curtailing	the	current	obesity	epidemic	will	result	in	health	and	economic	benefits.		
1.3	 The	hypothalamus	The	hypothalamus	is	located	in	the	ventral	diencephalon,	and	surrounds	the	third	ventricle.	The	hypothalamus	 is	 located	 immediately	dorsal	 to	 the	pituitary	gland,	and	exerts	direct	control	over	gonadotropin,	thyrotropin	and	corticotropin	release	through	the	production	and	secretion	of	releasing	hormones.	It	functions	as	a	site	of	 neuronal	 and	 hormonal	 integration.	 Neurons	 within	 it	 respond	 to	 afferent	central	 and	peripheral	hormonal	 stimuli	 in	order	 to	 generate	 functional	 outputs.	The	hypothalamus	exerts	a	regulatory	effect	over	diverse	physiological	processes	such	 as,	 reproduction,	 blood	 pressure,	 temperature	 regulation,	 osmoregulation,	circadian	rhythms,	sleep,	stress,	food	intake,	and	energy	expenditure.		The	role	of	the	hypothalamus	in	the	regulation	of	energy	homeostasis	was	initially	 suggested	 by	 (Erdheim,	 1904),	 previous	 to	 which	 dysfunction	 of	 the	pituitary	 gland	 had	 been	 assumed	 to	 be	 the	 etiology	 of	 diseases	 such	 as	 obesity	(Fröhlich,	 1901).	 Hypothalamic	 control	 of	 energy	 balance	 was	 first	 formally	documented	in	1940	with	studies	by	Hetherington	and	Ranson,	showing	bilateral	
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electrolytic	 lesions	 in	 rat	 the	 hypothalamus,	 caused	 extensive	 damage	 to	 the	dorsomedial	 hypothalamus	 (DMH),	 ventromedial	 hypothalamus	 (VMH),	 arcuate	nucleus	 (ARH),	 the	 fornix,	 ‘and	 that	 portion	 of	 the	 lateral	 hypothalamic	 area	ventral	to	it’.	The	resulting	rats	were	obese,	some	of	which	being	twice	as	heavy	as	controls.	Conversely	 rats	 given	 lesions	 in	 the	 lateral	hypothalamus	 (LH)	 reduced	their	food	intake	(Hetherington,	1940).	Further	work	by	Anand	and	Brobeck	found	that	bilateral	 lesions	of	 the	LH	resulted	 in	 the	complete	 cessation	of	 food	 intake,	causing	death	by	starvation	(Anand	and	Brobeck,	1951).	This	work	indicated	that	the	 hypothalamus	 contained	 function-specific	 neuroanatomical	 loci,	 controlling	specific	physiological	processes,	including	a	feeding	center	in	the	LH	and	a	satiety	center	in	the	VMH.	Subsequent	work	has	supplanted	the	view	of	the	hypothalamus	as	 housing	 function	 specific	 “centers”,	 with	 the	 concept	 that	 it	 contains	 discreet	neuronal	 populations,	 expressing	 characteristic	 profiles	 of	 receptors,	neuropeptides	and	transmitters.		
1.4	 The	arcuate	nucleus	of	the	hypothalamus	The	arcuate	nucleus	of	the	hypothalamus	(ARH)	surrounds	the	ventral	end	of	the	third	 ventricle	 and	 is	 immediately	 dorsal	 to	 the	 median	 eminence.	 The	 median	eminence	itself	is	a	circumventricular	organ,	with	a	relatively	passive	blood	brain	barrier,	 allowing	 for	 proteins	 as	 large	 as	 horseradish	 peroxidase	 to	 enter	 the	hypophyseal	 blood	 (Broadwell	 and	 Brightman,	 1976)	 and	 circulatory	 factors	including	 the	 16	 kDa	 hormone	 leptin	 to	 pass	 from	 the	 blood,	 into	 the	 arcuate	nucleus	(Banks	et	al.,	1996).		Damage	to	the	ARH	caused	by	gold	thioglucose	administration	is	associated	with	 hyperphagia	 and	 weight	 gain	 in	 addition	 to	 the	 reduction	 of	 both	
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Neuropeptide-Y	 (NPY)	 and	 pro-opiomelanocortin	 (POMC)	 mRNA	 (Debons	 et	 al.,	1982,	Bergen	et	al.,	1998).	90%	of	arcuate	NPY	neurons	co-express	agouti-related	peptide	 (AgRP)	 (Broberger	 et	 al.,	 1998),	 and	 as	 such	 these	 neurons	 are	 termed	NPY/AgRP,	 whilst	 POMC	 is	 co-expressed	 in	 neurons	 with	 cocaine	 and	amphetamine-regulated	transcript	(CART)	(Elias	et	al.,	1998),	these	neurons	being	referred	to	in	the	literature	as	POMC/CART.	NPY/AgRP	and	POMC/CART	neurons	of	the	ARH	have	been	extensively	studied	and	are	known	to	be	sensitive	to	glucose	and	 a	 number	 of	 peripheral	 hormones	 including	 leptin,	 insulin	 and	 ghrelin	(Spanswick	et	al.,	1997,	van	den	Top	et	al.,	2004,	Cowley	et	al.,	2001,	Spanswick	et	al.,	 2000).	 In	 addition	 to	 the	 action	 of	 circulatory	 factors,	 central	 inputs	 also	modulate	 arcuate	 neuron	 electrical	 activity.	 Arcuate	 neurons	 have	 reciprocal	connections	with	second	order	neurons	in	other	hypothalamic	nuclei	including	the	paraventricular	 nucleus	 (PVN),	 dorsomedial	 hypothalamic	 nucleus	 (DMH),	ventromedial	hypothalamic	nucleus	(VMH),	lateral	hypothalamus	(LH)	and	medial	preoptic	area	(MPO)	(Williams	et	al.,	2001,	Bouret	et	al.,	2004).	These	second	order	neurons	 then	 project	 to	 extrahypothalamic	 nuclei	 such	 as	 the	 nucleus	 tractus	solitarius	 (NTS)	 and	 the	 dorsal	 motor	 nucleus	 of	 the	 vagus	 (DMV)	 (Smith	 and	Ferguson,	 2008),	 these	 pathways	 providing	 conduits	 through	 which	 the	 ARH	exerts	its	influence	upon	energy	homeostasis.	The	location	of	hypothalamic	nuclei	in	relation	to	one	another	is	outlined	in	Figure	1.1,	below:		
1.5	 NPY/AgRP	Neurons	NPY/AgRP	 neuronal	 activity	 promotes	 feeding	 and	 reduces	 energy	 expenditure.	Optogenetic	and	pharmacogenetic	activation	of	NPY/AgRP	neurons	is	sufficient	to	elevate	food	intake	(Aponte	et	al.,	2011,	Atasoy	et	al.,	2012,	Krashes	et	al.,	2011),	
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whilst	pharmacogenetic	inhibition	causes	a	reduction	of	food	intake	(Krashes	et	al.,	2011).	 Ablation	 of	 NPY/AgRP	 neurons	 in	 the	 adult	mouse	 causes	 a	 cessation	 of	food	 intake,	 ultimately	 resulting	 in	 death	 by	 starvation	 (Luquet	 et	 al.,	 2005).	Fasting	 has	 been	 reported	 to	 increase	 NPY/AgRP	 neuron	 electrical	 activity	(Takahashi	 and	Cone,	 2005),	 in	 addition	 to	 elevating	both	NPY	 and	AgRP	mRNA	expression	in	the	ARH	(Hahn	et	al.,	1998).	Multiple	 peripheral	 hormones,	 indicative	 of	 energy	 status,	 affect	 the	electrical	 activity	 of	 NPY/AgRP	 neurons.	 These	 include	 membrane	hyperpolarization	 by	 the	 adipokine	 leptin,	 and	membrane	 depolarization	 by	 the	gut-derived	orexigen	ghrelin	(van	den	Top	et	al.,	2004).	Insulin	is	also	known	to	act	upon	 NPY/AgRP	 neurons	 (Konner	 et	 al.,	 2007)	 and	 has	 been	 shown	 to	 inhibit	neurons	of	the	ARH	via	the	activation	of	ATP-sensitive	potassium	(KATP)	channels	(Spanswick	et	al.,	2000).		In	 addition	 to	 NPY	 and	 AgRP,	 γ-aminobutyric	 acid	 (GABA)	 is	 also	synthesized	 within	 and	 released	 by	 arcuate	 NPY/AgRP	 neurons	 (Horvath	 et	 al.,	1997).	 Both	NPY	 and	 AgRP,	when	 administered	 through	 intracerebroventricular	(ICV)	injection	in	vivo	act	as	orexigens,	stimulating	food	intake	(Rossi	et	al.,	1998,	Billington	et	al.,	1991).	 	The	GABA	agonists	muscimol	and	baclofen	also	stimulate	food	intake	when	injected	ICV	(Olgiati	et	al.,	1980,	Ebenezer,	1990).	NPY/AgRP	 neurons	 have	 been	 shown	 to	 receive	 excitatory	 glutamatergic	innervation	 from	 the	 DMH	 and	 to	 a	 greater	 extent	 from	 Thyrotropin-releasing	hormone	 (TRH)	 and	 pituitary	 adenylate	 cyclase-activating	 polypeptide	 (PACAP)-expressing	 neurons	 of	 the	 paraventricular	 hypothalamus	 (PVH).	 Chemogenic	stimulation	of	this	synapse	in	vivo	results	in	NPY/AgRP	neuron	activation	and	the	stimulation	of	food	intake	(Krashes	et	al.,	2014).	
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NPY/AgRP	neurons	have	diverse	projection	 targets	 including	 the	 anterior	portion	 of	 the	 bed	 nucleus	 of	 the	 stria	 terminalis	 (aBNST),	 PVH,	 paraventricular	thalamus	(PVT),	lateral	hypothalamus	(LH),	central	nucleus	of	the	amygdala	(CEA),	parabrachial	nucleus	(PBN),	POMC	neurons	and	possibly	other	NPY/AgRP	neurons	within	 the	 ARH	 itself	 (Betley	 et	 al.,	 2013).	 NPY/AgRP	 target	 sites	 affecting	 food	intake	to	the	greatest	degree	are		the	BNST,	PVH	and	LH	(Betley	et	al.,	2013).		In	addition	to	food	intake	regulation	NPY/AgRP	neurons	also	exert	a	degree	of	 control	 over	 glucose	 homeostasis.	 Konner	 et	 al.	 demonstrated	 that	 insulin	signaling	 within	 NPY/AgRP	 neurons	 is	 required	 for	 the	 suppression	 of	 hepatic	glucose	production	(Konner	et	al.,	2007).		NPY/AgRP	neurons	are	also	important	in	the	regulation	of	energy	expenditure.	 In	 low	energy	contexts	the	ARH	NPY/AgRP	neurons	 reduce	 sympathetic	 outflow	 and	 brown	 adipose	 tissue	 (BAT)	thermogenesis	via	 the	 inhibition	of	dopaminergic	PVH	neurons	(Shi	et	al.,	2013).	Together	these	data	indicate	a	complex	population	of	function-specific	NPY/AgRP	neurons	in	the	ARH.		
1.6	 POMC/CART	Neurons	POMC/CART	 neuron	 activity	 helps	 maintain	 normal	 energy	 homeostasis	 by	promoting	 a	 decrease	 in	 food	 intake	 and	 an	 increase	 in	 energy	 expenditure	(Schwartz	 et	 al.,	 2000).	 Chronic	 chemogenic	 activation	 of	 arcuate	 POMC/CART	neurons	 elevates	 food	 intake	 whilst	 their	 ablation	 results	 in	 hyperphagia	 and	obesity	 (Zhan	 et	 al.,	 2013).	 POMC	 neuron	 activity	 is	 elevated	 in	 positive	 energy	states,	with	 threefold	 increases	 in	POMC	mRNA	expression	observed	 in	response	to	 involuntary	 overfeeding	 in	 rats	 (Hagan	 et	 al.,	 1999).	 POMC/CART	 neuron	electrical	 activity	 is	 affected	 by	 a	 number	 of	 peripheral	 hormones,	 including	
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membrane	depolarization	by	leptin	(Cowley	et	al.,	2001)	and	hyperpolarization	by	insulin	(Williams	et	al.,	2010).	POMC	 is	 the	 precursor	 of	 a	 number	 of	 peptides	 produced	 within	POMC/CART	 neurons,	 with	 post-translational	modification	 yielding	 a	 number	 of	functional	peptides	including	the	α-,	β-	and	γ2-	melanocyte	stimulating	hormones	(MSHs),	 corticotrophin	 (ACTH),	 corticotrophin-like	 intermediate	 peptide	 (CLIP)	and		β-endorphin.	Also	produced	are	intermediate	peptides,	resulting	from	peptide	cleavages,	 the	 function	 of	 which	 remains	 unclear	 (Millington,	 2007).	Intracerebroventricular	 (ICV)	 administration	 of	 α-MSH	 β-MSH	 and	 γ2-MSH	 can	reduce	 food	 intake,	 however	 α-MSH	 is	 the	 only	 POMC	 derivative	 capable	 of	reducing	weight	gain	(Tung	et	al.,	2006)	indicating	that	it	is	likely	to	be	the	primary	anorectic	 agent	 produced	 in	 these	 neurons.	 Chronic	 ICV	 CART	 injection	 also	reduces	 food	 intake	and	bodyweight	 (Dornonville	de	 la	Cour	et	al.,	2001)	 in	 rats	(Nakhate	 et	 al.,	 2011).	 Subpopulations	 of	 POMC/CART	 neurons	 can	 be	distinguished	 in	 terms	of	differential	GABA	and	glutamate	expression	 (Wittmann	et	al.,	2013,	Dicken	et	al.,	2012,	Hentges	et	al.,	2009).	This	heterogeneity	may	be	indicative	of	functional	divergences.	POMC/CART	 neurons	 receive	 local	 GABAergic	 afferents	 from	 arcuate	NPY/AgRP	neurons	and	non-NPY/AgRP	neurons	(Cowley	et	al.,	2001,	Vong	et	al.,	2011)	 as	 well	 as	 glutamatergic	 innervation	 from	 neurons	 of	 the	 medial	 VMH	(Sternson	et	al.,	2005).	POMC/CART	neuron	afferents	project	to	nuclei	within	the	hypothalamus	 including	 the	 ARH,	 DMH,	 VMH,	 LVN,	 LH,	 PVN,	 supraoptic	 nucleus	(SON)	 and	 extrahypothalamic	 areas	 including	 the	 brainstem,	 nucleus	 accumbens	and	amygdala	(Bagnol	et	al.,	1999).	POMC/CART	projections	to	the	PVN	are	those	with	the	most	potent	ability	to	suppress	feeding	(Bouret	et	al.,	2004).	
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1.7	 The	melanocortin	system	NPY/AgRP	and	POMC/CART	neurons	of	 the	ARH,	and	the	second	order	neuronal	population	 to	 which	 they	 both	 project	 forms	 the	 arcuate	 melanocortin	 system,	which	is	the	key	regulator	of	energy	homeostasis	within	the	hypothalamus	(Cone,	2005).	Five	melanocortin	receptors	(MCRs)	exist	(MC1R	to	MC5R),	with	only	MC3R	and	 MC4Rs	 expressed	 in	 the	 brain	 (Kishi	 et	 al.,	 2003)	 (Haskell-Luevano	 et	 al.,	1999).	 Melanocortins,	 released	 by	 POMC/CART	 neuron	 terminals	 are	 the	endogenous	 agonists	 of	 MC3	 and	 MC4Rs	 whilst	 AgRP	 released	 by	 NPY/AgRP	neurons	 is	 the	 endogenous	 antagonist	 of	 these	 receptors	 (Cone,	 2005).	Functionality	 of	 the	 melanocortin	 receptors	 is	 highlighted	 by	 the	 obesity	associated	with	MC3R	and	MC4R	knockout	mice	(Huszar	et	al.,	1997,	Butler	et	al.,	2000).	The	integration	of	both	POMC/CART	and	NPY/AgRP	neuron	signals	at	the	MCR-expressing	 second	 order	 neuron	 is	 the	 site	 of	 signal	 integration,	with	MCR	antagonism	 promoting	 feeding,	 and	 agonism	 promoting	 satiety.	 Current	 dogma	suggests	that	in	positive	energy	states,	increased	POMC/CART	neuron	activity	and	decreased	 NPY/AgRP	 neuron	 activity	 will	 result	 in	 an	 increased	 α-MSH	 and	decreased	 AgRP	 release	 at	 second	 order	 neuron	 melanocortin	 receptors,	promoting	 receptor	 agonism,	 reduced	 food	 intake	 and	 elevated	 energy	expenditure.	Conversely	in	negative	energy	states,	decreased	POMC/CART	neuron	activity	 and	 increased	NPY/AgRP	neuron	activity	will	 result	 in	decreased	α-MSH	and	 increased	 AgRP	 at	 second	 order	 neuron	melanocortin	 receptors,	 promoting	receptor	antagonism,	 this	 inducing	an	 increase	 in	 food	 intake	and	a	 reduction	of	energy	expenditure.	NPY/AgRP	 and	 POMC/CART	 neurons	 are	 functionally	 antagonistic.	 Both	glucose	and	hormonal	energy	status	secretagogues	affect	 the	electrical	activity	of	
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NPY/AgRP	 and	POMC/CART	neurons.	Orexigenic	 peptides	 such	 as	 ghrelin	 excite	NPY/AgRP	neurons	directly.	NPY/AgRP	neuron	activation	increases	GABA	release	onto	POMC/CART	neurons,	GABA	acting	 to	 inhibit	POMC	neurons	 (Cowley	 et	 al.,	2001).	Anorexigenic	peptides	such	as	leptin	and	insulin	inhibit	NPY/AgRP	neurons	via	activation	of	KATP	channel	and	excite	subpopulations	of	POMC/CART	neurons	(Belgardt	et	al.,	2009).	The	KATP	channel	is	also	the	signal	transduction	endpoint	of	glucose	 sensing	 in	 POMC/CART	 neurons,	 making	 it	 a	 critical	 regulator	 of	hypothalamic	energy	homeostasis	(van	den	Top	et	al.,	2007,	Parton	et	al.,	2007).	
	
1.8	 KATP	channels	KATP	channels	are	hetero-octamers	of	 four	 inwardly	rectifying	potassium	channel	subunits	 (Kir6.1,	Kir6.2)	and	 four	sulphonylurea	receptor	 (SUR1,	SUR2)	subunits	(Miki	et	al.,	1999).	KATP	channels	are	expressed	in	the	heart,	brain,	skeletal	muscle	and	 pancreatic	 β-cells	 where	 they	 couple	 the	 metabolic	 state	 of	 the	 cell,	 to	 the	electrical	excitability	of	the	cell	(Ashcroft,	1988).	Coexpression	of	Kir6.2	and	SUR1	in	 COS-1	 cells	 generates	 inwardly	 rectifying	 potassium	 channels	 with	 single	channel	conductances	of	76	pS	at	140	mM	K+	either	side	of	the	membrane.	These	channels	are	inhibited	by	ATP	in	a	concentration-dependent	manner	and	exhibited	an	 IC50	of	10	μM.	The	sulphonylureas	 tolbutamide	and	glibenclamide	 inhibit	KATP	channels	whilst	diazoxide	stimulates	channel	activity	(Inagaki	et	al.,	1995,	Miki	et	al.,	1999).	KATP	channels	are	vital	to	glucose	homeostasis	and	hormone	signaling	in	the	hypothalamus	(Miki	et	al.,	2001,	Spanswick	et	al.,	1997,	Spanswick	et	al.,	2000)	and	are	expressed	on	both	NPY/AgRP	and	POMC/CART	neurons	(Ibrahim	et	al.,	2003,	van	 den	 Top	 et	 al.,	 2007).	 In	 neurons,	 an	 increased	 intracellular	 ATP/ADP	 ratio	
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results	 in	 channel	 closure,	 resulting	 in	 membrane	 depolarization,	 conversely	 a	reduction	 in	 the	 ATP/ADP	 ratio	 results	 in	 channel	 opening	 and	 membrane	hyperpolarization	 (van	 den	 Top	 et	 al.,	 2007).	 In	 glucose-excited	 hypothalamic	neurons,	 elevated	 extracellular	 glucose	 concentrations,	 glucose	 uptake	 and	metabolism	 to	 ATP	 leads	 to	 KATP	 channel	 inhibition	 and	 neuron	 depolarization	(Ashford	et	al.,	1990a).	KATP	channels	are	also	the	signal	transduction	endpoint	of	many	peripheral	hormones	that	act	upon	hypothalamic	neurons	including	insulin	and	leptin	(van	den	Top	et	al.,	2004,	Spanswick	et	al.,	1997,	Spanswick	et	al.,	2000).		
1.9	 Ghrelin	Ghrelin	is	a	28	amino	acid	orexigenic	peptide	and	is	the	endogenous	ligand	of	the	growth	 hormone	 secretagogue	 receptor	 (GHSR).	 Ghrelin	 is	 produced	within	 and	secreted	from	A-cells	 in	oxyntic	glands	of	 the	stomach	(Dornonville	de	 la	Cour	et	al.,	 2001,	 Sakata	 et	 al.,	 2002).	 Circulatory	 ghrelin	 concentrations	 rise	 pre-prandially	 and	 fall	 post-prandially	 (Cummings	et	 al.,	 2001,	Tschop	et	 al.,	 2001a).	Chronic	peripheral	administration	of	ghrelin	 can	 induce	obesity	 in	mice	and	rats	(Tschop	 et	 al.,	 2000)	 and	 in	 humans,	 plasma	 ghrelin	 concentration	 is	 negatively	correlated	 with	 adiposity	 (Tschop	 et	 al.,	 2001b).	 The	 GHSR1a	 is	 the	 target	 and	signal	transducer	for	ghrelin	and	is	expressed	in	the	anterior	pituitary,	pancreatic	islets,	 adrenal	 gland,	 thyroid,	 myocardium,	 hippocampus,	 substantia	 nigra	 pars	compacta	 (SNc),	 ventral	 tegmental	 area	 (VTA),	 raphe	nuclei,	 in	 growth	hormone	releasing	hormone	(GHRH)	neurons	and	NPY/AgRP	neurons	of	 the	ARH	(Zigman	et	al.,	2006,	Willesen	et	al.,	1999).	The	 orexigenic	 effects	 of	 ghrelin	 have	 been	 attributed	 to	 its	 actions	 at	arcuate	NPY/AgRP	neurons	as	knockout	of	both	NPY	and	AgRP	 in	mice	prevents	
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ghrelin	from	inducing	feeding	(Chen	et	al.,	2004).	Van	den	Top	et	al	demonstrated	that	ghrelin	depolarizes	NPY/AgRP	pacemaker	neurons	of	the	ARH,	with	rhythmic	firing	resulting	from	the	activation	of	low-threshold	T-type	calcium,	and	outwardly	rectifying	potassium	conductances,	with	this	increase	in	orexigenic	neuron	output	attributed	to	ghrelin-induced	hyperphagia	(van	den	Top	et	al.,	2004).		
	
1.10	 Insulin	Insulin	was	isolated	in	1921	(Bliss,	1982),	and	in	1955		it	became	the	first	protein	to	have	its	primary	amino	acid	structure	sequenced,	winning	Fred	Sanger	his	first	Nobel	prize	(Sanger,	1988).	It	is	produced	within	pancreatic	β-cells	from	which	it	is	 secreted	 in	 response	 to	 elevated	 blood	 glucose	 (Rorsman	 and	 Braun,	 2013).	Insulin	 functions	 to	 lower	 plasma	 glucose	 concentration	 by	 increasing	 glucose	uptake	 to	 peripheral	 muscle	 and	 fat	 and	 reducing	 hepatic	 glucose	 production	(Woods	et	al.,	2006).	The	mechanism	of	secretion	is	KATP	channel-dependent,	with	glucose	uptake	via	GLUT1	and	GLUT3	in	humans	and	GLUT2	in	rodents,	followed	by	metabolism	to	ATP,	 inhibition	of	KATP	channels,	membrane	depolarization	and	insulin	exocytosis	(Rorsman	and	Braun,	2013).	The	 insulin	 receptor	 (IR)	 is	 expressed	 throughout	 the	 CNS,	 including	 the	olfactory	bulb,	 cerebellum,	dentate	gyrus,	hippocampus,	 choroid	plexus	and	ARH	(Marks	et	al.,	1990).	Centrally	acting	insulin	has	been	shown	to	reduce	food	intake	and	hepatic	glucose	production	via	arcuate	POMC/CART	and	NPY/AgRP	neurons	respectively	 (Benoit	 et	 al.,	 2002,	 Konner	 et	 al.,	 2007).	 Electrophysiological	evidence	has	demonstrated	that	insulin	activates	KATP	channels	in	the	lean	rat	ARH	(Spanswick	 et	 al.,	 2000),	 and	 that	 it	 hyperpolarizes	 both	 POMC/CART	 neurons	
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(Williams	 et	 al.,	 2010)	 and	 NPY/AgRP	 neurons	 (Konner	 et	 al.,	 2007)	 via	phosphoinositide-3	kinase	(PI3K)	and	KATP	channels	(Plum	et	al.,	2006b).		
1.11	 Leptin	Leptin,	 the	 16kDa	 product	 of	 the	 ob	 gene	 (Zhang	 et	 al.,	 1994),	 is	 produced	 in	adipocytes	and	plasma	leptin	levels	are	proportional	to	body	adiposity	(Considine	et	 al.,	 1996).	 Leptin	 regulates	 energy	 homeostasis	 through	 actions	 at	 leptin	receptor	 (LepR)-expressing	 neurons	 throughout	 the	 hypothalamus	 including	arcuate	 NPY/AgRP,	 POMC/CART	 neurons,	 and	 LepR-expressing	 neurons	 in	 the	DMH	(Cowley	et	al.,	2001,	Enriori	et	al.,	2011,	Spanswick	et	al.,	1997).	In	the	ARH	leptin	has	been	shown	to	hyperpolarize	a	population	of	neurons	via	KATP	channel	activation,	 these	 neurons	 are	 now	 understood	 to	 be	 NPY/AgRP	 neurons	(Spanswick	 et	 al.,	 1997).	 It	 has	 also	 been	 demonstrated	 that	 leptin	 depolarizes	POMC	 neurons	 (Cowley	 et	 al.,	 2001)	 leading	 to	 elevated	 αMSH	 and	 increased	MC4R-dependent	 activation	 of	 neurons	 in	 the	 PVH,	 resulting	 in	 elevated	 energy	expenditure	and	reduced	food	intake	(Cone,	2005).	One	major	reason	for	the	development	of	obesity	is	that,	despite	increased	circulatory	leptin	with	increased	fat	mass,	ARH	neurons	develop	leptin	resistance	and	 no	 longer	 recognize	 exogenous	 leptin	 (Enriori	 et	 al.,	 2007).	 Despite	 the	development	of	leptin	resistance	in	the	ARH	in	obesity,	resistance	is	not	observed	in	 other	 hypothalamic	 nuclei	 including	 the	DMH,	 here	 leptin	 has	 been	 shown	 to	regulate	 sympathetic	 outflow,	 BAT	 thermogenesis	 and	 blood	 pressure	 via	 LepR	neuron	depolarization	(Simonds	et	al.,	2014,	Enriori	et	al.,	2011).		
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1.12	 Leptin	Signaling		The	 long-form	 leptin	 receptor	 (ObRb)	 is	 a	 member	 of	 the	 cytokine	 family	 of	receptors,	 structurally	 associated	 with	 Janus-activated	 kinase	 2	 (JAK2).	 Leptin	receptor	 activation	 initiates	 receptor	 structural	 conformation	 change	 allowing	autophosphorylation	 of	 JAK2	 following	BOX1	 binding.	 JAK2	 then	 phosphorylates	the	 leptin	 receptor	 at	 tyrosine	 (Y)	 residues	 985,	 1077	 and	 1138.	 Y1138	phosphorylation	 activates	 signal	 transducer	 and	 activator	 of	 transcription	 3	(STAT3).	 Phosphorylated	 STAT3	 then	 translocates	 to	 the	 nucleus	 where	 it	dimerizes	and	modifies	gene	expression	(Increased	POMC	and	reduced	AgRP).		Nuclear	pSTAT3	activates	suppressor	of	cytokine	signaling	3	(SOCS3)	that	effects	negative	 feedback	 on	 leptin	 signaling,	 inhibiting	 Y985	 phosphorylation	 by	 JAK2.	Y985	 phosphorylation	 initiates	 SHP2	 phosphorylation	 and	 stimulation	 of	 MAPK	signaling.	 SHP2	 disinhibits	 leptin	 signaling	 via	 competing	 with	 SOCS3	 for	 JAK2	binding,	 preventing	 dephosphorylation.	 Activated	 JAK2	 also	 phosphorylates	insulin	receptor	substrate	2	(IRS2),	stimulating	the	phosphatidylinositide	3-kinase	(PI3K)	signaling	cascade.	Here,	phosphatidylinositide	(4,5)-bisphosphate	(PIP2)	is	phosphorylated	 on	 position	 3	 of	 its	 inositol	 ring,	 forming	 phosphatidylinositide	(3,4,5)-bisphosphate	 (PIP3).	 PIP3	 signaling	 includes	 AMPK	 inhibition	 and	 KATP	channel	 activation	 (Zhang	 et	 al.,	 2015).	 An	 overview	 of	 leptin	 receptor	 signal	transduction	is	outlined	in	figure	1.2.	Although	 the	 functional	 significance	 of	 leptin-induced	 MAPK	 signaling	remains	 unclear,	 SHP2	 is	 required	 for	 the	 activation	 of	 ERK,	which	 is	 protective	against	 hyperphagia	 and	 hyperglycemia	 (Krajewska	 et	 al.,	 2008).	 STAT3	 is	required	 for	 normal	 energy	 homeostasis	 and	 hypothalamic	 signaling	 is	 drives	decreased	 food	 intake	 and	 increased	 energy	 expenditure.	 Disruption	 of	 STAT3	
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signaling	 in	 POMC	 neurons	 results	 in	 hyperphagic,	 obese	 mice	 (Xu	 et	 al.,	 2007,	Saadat	 et	 al.,	 2012).	 Conversely	 activation	 of	 STAT3	 in	 AgRP	 neurons	 confers	resistance	to	obesity	via	increased	energy	expenditure	(Mesaros	et	al.,	2008).	Leptin	 simulation	 of	 the	 PI3K	 pathway	 can	 be	 effected	 through	 two	mechanisms,	1:	IRS	stimulation	of	PI3K,	assisted	by	P85	and	p110	(Xu	et	al.,	2005).	2:	Inhibition	of	phosphatase	tensin	homologue	(PTEN)	by	leptin,	resulting	in	PI3K	disinhibition.	Although	leptin	and	insulin	can	activate	PI3K	concomitantly,	insulin	is	 unable	 to	 inhibit	 PTEN.	 Differences	 in	 the	 physiological	 response	 to	 central	leptin	 and	 insulin	 signaling	 may	 be	 attributable	 to	 this	 divergence	 in	 signaling.	PI3K	signaling	in	hypothalamic	neurons	mediates	changes	in	electrical	activity.	In	NPY/AgRP	 neurons	 of	 the	 ARH,	 increased	 intracellular	 PIP3	 activates	 KATP	channels,	inducing	membrane	hyperpolarization,	and	this	signaling	is	required	for	the	anorectic	effects	of	 leptin	 in	vivo	 (Niswender	and	Schwartz,	2003).	 In	arcuate	POMC	 neurons,	 PI3K-activated	 PLC	 activates	 transient	 receptor	 potential	 cation	channels	(TRPC),	resulting	in	membrane	depolarization	(Qiu	et	al.,	2010).		
1.13	 Insulin	signaling		Insulin	receptors	are	also	expressed	on	both	NPY/AgRP	and	POMC/CART	neurons.	Binding	 of	 insulin	 to	 the	 insulin	 receptor	 (IR)	 initiates	 Y1162	 and	 Y1163	phosphorylation,	 IRS2	 phosphorylation	 and	 PI3K	 activation.	 The	 conversion	 of	PIP2	to	PIP3	then	stimulates	protein	kinase	B	(PKB)	to	phosphorylate	forkhead	box	protein	 (FOXO1),	 increasing	 POMC	 and	 decreasing	 AgRP	 expression.	 Insulin-induced	 elevated	 cytoplasmic	 PIP3	 also	 activates	 KATP	 channels,	 hyperpolarizing	the	 neuron	 (Zhang	 et	 al.,	 2015).	 POMC	 neurons	 of	 the	 ARH	 are	 depolarized	 by	
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insulin	 via	 TRPC	 channels	 (Qiu	 et	 al.,	 2014).	 An	 overview	 of	 Insulin	 and	 Leptin	receptor	signaling	is	outlined	in	figure	1.2,	below:		
1.14	 Protein	tyrosine	phosphatases;	hypothalamic	leptin	signaling	The	 protein	 tyrosine	 phosphatases	 T	 cell	 protein	 tyrosine	 phosphatase	 (TCPTP)	and	protein	tyrosine	phosphatase	1B	(PTP1B)	have	been	implicated	in	attenuating	central	 leptin	and	 insulin	 signaling	 (proposed	sites	of	 action	are	 shown	 in	 figure	1.2).	 Increased	 expression	 levels	 of	 TCPTP	 and	 PTP1B	 in	 both	 NPY/AgRP	 and	POMC/CART	neurons	of	obese	mice	has	been	suggested	responsible	for	the	central	leptin	 and	 insulin	 resistance	 associated	 with	 clinical	 obesity	 (Loh	 et	 al.,	 2011).	PTP1B	 attenuates	 leptin	 signaling	 by	 dephosphorylating	 tyrosine	 residues	 1007	and	 1008	 in	 the	 JAK2	 activation	 loop.	 Knockout	 of	 PTP1B	 in	 neurons	 and	 glia	results	 in	 mice	 resistant	 to	 diet-induced	 obesity,	 with	 decreased	 food	 intake,	elevated	energy	expenditure	and	increased	leptin	sensitivity	(Bence	et	al.,	2006).		TCPTP	 impairs	 the	 ability	 of	 leptin	 to	 regulate	 gene	 expression	 via	 the	dephosphorylation	 of	 nuclear	 STAT3.	 Brain-specific	 TCPTP	 knock	 out	 promotes	STAT3	 signaling	 and	 increased	 expression	 of	 POMC	 expression	 and	 reduced	expression	of	AgRP	(Loh	et	al.,	2011).	SOCS3	is	an	additional	negative	regulator	of	hypothalamic	 leptin	 signaling,	 activated	 by	 nuclear	 pSTAT3.	 SOCS3	dephosphorylates	 and	 in	 doing	 so,	 inhibits	 the	 ability	 of	 JAK2	 to	 activate	 signal	transduction	(Bjorbaek	et	al.,	1999).	SOCS3	knockout	mice	are	resistant	to	obesity	(Kievit	et	al.,	2006)	
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1.15	 Protein	tyrosine	phosphatases;	hypothalamic	insulin	signaling	Both	PTP1B	and	TCPTP	attenuate	insulin	signaling	via	dephosphorylation	of	1162	and	1163	tyrosine	residues	of	 the	IR.	Hypothalamic	PTP1B	knockdown	increases	insulin	signaling	and	produced	DIO	resistant	rats	(Picardi	et	al.,	2008)	(Dodd	et	al.,	2015).		
1.16	 Glucose	The	provision	of	glucose	 is	a	prerequisite	 for	mammalian	 life	and	 is	 the	primary	fuel	 source	 of	 the	 brain.	 Glucose	 is	 used	 to	 synthesize	 the	 ATP	 required	 for	neuronal	 maintenance	 and	 the	 production	 of	 brain-derived	 transmitters	 and	metabolites	(Mergenthaler	et	al.,	2013).	All	glucose	utilized	by	the	CNS	is	absorbed	from	 the	 circulation,	 as	 such	 central	 glucose	 concentration	 is	 the	 product	 of	peripheral	 glucose	 concentration	 and	 is	 around	 20%	 of	 that	 found	 in	 the	 blood	(Simpson	et	al.,	2007).	Glucose	transport	across	the	BBB	is	mediated	primarily	by	GLUT1,	which	is	also	responsible	for	uptake	from	extracellular	fluid	to	astrocytes,	oligodendrocytes	 and	 microglia	 whilst	 GLUT3	 is	 primarily	 responsible	 for	neuronal	uptake	(Simpson	et	al.,	2007).	All	 neurons	 rely	 upon	 glucose	 to	 function,	 however	 specialized	 neuronal	populations	 regulate	 glucose	 homeostasis	 by	 facilitating	 changes	 in	 food	 intake,	energy	 expenditure	 and	 hepatic	 gluconeogenesis	 (Lam,	 2010).	 Whilst	 some	 of	these	 neurons	 respond	 to	 circulatory	 hormones	 indicative	 of	 somatic	 energy	status,	 others	 are	 intrinsic	 glucose	 sensors,	 altering	 their	 electrical	 activity	 in	direct	 response	 to	 changes	 in	 ambient	 glucose	 concentration	 (Spanswick	 et	 al.,	1997,	Routh,	2010).	Glucose	sensing	regions	of	the	hypothalamus	are	the	LH,	VMH	and	 the	ARH.	Both	 the	ARH	and	VMH	are	 in	close	apposition	 to	 the	BBB,	 leaving	
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them	 exposed	 to	 constant	 fluctuations	 in	 peripheral	 glucose	 concentrations.	Glucose-sensing	 neurons	 can	 be	 divided	 into	 glucose	 inhibited	 (GI)	 and	 glucose	excited	(GE).	GI	neurons	decrease	 their	electrical	activity	 in	response	to	elevated	extracellular	 glucose	 whilst	 GE	 neurons	 increase	 their	 electrical	 activity	 in	response	 to	 increased	 central	 glucose	 concentration.	 Multiple	 mechanisms	 of	neuronal	 GI	 have	 been	 proposed	 and	 include	 Na+/K+	 ATPase	 pump,	 K+,	 and	 Cl-	channels	 (Oomura	 et	 al.,	 1974,	 Fioramonti	 et	 al.,	 2007,	 Burdakov	 and	 Gonzalez,	2009,	 Jordan	et	al.,	2010,	Canabal	et	al.,	2007).	The	mechanism	of	GE	 in	both	the	VMH	 ad	ARH	has	 been	 determined	 to	 occur	 via	 glucose-induced	ATP-dependent	KATP	channel	inhibition	(Spanswick	et	al.,	1997,	Ashford	et	al.,	1990a,	Ashford	et	al.,	1990b).	 This	mechanism	 is	 analogous	 to	 β-cell	 glucose	 sensing	whereby	 cellular	glucose	uptake	 is	mediated	by	a	GLUT,	 followed	by	glycolysis,	elevated	ATP/ADP	ratio,	KATP	channel	inhibition	and	membrane	depolarization	(Schuit	et	al.,	2001).		Both	NPY/AgRP	and	POMC/CART	neurons	express	functional	KATP	channels	(Parton	et	al.,	2007,	van	den	Top	et	al.,	2007)	and	both	cell	types	contain	glucose-sensing	 subpopulations	 (Claret	 et	 al.,	 2007).	 Previous	 studies	 have	 determined	NPY/AgRP	 neurons	 to	 be	 GI	 (Muroya	 et	 al.,	 1999),	 whilst	 POMC/CART	 neurons	have	 been	 found	 to	 be	 GE	 (Ibrahim	 et	 al.,	 2003).	 It	 has	 been	 demonstrated	 that	functional	 KATP	 channels	 on	 POMC	 neurons	 is	 required	 for	 normal	 glucose	tolerance	 (Parton	 et	 al.,	 2007),	 whilst	 KATP	 channels	 on	 NPY/AgRP	 neuron	membranes	are	required	for	hepatic	glucose	production	(Konner	et	al.,	2007).		All	 cells	 of	 the	 CNS	 require	 glucose	 for	 survival.	 Astroglia	 outnumber	neurons	in	the	CNS	and	some	evidence	suggests	that	glia-neuron	connectivity	is	a	mechanism	 of	 central	 glucose	 sensing.	 Glia	 modulate	 synaptic	 properties	 and	neuronal	 activity	 through	 the	 removal	 of	 neuronal	 transmitters	 from	 the	
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extracellular	 space	 and	 through	 the	 release	 of	 gliotransmitters	 (Belanger	 et	 al.,	2011,	 Belanger	 and	 Magistretti,	 2009).	 Gliotransmitters	 include	 glutamate	 D-serine,	ATP	 and	 adenosine	 (Volterra	 and	Meldolesi,	 2005,	Belanger	 et	 al.,	 2011).	For	 some	 time,	 glia	 have	 been	 implicated	 in	 central	 glucose	 metabolism.	Magistretti	 et	 al	 suggest	 that	 glucose	 is	 taken-up	 by	 glia,	 within	 which	 it	 is	metabolized	 to	 lactate.	 Lactate	 is	 then	 released	 into	 the	 extracellular	 space	 and	transported	 into	 neurons,	 which	 then	 use	 it	 as	 a	 substrate	 for	 oxidative	metabolism	 (Magistretti	 et	 al.,	 1999).	 More	 recent	 work	 suggests	 that	 glucose	sensing	in	arcuate	NPY/AgRP	is	via	glial	release	of	adenosine.	Yang	et	al	conclude	that	the	release	of	adenosine	from	hypothalamic	astrocytes	activates	A1	adenosine	receptors	 on	 NPY/AgRP	 neurons,	 inhibiting	 them	 (Yang	 et	 al.,	 2015).	 Some	evidence	 exists,	 linking	 adenosine	 receptors	 to	 KATP	 channels	 (Heurteaux	 et	 al.,	1995,	 Kleppisch	 and	 Nelson,	 1995,	 Tang	 et	 al.,	 1999).	 Hypothalamic	 adenosine	receptor-KATP	 channel	 signal	 transduction	 may	 well	 be	 a	 critical	 mechanism	 of	central	glucose	sensing.		
1.17	 Adenosine	Adenosine	is	a	ribonucleoside	important	in	multifarious	biochemical	processes	in	all	 life.	 It	 is	most	 recognizable	as	one	of	 the	 four	building	blocks	of	nucleic	acids	and	 as	 a	 coenzyme,	 when	 in	 its	 phosphorylated	 state;	 adenosine	 triphosphate	(ATP)	(Watson	and	Crick,	1953,	Knowles,	1980).	In	addition	to	its	role	in	cellular	metabolism,	adenosine	has	been	shown	to	act	as	a	neuromodulatory	agent	in	the	CNS.	 Here	 adenosine	 has	 a	 regulatory	 role	 in	 physiological	 processes	 such	 as	arousal,	memory	 and	 learning,	 cognition	 and	 sleep	 and	has	 been	 implicated	 in	 a	
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number	 of	 pathophysiological	 processes	 including	 Parkinson’s	 disease,	 stroke,	epilepsy,	pain,	schizophrenia	and	depression	(Sebastiao	and	Ribeiro,	2009).		Adenosine	 is	 produced	 as	 a	 product	 of	 adenosine	monophosphate	 (AMP)	hydrolysis	by	ecto-5’-nucleotidases,	this	occurring	both	within	CNS	cells	and	in	the	extracellular	 space	 (Latini	 and	 Pedata,	 2001).	 Adenosine	 does	 not	 function	 as	 a	classical	neurotransmitter	in	that	its	release	mechanism	is	not	via	synaptic	vesicles	but	is	instead	via	nucleoside	transporters	(Gu	et	al.,	1995).	Four	G-protein	coupled	adenosine	 receptors	 exist	 within	 the	 CNS;	 A1,	 A2A,	 A2B	 and	 A3	 (Fredholm	 et	 al.,	1994).	Adenosine	receptors	would	appear	to	be	somewhat	ubiquitous	throughout	the	CNS,	with	A1	and	A2A	receptors	being	present	in	all	neurons	and	glia	(Sebastiao	and	 Ribeiro,	 2009).	 Generally,	 A1	 and	 A3	 receptor	 activation	 elicits	 inhibitory	effects	whilst	A2A	 and	A2B	mediate	 excitatory	 actions	on	CNS	 cells	 (Klinger	 et	 al.,	2002).		
1.17.1	The	A1	adenosine	receptor	A1	receptors	 are	 exclusively	 coupled	 to	 Gi	 and	 Go	 proteins	 (Klinger	 et	 al.,	 2002).	Here,	 G-proteins	 inhibit	 adenylate	 cyclase	 and	 reduce	 intracellular	 cAMP	production	 from	ATP	and	 in	 turn	reduce	 the	activity	of	 cAMP-dependent	protein	kinase	 (PKA)	 (Dunwiddie	 and	Masino,	 2001).	 A1	 receptor	 signaling	 is	 inhibitory	and	 is	 neuroprotective	 in	 hypoxic	 and	 excitotoxic	 conditions	 (Latini	 and	 Pedata,	2001).	A1	activation	can	elicit	membrane	hyperpolarization	independent	of	cAMP,	via	G	protein-gated	inwardly	rectifying	K+	channels	(GIRKs)	(Bunemann	and	Pott,	1995),	and	can	also	induce	neuronal	membrane	inhibition	via	the	reduction	of	N-type	calcium	channels	(Mynlieff	and	Beam,	1994).	Inhibition	of	AgRP	neurons	via	
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astrocytic	adenosine	release	and	A1	receptor	activation	has	been	demonstrated	to	inhibit	food	intake	in	mice	(Yang	et	al.,	2015).		
1.17.2	The	A2A	adenosine	receptor	A2A	 receptors	 are	 Gs-protein	 coupled	 (Klinger	 et	 al.,	 2002),	 ligand	 binding	activating	 the	 cAMP-dependent	 pathway	 through	 increasing	 adenylate	 cyclase	activity	 and	 stimulating	 PKA	 activity	 (Dunwiddie	 and	Masino,	 2001).	 In	 arterial	myocytes	adenosine-induced	membrane	hyperpolarization	has	been	suggested	to	be	 via	 an	 A2-PKA-KATP	 channel-dependent	 mechanism	 (Kleppisch	 and	 Nelson,	1995).		
1.17.3	The	A2B	adenosine	receptor	A2B	 receptors	 couple	 to	 both	 Gs	 and	 Gq	 proteins	 and	 have	 a	 low	 affinity	 for	adenosine	relative	to	other	adenosine	receptors	(>10	μM	vs.	0.1-1	μM)	(Klinger	et	al.,	2002).	Gs	signaling	activates	the	cAMP-dependent	pathway,	whilst	Gq	signaling	activates	 phospholipase-C	 (PLC)	 to	 hydrolyze	 PIP2	 to	 diacylglycerol	 (DAG)	 and	inositol	 triphosphate	 (IP3),	 with	 DAG	 then	 activating	 protein	 kinase	 C	 (PKC)	(Dunwiddie	and	Masino,	2001).		
1.17.4	The	A3	adenosine	receptor	A3	 receptors	 are	 coupled	 to	 Gi	 and	 Go	 proteins	 (Klinger	 et	 al.,	 2002)	 and	 bind	adenosine	 with	 similar	 affinity	 to	 the	 A1	 receptor.	 Signal	 transduction	 inhibits	adenylate	cyclase	and	reduces	intracellular	cAMP	production,	reducing	the	activity	of	PKA	(Dunwiddie	and	Masino,	2001).	This	inhibitory	adenosine	receptor	differs	
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from	A1	 in	 that	 it	undergoes	 rapid,	 agonist-dependent	desensitization	 (Palmer	et	al.,	1996).		
1.18	 The	dorsomedial	nucleus	of	the	hypothalamus	The	 dorsomedial	 nucleus	 of	 the	 hypothalamus	 (DMH)	 is	 located	 lateral	 to	 the	dorsal-end	 of	 the	 third	 ventricle,	 immediately	 posterior	 to	 the	 PVH	 (Paxinos,	2008).	 The	 DMH	 has	 been	 implicated	 in	 a	 variety	 of	 physiological	 processes	including	food	intake,	reproduction,	stress,	circadian	rhythms,	energy	expenditure	and	blood	pressure	regulation	(Simonds	et	al.,	2014,	Bernardis,	1972,	Coolen	et	al.,	1996,	Gallo,	1981,	Inglefield	et	al.,	1994,	Keim	and	Shekhar,	1996,	Bellinger	et	al.,	1976,	 Enriori	 et	 al.,	 2011).	 The	 DMH	 receives	 afferent	 inputs	 from	 the	suprachiasmatic	nucleus	(SCN),	the	hypothalamic	periventricular	zone	(PVZ),	ARH,	VMH	and	PVH	and	sends	intrahypothalamic	projections	to	the	PVH,	preoptic	area	(POA),	 ARH	 and	 LH	 (Gautron	 et	 al.,	 2010),	 whilst	 extrahypothalamic	 efferents	include	 the	 Raphe	 pallidus	 nucleus	 (RPa)	 and	 the	 rostral	 ventrolateral	 medulla	(RVLM),	 the	former	connection	being	 important	 in	BAT	thermoregulation	(Zhang	et	al.,	2011)	and	the	latter	more	closely	controlling	blood	pressure	(Horiuchi	et	al.,	2006).	 The	 molecular	 and	 pharmacological	 profiles	 of	 DMH	 neurons	 remain	relatively	 uncharacterized,	 when	 compared	 to	 other	 hypothalamic	 nuclei.	However,	it	is	known	that	some	DMH	neurons	express	leptin	receptors	(Enriori	et	al.,	2011).	Another	peptide	expressed	in	DMH	neurons	is	gonadotrophin	inhibitory	hormone	(GnIH)	(Soga	et	al.,	2014).		
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1.19	 Gonadotropin	inhibitory	hormone		In	2000,	Tsutsui	et	al.,	discovered	a	novel	neuropeptide	in	the	quail	hypothalamus,	capable	 of	 inhibiting	 luteinizing	 hormone	 (LH)	 and	 follicle	 stimulating	 hormone	(FSH)	 release	 from	 the	 anterior	 pituitary	 (Tsutsui	 et	 al.,	 2000).	 Previous	 to	 this,	gonadotropin-releasing	hormone	(GnRH)	was	thought	to	be	the	only	hypothalamic	peptide	involved	in	the	regulation	of	gonadotropin	release.	In	mammals,	two	GnIH	variants	are	translated;	GnIH-RP-1	and	GnIH-RP-3	(Tsutsui	et	al.,	2010).	In	the	rat,	GnIH	is	produced	within	neurons	of	the	DMH	and	tuberomamillary	nucleus	(TMN)	(Johnson	 et	 al.,	 2007).	 	 Extrahypothalamic	 GnIH	 neuron	 projections	 have	 been	demonstrated	 throughout	 the	 amygdala,	 bed	 nucleus	 of	 the	 stria	 terminalis	(BnST),	septal	nuclei	and	the	paraventricular	thalamic	nucleus	(PVT)	(Johnson	et	al.,	 2007)	 whilst	 GnIH	 projections	 within	 the	 hypothalamus	 include	 the	 medial	preoptic	area	(MPOA)	and	other	neurons	within	the	DMH	(Johnson	et	al.,	2007).	In	the	rat	75%	of	GnIH	projections	in	the	MPOA	have	been	shown	to	co-localize	with	GnRH	 cell	 bodies	 (Johnson	 et	 al.,	 2007)	 whilst	 in	 sheep	 and	 primates	 GnIH	immunoreactive	terminals	have	been	observed	 in	the	neurosecretory	zone	of	 the	median	 eminence	 (Clarke	 et	 al.,	 2008,	 Ubuka	 et	 al.,	 2009a,	 Ubuka	 et	 al.,	 2009b).		The	 lack	 of	 interspecies	 consistency	 of	 GnIH	 neuron	 projection	 sites	 suggests	 a	degree	 of	 variation	 in	 the	 specific	 regulatory	 mechanisms	 of	 gonadotropin	secretion.		GnIH	is	the	endogenous	agonist	of	the	GPR147	receptor,	the	receptor	being	located	 in	 both	 the	 gonads	 and	 CNS	 (Ubuka	 et	 al.,	 2013).	 	 In	 the	 ovine	 brain,	GPR147	 is	 expressed	 in	 the	 suprachiasmatic	 nucleus,	 supraoptic	 nucleus	periventricular	 nucleus	 and	 the	 pars	 tuberalis	 of	 the	 anterior	 pituitary	 (Clarke,	2011).	In	the	Siberian	hamster	over	85%	of	GnRH-expressing	neurons	in	the	POA	
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express	GPR147	(Ubuka	et	al.,	2012)	and	in	the	mouse	application	of	GnIH-3	has	been	 found	 to	 inhibit	 a	 subset	 of	 GnRH	 neurons	 (Ducret	 et	 al.,	 2009).	Wu	 et	 al.	indicate	 the	mechanism	of	 inhibition	 to	be	via	potassium	conductance	activation	(Wu	et	al.,	2009).		Reproductive	competence	is	affected	by	various	factors	including	stress	and	energy	 status	 (ECWG,	 2006).	 Changes	 in	 nutrient	 availability	 are	 coupled	 with	fluctuations	 in	 the	 central	 concentration	 of	 energy	 status	 secretagogues,	 such	 as	ghrelin	 and	 thyrotropin	 releasing	 hormone	 (TRH).	 Although	 there	 is	 a	 lack	 of	literature	regarding	the	effects	of	TRH	on	reproductive	function,	ghrelin	is	known	to	inhibit	GnRH	and	LH	pulse	frequency	in	vivo	(Fernandez-Fernandez	et	al.,	2004).	Serotonin	 and	 noradrenaline	 are	 central	 transducers	 of	 environmental	 stress	signals.	 Some	 evidence	 suggests	 that	 the	 central	 noradrenergic	 and	 serotonergic	systems	negatively	regulate	the	hypothalamic-pituitary-gonadal	axis	via	actions	at	GnIH	neurons	(Tobari	et	al.,	2014,	Geraghty	et	al.,	2015,	Soga	et	al.,	2010).			
1.20	 5-Hydroxytryptamine	5-Hydroxytryptamine	 (5-HT)	 was	 first	 isolated	 and	 characterized	 in	 1948	 by	Rapport	and	Page	(Rapport	et	al.,	1948).	Its	role	as	a	neurotransmitter	was	initially	proposed	in	1957	by	Brodie	and	Shore	(Brodie	and	Shore,	1957),	whilst	Dahlstrom	and	 Fuxe	 were	 the	 first	 to	 map	 the	 distribution	 of	 5-HT	 expression	 in	 the	 CNS	(Dahlstrom	and	Fuxe,	1964).	5-HT,	a	monoamine	is	synthesized	from	tryptophan.	The	 amino	 acid	 is	 hydroxylated	 by	 tryptophan	 hydroxylase	 to	 form	 5-hydroxytryptophan	 (5-HTP),	 and	 then	 decarboxylated	 by	 tryptophan	decarboxylase	to	form	5-HT	(Clark	et	al.,	1954).		
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Within	the	CNS,	5-HT	is	produced	within	neurons	of	the	raphe	nuclei	in	the	brainstem,	some	of	which	send	descending	projections,	to	the	medulla	and	spinal	cord	whilst	 ascending	 projections	 extend	 to	 areas	 of	 the	 forebrain	 including	 the	hypothalamus	 (Dahlstrom	 and	 Fuxe,	 1964).	 5-HT	 has	 been	 implicated	 in	 the	regulation	 of	 hypothalamic	 processes	 including	 food	 intake,	 body	 weight	 and	reproductive	function	(Blundell,	1984,	Soga	et	al.,	2015,	Soga	et	al.,	2010).	There	 are	 14	 subtypes	 of	 5-HT	 receptors,	 divided	 into	 7	 classes	 (5-HT1	through	5-HT7),	all	of	which	are	metabotropic	with	the	exception	of	the	ionotropic	5-HT3-receptor	(Derkach	et	al.,	1989,	Puig	and	Gulledge,	2011).	Metabotropic	5-HT	receptors	 are	 G-protein-coupled,	 7-transmembrane	 domain	 receptor	 class	receptors.	With	the	exception	of	5-HT3	receptors,	all	5-HT	receptors	mediate	their	electrophysiological	effects	on	neurons	through	potassium	channel	modulation.		5-HT	 1A,	 1D,	 1F,	 2A,	 2B,	 3A,	 5A,	 5B,	 6	 and	 7	 receptors	 (but	 not	 2C,	 3B	 or	 4)	 are	expressed	 in	 all	 GnIH	 neurons	 (Soga	 et	 al.,	 2010)	 and	 the	 selective	 serotonin	reuptake	 inhibitor	(SSRI)	citalopram	can	cause	sexual	dysfunction	(de	Jong	et	al.,	2005)	 (Soga	 et	 al.,	 2010).	 Citalopram	 treatment	 is	 also	 associated	with	 reduced	GnRH	and	elevated	GnIH	mRNA	expression	(Soga	et	al.,	2010,	Prasad	et	al.,	2015).		
1.20.1	The	5-HT1	receptors	The	 5-HT1	 receptor	 class	 contains	 five	 isoforms;	 5-HT1A,	 5-HT1B,	 5-HT1D,	 5-HT1E	and	 5-HT1F.	 All	 subtypes	 couple	 to	 Gi/o-proteins	 to	 inhibit	 adenylyl	 cyclase	 and	decrease	intracellular	adenosine-mono-phosphate	(cAMP)	(Barnes,	2011).	5-HT1A	is	 expressed	 throughout	 the	 CNS	 including	 the	 limbic	 system,	 raphé	 nuclei	 and	hypothalamus,	 located	 on	 soma,	 dendrites	 and	 axon	 hillocks.	 It	 functions	 as	 an	auto-receptor	 on	 all	 serotonergic	 neurons.	 5-HT1B	 is	 found	 throughout	 the	
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mammalian	 CNS	 including	 the	 hippocampus,	 striatum,	 cerebellum	 and	 basal	ganglia.	 It	 is	 expressed	 on	 both	 serotonergic	 and	 non-serotonergic	 neuron	 axon	terminals.	 5-HT1D	 expression	 levels	 are	 highest	 in	 the	 raphé	 nuclei	 whilst	expression	 is	also	 found	 in	 the	amygdala	and	caudate-putamen.	5-HT1E	 functions	remain	 unclear	 however	 it	 is	 expressed	 in	 the	 cortex	 caudate-putamen	 and	amygdala	(Bruinvels	et	al.,	1994).	5-HT1F	receptors	are	expressed	at	relatively	low	levels	 within	 the	 CNS,	 but	 are	 found	 in	 areas	 including	 the	 raphé	 nuclei,	hippocampus,	 striatum,	 thalamus,	 trigeminal	 ganglion	 and	 vestibular	 nucleus	(Barnes,	2011).			
1.20.2	The	5-HT2	receptors	There	 are	 three	 isoforms	 of	 5-HT2	 receptors,	 5-HT2A,	 5-HT2B	 and	 5-HT2C,	 all	 of	which	 excite	 neurons	 through	 coupling	 to	 Gq/11-proteins,	 increasing	 intracellular	IP3	and	diacylglycerol	(DAG).	5-HT2A	receptors	are	expressed	in	the	hippocampus,	hypothalamus,	amygdala,	substantia	nigra	and	cerebral	cortex.	5-HT2A	agonists	are	psychotomimetic	 and	 as	 such	 this	 receptor	 is	 the	 target	 for	 antipsychotic	medications	 (Barnes,	 2011).	 The	 physiological	 significance	 of	 5-HT2B	 receptors	remains	 unclear	 however	 expression	 is	 found	 in	 the	 cerebellum,	 amygdala	 and	raphé	 nuclei.	 5-HT2C	 receptors	 are	 expressed	 in	 the	 choroid	 plexus,	 substantia	nigra	and	globus	pallidus.	5-HT2C	receptors	are	expressed	on	POMC	neurons	of	the	ARH	and	are	a	target	for	appetite	suppressive	drugs	(Doslikova	et	al.,	2013).			
1.20.3	The	5-HT3	receptor	This	5-HT	receptor	is	an	exception	in	that	it	is	a	ligand	gated	non-selective	cation	channel,	not	a	GPCR,	mediating	 fast,	excitatory	neurotransmission.	Highest	 levels	
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within	the	CNS	are	found	in	brainstem	nuclei,	 including	the	dorsal	motor	nucleus	of	the	vagus	nerve,	area	postrema	and	NTS	(Pratt	et	al.,	1990).	Expression	is	also	found	within	the	hippocampus,	amygdala	and	caudate	putamen	(Barnes,	2011).		
1.20.4	The	5-HT4	receptor	5-HT4	 receptors	 are	 Gs-protein	 coupled	 and	 activation	 excites	 neurons	 via	increasing	 intracellular	 cAMP	 levels	 and	 potassium	 channel	 inhibition.	 CNS	expression	 levels	 are	 highest	 in	 the	 substantia	 nigra,	 globus	 pallidus,	 caudate	putamen,	nucleus	accumbens,	hypothalamus,	hippocampus	and	cortex	(Varnas	et	al.,	2003)	and	would	appear	to	be	predominantly	postsynaptic.		
1.20.5	The	5-HT5	receptors	Both	 5-HT5A	 and	 5-HT5B	 receptors	 are	 Gi/o-protein	 coupled,	 and	 inhibit	 neurons	through	 decreasing	 intracellular	 cAMP	 and	 activating	 a	 potassium	 conductance	(Hurley	 et	 al.,	 1998).	 5-HT5A	 receptor	 expression	 is	 found	 in	 the	 hypothalamus,	raphe	nuclei,	locus	coeruleus,	and	amygdala	and	to	a	lesser	extent	in	the	cerebral	cortex,	 hippocampus	 substantia	 nigra,	 ventral	 tegmental	 area	 (VTA)	 and	cerebellum	 (Pasqualetti	 et	 al.,	 1998).	 5-HT5B	 receptor	 expression	 is	 found	 in	 the	hippocampus,	 dorsal	 raphé,	 habenula,	 entorhinal	 cortex,	 piriform	 cortex	 and	olfactory	bulb	(Matthes	et	al.,	1993).		
1.20.6	The	5-HT6	receptors	5-HT6	receptors	are	Gs-protein	coupled	and	excite	neurons	via	activating	adenylyl	cyclase,	 increasing	 intracellular	 cAMP	 levels	 and	 inhibiting	 a	 potassium	
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conductance.	 Expression	 is	 found	 in	 the	 striatum,	 nucleus	 accumbens,	hippocampus	 and	 neocortex	 (Lieben	 et	 al.,	 2005).	 Receptor	 agonism	 has	 been	found	to	improve	memory	and	cognition	(Ramirez,	2013).		
1.20.7	The	5-HT7	receptor	5-HT7	 receptors	 are	 Gs-protein	 coupled	 and	 excite	 neurons	 via	 increasing	intracellular	 cAMP	 levels	 and	 inhibiting	 a	 potassium	 conductance.	 Receptor	expression	 in	 found	 within	 the	 thalamus,	 hypothalamus,	 hippocampus	 and	amygdala	(Bonaventure	et	al.,	2011).	Some	evidence	suggests	that	5-HT7	receptor	antagonism	may	be	an	effective	antidepressant	strategy	(Hedlund,	2009).		
1.21	 Noradrenaline	Central	 noradrenaline	 (NA)	 is	 produced	 within	 neurons	 of	 the	 locus	 coeruleus,	dorsal	 vagal	 complex	 and	 ventrolateral	 medulla	 (Dahlstrom	 and	 Fuxe,	 1964,	Sawchenko	 and	 Swanson,	 1981).	 NA,	 a	 catecholamine,	 is	 synthesized	 from	tyrosine.	 Tyrosine	 is	 hydroxylated	 to	 dihydroxyphenylalanine	 (DOPA),	decarboxylated	to	dopamine	(DA)	by	aromatic	L-amino	acid	decarboxylase.	DA-β-hydroxylase	 then	 converts	 DA	 to	 NA	 (Fernstrom	 and	 Fernstrom,	 2007).	 In	dopaminergic	 neurons	 DA-β-hydroxylase	 is	 not	 expressed,	 and	 DA	 is	 not	hydroxylated	 to	 NA.	 NA	 functions	 in	 the	 CNS	 to	 regulate	 sensory,	 memory	 and	motor	 and	 mood	 processes	 (Berridge	 and	 Waterhouse,	 2003).	 Noradrenergic	neurons	of	the	locus	coeruleus	project	throughout	the	CNS,	with	a	notable	absence	of	terminals	in	the	striatum	and	globus	pallidus	(Berridge	and	Waterhouse,	2003).			 Multiple	 hypothalamic	 nuclei	 including	 the	 PVN	 and	 supraoptic	 nucleus	(SON)	receive	noradrenergic	afferents	(Sawchenko	and	Swanson,	1981),	and	NA-
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sensitive	 neurons	 have	 been	 detected	 in	 other	 hypothalamic	 nuclei	 including	orexin-neurons	of	the	LH	(Yamanaka	et	al.,	2006)	and		NPY/AgRP	neurons	of	the	ARH	(Kang	et	al.,	2000).	Elevated	extracellular	NA	has	also	been	implicated	in	the	DMH-dependent	panic	response	(Shekhar	et	al.,	2002).	Injection	of	NA	to	the	PVH	stimulates	 food	 intake,	 and	 elevates	 plasma	 coritcosterone	 and	 vasopressin	(Leibowitz	 et	 al.,	 1988).	 Both	 α-adrenoceptors	 (α-ARs)	 and	 β-adrenoceptors	 (β-ARs)	are	GCPRs	and	bind	both	NA	and	adrenaline	(Cotecchia	et	al.,	1998).	The	α-AR	group	contains	α1a,	α1b,	α1d,	α2a,	α2b	and	α2c	whilst	the	β-ARs	include	β1,	β2	and	β3	(Cotecchia	 et	 al.,	 1998).	 α1-AR	 activation	 generally	mediates	 neuronal	 excitation	whilst	 α2-AR	 and	 β-AR	 activation	 results	 in	 membrane	 hyperpolarization	 (Hein,	2006).	 Of	 the	 α-ARs,	 α1-ARs	 are	 Gq/11	 coupled	 and	 receptor	 activation	 results	 in	PLC	activation,	elevations	in	intracellular	IP3	and	calcium	mobilization	(Koshimizu	et	al.,	2007).	α2-ARs	are	Gi/o	 coupled	and	receptor	activation	results	 in	adenylate	cyclase	 inhibition,	 reductions	 in	 intracellular	 cAMP,	 inhibition	 of	 voltage-gated	Ca2+	 channels	 and	 activation	 of	 G-protein	 coupled	 inwardly	 rectifying	 potassium	channels	(GIRKs)	(Hein,	2006).	
	
1.22	 Thyrotropin-releasing	hormone	Thyrotropin-releasing	 hormone	 (TRH)	 is	 a	 key	 regulator	 of	 plasma	 thyroid	hormone	 (TH)	 concentration	 (Lechan	 and	 Fekete,	 2006).	 Neurons	 originating	 in	the	 PVH	 and	 LH	 release	 TRH	 at	 the	 median	 eminence,	 stimulating	 thyrotropin	secreting	hormone	(TSH)	from	the	pituitary,	which	in	turn	stimulates	the	thyroid	gland	to	produce	the	thyroid	hormones	T3	and	T4.	Thyroid	hormones	then	provide	negative	 feedback	 to	 hypothalamic	 TRH	 neurons,	 completing	 the	 self-regulatory	
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loop	 (Ghamari-Langroudi	 et	 al.,	 2010).	 T3	 and	 T4	 are	 key	 regulators	 of	 tissue	development,	membrane	transport	and	cellular	metabolism	(Davis	et	al.,	2016).	TRH	 neurons,	 in	 addition	 to	 hormonal	 regulation	 by	 T3	 and	 T4,	 are	innervated	 by	 arcuate	 NPY	 and	 POMC	 neurons	 (Toni	 et	 al.,	 1990,	 Fekete	 et	 al.,	2000),	 brainstem	noradrenergic	 neurons	 (Tapia-Arancibia	 et	 al.,	 1985,	 Shioda	 et	al.,	 1986)	 and	 neurons	 of	 the	 DMH	 (Ghamari-Langroudi	 et	 al.,	 2010).	 The	hypothalamic-pituitary-thyroid	(HPT)	axis	 is	regulated	by	energy	status	and	TRH	gene	expression	is	positively	regulated	by	leptin	(Ghamari-Langroudi	et	al.,	2010).	Reduced	plasma	leptin,	resulting	from	reduced	food	intake,	results	in	reduced	TRH	expression	and	reduced	somatic	energy	expenditure.	Leptin	increases	TRH	neuron	activity	both	directly	at	 leptin	receptors	on	TRH	neurons,	and	via	MC4R	agonism	due	to	increased	POMC	neuron	activity	(Ghamari-Langroudi	et	al.,	2010).		
1.23	 Gap-junctions	and	electrotonic	coupling	Gap-junctions	 are	 transmembrane	 proteins,	 providing	 direct	 intercytoplasmic	links	between	adjacent	 cells	 in	animals,	 allowing	 for	 the	electrical	 and	metabolic	coupling	of	extensive	cellular	networks	(Harris,	2001,	Orellana	et	al.,	2009,	Saez	et	al.,	2005).	Two	distinct	protein	families	are	responsible	for	gap-junction	formation;	pannexins	and	connexins.	Pannexins	are	found	in	all	eumotazoa	with	the	exception	of	 echinoderms.	 Orthologous	 proteins	 in	 non-chordates	 are	 termed	 innexins.	Connexins	are	found	exclusively	in	chordates	(Abascal	and	Zardoya,	2013).		To	 date,	 20	 connexin	 (Cx)	 genes	 have	 been	 identified	 in	mice,	 and	 21	 in	humans,	19	of	which	are	considered	to	be	orthologous	(Sohl	and	Willecke,	2004).	Connexin	 isoforms	 are	 differentially	 expressed	 both	 temporally	 and	 spatially	 in	
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mammalian	 tissues,	 gap-junctions	would	 seem	 to	 be	 somewhat	 ubiquitous,	with	the	few	naive	cell	populations	including	circulatory	cells	(Dbouk	et	al.,	2009).	All	 connexin	 proteins	 share	 a	 conserved	 topology,	 with	 four	transmembrane	 domains,	 termed	M1,	M2,	M3	 and	M4.	 The	N	 and	 C	 termini	 are	both	 located	 on	 the	 cytoplasmic	 face	 of	 the	 membrane	 with	 the	 N	 terminus	upstream	of	M1,	and	the	C-terminus	downstream	of	M4.	Two	extracellular	 loops,	E1	and	E2,	 connect	M1	 to	M2	and	M3	 to	M4	 respectively,	whilst	 an	 intracellular	loop	 domain	 connects	 M2	 to	 M3	 (Harris,	 2001,	 Meier	 and	 Dermietzel,	 2006).	Connexin-based	 gap-junction	 channels	 consist	 of	 two	 ‘docked’	 hemichannels	 or	connexons,	 one	 contributed	 by	 each	 cell	 membrane.	 Each	 hemichannel	 is	 a	hexamer	 of	 connexin	 subunits,	which	 oligomerize	 in	 the	 endoplasmic	 reticulum.	The	 hemichannel	 is	 then	 processed	 through	 the	 golgi	 apparatus	 (Segretain	 and	Falk,	 2004),	 trafficked	 to	 and	 inserted	 in	 the	 plasma	membrane.	 These	 channels	then	 dock	 to	 other	 hemichannels	 in	 opposing	 plasma	 membranes	 via	 their	extracellular	E1	and	E2	moieties.	This	results	 in	 the	 formation	of	an	 intercellular	gap	 junction	 channel	 (IGJC)	 (Harris,	 2001).	 However	 hemichannels	 may	 remain	undocked	 within	 the	 plasma	 membrane	 where	 they	 may	 act	 as	 functional	 ion	channels	 (Saez	 et	 al.,	 2005).	 Connexin	 subunit	 and	 hemichannel	 topology	 are	outlined	in	Figure	1.3.	Hemichannels	 exist	 in	 both	 homomeric	 and	 heteromeric	 combinations,	homomeric	describing	a	hemichannel	composed	of	six	identical	connexin	isoforms,	whilst	 heteromeric	 describes	 a	 hemichannel	 formed	 of	 a	 combination	 of	 two	 or	more	 isoforms	 (Dbouk	 et	 al.,	 2009,	 Harris,	 2001).	 Furthering	 the	 degree	 of	structural	 heterogeneity	 amongst	 connexins	 is	 the	 existence	 of	 both	 homotypic	and	 heterotypic	 gap	 junction	 formation,	 with	 homotypic	 describing	 a	 junction	
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formed	 of	 two	 symmetrical	 hemichannels	 and	 heterotypic	 referring	 to	 a	structurally	 asymmetrical	 junction.	 Some	 hemichannels	 are	 only	 capable	 of	forming	homotypic	gap	junctions	(e.g.	Cx36)	whilst	other	isoforms	are	capable	of	docking	with	multiple	others.	As	each	connexin	has	unique	biophysical	properties,	heterotypic	channels	confer	specific	biophysical	properties	to	the	junction	such	as	channel	rectification	and	the	existence	of	sub-conductance	states	(Harris,	2001).																		
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1.24	 Connexins	in	the	Central	Nervous	System	11	connexins	are	expressed	in	the	rodent	CNS	(Belousov	and	Fontes,	2013),	six	of	which	are	expressed	 in	neurons	(Sohl	et	al.,	2005).	The	differential	expression	of	connexins	is	outlined	in	table	1.1,	below:	
Isoform	 Cell	type	26	 Neuron,	astrocyte	29	 Oligodendrocyte	30	 Astrocyte	32	 Neuron,	oligodendrocyte	36	 Neuron,	oligodendrocyte,	microglia	37	 Neuron	40	 Neuron	(developing),	astrocyte	43	 Neuron,	astrocyte,	microglia	(activated)	45	 Neuron,	astrocyte	46	 Astrocyte	47	 Neuron,	astrocyte,	oligodendrocyte	
	
Table	1.1:	Differential	tissue	expression	of	connexin	isoforms	
Adapted	from	(Nakase	and	Naus,	2004).						
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Differential	 knock	 out	 of	 CNS	 connexin	 isoforms	 yields	 a	 variety	 of	phenotypes	in	mouse	models,	outlined	in	table	1.2,	below:	
Knockout	mouse	 Phenotype	Cx26	 Embryonic	lethal	Cx26fl/fl	Otog-cre	 Hearing	impairment	Cx30	 Sever	hearing	impairment	Cx32	 PNS	demyelination,	CNS	hyperexcitability,		Increased	ischemic	injury	Cx36	 Visual	deficit	Desynchronization	of	cortical	and	hippocampal	gamma	oscillations	Desynchronization	of	neocortical	interneuron	activity	Cx43	 Neonatal	lethal	Embryonic	neural	crest	migration	deficit	Embryonic	neocortical	neuron	migration	deficit	(Cx43+/-)	 Increased	ischemic	injury	Cx43fl/fl	GFAP-cre	 Increased	spreading	depression	in	hippocampus	Increased	ischemic	injury	Cx45	 Embryonic	lethal	Cx47	 Vacuolation	in	nerve	fibers		Cx47/32	(Double	KO)	 Severe	CNS	demyelination	
	
Table	1.2:	Phenotype	of	specific	connexin	knockout	mouse	models	
Adapted	from	(Nakase	and	Naus,	2004).	
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Connexin	 36	 (Cx36)	 would	 appear	 to	 be	 the	 predominant	 isoform	responsible	 for	 neuron-to-neuron	 electrotonic	 coupling	 (Belousov	 and	 Fontes,	2013).	 Cx36	 mRNA	 expression	 is	 found	 throughout	 the	 adult	 rodent	 CNS	 with	higher	 levels	 expressed	during	prenatal	 and	neonatal	development	 (Belluardo	et	al.,	 2000).	 Regions	 with	 high	 Cx36	 mRNA	 expression	 include	 the	 inferior	 olive,	cerebellum,	striatum,	hippocampus,	thalamus	and	cerebral	cortex	(Belluardo	et	al.,	2000).	 In	 many	 CNS	 regions	 Cx36	 displays	 highly	 regulated	 spatio-temporal	specificity,	 with	 the	 incidence	 of	 electrotonic	 coupling	 and	mRNA	 expression	 in	spinal	 motor	 neurons	 found	 to	 be	 at	 its	 highest	 during	 late	 embryonic	development,	and	falling	within	the	first	few	postnatal	days	(Belousov	and	Fontes,	2013).	In	the	cortex	and	hypothalamus	CX36	expression	increases	during	the	first	two	 postnatal	 weeks	 and	 subsequently	 decreases	 therein	 (Belousov	 and	 Fontes,	2013).	Such	observations	of	transient	connexin	expression	and	its	correlation	with	neuronal	 differentiation	 implicate	 connexins	 as	 having	 a	 role	 in	 neural	development,	 allowing	 for	 the	 intercellular	 exchange	 of	 signaling	 molecules,	driving	 differentiation	 (Rozental	 et	 al.,	 2000).	 However,	 in	 many	 CNS	 regions	neuronal	 connexin	 expression	 persists	 into	 adulthood,	 and	 functional	 electrical	synapses	can	be	 found	 in	 the	 inferior	olive,	 retina,	 spinal	cord,	hippocampus	and	cerebral	cortex	(Rash	et	al.,	2000).	GJICs	 permit	 current	 flow	 between	 neurons.	 Any	 depolarization	 or	hyperpolarization	of	cell(s)	within	a	coupled	network,	generates	a	transjunctional	voltage,	and	drives	current	 through	electrical	synapses	(Spray	et	al.,	1985).	Cx36	based	 channels	 are	 relatively	 voltage-insensitive	 (Srinivas	 et	 al.,	 1999),	 as	 such	electrical	 synapses	 are	 bidirectional,	 reliably	 conducting	 both	 excitatory	 and	inhibitory	postsynaptic	 currents	without	delay.	Electrical	 Inhibitory	postsynaptic	
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potentials	 (eIPSPs)	 can	 result	 from	 the	 electrotonic	 dissemination	 of	hyperpolarizing	 chemical	 PSPs	 or	 can	 result	 from	 the	 transmission	 of	 a	presynaptic	afterhyperpolarisation	potential	(AHP)	across	the	junction.	Conversely	excitatory	PSPs	 (eEPSPs)	 can	 result	 from	 the	 electrotonic	 spread	of	depolarizing	chemical	 PSPs,	 or	 action	 potentials.	 In	 the	 latter	 case,	 if	 the	 transjunctional	conductance	 is	 of	 sufficient	magnitude,	 synchronous	 suprathreshold	 activity	 can	be	 generated	 in	multiple	 neurons	within	 the	 network	 (Logan	 et	 al.,	 1996).	 Such	activity	patterning	is	known	to	regulate	neurotransmitter	release,	with	burst	firing	capable	of	initiating	more	transmitter	release	than	high	frequency	repetitive	firing	(Poulain	and	Wakerley,	1982,	Murase	et	al.,	1993).	Gap	 junctions	act	as	 low	pass	 filters,	 filtering	 the	amplitude	of	 fast	events	such	as	action	potentials	to	a	greater	extent	than	slower	events	such	as	AHPs.	As	a	result,	the	filtered	remnants	of	presynaptic	action	potentials	appear	as	truncated,	biphasic	membrane	oscillations	or	‘spikelets’	in	the	postsynaptic	neuron	(Nolan	et	al.,	1999).	Factors	that	also	contribute	to	the	postsynaptic	oscillation	waveform	are	the	 electrophysiological	 characteristics	 of	 the	 coupled	 cells	 (e.g.	 conductances	contributing	to	the	action	potential	waveform),	 the	topographical	organization	of	the	 gap	 junction(s)	 and	 the	 number	 of	 individual	 channels	 contributing	 to	 the	junction(s).	As	such	the	characteristics	and	 function	of	electrotonic	coupling	may	vary	substantially	both	within	and	between	coupled	networks.		
1.25	 Cx36-Based	Electrical	Synapses	The	 connexin	 isoforms	 that	 constitute	 any	 given	 channel	 confer	 single	 channel	conductance,	 ionic	 selectivity	 and	 voltage	 gating	 characteristics	 (Bukauskas,	2012).	 Therefore	 the	 existence	 of	 both	 heterotypic	 and	 heteromeric	 channels	
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provides	 a	 huge	 array	 of	 channel	 characteristics.	 Cx36	 only	 forms	 homotypic	channels	(Harris,	2001).	Other	connexin	isoforms	known	to	only	form	homotypic	channels	 include	 Cx31	 and	 Cx23	 (Harris,	 2001,	 Schalper	 et	 al.,	 2012).	 In	 these	cases,	 the	 inability	 to	 form	 heterotypic	 channels	 is	 ascribed	 to	 atypical	 Cysteine	residue	 patterning	 in	 the	 extracellular	 loop	 domains,	 which	 is	 highly	 conserved	amongst	most	connexins.	However	this	conserved	Cysteine	pattern	is	indeed	found	in	 the	 Cx36	 amino	 acid	 sequence	 (Condorelli	 et	 al.,	 1998)	 and	 as	 such,	 either	another	 mechanism	 exists	 to	 confer	 Cx36	 its	 selectivity	 profile,	 or	 heterotypic	channels	 do	 exist,	 but	 are	 yet	 to	 be	 identified.	Homotypic	Cx36	 channels,	 have	 a	unitary	conductance	of	~15	nS	(Harris,	2001),	they	do	not	rectify	current	and	any	ostensible	 rectification	 is	 usually	 due	 to	 differences	 in	 neuronal	 capacitance	 on	either	side	of	 the	 junction.	Cx36	channels	 in	both	neurons	and	pancreatic	β	cells	have	 been	 demonstrated	 to	 be	 cation-selective	 (Bukauskas,	 2012)	 suggesting	 a	specialized	 role	 in	 electrical	 synaptic	 communication,	 as	 opposed	 to	 metabolic	communication,	via	negatively	charged	signaling	molecules	such	as	cAMP,	IP3,	ATP,	ADP,	AMP	and	phosphocreatine	(Bukauskas,	2012).		Cx36	hemichannels	aggregate	into	plaques	within	plasma	membranes	(Lauf	et	al.,	2002)	allowing	for	connexons	on	 opposing	 neurons	 to	 dock	 via	 the	 interdigitation	 of	 extracellular	 moieties	(Foote	et	al.,	1998).	The	number	of	channels	per	plaque	can	range	from	fewer	than	a	 dozen	 to	 thousands	 (Segretain	 and	 Falk,	 2004).	 Cx36	 can	 form	 gap-junctions	between	 dendrites,	 somata	 and	 axons	 of	 apposing	 neurons	 (Traub	 et	 al.,	 2003).	Electrotonic	 coupling	 between	 interneurons	 would	 appear	 to	 be	 predominantly	dendro-dendritic	 whist	 some	 principal	 cells	 are	 coupled	 via	 axo-axonal	 gap	junctions	(Bukalo	et	al.,	2013).	
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The	 endogenous	 mechanisms	 of	 Cx36	 channel	 gating	 are	 poorly	understood,	 however	 studies	 have	 found	 Cx36	 mediated	 electrical	 synaptic	transmission	 to	 be	 modulated	 by	 glucose,	 pH,	 intracellular	 calcium,	 connexin	phosphorylation	 state,	 dopaminergic	 and	 glutamatergic	 synaptic	 transmission,	redox	state	and	nitric	oxide	(NO).		(Srinivas	et	al.,	1999,	Gonzalez-Nieto	et	al.,	2008,	Del	Corsso	et	al.,	2012,	Orellana	et	al.,	2009,	Orellana	et	al.,	2013,	Saez	et	al.,	2005,	Pizarro-Delgado	et	al.,	2014).		
1.26	 Project	aims	
1.	Electrophysiological	characterization	of	arcuate	NPY	neurons	
• Determine	the	effects	of	fasting	and	extracellular	glucose	concentration	on	the	passive	membrane	properties	of	arcuate	NPY	neurons.	
• Determine	the	effects	of	fasting	and	glucose	concentration	on	the	active	membrane	properties	of	arcuate	NPY	neurons.		
2.	Energy	status-dependent	plasticity	of	arcuate	NPY	neurons	
• Determine	 the	 effects	 of	 energy-status	 (fed	 versus	 fasted)	 and	 ambient	physiologically	 relevant	 glucose	 levels	 on	 the	 electrophysiological	properties	of	arcuate	NPY	neurons.	
• Investigate	glucose	sensitivity	of	NPY	neurons	in	fed	and	fasted	conditions.	
• Investigate	 the	 ionic	 mechanisms	 underlying	 glucose-induced	 changes	 in	NPY	neuron	excitability.		
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3.	To	investigate	the	effects	of	ghrelin	on	arcuate	NPY	neurons	under	fed	and	
fasted	conditions	and	the	relationship	between	ghrelin	signaling	and	glucose	
levels.	
• Investigate	the	effect	of	ghrelin	upon	NPY/AgRP	neurons	in	fed	and	fasted	conditions	and	in	the	presence	of	physiologically	relevant	ambient	glucose	levels.	
• Investigate	the	mechanism	of	ghrelin	excitation	in	NPY/AgRP	neurons		
4.	Protein	tyrosine	phosphatases	and	insulin	signaling	in	arcuate	POMC	
neurons	
• Characterize	the	effects	of	insulin	on	wild	type	arcuate	POMC	neurons.	
• Characterize	 the	 effects	 of	 TCPTP	 knockout	 in	 arcuate	 POMC	 neurons	 on	insulin-induced	changes	in	neuronal	excitability.	
• Characterize	the	effects	of	a	TCPTP	inhibitor	on	insulin-induced	responses	in	wild-type	arcuate	POMC	neurons.		
5.	Electrophysiological	characteristics	of	leptin	receptor	expressing	neurons	
of	the	dorsomedial	hypothalamus	
• Characterize	 the	 electrophysiological	 properties	 of	 LepR-expressing	neurons	in	the	mouse	DMH.	
• Characterize	 the	 electrophysiological	 effects	 and	 mechanism	 of	 action	 of	leptin	on	LepR-expressing	neurons	in	the	DMH.			
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6.	An	electrophysiological	and	pharmacological	characterization	of	GnIH	
neurons	in	the	rat	
• Characterize	the	electrophysiological	properties	of	rat	GnIH	neurons.	
• Characterize	the	electrophysiology	and	pharmacology	of	afferent	 inputs	to	GnIH	neurons.	
• Determine	 GnIH	 neuron	 sensitivity	 to	 neurotransmitters	 and	 peptides,	known	to	modulate	energy	homeostasis	and	gonadotroph	secretion.		
7.	Electrotonic	coupling	and	electrical	synaptic	transmission	in	cortical	
interneurons	
• Investigate	the	electrophysiological	properties	and	function	of	electrotonic	coupling	between	cortical	interneurons.	
• Investigate	the	sensitivity	of	these	coupled	neurons	to	5-HT	
• Investigate	 the	 effects	 of	 putative	 gap-junction	 blockers	 on	 epileptiform	activity		
	 	
				
 
 
 
 
 	
	 40	
Figure	1.1:	Anatomy	of	murine	hypothalamic	nuclei		A	cartoon,	highlighting	the	anatomical	location	of	the	murine	hypothalamic	arcuate	nucleus	(ARH)	in	two	dimensions,	adapted	from	(Choi	et	al.,	2013,	Breton,	2013,	Paxinos,	2008).	
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Figure	1.2:	Leptin	and	insulin	receptor	signal	transduction	Cartoon	schematic,	demonstrating	insulin	and	leptin	receptor	signal	transduction.	Recruited	second	messenger	pathways	of	the	insulin	receptor	include	PI3K,	whilst	leptin	 receptor	 signaling	 recruits	 JAK-STAT	 signaling.	 Short-term	 effector	mechanisms	 include	 ATP-sensitive	 potassium	 channels	 and	 transient	 receptor	potential	 channels,	 whilst	 AKT/Foxo1	 and	 STAT-dependent	 gene	 transcription	mediates	long-term	effects	of	leptin	and	insulin,	respectively.	
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Figure	1.3:	Connexin	and	connexon	topology	Cartoon	 highlighting	 two	 dimensional	 connexin	 structure	 (left	 panel),	 and	 three	dimensional	 gap-junction	 channel	 (right	 panel)	 topology,	 in	 relation	 to	 the	phospholipid	membrane,	adapted	from	(Meier	and	Dermietzel,	2006).	
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Chapter	2:	Experimental	Procedures	
All	 animal	 procedures	 described	 here	were	 conducted	with	 approval	 of	Monash	Animal	 Research	 Platform	 (MARP)	 ethics	 committee	 (2008/31,	 2010/51,	2011/174,	2015/104)	and	in	accordance	with	the	Australian	National	Health	and	Medical	Research	Council	(NHMRC)	code	of	practice.	Mice	and	rats	were	housed	in	the	Animal	Research	Laboratory,	Building	77,	Monash	University,	Clayton,	Victoria	3800	 and	 The	 Large	 Animal	 Facility,	 Building	 13F,	 Monash	 University,	 Clayton,	Victoria,	3800.	Both	 female	and	male	animals	were	employed	over	 the	 course	of	this	study.	Unless	otherwise	stated,	animals	were	always	housed	in	groups	of	3-5	per	 cage,	 in	 a	 temperature-controlled	 room,	 on	 a	 12-hour	 light/dark	 cycle,	with	food	and	water	administered	ad	libitum.	Table	2.1	gives	details	of	rodents	used	in	this	study,	below:												
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Rodent		 Age	 Source	GnIH-EGFP	Wistar	Rat	 >	6	weeks	 Bred	internally	(Monash).	Previously	 described	 by	(Soga	et	al.,	2014).	POMC	Z/EG	TCPTP	lox/lox	mouse		 >	6	weeks	 Bred	internally	(Monash).	Previously	 described	 by	(Dodd	et	al.,	2015).	LepR	YFP	Mouse	 >	6	weeks	 Bred	internally	(Monash).	Previously	 described	 by	(Simonds	et	al.,	2014).		NPY	renilla	GFP	Mouse	 >	6	weeks	 Bred	internally	(Monash).	Previously	 described	 by	(Cowley	et	al.,	2003)	POMC	eGFP	Mouse	 >	6	weeks	 Bred	internally	(Monash).	Previously	 described	 by	(Cowley	et	al.,	2001)	Wild	type	C57BL/6	Mouse	 >	6	weeks	 Bred	internally	(Monash).	Originally	 obtained	 from	The	 Jackson	 Laboratory,	USA.	
	
Table	2.1:	Details	of	rodents	used	in	this	study		
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2.1	 Generation	and	validation	of	animal	models	GnIH-EGFP	 Wistar	 Rat;	 >	 6	 weeks	 old;	 Bred	 internally	 (Monash),	 previously	described	 by	 (Soga	 et	 al.,	 2014).	 To	 generate	 the	 GnIH-EGFP	Wistar	 Rat,	 GnIH-EGFP	 transgene	 was	 produced	 using	 pEGFP-1	 plasmid	 (Clontech	 Laboratories,	Inc.)	and	the	predicted	GnIH	promoter	region	(1.7	kb	of	the	5’	upstream	sequence).	The	rat	GnIH	gene	was	amplified	using	PCR,	the	product	of	which	was	cloned	into	pGEM-T	Easy	Vector	plasmid	(Promega)	and	transformed	into	Escherichia	coli.	To	construct	 the	 GnIH-EGFP	 plasmid,	 the	 pGEM-T	 vector	was	 digested	with	HindIII	and	 BamHI	 and	 ligated	 into	 the	 pEGFP	 plasmid.	 The	 resulting	 GnIH	 promoter–EGFP	 plasmid	 was	 then	 digested	 with	 Zsp2I	 (Vivantis	 Technologies)	 and	 the	resulting	3.5	kb	DNA	fragment	was	purified	using	agarose	gel	electrophoresis.	This	DNA	 fragment	 was	 then	 microinjected	 into	 the	 pronuclei	 of	 fertilized	 oocytes	(PhoenixBio,	Co,	Ltd.).	A	caveat	of	 this	model	 is	 that	as	 it	 is	unknown	what	other	else	may	be	coded	 in	 the	1.7	kb	 fragment	5’	 to	 the	GnIH	gene.	 Indeed	 in	 this	 rat	model	 EGFP-positive,	 GnIH	 negative	 neurons	 are	 found	 in	 the	 ventromedial	hypothalamus	(VMH)	whilst	GnIH	positive,	EGFP	negative	 fibers	are	 found	 in	 the	median	 eminence	 of	 this	 model.	 This	 should	 be	 considered	 whilst	 interpreting	results	of	experiments	conducted	on	this	animal	model.	POMC	 Z/EG	 TCPTP	 lox/lox	 mouse;	 >	 6	 weeks	 old;	 Bred	 internally	 (Monash),	previously	described	by	 (Dodd	et	 al.,	 2015).	To	 generate	 the	POMC	Z/EG	TCPTP	
lox/lox	mouse,	the	TCPTP-floxed	mouse	Ptpn2fl/fl	were	mated	with	Z/EG	(C57BL/6)	reporter	mouse	 (Jackson	 Laboratories).	 In	 these	 animals,	 92%	 of	 arcuate	 POMC	neurons	expressed	GFP,	and	no	non-POMC	neurons	expressed	GFP.	LepR	 YFP	 Mouse;	 >	 6	 weeks	 old;	 Bred	 internally	 (Monash),	 previously	described	 by	 (Simonds	 et	 al.,	 2014).	 LepRb-internal	 ribosome	 entry	 site	 (IRES)-
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Cre	recombinase	 mice	 generated	 using	 homologous	 recombination	 to	 introduce	an	IRES-nuclear	 localization	 sequence	 (NLS)-Cre	cassette	 into	 the	 region	immediately	3	prime	to	the	LepRb	stop	codon.	Cre	recombinase	is	only	expressed	in	cells	that	produce	the	LepRb.	LepRb-IRES-Cre	mice	were	then	crossed	with	mice	with	the	EYFP	gene	inserted	into	the	ROSA26	locus.	EYFP	gene	transcriptional	stop	codon	 was	 flanked	 with	 lox-P	 sites.	 Upon	 successful	 recombination,	 the	transcriptional	 termination	 sequence	 is	 excised	 allowing	 EYFP	 expression	 in	LepRb-expressing	 cells.	 In	 the	 absence	 of	 a	 recombination	 event,	 premature	transcription	termination	results	in	no	EYFP	expression.	NPY	renilla	GFP	Mouse;	>	6	weeks	old;	Bred	internally	(Monash),	previously	described	 by	 (Cowley	 et	 al.,	 2003).	 To	 generate	 the	 NPY	 renilla	 GFP	Mouse,	 the	FRT-Kan-FRT	 cassette	 from	 the	 pIGCN21	 plasmid	 was	 amplified	 using	 PCR	 and	inserted	into	the	Mlul	site	of	phrGFP-1	(Stratagene)	producing	in	the	phrGFP-FRT-Kan-FRT	plasmid	which	contained	114	kb	5’	and	29	kb	3’	of	the	murine	NPY	gene.	This	 plasmid	 was	 transformed	 into	 EL250	 bacteria	 and	 amplified	 using	 PCR.	Amplified	DNA	was	purified	and	microinjected	into	the	pronuclei	of	fertilized	FVB	mice	(Jackson	Laboratories).	POMC	 eGFP	Mouse;	 >	 6	 weeks	 old;	 Bred	 internally	 (Monash),	 previously	described	by	(Cowley	et	al.,	2001).	To	generate	the	POMC	eGFP	Mouse,	 the	EGFP	cassette	was	inserted	into	the	5’	untranslated	region	of	exon	2	of	the	mouse	Pomc	gene	 fragment	with	13	kb	5’	 and	2	kb	3’	 flanking	 sequences.	The	 transgene	was	then	 microinjected	 into	 the	 pronuclei	 of	 C57BL/6J	 mice	 (Jackson	 Laboratories).	Double	 EGFP-POMC	 immunohistochemistry	 demonstrated	 >99%	 localization	 in	the	ARH	but	no	colocalization	of	EGFP	with	tyrosine	hydroxylase	or	NPY.	
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Wild	 type	 C57BL/6	 Mouse;	 >	 6	 weeks	 old;	 Bred	 internally	 (Monash);	originally	obtained	from	The	Jackson	Laboratory,	USA.		
2.2	 Mice	All	mice	 included	 in	 experiments	were	 from	 lineages	 that	 had	been	backcrossed	onto	 a	 C57B1/6J	 background.	 Said	 C57B1/6J	 mice	 were	 obtained	 from	Monash	animal	services	(MAS),	Monash	University,	Clayton,	Victoria,	Australia.	
	
2.2.1	 Generation	of	POMC	Z/EG	TCPTP	lox/lox	mice	This	 study	 used	mice,	 produced	 as	 previously	 described	 by	 (Dodd	 et	 al.,	 2015).	
Pomc-Cre	 transgenic	mice	were	 crossed	with	Ptpn2fl/fl	 mice	 to	 selectively	 delete	TCPTP	from	POMC	neurons	(Loh	et	al.,	2011).	These	mice	were	then	crossed	onto	a	
Z/EG	 reporter	 line,	 causing	GFP	 expression	 in	 neurons	 only	within	which	 a	 Cre-dependent	recombination	event	had	occurred.		
	
2.2.2	 POMC-eGFP,	POMC	Z/EG	TCPTP	lox/lox	and	NPY-GFP	mouse	brain	slices	Hypothalamic	 slice	 preparations	 containing	 the	 arcuate	 nucleus	 (ARH)	 were	obtained	 from	mice	 over	 6	weeks	 of	 age.	 Brain	 slice	 preparations	were	 250	 μm	thick,	and	cut	 in	 the	coronal	plane.	Mice	were	split	 into	one	of	 “fed”	and	“fasted”	experimental	groups.	Here	“fed”	animals	were	administered	food	ad	libitum,	whilst	“fasted”	animals	were	subjected	to	an	18-hour	fast	prior	to	culling.		
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2.2.3	 LepR-YFP	mouse	brain	slices	Hypothalamic	slice	preparations	containing	the	dorsomedial	hypothalamus	(DMH)	were	 obtained	 from	 LepR-YFP	 transgenic	mice	 over	 6	 weeks	 of	 age.	 Brain	 slice	preparations	were	250	μm	thick,	and	cut	in	the	coronal	plane.	
	
2.2.4	 Wild	type	C57BL/6	mouse	brain	slices	Cortical	 slice	 preparations	 were	 obtained	 from	 C57BL/6	 mice.	 Brain	 slice	preparations	were	250	μm	thick,	and	cut	in	the	coronal	plane.		
2.2.5	 GnIH-EGFP	Wistar	rat	brain	slices	Hypothalamic	slice	preparations	containing	the	dorsomedial	hypothalamus	(DMH)	were	obtained	 from	 transgenic	GnIH-GFP	Wistar	 rats	over	6	weeks	of	 age.	Brain	slice	preparations	were	250	μm	thick,	and	cut	in	the	coronal	plane.		
2.3	 Fasting	protocol	Mice	 to	 be	 included	 in	 ‘fasted’	 experimental	 groups	 were	 always	 collectively	housed	to	minimize	stress.	Food	was	removed	from	the	cage	hopper	and	cage	floor	18	hours	prior	to	culling.	The	fast	period	was	always	kept	constant	with	respect	to	the	 light/dark	 cycle.	 Fasting	 always	 began	 three	 hours	 prior	 to	 the	 dark	 period.	Water	was	 always	 available	 to	 animals	ad	 libitum.	 Animals	 fasted	 but	 not	 culled	were	not	subjected	to	another	fast	for	at	least	one	week	to	ensure	recovery.		
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2.4	 Physiology	
2.4.1	 Diet	At	4-6	weeks	of	age	mice	were	weaned	and	placed	on	solid	food	diets.	Mice	were	given	 a	 chow	 diet	 (Specialty	 Feeds,	 meat-free	 rat	 and	 mouse	 diet,	 Western	Australia,	 Australia)	 containing	 3.1	 kcal/g,	 4.8%	 fat.	 	 In	 some	 experiments	mice	were	given	a	high	fat	diet	(Specialty	Feeds,	meat-free	rat	and	mouse	diet,	Western	Australia,	Australia)	containing	4.75	kcal/6	and	42%	fat.		
2.4.2	 Food	Intake	Food	 intake	 was	 quantified	 in	 multiple	 studies	 outlined	 here.	 Food	 intake	 was	always	 measured	 post-surgery	 in	 order	 to	 monitor	 the	 health	 and	 recovery	progress	of	mice.	Food	intake	measurements	were	always	taken	at	the	same	time	each	 day,	 immediately	 prior	 to	 the	 onset	 of	 the	 dark	 period.	 Mice	 whose	 food	intake	was	monitored	were	always	individually	housed.	To	check	intake,	food	from	the	cage	hopper	was	transferred	to	the	scale,	with	care	taken	to	look	for	scraps	of	food	within	the	cage	itself.	All	food	intake	measurements	were	taken	on	a	UME	600	±	0.1g	Z	series	scale.		
2.4.3	 Body	Weight	Body	weight	was	 taken	 as	 a	measurement	 throughout	multiple	 studies,	 and	was	always	 taken	 alongside	 food	 intake	 measurements.	 Body	 weight	 was	 always	measured	at	 the	 same	 time	each	day,	 immediately	prior	 to	 the	onset	of	 the	dark	period.	Mice	subjected	to	these	experiments	were	always	individually	housed	and	all	measurements	were	taken	on	a	UME	600	±	0.1g	Z	series	scale.	
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2.5	 Electrophysiology	
2.5.1	 Slice	Preparation	Rats	 and	mice	were	 euthanized	using	 terminal	 inhalation	 anesthesia	 (Isoflurane,	Baxter	 Healthcare,	 NSW,	 Australia)	 followed	 by	 decapitation.	 Following	decapitation,	 the	 brain	 was	 swiftly	 removed	 from	 the	 cranial	 cavity	 and	transferred	 into	 freshly	 prepared,	 ice-cold	 (<4°C),	 carbogen	 (95%	 O2,	 5%	 CO2)	gassed	 artificial	 cerebrospinal	 fluid	 (aCSF).	 pH	 and	 osmolarity	 of	 aCSF	 was	regularly	 checked	 and	 maintained	 at	 7.4	 and	 between	 310-315	 mOsm.kg-1,	respectively.	 For	 experiments	 requiring	 the	 use	 of	 aCSF	 containing	 <10	 mM	glucose,	 osmolarity	 was	 compensated	 with	 the	 addition	 of	 D-mannitol	 at	 levels	equimolar	to	the	glucose	levels	removed.	Dura,	arachnoid	and	pia	matter	were	removed	from	the	surface	of	the	brain	using	 fine	 forceps	 (Fine	 Science	 Tools).	 The	 cerebellum	 was	 removed	 using	 a	razorblade	to	provide	a	flat	edge	for	the	remaining	brain	to	be	adhered	to	a	tissue	plate	 of	 a	 vibratome	 (Leica	 VTS	 1000S,	 Leica	Microsystems	Nussloch,	 Germany)	using	cyanoacrylate	glue.	Coronal	slices	(200-300	μm)	containing	the	dorsomedial	hypothalamus	 (DMH),	 arcuate	 nucleus	 (ARH),	 and/or	 cortex	were	 cut	 using	 the	vibratome.	The	vibratome	cutting	chamber	was	filled	with	ice-cold	aCSF,	and	was	regularly	replaced	to	keep	temperature	as	constant	as	possible	during	slicing.	The	arcuate	 nucleus	 was	 identified	 as:	 the	 area	 immediately	 dorsal	 to	 the	 median	eminence	 and	 immediately	 lateral	 to	 the	 third	 ventricle.	 The	 dorsomedial	hypothalamus	was	 identified	as	 the	area	 immediately	 lateral	 to	 the	dorsal	end	of	the	third	ventricle,	and	immediately	posterior	to	the	paraventricular	nucleus,	both	in	 accordance	 with	 coordinates	 determined	 from	 a	 brain	 atlas	 (Paxinos,	 2008).	Once	 brain	 slices	were	 cut,	 they	were	 immediately	 transferred	 from	 the	 cutting	
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bath	 to	a	200	ml	beaker	containing	aCSF	warmed	to	34°C	 in	a	water	bath	where	they	 were	 incubated	 for	 20	 minutes.	 After	 incubation	 the	 beaker	 was	 removed	from	 the	 water	 bath	 and	 placed	 on	 the	 lab	 bench	 to	 acclimatize	 to	 room	temperature	for	at	least	an	hour	before	the	slices	were	used	for	recording.	Prior	to	recording	slices	were	transferred	to	a	recording	chamber	for	electrophysiological	experiments.	 The	 slices	 were	 secured	 to	 the	 cover	 slip-bottomed	 recording	chamber	with	a	custom-made	nylon	grid,	weighted	with	a	platinum	arc	to	prevent	any	 movement	 of	 the	 tissue	 during	 recording.	 The	 recording	 chamber	 was	constantly	perfused	with	room	temperature,	carbogen-bubbled	aCSF,	and	the	flow	rate	of	aCSF	was	maintained	between	2-10	ml/min.		
2.5.2	 Recording	Procedure	Brain	 slices	 and	 individual	 cells	 were	 visualized	 using	 a	 Zeiss	 Axioskop	 2	microscope	 (Carl	 Zeiss	 Ltd.,	 Welwyn	 Garden	 City,	 UK)	 equipped	 with	 a	 Zeiss	Axiocam	MRc	 camera	 (Carl	 Zeiss	 Ltd.,	Welwyn	 Garden	 City,	 UK)	 connected	 to	 a	computer	 running	 Axiovision	 4.1	 imaging	 software	 (Carl	 Zeiss	 Vision).	 The	microscope	 was	 fitted	 with	 two	 immersion	 lenses	 (20X	 and	 63X)	 and	 a	 2.5X	booster	 lens	mounted	 in	 the	microscopes	 rotational	magazine	 allowing	 for	 slice	visualization	at	20X,	50X	and	63X	and	157.5X.	The	microscope	was	also	fitted	with	a	 fiber	optic	 fluorescent	 light	source	 (Carl	Zeiss	Vision)	and	 filter	sets	37	and	46	allowing	for	the	visualization	neurons	expressing	eGFP	and	YFP,	respectively.	Whole-cell	 current-clamp	 and	 voltage-clamp	 recordings	 were	 performed	using	recording	electrodes	pulled	 from	borosilicate,	 filamented,	 thin-walled	glass	capillaries	 (GC150TF-10)	 using	 a	 horizontal	 electrode	 puller	 (P1000	 or	 P-97,	
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Sutter	Instrument	Co,	Novato,	CA,	USA)	and	had	resistances	of	4-9	MΩ	when	back-filled	with	intracellular	pipette	solution.		Electrophysiological	 recordings	 were	 made	 with	 an	 Axon	 700B	 amplifier	(Axon	 Instruments,	 Foster	 City,	 CA,	 USA)	 connected	 to	 a	 personal	 computer	running	multiclamp,	pClamp	9	(Axon	Instruments)	and	Axiovision	4.1	(Carl	Zeiss	Vision)	software.	Experimental	data	was	monitored	online	using	Clampex	9	(Axon	instruments)	and	Multiclamp	(Axon	instruments)	software.	Data	was	filtered	at	1-5	KHz	 (for	 voltage-clamp	 experiments),	 digitized	 at	 2-100	KHz	 (Digidata	 1322A,	Axon	instruments)	and	was	saved	directly	to	the	PC	hard	drive	for	analysis	using	Clampfit	9	(Axon	instruments)	software.		Resting	membrane	potential	and	firing	rate	was	established	from	traces	in	Clampfit	 software	 (Axon	 Instruments)	 and	 value	 offsets	 due	 to	 liquid	 junction	potentials	 were	 not	 accounted	 for.	 Input	 resistance	 was	 calculated	 from	 Ohm’s	Law	(R=V/I)	using	an	experimental	protocol	in	which	square-wave	current	steps	(-5	to	-100	pA,	500	ms	to	1000	ms)	were	injected	and	the	amplitude	of	the	evoked	membrane	voltage	deflections	subsequently	measured.	All	 electrophysiological	 recordings	were	made	 at	 room	 temperature	 as	 it	was	 deemed	 unrealistic	 to	 perform	 long-term	 recordings	 at	 physiological	temperature.	It	must	be	noted	that	this	is	a	caveat	of	research	described	here,	not	least	 because	 the	 hypothalamus	 contains	 populations	 of	 temperature-sensitive	neurons.	In	 experiments	 demanding	 recordings	 of	 fluorescent	 neurons,	 cell	phenotype	was	confirmed	after	whole-cell	access	was	attained.	This	was	achieved	under	 fluorescent	 illumination,	 observing	 that	 the	 flurophore	 had	 been	 partially	drawn-up	into	the	recording	electrode.	In	these	experiments,	any	neuron	in	which	
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this	 was	 not	 observed	 was	 deemed	 to	 not	 contain	 the	 flurophore	 and	 was	discarded.	Electrotonic	coupling	between	pairs	of	cortical	interneurons	was	confirmed	when	 the	 injection	 of	 negative	 current	 into	 only	 one	 of	 two	 simultaneously	recorded	 neurons,	 evoked	 a	 voltage	 change	 in	 both	 neurons.	 	 Neuronal	 input	resistance	 and	 coupling	 coefficients	 were	 determined	 from	membrane	 potential	responses	 to	 injection	 of	 a	 range	 of	 depolarizing	 and	 hyperpolarizing	 current	pulses	into	either	neuron.	Coupling	coefficients	were	determined	as	the	ratio	of	the	postsynaptic	 to	 presynaptic	 membrane	 potential	 change	 elicited	 in	 response	 to	current	 injection.	 	 The	 junctional	 conductance	 (gj)	 was	 estimated	 from	 the	experimentally	 determined	 input	 resistance	 and	 coupling	 coefficients	 using	 a	model	 system	 whereby	 each	 neuron	 was	 represented	 by	 a	 single	 compartment	connected	via	a	resistor	constituting	the	electrical	synapse.	 	Thus	gj	between	two	cells	was	estimated	from:		 gj1-2	=	R1k1-2/((R1R2)-R1k1-2)2)	In	 which	 R1	 and	 R2	 represent	 the	 input	 resistances	 of	 the	 pre-and	postsynaptic	 neurons	 respectively	 and	 k1-2	 represents	 the	 coupling	 coefficient	between	these	neurons	(See	(Nolan	et	al.,	1999).						
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2.6	 Solutions	
2.6.1	 aCSF	The	composition	of	aCSF	used	in	this	study	is	shown	in	table	2.2,	below:		 	 1	mM	
Glucose	
aCSF	(mM)	
2	mM	
Glucose	
aCSF	(mM)	
3	mM	
Glucose	
aCSF	(mM)	
5	mM	
Glucose	
aCSF	(mM)	
10	mM	
Glucose	
aCSF	(mM)	
NaCL	 127	 127	 127	 127	 127	
KCL	 1.9	 1.9	 1.9	 1.9	 1.9	
KH2PO4	 1.2	 1.2	 1.2	 1.2	 1.2	
NaHCO3	 26	 26	 26	 26	 26	
D-Glucose	 1	 2	 3	 5	 10	
D-Mannitol	 9	 8	 7	 5	 0	
Ascorbic	
Acid	 0.34	 0.34	 0.34	 0.34	 0.34	
CaCl2	 2.4	 2.4	 2.4	 2.4	 2.4	
MgCl2	 1.3	 1.3	 1.3	 1.3	 1.3	
	
Table	2.2:	aCSF	composition					
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2.6.2	 Pipette	solution		Intracellular	 pipette	 solution	 was	 made	 daily	 from	 stock	 solutions	 kept	 at	 4°C	except	adenosine	triphosphate	(ATP)	which	was	stored	at	-20°C.	The	compositions	of	pipette	solutions	used	in	this	study	are	shown	in	table	2.3,	below:	
	 	 2mM	ATP	pipette	
solution	(mM)	
4mM	ATP	pipette	
solution	(mM)	
K-gluconate	 140	 140	
HEPES	 10	 10	
KCL	 10	 10	
EGTA	 1	 1	
Na2ATP	 2	 4	
Biocytin	 5	 5		
Table	2.3:	Pipette	solution	composition		 The	pH	was	adjusted	to	7.4	with	KOH	and	osmolarity	adjusted	to	within	10	mOsm.kg-1	below	that	of	the	aCSF	(typically	290	-310)	with	sucrose.						
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2.6.3	 Solutions	used	in	thesis	chapters	aCSF	glucose	concentration	and	pipette	solution	ATP	concentration	was	tailored	to	the	 requirements	of	 the	experiment	on	 the	day.	During	 tissue	preparation,	brain	slices	were	maintained	 in	aCSF	of	 identical	glucose	concentration	 to	 that	used	 in	experimental	 control	 conditions.	 aCSF	 flow	rate	was	kept	between	2	–	5	ml/min	and	 system	 volume	 was	 around	 15	 ml	 meaning	 that	 upon	 drug/	 glucose	application,	 the	 intended	 concentration	 of	 drug/glucose	 was	 present	 in	 the	recording	 chamber	 after	 a	 maximum	 of	 7.5	 minutes.	 aCSF	 glucose	 and	 pipette	solution	ATP	concentration	used	in	experiments	presented	in	this	thesis	are	shown	in	table	2.4,	below:	
	
Thesis	Chapter	 aCSF	Glucose	
(mM)	
aCSF	Mannitol	
(mM)	
Pipette	Solution	
ATP	(mM)	
Chapter	3	 1	or	5	 9	or	5	 2	
Chapter	4	 1	or	5	 9	or	5	 2	
Chapter	5	 3	 7	 2	
Chapter	6	 2	 8	 2	
Chapter	7	 5	 5	 2	
Chapter	8	 10	 0	 4	
	
Table	2.4:	Composition	of	aCSF	and	pipette	solution		
2.7	 Reversal	Potentials	Reversal	potentials	were	calculated	from	current-voltage	relationship	plots.	These	plots	were	 generated	 from	programmed	Clampex	protocols	 for	 both	 control	 and	
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test	 conditions.	 Here,	 negative,	 square-wave	 current	 pulses	 were	 injected	 at	decreasing	 magnitude	 and	 equal	 integer	 with	 the	 most	 negative	 current	 pulse	being	sufficient	to	hyperpolarize	the	neurons	membrane	potential	beyond	-90	mV.	Reversal	 potentials	 were	 determined	 from	 the	 intersection	 or	 extrapolated	intersection	of	current-voltage	scatter	plots.		Ionic	reversal	potentials	were	determined	using	the	Nernst	Equation:																																														Eion=RT	ln[ion]o																																																								zF					[ion]i		Where	Eion	is	the	equilibrium	potential	for	the	ion	in	question,	R	is	the	gas	constant	(8.315	J	K-1	mol-1),	T	is	absolute	temperature	(273.16	+	T	[25oC]),	Z	is	the	valency	of	 the	 ion	 in	 question,	 F	 is	 Faraday’s	 constant	 (96,485	 C	 mol-1),	 [Ion]o	 is	 the	extracellular	 concentration	 of	 the	 ion	 in	 question	 and	 [ion]I	 is	 the	 intracellular	concentration	 of	 the	 ion	 in	 question.	 Reversal	 potentials	 of	 ions	 critical	 to	 the	maintenance	of	membrane	voltage	are	given	in	table	2.5,	below:	
	
Ion	 Extracellular	
Concentration	(mM)	
Intracellular	
Concentration	(mM)	
Reversal	
Potential	(mV)	
Na+	 153		 6	 81.6	
Cl-	 136.3	 10	 -65.8	
Ca2+	 2.4	 0.001	 196	
K+	 3.1	 150	 -97.7		
Table	2.5:	Ionic	reversal	potentials	
	 61	
2.8	 Drugs	Drugs	 were	 applied	 to	 brain	 slices	 during	 recording	 through	 the	 use	 of	 60	 ml	syringes	 connected	 to	 the	 aCSF	 bath	 perfusion	 setup	 via	 three-way	 taps.	 Drugs	were	 prepared	 as	 a	 stock	 solution	 at	 a	 concentration	 >1000	 times	 that	 of	 the	concentration	 used	 for	 experimentation,	 and	 were	 stored	 at	 <-20°C.	 Stock	solutions	were	made	using	either	distilled	water	or	DMSO	as	a	solvent.	Final	bath	concentrations	 of	 DMSO	 never	 exceeded	 0.1%.	 Drug	 stocks	 were	 defrosted	 and	added	to	60	ml	syringes	ready	for	bath	application	at	the	desired	concentration	at	the	 last	 convenient	 moment	 to	 minimize	 drug	 oxidation	 or	 degradation.	 Drugs	used	in	these	experiments	are	listed	below	in	table	2.6,	below:	
	
Drug	 Concentration	 Solvent	Tetrodotoxin	citrate	(TTX)	 1μM	 Distilled	water	Bicuculine	methiodide	 20	μM	 Distilled	water	6-nitro-7sulphamoybenzo(f)-	quinoxaline-2,3-dione	(NBQX)	 10	μM	 Distilled	water	Ghrelin	 3	nM,	10	nM,	30	nM,	100	nM	 Distilled	water	Leptin	 100	nM	 Distilled	water	Insulin	 100	nM	 HCl	Thyrotropin	releasing	hormone	(TRH)	 400	nM	 Distilled	water	Carbenoxolone	(CBX)	 30	μM,	100	μM	 Distilled	water	4-amino	pyrimidine	(4-AP)	 1	mM	 DMSO	5-hydroxytryptamine	(5-HT)	 50	μM	 Distilled	water	Noradrenaline	(NA)	 40	μM	 Distilled	water	
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Table	2.6:	Drugs	used	in	experiments	
	
2.9	 Statistical	Analysis	Statistical	 analysis	 was	 performed	 using	 Excel	 (Microsoft)	 and	 Graphpad	(Graphpad	Software	Inc.	San	Diego,	USA)	and	all	values	are	expressed	as	a	mean	±	SEM.	Numbers	of	observations	are	stated	as	n	 values.	Statistical	 significance	was	
Compound	8	(TCPTP	inhibitor)	 20	nM	 Distilled	water	Tonabersat	 10	μM	 Distilled	water	Carabersat	 10	μM	 Distilled	water	(2R)-amino-5-phosphonopentanoate	(APV)	 20	μM	 Distilled	water	Nickel	Chloride	(NiCl2)	 1	mM	 Distilled	water	Cesium	Chloride	(CsCl)	 500	μM	 Distilled	water	Barium	Chloride	(BaCl2)	 100	μM	 Distilled	water	PSB	603	(A2B	antagonist)	 100	nM	 DMSO	MRS	1523	(A3	antagonist)	 300	nM	 DMSO	Istradefylline	(A2A	antagonist)	 50	nM	 DMSO	DPCPX	(A1	antagonist)	 1	μM	 DMSO	LY294002	(PI3K	inhibitor)	 10	μM	 DMSO	SB224289	(5-HT	1B	antagonist)	 10	μM	 DMSO	(S)-WAY	100135	(5-HT	1A	antagonist)	 100	nM	 DMSO	SB-269970	hydrochloride	(5-HT	7	antagonist)	 100	nM	 Distilled	Water	β-estradiol	 400	nM	 DMSO	Coritcosterone	 400	nM	 DMSO	
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determined	using	a	two-tailed	student’s	t-test,	paired	or	unpaired,	1-way	ANOVA,	2-way	ANOVA	or	Chi-square	test,	as	appropriate.																																									
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Chapter	3:	Electrophysiological	
characterization	of	NPY/AgRP	
neurons	
	
3.1		 Introduction	Active	and	passive	membrane	properties	are	critical	biophysical	parameters	 that	can	 define	 the	 computational	 power	 of	 neurons,	 directly	modulating	 the	 gain	 of	neuronal	 inputs	 and	 outputs.	 Passive	 membrane	 properties	 include	 the	capacitance	 and	 resistance	 of	 the	 neuron	 membrane	 whilst	 active	 membrane	properties	include	biophysical	characteristics	modulated	by	voltage,	ligands	and	or	second	messengers.	Passive	membrane	properties	can	be	indicative	of	the	size	of	the	 neuron,	 its	 level	 of	 compartmentalization	 and	 degree	 of	 connectivity	 with	neighboring	 neurons	 in	 the	 case	 of	 electrotonically	 coupled	 networks.	Suprathreshold	 active	 conductances	 include	 all	 of	 those,	 sodium,	 potassium	 and	calcium	conductances	that	can	contribute	to	action	potential	firing	(Meech,	1978).		Also	associated	with	suprathreshold	active	conductances	are	those	that	contribute	to	 afterpotentials	 (afterhyperpolarisation	 (AHP)	 and	 in	 some	 cases	afterdepolarization	 (ADP)).	 	The	AHP	 is	a	critical	determinant	of	action	potential	firing	 frequency	and	can	 comprise	of	multiple	 conductances	 including	potassium	and	calcium-activated	potassium	conductances	(Wu	et	al.,	2004).		ADP’s	following	action	potentials	rather	than	regulating	firing	frequency	tend	to	promote	extended	periods	 of	 increased	 action	 potential	 firing.	 	 Other	 conductances	 critical	 to	regulating	 neuronal	 excitability	 are	 subthreshold	 active	 conductances	 i.e.	 those	conductances	 that	are	generally	activated	by	subthreshold	changes	 in	membrane	potential	and	contribute	driving	or	regulating	suprathreshold	activity.	Examples	of	
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subthreshold	 active	 conductances	 include:	 T-type	 calcium	 (IT)	 and	hyperpolarization-activated	 cyclic	 nucleotide	 gated	non-selective	 cation	 channels	(IH),	 both	 of	 which	 promote	 regenerative	 rhythmic	 patterns	 of	 activity	 in	 many	neurons	 (van	 den	 Top	 et	 al.,	 2004,	 McCormick	 and	 Pape,	 1990);	 instantaneous,	anomalous	 inwardly	 rectifying	 potassium	 conductances	 (Kir;	 IAN),	 activated	 at	negative	 membrane	 potentials	 and	 thought	 important	 in	 maintaining	 neuronal	membrane	 potential	 within	 a	 functionally	 operative	 window;	 transient	 outward	rectification	 (ITOR)	 observed	 as	 a	 delayed	 return	 to	 rest	 following	 membrane	hyperpolarization	 or	 as	 a	 delay	 in	 reaching	 threshold	 from	 negative	 resting	potentials	 (Whyment	 et	 al.,	 2011).	 Voltage-sensing	 channels	 confer	 specific	biophysical	 properties	 to	 the	 neuron	 within	 which	 they	 are	 expressed.	 The	endpoints	of	many	endogenous	and	exogenous	ligands	are	ion	channels.	Increases	or	 decreases	 in	 single	 channel	 conductance	 or	 channel	 voltage-gating	 properties	can	affect	neuron	excitability	and	output.	Furthermore	these	conductances	change	with	 development,	 in	 disease	 states	 and	 in	 responses	 to	 environmental	perturbations	 and	 are	 critical	 determinants	 of	 both	 physiological	 and	pathophysiological	output	 from	neural	networks	 to	drive	appropriate	 changes	 in	behavior	(Dworakowska	and	Dolowy,	2000,	Ashcroft,	2006).	Previous	 studies	 have	 characterized	 the	 morphological	 and	electrophysiological	 properties	 of	 hypothalamic	 neuron	 populations	 (Fioramonti	et	 al.,	 2004,	 Burdakov	 and	 Ashcroft,	 2002,	 Armstrong,	 1995,	 Tasker	 and	 Dudek,	1991,	 Stern,	 2001,	 Pennartz	 et	 al.,	 1998,	 Gonzalez	 et	 al.,	 2012).	 Three	electrophysiologically	 distinct	 neuronal	 populations	 residing	 in	 the	 arcuate	nucleus	of	the	hypothalamus	(ARH)	have	been	defined,	in	terms	of	their	membrane	response	 to	 the	 offset	 of	 negative	 square-phase	 current	 injection:	 1;	 rebound	
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depolarization,	 2;	 no	 rebound	 depolarization,	 and	 3;	 transient	 outward	rectification	(Burdakov	and	Ashcroft,	2002).	To	 date,	 a	 thorough	 characterization	 of	 the	 active	 and	 passive	membrane	properties	of	 functionally	defined	neurons	of	known	chemical	phenotype	has	not	been	undertaken.	Neuropeptide	Y	 (NPY)	neurons	of	 the	ARH	are	 the	key	 central	neural	population	responsible	for	driving	food	intake	and	hunger.	NPY	neurons	are	required	 for	 the	maintenance	of	 food	 intake	and	glucose	homeostasis	 (Luquet	et	al.,	 2005,	 Konner	 et	 al.,	 2007).	 NPY	 neurons	 elevate	 their	 electrical	 activity	 in	negative	 energy	 states	 (Takahashi	 and	 Cone,	 2005).	 Pharmacological	 and	optogenetic	 excitation	 of	 NPY	 neurons	 elicits	 elevations	 in	 food	 intake,	 whilst	neuronal	inhibition	results	in	food	intake	reductions	(Aponte	et	al.,	2011,	Atasoy	et	al.,	2012,	Krashes	et	al.,	2011).	NPY	neurons	are	sensitive	to	glucose	and	a	number	of	peripheral	hormones	including	leptin,	insulin	and	ghrelin	(Belgardt	et	al.,	2009,	van	den	Top	et	al.,	2004,	Vong	et	al.,	2011,	Konner	et	al.,	2007,	Claret	et	al.,	2007).	Despite	 the	 obvious	 critical	 role	 of	 NPY	 neurons	 in	 the	 central	 control	 of	energy	balance	and	food	intake,	there	have	been	no	electrophysiological	studies	to	date	 showing	 how	 these	 neurons	 process	 and	 adapt	 to	 changes	 in	 energy	 or	hunger	 status	 and	 formulate	 electrically	 coded	 commands	 to	 drive	 appropriate	behavioral	 changes.	 Changes	 in	 active	 and	passive	membrane	properties	may	be	indicative	 of	 functionality	 in	 vivo	 and	 is	 of	 value	 to	 our	 understanding	 of	hypothalamic	neuron	function	and	their	regulation	of	somatic	energy	homeostasis.	Aims	 of	 this	 study	 are	 to	 characterize	 the	 active	 and	 passive	 membrane	properties	of	NPY/AgRP	neurons	in	fed	and	fasted	conditions,	and	investigate	the	effects	of	extracellular	glucose	concentration	on	these	parameters.		
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3.2	 	Results	Whole-cell	 recordings	were	 obtained	 from	 40	 NPY	 eGFP	 neurons	 located	 in	 the	arcuate	 nucleus	 of	 hypothalamic	 brain	 slices	 bathed	 in	 aCSF	 containing	 1	 mM	glucose,	 taken	from	animals	subjected	to	an	18-hour	 fast	prior	 to	culling.	Whole-cell	 recordings	 were	 also	 obtained	 from	 40	 NPY	 eGFP	 neurons	 of	 brain	 slices	bathed	 in	 aCSF	 containing	 1	 mM	 glucose,	 taken	 from	 animals	 fed	 ad	 libitum.	Finally,	whole-cell	recordings	were	obtained	from	40	NPY	eGFP	neurons	of	brain	slices	bathed	in	aCSF	containing	5	mM	glucose,	taken	from	animals	fed	ad	libitum.		To	 investigate	 subthreshold	 and	 suprathreshold	 voltage-sensitive	conductances	 expressed	 by	 NPY	 eGFP	 neurons,	 the	 membrane	 current-voltage	relationship	 of	 neurons	was	 investigated.	Here	 hyperpolarizing	 and	depolarizing	square-phase	current	steps	of	equal	 increment	were	 injected	(<±100	pA,	200	ms	duration),	with	negative	current	sufficient	to	drive	membrane	voltage	to	around	-100	mV	and	positive	current	sufficient	to	induce	action	potential	firing.			
3.2.1	 	Effects	of	Energy	status	and	D-glucose	levels	on	EPSC	frequency	Of	 the	Fasted	1	mM	glucose	population,	voltage	clamp	recordings	were	obtained	from	 16	 NPY	 eGFP	 neurons.	 Neurons	 were	 held	 at	 a	 potential	 of	 -90mV	 to	maximize	 EPSC	 current	 amplitude.	 Of	 neurons	 recorded	 in	 1mM	D-glucose	 from	slices	prepared	from	fasted	animals,	mean	EPSC	frequency	was	0.86	±	0.13	Hz.	Of	the	Fed	1	mM	glucose	population,	voltage	clamp	recordings	were	obtained	from	16	NPY	eGFP	neurons.	Of	neurons	recorded,	mean	EPSC	frequency	was	0.55	±	0.06	Hz.	Of	the	Fed	5	mM	glucose	population,	voltage	clamp	recordings	were	obtained	from	13	NPY	eGFP	neurons.	Of	neurons	recorded,	mean	EPSC	frequency	was	1.01	±	0.13	Hz.	 Neurons	 of	 the	 Fed	 1	 mM	 glucose	 group	 had	 a	 significantly	 lower	 EPSC	
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frequency	 than	 the	neurons	 of	 the	 Fed	5	mM	glucose	 groups	 (p=>0.05;	 one-way	ANOVA	 &	 post-hoc	 Bonferroni	 test)	 (figure	 3.1).	 The	 GABA	 receptor	 antagonist	bicuculine	was	not	bath	applied	during	these	experiments.		
3.2.2		 Passive	membrane	properties	NPY	neurons	recorded	in	brain	slices	from	fasted	mice,	incubated	in	1	mM	glucose	aCSF,	 had	 a	 mean	 resting	 membrane	 potential	 of	 -39.44	 ±	 0.82	 mV	 and	 mean	neuronal	 input	resistance	of	1484	±	166	MΩ.	Of	 these	neurons	35	of	40	(87.5%)	were	 spontaneously	 active	with	mean	 spontaneous	 firing	 rate	of	 1.52	±	0.22	Hz.	The	mean	threshold	for	action	potential	firing	was	-24.28	±	2.35	mV	and	the	mean	action	potential	amplitude	amounted	to	42.6	±	3.7mV.	Here,	mean	action	potential	duration	at	½	amplitude	was	2.6	±	0.1	ms,	whilst	mean	action	potential	duration	at	threshold	was	6.6	±	0.5	ms,	this	gave	a	threshold	to	½	duration	ratio	of	2.4	±	0.1.	NPY	 eGFP	 neurons	 recorded	 from	 fasted	 animals	 in	 1mM	 glucose	 had	 mean	membrane	time	constant	of	59.5	±	7.4	ms.	Mean	AHP	amplitude	was	measured	at	17.0.	±	0.8	mV	and	AHP	½	decay	was	313	±	48	ms	(n=40).	Recordings	obtained	from	brain	slices	 from	mice	 fed	ad	libitum,	 incubated	in	1	mM	glucose	aCSF,	 revealed	NPY	eGFP	neurons	had	mean	resting	membrane	potential	 of	 -39.05	±	 0.49	mV	and	 input	 resistance	 of	 1975	±	292	MΩ.	 	Of	 these	neurons	38	of	40	(95%)	were	spontaneously	active	with	mean	spontaneous	firing	rate	was	 1.41	 ±	 0.14	Hz.	 In	 this	 population,	mean	 threshold	 for	 action	 potential	firing	was	-26.4	±	1.5	mV	and	mean	action	potential	amplitude	was	44.2	±	2.6	mV.	The	mean	action	potential	duration	at	½	amplitude	was	3.5	±	0.2	ms,	whilst	mean	action	potential	 duration	 at	 threshold	was	9.3	±	0.5	ms,	 giving	 a	 threshold	 to	½	duration	ratio	of	2.64	±	0.08.	Of	these	NPY	eGFP	neurons	the	mean	membrane	time	
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constant	was	73.2	±	5.7	ms.	Mean	AHP	amplitude	was	measured	at	16.	±	0.7	mV	and	AHP	½	decay	was	461±	48	ms	(n=40).	In	brain	slices	from	mice	fed	ad	libitum,	incubated	in	5	mM	glucose	aCSF,	NPY	eGFP	neurons	 had	 a	 mean	 resting	 membrane	 potential	 of	 -39.3	 ±	 0.9	 mV	 and	 input	resistance	 of	 1686	 ±	 131MW.	 	 Of	 these	 neurons	 33	 of	 40	 (82.5%)	 were	spontaneously	active	with	mean	spontaneous	firing	rate	of	1.8	±	0.3	Hz.	The	mean	threshold	 for	 action	 potential	 firing	 was	 -26.22	 ±	 0.44	 mV	 and	 mean	 action	potential	 amplitude	 amounted	 to	 42.9	 ±	 1.2	 mV.	 The	 mean	 action	 potential	duration	at	½	amplitude	was	3.1	±	0.2	ms,	whilst	mean	action	potential	duration	at	threshold	was	8.0	±	0.6	ms,	this	gave	a	threshold	to	½	amplitude	duration	ratio	of	2.6	±	0.1.	Of	 these	NPY	eGFP	neurons	mean	membrane	time	constant	was	70.4	±	9.2	ms.	Mean	AHP	amplitude	was	measured	at	18.00	±	0.84	mV	and	AHP	½	decay	was	 442±	 73	 ms	 (n=40).	 When	 comparing	 Fasted	 1mM	 glucose	 and	 Fed	 1	 mM	glucose	populations,	 statistical	 significance	was	obtained	when	comparing	action	potential	 duration,	 both	 at	 ½	 amplitude,	 and	 at	 action	 potential	 duration	 at	threshold	(p=0.0005	and	0.0001,	respectively;	2-way	ANOVA,	post-hoc	Bonferroni	test).			
3.2.3	 	Pharmacological	properties	of	action	potentials	in	NPY	neurons	Action	 potentials	 were	 sensitive	 to	 1	 μM	 TTX	 (n=6),	 whilst	 oscillations	 in	membrane	 potential	 persisted,	 most	 likely	 mediated	 via	 calcium-dependent	mechanisms	(figure	3.7B).		
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3.2.4		 Subthreshold	active	membrane	properties	IV	 relations	 were	 investigated	 in	 all	 neurons	 to	 identify	 subthreshold	 active	conductances	 expressed	 in	 NPY	 neurons	 under	 the	 various	 fed,	 fasted	 and	extracellular	 glucose	 conditions.	 	 Of	 recordings	 obtained	 from	 NPY	 neurons	 in	brain	 slices	 from	 fasted	 mice,	 incubated	 in	 1	 mM	 glucose	 aCSF,	 membrane	response	to	hyperpolarizing	and	depolarizing	current	injection	revealed	that	30%	of	 these	 neurons	 did	 not	 express	 any	 obvious	 subthreshold	 active,	 voltage-dependent	 conductances	 under	 these	 conditions.	 In	 a	 further	 30%	 of	 NPY	 eGFP	neurons	IH	was	the	only	conductance	expressed.		IH	was	identified	as	a	depolarizing	sag	 in	 the	membrane	 response	 to	 large	 amplitude	hyperpolarizing	 current	 pulse	injection	 and	 as	 a	 rebound	 excitation	 at	 the	 offset	 of	 these	 responses	 to	 current	injection	(see	figure	3.2C).	Ih	was	also	confirmed	by	its	sensitivity	to	extracellular	cesium	 chloride	 (500	 μM;	 n=4).	 	 A	 further	 22.5%	 of	 neurons	 in	 this	 population	were	 characterized	 by	 expression	 of	 IT	 only.	 	 IT	was	 characterized	 by	 a	 rebound	depolarization	 at	 the	 offset	 of	 membrane	 responses	 to	 hyperpolarizing	 current	injection	(see	 figure	3.2D).	 	To	ensure	the	presence	of	 IT	as	opposed	to	 IH,	 IT	was	also	 characterized	 as	 a	 peak	 depolarizing	 “hump”	 in	 response	 to	 depolarizing	current	 pulses	 from	 relatively	 negative	 holding	 potentials	 (>-60mV).	 	 IT	 can	 be	distinguished	 from	 IH	 by	 the	 fact	 that	 IH	 is	 hyperpolarizing,	 not	 depolarizing	activated	whereas	T-type	is	de-inactivated	by	hyperpolarization	but	only	activated	by	 depolarization.	 IT	 expression	 in	 NPY	 neurons	 was	 further	 confirmed	 by	 its	sensitivity	to	extracellular	Nickel	chloride	(1mM;	n=4).	15%	of	this	population	of	NPY	neurons	expressed	IH	and	IT,	whereas	2.5%	of	neurons	expressed	IH,	IT	and	IAN.	Ian	was	 identified	 as	 an	 instantaneous	 inward	 rectification	 observed	 as	 a	 fall	 in	
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neuronal	 input	 resistance	at	negative	membrane	potentials	 (>-80mV)	 (see	 figure	3.2Bi	and	Bii).	IV	 relations	 from	NPY	 neurons	 recorded	 in	 brain	 slices	 from	mice	 fed	ad	
libitum,	incubated	in	1	mM	glucose	aCSF,	revealed	that	40%	of	NPY	eGFP	neurons	do	 not	 express	 any	 subthreshold	 voltage-dependent	 conductances	 under	 these	conditions.	 Furthermore	 experiments	 revealed	 12.5%	 of	 neurons	 to	 express	 IH	only,	30%	of	neurons	expressed	IT	only,	5%	of	NPY	eGFP	neurons	expressed	IH	and	IT	whilst	12.5%	of	neurons	expressed	IT	and	IAN	(figure	3.5).	IV	 relations	 in	 NPY	 neurons	 recorded	 in	 brain	 slices	 from	 mice	 fed	 ad	
libitum,	incubated	in	5	mM	glucose	aCSF,	revealed	that	35%	of	NPY	eGFP	neurons	do	 not	 express	 any	 voltage-dependent	 conductances	 under	 these	 conditions.	52.5%	 of	 neurons	 expressed	 IT	 only,	 7.5%	 of	 neurons	 expressed	 IH	 only,	 2.5%	expressed	IH	and	IT,	and	a	further	2.5	%	expressed	IT	and	IAN	(figure	3.5).	
	
3.3		 Discussion	Here,	 for	 the	 first	 time	 passive	 and	 active	 membrane	 properties	 of	 NPY	 eGFP	neurons	 in	 in	vitro	conditions,	replicating	positive	and	negative	energy	states	are	reported.	 The	 ARH	 is	 well	 recognized	 as	 containing	 glucose-sensitive	 neurons	(Spanswick	et	al.,	1997,	Ibrahim	et	al.,	2003)	and	NPY	neurons	have	been	reported	exclusively	glucose	inhibited	(Burdakov	and	Gonzalez,	2009,	Muroya	et	al.,	1999).	Here	 I	 show	glucose	and	 feeding	status-dependent	changes	 in	passive	and	active	NPY	neuron	membrane	properties.			
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3.3.1	 	Energy	status-sensitive	EPSC	frequency	NPY	neurons	of	the	Fed	1	mM	glucose	group	had	a	significantly	lower	spontaneous	EPSC	frequency	than	NPY	neurons	from	the	Fed	5	mM	populations.	The	relatively	elevated	 EPSC	 frequency	 in	 1	 mM	 glucose,	 compared	 to	 5	 mM	 glucose,	 is	 in	agreement	 with	 previous	 research	 and	 fits	 with	 our	 current	 understanding	 of	arcuate	 NPY	 neurons;	 elevated	 excitation	 under	 negative	 energy	 states	 drives	increases	 in	 food	 intake	 and	 suppresses	 energy	 expenditure	 (Kong	 et	 al.,	 2016,	Krashes	 et	 al.,	 2014).	 The	 absence	 of	 significance	when	 comparing	 the	 Fasted	 1	mM	and	fed	5	mM	glucose	groups	seems	somewhat	paradoxical,	but	may	indicate	that	changes	 in	afferent	excitatory	 innervation	of	NPY	neurons	 is	an	acute	rather	than	 chronic	 effector	 of	 behavioral	 and	 physiological	 changes.	 Further	 work	 is	required	to	investigate	the	nuances	of	energy	status	sensing	neurotransmission	at	arcuate	 NPY	 neurons.	 It	 must	 be	 acknowledged	 that,	 as	 neuronal	 membrane	potential	was	 held	more	 negative	 than	 the	 reversal	 potential	 for	 chloride	 under	our	 recording	 conditions,	 EPSCs	 ostensibly	 observed	 may	 indeed	 be	 reversed	IPSCs.	As	such	the	implications	of	this	data	is	limited.		
3.3.2		 Passive	membrane	properties	Neurons	 of	 the	 Fasted	 1	mM	 glucose	 population	 had	 significantly	 shorter	 action	potential	 duration	 at	 ½	 amplitude	 (p=0.0007)	 and	 action	 potential	 duration	 at	threshold	(p=0.0002),	compared	to	neurons	of	the	Fed	1	mM	population.		No	 statistical	 significance	was	 observed	when	 comparing	 the	 passive	membrane	properties	 of	 Fasted	 1	mM	 glucose	 and	 Fed	 5	mM	 glucose	 experimental	 groups.	However	neurons	of	the	Fasted	1	mM	glucose	group	did	display	a	trend	for	shorter	
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action	 potential	 duration	 at	 threshold	 (p=0.069;	 2-way	 ANOVA,	 post-hoc	Bonferroni	test)	relative	to	Fed	5	mM	neurons.	No	 statistical	 significance	 was	 observed	 when	 comparing	 the	 passive	membrane	properties	 of	 Fed	1	mM	glucose	 and	Fed	5	mM	glucose	 experimental	populations.	Here	 I	 show	 that	 negative	 energy	 state	 is	 associated	 with	 faster	 action	potential	and	AHP	kinetics.	Our	current	understanding	is	that	In	vivo	NPY	neuron	activity	 is	 elevated	 in	 negative	 energy	 states,	 and	 faster	 rise	 and	 decay	 times	increases	 the	 neurons	 competence	 for	 high	 frequency	 discharge	 (Krashes	 et	 al.,	2014,	Cone,	2005).	Further	work	would	be	of	use,	using	larger	samples	of	neurons,	to	 determine	 if	 other	 passive	membrane	 parameters	 are	 subtly	 yet	 significantly	altered	in	differing	energy	states.		
3.3.4		 Active	membrane	properties	Here	 I	 show	 energy-status-dependent	 plasticity	 of	 expression	 of	 active	conductances	differentially	expressed	in	NPY	neurons	depending	on	glucose	levels	and	 energy	 status	 (fed	 versus	 fasted).	 Of	 note	 is	 a	 negative	 correlation	 between	energy	abundance	and	IH	conductance	expression,	with	7.5%	of	NPY	eGFP	neurons	expressing	 this	 conductance	 in	 the	 Fed	 5	 mM	 glucose	 population,	 12.5	 %	 of	neurons	 in	 the	Fed	1	mM	glucose	population	expressed	 IH,	whereas	30%	of	NPY	neurons	expressed	IH	in	the	Fasted	1	mM	glucose	group.		 Also	 of	 note	 is	 a	 positive	 correlation	 between	 energy	 abundance	 and	 IT	conductance	expression,	with	52.5%	of	neurons	expressing	this	conductance	in	the	Fed	 5	 mM	 glucose	 group,	 30%	 of	 NPY	 neurons	 expressed	 IT	 in	 the	 Fed	 1	 mM	
	 74	
population,	 whereas	 only	 22.5%	 of	 neurons	 expressed	 IT	 in	 the	 Fasted	 1	 mM	glucose	population.		 In	 this	 study,	 there	 was	 a	 notable	 absence	 of	 any	 clear	 instantaneous	inward	 rectification,	 upon	 membrane	 hyperpolarization.	 Arcuate	 NPY	 neurons	express	 potassium	 inward	 rectifier	 6.2	 (Kir6.2)	 and	 it	 may	 therefore	 seem	surprising	 that	 IAN	 expression	 was	 observed	 so	 seldom.	 However	 the	 Kir6.2	isoform	 confers	 weak	 rectification	 properties	 unto	 the	 neuron	 in	 question,	 and	therefore	the	ostensible	absence	of	this	conductance	does	not	indicate	the	absence	of	 functional	Kir	channels	 in	the	NPY	neuron	membrane	(Kurata	et	al.,	2004,	van	den	Top	et	al.,	2007).		 A	 degree	 of	 plasticity	was	 also	 observed	 in	 the	 Coexpression	 of	 IH	 and	 IT,	with	 2.5%	 of	 neurons	 expressing	 both	 in	 the	 Fed	 mM	 glucose	 group,	 5%	 co-expressing	IH	and	IT	in	the	Fed	1	mM	group	and	15%	of	neurons	expressing	both	IH	and	IT	in	the	Fasted	1	mM	population.	Both	 IH	 and	 IT	 conductances	 can	 generate	 pacemaker-like	 activity,	 which	has	previously	been	observed	in	orexigen-sensing	arcuate	neurons,	and	also	in	my	experiments	(van	den	Top	et	al.,	2004).	Data	presented	here	would	suggest	that	IH	and	not	IT	is	more	associated	with	states	of	negative	energy	balance.	NPY	neurons	are	known	 to	elevate	electrical	 activity	during	energy	deficit	 in	vivo,	 as	 such	one	can	 postulate	 that	 elevated	 IH	 expression	 under	 such	 conditions,	 contributes	 to	NPY	 neuron	 firing	 frequency	 and	 firing	 pattern.	 Furthermore,	 NPY	 neurons	 co-expressing	AgRP	can	differentially	regulate	release	of	AgRP	versus	NPY	and	GABA	depending	on	the	physiological	status	of	the	organism.		These	changes	in	intrinsic	membrane	 conductances	 may	 therefore	 be	 fundamental	 to	 encoding	 and	
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formulating	output	that	drives	differential	release	of	these	peptides	and/or	amino	acid	transmitters	appropriate	to	physiological	energy	status.	The	 proportion	 of	 neurons	 expressing	 no	 active	 conductances	 was	relatively	 consistent	 across	 experimental	 groups	 with	 35%	 in	 Fed	 5	 mM	conditions,	40%	in	Fed	1	mM	conditions	and	30%	in	Fasted	1	mM	conditions.	This	may	suggest	that	these	neurons	contribute	a	subpopulation	of	non-energy-sensing	population	of	NPY	neurons	 in	 the	ARH.	Further	work	 should	use	anterograde	or	retrograde	 tracing	 to	 investigate	 how	 differences	 in	 electrophysiological	properties	pertain	to	target	innervation	and	physiological	output	functions.		 Previous	 publications	 have	 highlighted	 the	 heterogeneity	 of	 arcuate	 NPY	neurons,	 in	 terms	 of	 their	molecular	 expression	 profile,	 afferent	 inputs,	 efferent	connections	 and	 physiological	 function	 (Krashes	 et	 al.,	 2014,	 Betley	 et	 al.,	 2013,	Konner	 et	 al.,	 2007,	 Shi	 et	 al.,	 2013).	 However	 a	 thorough	 investigation	 of	 the	electrophysiological	heterogeneity	of	arcuate	NPY	neurons	has	been	lacking,	as	has	research	into	the	manner	in	which	electrophysiological	characteristics	are	affected	by	 feeding	 status.	 Research	 presented	 here	 represents	 the	 first	 description	 of	feeding	 state-dependent	 changes	 in	 arcuate	 NPY	 neuron	 characteristics	 and	contributes	significantly	 to	our	current	understanding	of	NPY	neuron	 function	 in	
vivo.	It	is	clear	that	in	order	to	better	understand	these	neurons,	we	must	attain	a	better	 appreciation	 of	 their	 complexity	 as	 a	 network	 of	 cells	 and	 as	 individual	information	 processing	 units.	 Work	 presented	 here	 is	 a	 positive	 step	 in	 that	direction.			
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Figure	 3.1:	 The	 frequency	 of	 excitatory	 post-synaptic	 currents	 (EPSCs)	 is	
modulated	by	extracellular	glucose	concentration	and	feeding	state	
A:	Voltage	clamp	recording	taken	from	an	NPY	eGFP	neuron	held	at	-90	mV,	from	a	mouse	fed	ad	libitum	prior	to	culling	with	brain	slices	incubated	in	aCSF	containing	1	mM	glucose.	
B:	Voltage	clamp	recording	taken	from	an	NPY	eGFP	neuron	held	at	-90	mV,	from	a	mouse	subjected	to	an	18-hour	fast	prior	to	culling	with	brain	slices	incubated	in	aCSF	containing	1	mM	glucose.	
C:	Voltage	clamp	recording	taken	from	an	NPY	eGFP	neuron	held	at	-90	mV,	from	a	mouse	fed	ad	libitum	prior	to	culling	with	brain	slices	incubated	in	aCSF	containing	5	mM	glucose.	
D:	Current	clamp	recording	taken	from	a	NPY	eGFP	neuron,	of	a	mouse	subjected	to	an	18-hour	fast	prior	to	culling	with	brain	slices	incubated	in	aCSF	containing	1	mM	 glucose.	 Here	 excitatory	 postsynaptic	 potentials	 (EPSPs)	 are	 sufficient	 to	evoke	action	potential	firing.											
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Figure	3.2:	Active	and	passive	neuronal	membrane	properties		
A:	 Current	 clamp	 recording	 showing	 action	 potential	 and	 afterhyperpolarisation	potential.	Annotations	highlight	parameters	quantified.	
Bi:	Superimposed	samples	of	a	continuous	current	clamp	recording	highlighting	an	anomalous	 inwardly	 rectifying	 potassium	 conductance	 (IAN),	 observed	 as	 a	reduction	in	neuron	input	resistance	at	more	hyperpolarized	membrane	potentials		Bii:	 Graph	 highlighting	 the	 current-voltage	 relationship	 of	 a	 neuron	 exhibiting	anomalous	inward	rectification.		
C:	 Current	 clamp	 recording	 showing	 a	 membrane	 response	 to	 hyperpolarizing	current	 injection	 (inset)	 highlighting	 a	 hyperpolarization-activated	 cation	conductance	(IH),	observed	as	a	time-	and	voltage-dependent	reduction	in	neuron	input	resistance,	upon	membrane	hyperpolarization	and	a	rebound	depolarization	at	the	offset	of	the	response	to	current	injection.	
D:	 Current	 clamp	 recording	 highlighting	 a	 T-type	 calcium	 conductance	 (IT),	observed	 as	 an	 overshoot	 in	 membrane	 potential,	 at	 the	 offset	 of	 membrane	hyperpolarization.			
	
	
	
	
	
	
	
200	ms	
20	mV	
-30 -20 -10 0
-110
-100
-90
-80
-70
-60
-50
-40
-30
pA
m
V
No Rectification
With Rectification
Ac3on	poten3al	amplitude	(mV)	
Threshold	for	ac3on	poten3al	ﬁring	(mV)		
AHP	half-3me	to	decay	(ms)	
AHP	amplitude	(mV)	
10	ms	
10	mV	
Ac3on	poten3al	half-height	(mV)	
A	
Figure	3.2		
Bi	
C	
D	
Bii	
	 80	
Figure	3.3:	Passive	membrane	properties	
A:	Table	summarizing	the	passive	membrane	properties	of	NPY	neurons	obtained	from	brain	slices	incubated	in	either	1	mM	or	5	mM	glucose,	of	mice	either	fed	ad	
libitum	or	fasted	for	18	hours	prior	to	culling.			
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.3		
A	
 Fasted 1 mM Glucose (n=40) 
Fed 1 mM 
Glucose (n=40)  
Fed 5 mM 
Glucose (n=40) 
2-Way 
ANOVA  
Significance 
Bonferroni 
Post-Hoc 
Analysis p 
Value * 
Spontaneous 
activity (%) 87.5 95 82.5 
NS	(Chi-
square;	
0.215)	
N/A	
Membrane 
potential (mV) -39.44 ± 0.83  -39.05 ± 0.49  -39.27 ± 0.94 NS	(0.9358)	
>0.9999	
>0.9999	
>0.9999	
Spontaneous 
Firing rate (Hz)  1.52 ± 0.22  1.41 ± 0.14  1.84 ± 0.35 NS	(0.4468)	
>0.9999	
>0.9999	
0.6667	
Input 
resistance 
(MΩ) 
 1484 ± 166  1975 ± 292  1686 ± 131 NS	(0.2682)	
0.3245	
>0.9999	
0.9972	
Membrane 
time-constant 
(ms) 
 59.45 ± 7.44  73.18 ± 5.70  70.45 ± 9.23 NS	(0.3571)	
0.525	
0.8445	
>0.9999	
Threshold for 
action potential 
(AP) firing (mV) 
 -24.28 ± 2.35  -26.39 ± 1.50 -26.22 ± 0.44  NS	(0.6111)	
>0.9999	
>0.9999	
>0.9999	
AP amplitude 
(mV) 42.59 ± 3.75   44.18 ± 2.57  42.87 ± 1.19 NS	(0.9088)	
>0.9999	
>0.9999	
>0.9999	
	
AP half-height 
duration (ms)  2.64 ± 0.15  3.53 ± 0.19  3.07 ± 0.18 S	(0.0007)	
0.0005	
0.1715	
0.1295	
AP threshold 
duration (ms) 6.62 ± 0.54   9.33 ± 0.54 8.05 ± 0.58  S	(0.0002)	
0.0001	
0.0692	
0.1261	
AP ratio; 
threshold: half-
height 
2.45 ± 0.10   2.64 ± 0.08 2.60 ± 0.09  NS	(0.1186)	
0.1744	
0.2919	
>0.9999	
Afterhyperpolar
isation potential 
(AHP) 
amplitude (mV) 
 16.99 ± 0.79 16.04 ± 0.66  18.00 ± 0.84  NS	(0.1664)	
>0.9999	
0.9858	
0.1772	
AHP half-decay 
time (ms) 313 ± 48  461 ± 48   442 ± 73.34 NS	(0.1183)	
0.1756	
0.2873	
>0.9999	
*	
Top: 	Fasted	1	mM	 	vs. 		Fed	1	mM	
Middle: 	Fasted	1	mM	 	vs. 		Fed	5	mM	
BoWom: 	Fed	1	mM	 	vs. 		Fed	5	mM	
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Figure	3.4:	NPY	neurons	express	multiple	subthreshold	active	conductances	Samples	of	continuous	whole-cell	recordings	are	shown	of	membrane	responses	to	current	injection.	
A:	Superimposed	current	clamp	recording	of	an	NPY	eGFP	neuron	with	membrane	potential	held	at	-60	mV,	in	control	conditions.	
B:	 Superimposed	 current	 clamp	 recordings	 from	 an	 NPY	 eGFP	 neuron	 with	membrane	potential	held	at	-60	mV,	in	the	presence	of	1	μM	TTX.		
C:	 Superimposed	 current	 clamp	 recordings	 from	 an	 NPY	 eGFP	 neuron	 with	membrane	potential	held	at	-60	mV,	in	the	presence	of	1	μM	TTX	and	the	inward	rectifier	blocker,	barium	chloride	100	μM.	
D:	 Superimposed	 current	 clamp	 recordings	 from	 of	 an	 NPY	 eGFP	 neuron	 with	membrane	potential	held	at	-60	mV,	in	the	presence	of	1	μM	TTX,	100	μM	barium	chloride	 and	 the	 Ih	 inhibitor	 cesium	 chloride	 500	 μM.	 Note	 the	 loss	 of	 the	hyperpolarizing	sag	in	response	to	larger	amplitude	current	injections.	
E:	 Superimposed	 current	 clamp	 recordings	 from	 an	 NPY	 eGFP	 neuron	 with	membrane	potential	held	at	-50	mV,	in	the	presence	of	1	μM	TTX,	100	μM	barium	chloride	 and	 500	 μM	 cesium	 chloride.	 Note	 the	 small	 rebound	 excitation	 at	 the	offset	 of	 the	 response	 to	 hyperpolarizing	 current	 injection	 that	 persists	 under	these	recording	conditions.	
F:	 Superimposed	 current	 clamp	 recordings	 from	 an	 NPY	 eGFP	 neuron	 with	membrane	potential	held	at	-50	mV,	in	the	presence	of	1	μM	TTX,	100	μM	barium	chloride,	 500	 μM	 cesium	 chloride	 and	 the	 low	 threshold	T-type	 calcium	 channel	blocker,	nickel	(1	mM	nickel	chloride).			
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Figure	 3.5:	 Energy	 Status-dependent	 plasticity	 of	 subthreshold	 active	
conductance	expression	
A:	Bar	chart	summarizing	the	active	conductance	expression	profile	of	arcuate	NPY	eGFP	neurons	in	fed	and	fasted	conditions	and	in	the	presence	of	fasted	(1mM)	or	fed	(5mM)	levels	of	D-glucose.			
B:	Table	summarizing	 the	differences	 in	active	conductance	expression	profile	of	arcuate	 NPY	 eGFP	 neurons	 in	 fed	 and	 fasted	 conditions	 and	 in	 the	 presence	 of	fasted	 (1mM)	or	 fed	 (5mM)	 levels	 of	D-glucose.	p-values	 as	 calculated	 from	Chi-square	testing.																	
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Figure	 3.6:	 Differential	 expression	 of	 subthreshold	 active	 conductances	 in	
NPY	eGFP	neuron	subpopulations	Samples	of	continuous	whole-cell	recordings	are	shown	of	membrane	responses	to	current	injection.	
A:	 An	 NPY	 eGFP	 neuron	 ostensibly	 lacking	 the	 expression	 of	 any	 subthreshold	active	conductances.	
B:	An	NPY	eGFP	neuron	only	expressing	the	IH	conductance.	
C:	An	NPY	eGFP	neuron	only	expressing	the	IT	conductance.	
D:		An	NPY	eGFP	neuron	expressing	IT	and	IAN	conductances.		
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Figure	3.7:	Voltage-dependence	of	oscillatory	membrane	activity	
Ai:	An	NPY	eGFP	neuron	with	membrane	potential	held	around	-38	mV,	displaying	tonic	firing.	
Aii:	 The	 same	NPY	 eGFP	 neuron	 as	 shown	 in	 Ai,	with	membrane	 potential	 held	around	-45	mV,	displaying	tonic	activity,	yet	at	slower	firing	frequency	as	in	Ai.	
Aiii:	The	same	NPY	eGFP	neuron	as	shown	above,	with	membrane	potential	held	around	-48	mV,	displaying	tonic	activity	beginning	to	transition	into	burst	firing.	
Aiv:	The	same	NPY	eGFP	neuron	as	shown	above,	with	membrane	potential	held	around	-55	mV,	with	more	pronounced	bursting	activity,	with	a	longer	interburst	interval	than	as	in	Aiii.	
Av:	 The	 same	NPY	eGFP	neuron	as	 shown	above,	with	membrane	potential	held	around	-70	mV,	with	more	pronounced	bursting	activity,	with	a	longer	interburst	interval	than	as	in	Aiii	and	Aiv.	
Avi:	The	same	NPY	eGFP	neuron	as	shown	above,	with	membrane	potential	held	around	-85	mV,	with	oscillatory	activity	totally	abolished.	
B:	 An	 NPY	 eGFP	 neuron	 bathed	 in	 TTX	 (1μM),	 with	 membrane	 potential	 held	around	 -50	 mV.	 Here,	 action	 potentials	 are	 abolished,	 but	 the	 underlying	oscillations	persist.								
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Chapter	4:	Functional,	energy	status-
dependent	plasticity	of	glucose	
sensing	in	NPY/AgRP	neurons		
4.1		 Introduction	Metabolic	 substrates	 are	 required	 for	 energy	 generation	 in	 al	 life.	 In	 mammals,	dietary	 fats,	 proteins	 and	 carbohydrates	 are	 catabolized	 for	 the	 generation	 of	adenosine	triphosphate	(ATP),	whilst	excess	calories	are	stored	predominantly	as	white	 fat	 and	 hepatic	 glycogen.	 Glucose	 homeostasis	 is	 regulated	 by	 central	 and	peripheral	 mechanisms,	 and	 through	 reciprocal	 hormonal-neuronal	communication.	 Peripheral	 mechanisms	 of	 glucose	 homeostasis	 include	 hepatic,	pancreatic	and	adrenomedullary	processes	whilst	central	mechanisms	involve	the	hedonic	and	homeostatic	control	of	 food	intake.	Direct	glucose-sensing	cells	exist	within	pancreatic	 islets	and	 in	central	nervous	system	(CNS)	regions	close	 to	 the	third	and	fourth	ventricles,	 including	the	hypothalamus	(McCrimmon,	2009,	Lam,	2010).	 Physiological	 counter-regulatory	 mechanisms	 to	 hypoglycemia	 include	reduced	 insulin	 secretion,	 increased	 glucagon	 secretion	 and	 increased	adrenomedullary	 catecholamine	 release	 via	 ventromedial	 hypothalamic-sympathetic	nervous	system	(VMH-SNS)	recruitment,	all	of	which	act	to	decrease	peripheral	 glucose	 uptake	 and	 increase	 glucose	 production	 by	 the	 liver	 and	kidneys	(Hoffman,	2007,	Borg	et	al.,	1995).	Conversely,	the	physiological	response	to	hyperglycemia	includes	increased	insulin	secretion,	decreased	glucagon	release,	reduced	 SNS	 tone	 and	 increased	 parasympathetic	 nervous	 system	 (PNS)	recruitment,	 all	 of	 which	 decreases	 hepatic	 and	 renal	 glucose	 production,	 and	increases	 glucose	 uptake	 to	 skeletal	 muscle	 and	 peripheral	 organs.	 These	
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mechanisms	ensure	the	tight	control	of	blood	glucose	concentration.	Physiological	plasma	glucose	concentration	lies	between	4	and	7	mM	whilst	cerebrospinal	fluid	(CSF)	 glucose	 levels	 are	 approximately	10	 to	30%	of	peripheral	 levels,	 and	have	been	 estimated	 to	 be	 around	 1	 to	 2.5	 mM	 (McNay	 and	 Gold,	 1999,	 Silver	 and	Erecinska,	 1994).	 In	 pathophysiological	 hyperglycemia,	 plasma	 glucose	concentration	 can	 rise	 as	 high	 as	 15	mM	whilst	 central	 levels	 can	 reach	4.5	mM	(Silver	and	Erecinska,	1994).	Hypoglycemia	can	result	in	peripheral	glucose	falling	as	low	as	2.8	mM	and	central	glucose	concentrations	decreasing	to	0.16	mM	(Silver	and	Erecinska,	1994).	These	data	indicate	that	central	glucose	concentrations	may	fluctuate	from	a	tenth	of	a	micromolar	to	as	high	as	15	millimolar.	As	such	a	more	modest	and	physiological	range	of	1	mM	glucose	–	replicating	fasted	conditions	–	and	 5	 mM	 –	 replicating	 fed	 conditions	 –	 are	 used	 in	 the	 experimental	 design	outlined	herein.	Hypothalamic	 glucose	 levels	 have	 been	 measured	 at	 around	 1.4	 mM,	however	 in	areas	such	as	 the	arcuate	nucleus	(ARH),	 in	close	apposition	to	more	permeable	 blood-brain-barrier	 (BBB)	 structures	 such	 as	 the	 median	 eminence,	glucose	 concentrations	 may	 fluctuate	 to	 a	 greater	 degree	 (Banks,	 2008).	Furthermore,	 in	 pathophysiological	 conditions	 such	 as	 obesity	 and	 diabetes,	elevated	central	glucose	concentrations	are	an	 inevitable	consequence	of	chronic	hyperglycemia.	The	effects	of	this	on	neuronal	function	are	yet	to	be	determined.	Previous	 reports	 have	 observed	 reductions	 in	 neuronal	 insulin	 signaling	 in	 the	hypothalamus	of	obese	rats	(Spanswick	et	al.,	2000).		The	brain	requires	a	constant	supply	of	glucose	from	the	periphery,	as	astrocytic	glycogen	stores	are	negligible.	Central	metabolism	of	glucose	is	in	part	limited	by	peripheral	 glucose	 concentration	 and	 glucose	 transporter	 kinetics.	 Glucose	
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transporters	 (GLUTs)	 are	 responsible	 for	 the	 trafficking	 of	 glucose	 into	 both	peripheral	 and	 central	 tissues	 (Vannucci	 et	 al.,	 1997).	 Seven	 GLUT	 isoforms	 are	expressed	in	mammalian	tissues.	Their	differential	expression	is	outlined	in	table	4.1,	below:	
GLUT	Isoform	 Tissue	Expression		GLUT1	(55kDa)	 Erythrocytes,	BBB	(KM:	17.6	mM)	GLUT1	(45	kDa)	 Glia,	neurons,	choroid	plexus	GLUT2	 Liver,	kidney,	pancreas,	astrocytes	(KM:	42.3	mM)	GLUT3	 Placenta,	sperm,	platelets,	neurons	(KM:	10.6	mM)	GLUT4	 Heart,	muscle,	adipocytes	GLUT5	 Small	intestine,	macrophage,	sperm,	microglia	GLUT6	 Pseudogene	GLUT7	 Liver,	kidney,	astrocytes	
	
Table	4.1:	Differential	tissue	expression	of	mammalian	GLUT	isoforms	
Table	adapted	from	(Gould	et	al.,	1991,	Vannucci	et	al.,	1997).			 Glucose	is	required	for	the	function	of	all	cells	in	the	CNS	including	neurons	and	astroglia,	both	of	which	use	it	as	the	main	substrate	to	generate	energy	(Yang	et	al.,	2015).	Central	glucose	signaling	can	occur	via	neuron-only	mechanisms	and	through	 the	 integration	 of	 both	 neuronal	 and	 glial	 signals.	 Astroglia	 outnumber	neurons	 in	 the	 CNS	 and	 form	 the	 bulk	 of	 CNS	 parenchyma	 (Nedergaard	 et	 al.,	2003).	 In	 the	 CNS,	 astroglia	 function	 to	 scale	 synaptic	 strength	 and	 modulate	neuronal	circuits	through	the	release	of	gliotransmitters	(Belanger	and	Magistretti,	2009,	Volterra	and	Meldolesi,	2005).	Gliotransmitters	include	glutamate,	D-serine	
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ATP	and	adenosine	(Belanger	et	al.,	2011,	Volterra	and	Meldolesi,	2005).	Astroglia	release	transmitters	via	calcium-dependent	exocytosis	and	through	non-exocytotic	mechanisms	 (Volterra	 and	 Meldolesi,	 2005).	 Connexin	 43	 (Cx43)	 hemichannels	have	been	shown	to	mediate	ATP	release	(Stout	et	al.,	2002,	Arcuino	et	al.,	2002).	ATP	 and	 adenosine	 signaling	 from	glia	 to	 neurons	may	present	 a	mechanism	by	which	hypothalamic	neurons	sense	 fluctuations	 in	central	glucose	concentrations	and	generate	functional	behavioral	outputs	(Newman,	2003,	Yang	et	al.,	2015).		The	hypothalamus	is	required	for	glucose	homeostasis	and	contains	neurons	that	couple	 extracellular	 glucose	 and	 metabolic	 secretagogue	 concentration	 to	electrical	 excitability.	 Changes	 in	 electrical	 activity	 generate	 functional	 outputs	that	regulate	physiological	processes	such	as	food	intake,	energy	expenditure	and	hepatic	 glucose	production	 (Hahn	et	 al.,	 1998,	 Luquet	 et	 al.,	 2005,	Muroya	et	 al.,	1999,	Shi	et	al.,	2013,	van	den	Top	et	al.,	2004,	Konner	et	al.,	2007,	Parton	et	al.,	2007,	Claret	et	al.,	2007).	Hypothalamic	loci	containing	glucose-sensitive	neurons	include	 the	VMH,	 lateral	hypothalamus	(LH)	and	ARH	(Ashford	et	al.,	1990a,	van	den	 Top	 et	 al.,	 2004,	 Spanswick	 et	 al.,	 2000,	 Oomura	 et	 al.,	 1974).	 Glucose	responsive	 (GR)	 neurons	 can	 be	 divided	 into	 glucose	 excited	 (GE)	 and	 glucose	inhibited	 (GI)	 neurons.	 GR	 neurons	 of	 the	 ARH	 include	 both	 orexigenic	neuropeptide	 Y/	 agouti-related	 peptide	 (NPY/AgRP)	 and	 anorexigenic	proopiomelanocortin/cocaine	 and	 amphetamine-regulated	 transcript	(POMC/CART)	neurons,	both	of	which	are	required	for	normal	energy	homeostasis	(Parton	et	al.,	2007,	Spanswick	et	al.,	2000,	Konner	et	al.,	2007).	Optogenetic	 and	 pharmacogenetic	 activation	 of	 NPY/AgRP	 neurons	elevates	 food	 intake,	whilst	 neuronal	 inhibition	 results	 in	 decreased	 food	 intake	(Aponte	 et	 al.,	 2011,	 Atasoy	 et	 al.,	 2012,	 Krashes	 et	 al.,	 2011).	 The	 functional	
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importance	 of	 arcuate	NPY/AgRP	 neurons	 is	 underlined	 by	work	 demonstrating	that	 ablation	 of	 these	 neurons	 in	 adult	 mice	 is	 sufficient	 to	 induce	 starvation	(Luquet	et	al.,	2005).	Fasting	has	been	reported	to	increase	action	potential	firing	rate	in	NPY/AgRP	neurons	(Takahashi	and	Cone,	2005).	NPY/AgRP	neurons	have	historically	 been	 assumed	 to	 be	 GI,	 are	 excited	 by	 orexigenic	 peptides	 such	 as	ghrelin,	and	are	inhibited	by	the	anorexigenic	peptides	insulin	and	leptin	(van	den	Top	 et	 al.,	 2004,	 Spanswick	 et	 al.,	 1997,	 Spanswick	 et	 al.,	 2000).	 Although	NPY/AgRP	neurons	have	been	 thoroughly	 characterized	 for	 their	 role	 regulating	food	 intake,	 they	 are	 also	 important	 in	 the	maintenance	 of	 glucose	 homeostasis	(Konner	et	al.,	 2007).	The	 functional	and	anatomical	heterogeneity	of	NPY/AgRP	neurons	 is	 highlighted	 by	work	 investigating	 the	 differential	 orexigenic	 effect	 of	efferent	target	innervation	in	vivo	(Betley	et	al.,	2013).		NPY/AgRP	 neurons	 have	 been	 shown	 to	 regulate	 POMC/CART	 neuron	activity	 via	 inhibitory	 GABAergic	 synapses	 (Cowley	 et	 al.,	 2001).	 Functionally	antagonistic	 NPY/AgRP	 and	 POMC/CART	 neurons	 of	 the	 ARH	 form	 the	melanocortin	 system,	 which	 regulates	 food	 intake	 and	 energy	 expenditure.	 The	melanocortin	 system	 affects	 physiological	 parameters	 through	 agonism	 and	antagonism	of	the	melanocortin-4	receptor	(MC4R)	at	second	order	neurons	(with	both	 NPY/AgRP	 and	 POMC/CART	 considered	 first	 order).	 α-melanocyte-stimulating	hormone	(α-MSH)	released	by	POMC/CART	neurons	is	the	endogenous	agonist	 of	 the	 MC4R,	 whilst	 AgRP	 is	 the	 endogenous	 antagonist	 of	 the	 MC4R	(Atasoy	 et	 al.,	 2012).	 NPY/AgRP	 and	 POMC/CART	 neurons	 share	 common	projection	sites	including	paraventricular	hypothalamic	(PVH)	neurons.	Increased	agonism	of	MC4	receptors	promotes	satiety	and	energy	expenditure	whilst	MC4R	antagonism	promotes	feeding	and	decreased	energy	expenditure.	Central	glucose	
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concentration	affects	 the	 tone	of	 the	melanocortin	 system	via	GR	NPY/AgRP	and	POMC/CART	neurons.	The	 ARH	 contains	 both	 GE	 and	 GI	 neuronal	 populations,	 with	 NPY/AgRP			assumed	to	be	GI	and	POMC/CART	assumed	to	be	GE.	Mechanisms	of	neuronal	GI	include	Na+/K+	ATPase	pump,	K+,	and	Cl-	channel	activation	(Oomura	et	al.,	1974,	Fioramonti	et	al.,	2007,	Burdakov	and	Gonzalez,	2009,	Jordan	et	al.,	2010,	Canabal	et	 al.,	 2007).	 	 The	mechanism	 of	 GE	 in	 the	 ARH	 has	 been	 shown	 to	 be	 via	 ATP-sensitive	potassium	(KATP)	channel	inhibition	and	has	been	described	as	analogous	to	pancreatic	β-cell	depolarization	(Ashford	et	al.,	1990a,	van	den	Top	et	al.,	2007,	Spanswick	et	 al.,	 1997,	Ashford	et	 al.,	 1990b).	A	KATP-independent	mechanism	of	GE	 has	 been	 reported,	 but	 is	 activated	 at	 supraphysiological	 concentrations,	between	 5	 and	 20	 mM	 glucose	 (Fioramonti	 et	 al.,	 2004).	 KATP	 channels	 couple	metabolic	 state	 to	 membrane	 potential	 by	 modulating	 plasma	 membrane	potassium	 flux	 (Ashcroft,	 1988).	 Both	 NPY/AgRP	 and	 POMC/CART	 neurons	express	functional	KATP	channels	(van	den	Top	et	al.,	2007,	Ibrahim	et	al.,	2003).	KATP	 channels	 are	 hetero-octamers,	 with	 four	 pore	 forming	 inwardly	 rectifying	potassium	 channel	 (Kir6.x)	 subunits	 surrounded	 by	 four	 sulfonylurea	 receptor	(SURx)	subunits	(Inagaki	et	al.,	1995,	Miki	et	al.,	1999).	Pancreatic	β-cells	express	Kir6.2	 and	 SUR1	 whilst	 neuronal	 KATP	 channels	 have	 been	 reported	 to	 be	composed	 of	 all	 possible	 combinations	 of	 Kir6.1,	 Kir6.2,	 SUR1	 and	 SUR2A	(Karschin	et	al.,	1998).	Kir6.x	subunits	confer	channel	rectification	properties	and	are	 the	 site	 of	 ATP	 binding,	 which	 initiates	 channel	 inhibition	 (Ashcroft,	 2005).	SUR	 subunits	 belong	 to	 the	 ATP-binding	 cassette	 (ABC)	 transporter	 family	 and	confer	channel	sensitivity	to	Mg2+	nucleotides,	channel	openers	such	as	diazoxide	and	channel	inhibitors	such	as	the	sulphonylureas	tolbutamide	and	glibenclamide	
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(Ashcroft,	 2005).	 Sulphonylureas	 are	 widely	 used	 in	 the	 treatment	 of	 type-II	diabetes,	 and	 can	 stimulate	 β	 cell	 insulin	 secretion	 via	 KATP	 channel	 inhibition	(Ashcroft	 and	 Gribble,	 2000).	 KATP	 channels	 are	 required	 for	 the	 secretion	 of	glucagon	from	pancreatic	α	cells,	insulin	from	pancreatic	β	cells,	somatostatin	from	D	 cells	 and	 glucagon-like	 peptide-1	 (GLP-1)	 from	 L	 cells	 (Ashcroft	 et	 al.,	 1984,	Gopel	 et	 al.,	 2000b,	 Gopel	 et	 al.,	 2000a,	 Gribble	 et	 al.,	 2003).	 In	 many	 central	neurons,	 KATP	 channels	 open	 only	 under	 pathophysiological	 conditions	 and	 offer	neuroprotection	for	hypoxia-induced	seizure	and	excitotoxic	cell	death	(Yamada	et	al.,	2001,	Hernandez-Sanchez	et	al.,	2001).		In	specialized	populations	of	central	GR	neurons	including	those	of	the	VMH	and	 ARH,	 KATP-regulated	 electrical	 activity	 controls	 glucostatic	 functions	 such	 as	hepatic	glucose	production,	energy	expenditure	and	food	intake	(Miki	et	al.,	2001,	Spanswick	 et	 al.,	 2000).	 The	 process	 of	 KATP	 mediated	 neuronal	 GE	 involves	GLUT3-dependent	 glucose	 uptake	 followed	 by	 glycolysis	 and	 oxidative	metabolism,	with	the	rate-limiting	step	in	β	cells	being	glucose	phosphorylation	to	glucose-6-phosphate	by	glucokinase	(GK)	(Sakura	et	al.,	1998).	 Increased	glucose	metabolism	 results	 in	 an	 elevated	 intracellular	 ATP/ADP	 ratio,	 increased	 ATP-Kir6.x	 subunit	 binding,	 KATP	 channel	 inhibition	 and	 membrane	 depolarization	(Sakura	et	al.,	1998).		NPY/AgRP	 are	 sensitive	 to	 a	 number	 of	 peripheral	 hormones,	 including	leptin,	 insulin	 and	 ghrelin	 (van	 den	 Top	 et	 al.,	 2007,	 van	 den	 Top	 et	 al.,	 2004,	Spanswick	 et	 al.,	 2000,	 Spanswick	 et	 al.,	 1997,	 Cone,	 2005).	 Insulin	 and	 leptin	hyperpolarize	 NPY/AgRP	 neurons	 through	 the	 activation	 of	 phosphoinositide-3	kinase	 (PI3K)	 signal	 transduction,	 increasing	 intracellular	 phosphatidylinositol	(3,4,5)-trisphosphate	(PIP3),	and	the	opening	of	KATP	channels	(Plum	et	al.,	2006b,	
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Spanswick	 et	 al.,	 1997,	 Spanswick	 et	 al.,	 2000,	 Harvey	 et	 al.,	 2000).	 Ghrelin	 is	 a	potent	orexigenic	hormone,	 secreted	 from	A-cells	of	gastric	mucosa	 (Dornonville	de	la	Cour	et	al.,	2001).	Plasma	ghrelin	concentration	increases	pre-prandially	and	falls	 post-prandially	 (Cummings	 et	 al.,	 2001,	 Tschop	 et	 al.,	 2001a).	 Chronic	administration	 of	 ghrelin	 can	 induce	 obesity	 (Tschop	 et	 al.,	 2000).	 The	 ghrelin	receptor	 growth	 hormone	 secretagogue	 receptor	 1a	 (GHSR1a)	 is	 expressed	 in	multiple	CNS	regions	including	the	VMH	and	ARH	(Guan	et	al.,	1997,	Bennett	et	al.,	1997).	 The	 orexigenic	 actions	 of	 ghrelin	 are	 attributed	 to	 its	 actions	 at	 GHSR1a	receptors	on	NPY/AgRP	neurons	and	afferent	glutamatergic	neurons	(Chen	et	al.,	2004,	Yang	et	al.,	2011).	Ghrelin	has	been	shown	to	induce	pacemaker-like	activity	in	 NPY/AgRP	 neurons	 that	 is	 dependent	 upon	 the	 modulation	 of	 a	 voltage-sensitive	 low-threshold	 t-type	 calcium	 conductance,	 intrinsic	 to	 NPY/AgRP	neurons	(van	den	Top	et	al.,	2004).		The	 ghrelin-induced	 depolarization	 of	 glutamatergic	 neurons	 afferent	 to	NPY/AgRP	neurons	has	been	shown	to	be	via	a	GHSR1-Gα/q11-AMPK-cADP	ribose-ryanodine	 receptor	 (RyR)-Ca2+	 release-dependent	mechanism	 (Yang	 et	 al.,	 2011,	Aponte	 et	 al.,	 2011).	 AMP-activated	 protein	 kinase	 (AMPK)	 is	 expressed	 in	 a	multiple	hypothalamic	nuclei	including	the	ARH,	VMH,	PVH	and	LH	and	is	a	central	regulator	of	 cellular	metabolism,	detecting	cellular	energy	status	 (Mihaylova	and	Shaw,	2011,	Lopez	et	al.,	2008,	Minokoshi	et	al.,	2004).	AMPK	is	a	serine/threonine	protein	kinase	that	 is	activated	under	negative	energy	states	due	to	an	 increased	intracellular	AMP/ATP	ratio.	AMPK	signaling	in	both	NPY/AgRP	and	POMC/CART	neurons	 is	 required	 for	 ARH	 glucose	 sensing	 and	 normal	 energy	 homeostasis	(Claret	 et	 al.,	 2007).	 AgRP-AMPK	 α2	 subunit	 deletion	 results	 in	 a	 lean	 mouse	phenotype	 and	 POMC-	 α2	 deletion	 results	 in	 obesity	 due	 to	 reduced	 energy	
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expenditure	(Claret	et	al.,	2007).	α2	deletion	results	in	neuronal	glucose	resistance	but	does	not	affect	leptin	and	insulin	sensitivity	(Claret	et	al.,	2007).	Many	 in	 vitro	 electrophysiological	 studies	 into	 the	 effects	 of	 glucose	 and	hormones	on	 the	 electrical	 activity	of	hypothalamic	neurons	have	used	 sub-	 and	supra-threshold	glucose	concentrations	in	artificial	cerebrospinal	fluid	(aCSF);	the	solution	in	which	brain	slices	are	incubated	(Takahashi	and	Cone,	2005,	Spanswick	et	al.,	1997,	Ashford	et	al.,	1990a).	Results	from	these	studies,	although	useful	may	not	be	representative	of	in	vivo	conditions.	In	 this	 study	 I	 used	 the	 visualized	 whole-cell	 patch-clamp	 technique	 to	explore	the	effects	of	fasting	upon	NPY/AgRP	neuron	electrical	activity,	and	also	to	investigate	the	effect	that	fasting	has	upon	glucose	sensitivity	in	these	neurons.	A	key	difference	of	this	work	compared	to	previous	studies	on	the	same	topic	such	as	(Takahashi	and	Cone,	2005)	is	that	here	I	describe	the	effects	of	fasting	on	neurons	incubated	 in	physiologically	 relevant	 glucose	 concentrations	post-dissection,	 and	during	experimentation.	I	also	look	at	the	effect	that	fed	state	and	ambient	glucose	concentration	has	upon	the	sensitivity	of	NPY/AgRP	neurons	to	ghrelin	in	vitro.		
4.2	 	Results	
4.2.1		 The	effects	of	ambient	extracellular	glucose	concentrations	and	
feeding	state	on	active	and	passive	membrane	properties	of	NPY	eGFP	
neurons	Whole-cell	 patch	 clamp	 recordings	 were	 obtained	 from	 NPY	 eGFP	 neurons	 in	hypothalamic	 brain	 slice	 preparations	 from	 mice	 fed	 ad	 libitum	 and	 from	 mice	fasted	 for	 18	 hours.	 The	 effects	 of	 extracellular	 glucose	 on	 passive	 and	 active	membrane	properties	were	investigated.	
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NPY	eGFP	neurons	of	the	fed	population	were	exposed	to	and	maintained	in	5	mM	glucose	(n=70).	Of	the	neurons	in	this	population	86%	were	spontaneously	active	 and	 the	 remaining	 14%	 were	 silent	 at	 rest.	 These	 neurons	 had	 a	 mean	resting	 membrane	 potential	 of	 -39.60	 ±	 0.84	 mV,	 mean	 spontaneous	 action	potential	firing	rate	of	2.18	±	0.24	Hz	and	neuronal	input	resistance	of	1827	±	132	MΩ.	 NPY	eGFP	neurons	of	an	ad	libitum	 fed	population	were	also	exposed	and	maintained	in	fasted	levels,	1	mM,	extracellular	glucose	(n=40).	Of	the	neurons	in	this	population,	95%	were	spontaneously	active	and	the	remaining	5%	were	silent	at	rest.	NPY	eGFP	neurons	of	the	‘fed	1	mM	glucose’	population	had	a	mean	resting	membrane	potential	of	38.68	±	0.63	mV,	mean	spontaneous	action	potential	firing	rate	of	1.33	±	0.14	Hz	and	neuronal	input	resistance	of	1680	±	136	MΩ.	NPY	 eGFP	 neurons	 of	 the	 fasted	 population	 were	 exposed	 to	 and	maintained	 in	 1	 mM	 extracellular	 glucose	 (n=240).	 Of	 the	 neurons	 in	 this	population	79%	of	neurons	were	spontaneously	active	and	the	remaining	21%	of	neurons	 were	 silent	 at	 rest.	 NPY	 eGFP	 neurons	 of	 the	 ‘fasted	 1	 mM	 glucose’	population	 had	 a	 mean	 resting	 membrane	 potential	 of	 41.04	 ±	 0.57	 mV,	 mean	spontaneous	 action	 potential	 firing	 rate	 of	 1.61	 ±	 0.11	 Hz	 and	 neuronal	 input	resistance	of	1538	±	66	MΩ.	Analysis	 of	 these	 groups	 revealed	 statistically	 significant	 differences	between	these	populations.	The	mean	action	potential	firing	rate	of	the	‘fed	5	mM	glucose’	population	is	significantly	different	to	that	observed	in	both	the	‘fed	1	mM	glucose’	population	and	the	‘fasted	1	mM	glucose’	population	(p-values;	<	0.05,	2-way	 ANOVA).	 Statistical	 significant	 differences	 were	 also	 observed	 in	 neuronal	input	 resistance.	 Mean	 neuronal	 input	 resistance	 of	 the	 ‘fed	 5	 mM	 glucose’	
	 100	
population	 being	 significantly	 higher	 than	 the	 ‘fasted	 1	 mM	 glucose	 population	(p=<0.05;	2-way	ANOVA).	See	figures	4.1	and	4.2.		
4.2.2		 Fasting-induced	reorganization	of	glucose	sensing	in	the	arcuate	
NPY/AgRP	neuron	population	NPY/AgRP	neuron	 responsiveness	 to	 an	 increase	 in	 extracellular	 glucose	 from	1	mM	 to	 5	mM	was	 determined	 in	 neurons	 in	 hypothalamic	 brain	 slices	 taken	 of	mice	 fed	ad	libitum	and	mice	subjected	to	an	18-hour	 fast	prior	 to	culling.	Of	 the	NPY	 eGFP	 neurons	 recorded	 from	 ‘fed’	 animals,	 increasing	 extracellular	 glucose	concentration	 from	 1	 to	 5	 mM	 resulted	 in	 membrane	 depolarization	 in	 25%	 of	neurons,	 membrane	 hyperpolarization	 in	 29%	 of	 neurons,	 and	 no	 discernable	response	 in	 46%	 of	 NPY	 eGFP	 neurons	 tested	 (n=36)	 (figure	 4.5A).	 Of	 the	 NPY	eGFP	 neurons	 from	 ‘fasted’	 animals	 increasing	 extracellular	 glucose	 depolarized	40%	 of	 neurons,	 hyperpolarized	 34%	 of	 neurons	 and	 in	 the	 remaining	 26%,	 no	response	to	glucose	was	observed	(n=73)	(figure	4.5B).	Although	not	a	statistically	significant	change	 in	 response	distribution,	Chi-square	analysis	 indicated	a	 trend	towards	a	significant	redistribution	(p=0.0783;	fed	vs.	fasted).	
	
4.2.3		 Ionic	mechanism	underlying	glucose-induced	inhibition	of	NPY	eGFP	
neurons	under	fed	and	fasted	conditions	Of	 the	 ‘fed’	 glucose-induced	 inhibitory	 (GI)	 responses,	 membrane	hyperpolarization	from	-52.73	±	1.54	mV	to	-59.39	±	1.76	mV	was	associated	with	a	decrease	in	spontaneous	action	potential	firing	rate	from	0.08	±	0.06	Hz	to	0.03	±	0.03	Hz,	and	a	decrease	in	input	resistance	from	1759	±	318	MΩ	to	1410	±	342	MΩ	(n=10).	Of	 the	 ‘fasted’	GI	 responses,	membrane	hyperpolarization	 from	–49.79	±	
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1.41	mV	 to	 -55.90	±	1.73	mV,	was	associated	with	a	decrease	 in	action	potential	firing	rate	from	0.11	±	0.08	Hz	to	0.03	±	0.03	Hz,	and	a	decrease	in	input	resistance	from	1559	±	165	MΩ	to	1150	±	174	MΩ	(n=25).	When	comparing	GI	responses	of	fed	and	fasted	groups,	no	statistical	significance	was	observed	in	the	magnitude	of	responses,	 measured	 in	 terms	 of	 membrane	 potential,	 spontaneous	 action	potential	 firing	 rate	 and	 input	 resistance	 (see	 figure	 4.6E).	 The	 decreased	 input	resistance	 associated	with	 glucose-induced	 inhibition	 in	 both	 the	 fed	 and	 fasted	states	was	accompanied	by	a	 reversal	potential	 around	 -70	mV,	 indicated	by	 the	point	of	intersection	of	voltage-current	relations	generated	in	response	to	injection	of	 a	 range	 of	 depolarizing	 and	 hyperpolarizing	 rectangular-wave	 current	 pulses	(figure	 4.3Biii).	 This	 reversal	 potential	 suggests	 that	 in	 these	 neurons,	 glucose-induced	the	activation	of	a	chloride	conductance	under	our	recording	conditions.	Reversal	 potentials	 associated	 with	 inhibitory	 responses	 to	 glucose	 varied	between	neurons	tested	here,	ranging	from	-50.00	mV	to	-87.00	mV	with	a	mean	of	-67.45	±	2.40	mV	(n=20).	The	 inhibitory	effects	of	glucose	on	NPY	eGFP	neurons	persisted	 in	 the	 presence	 of	 TTX	 suggesting	 activity-dependent	 synaptic	transmission	 did	 not	 indirectly	 underpin	 this	 effect	 (n=6).	 Control	 membrane	potential	 and	 spontaneous	 firing	 rate	 values	 here	 are	more	 hyperpolarized	 than	stated	 in	 section	4.2.1	 as	membrane	potential	was	held	down	 to	 around	 -50	mV	control	for	voltage-sensitive	conductances.	
	
4.2.4		 Ionic	mechanism	underlying	glucose-induced	excitation	of	NPY	eGFP	
neurons	under	fed	and	fasted	conditions	Of	the	‘fed’	population	of	NPY	neurons,	glucose-induced	excitatory	(GE)	responses	were	associated	with	membrane	depolarization	from	-48.94	±	2.46	mV	to	-43.80	±	
	 102	
2.78	mV	without	any	associated	changes	 in	 spontaneous	 firing	 rate.	Thus	 the	GE	response	of	neurons	recorded	in	slices	from	animals	fed	ad	libitum	failed	to	reach	threshold	 for	 firing.	 This	 response	 was	 associated	 with	 a	 decrease	 in	 input	resistance	from	1668	±	291	MΩ	to	1564	±	252	MΩ	(n=9).	In	the	‘fasted’	population	of	NPY	neurons,	GE	responses	were	observed	as	a	mean	membrane	depolarization	from	-49.07	±	1.44	mV	to	 -44.12	±	1.32	mV,	associated	with	an	 increase	 in	 firing	rate	from	0.00	±	0.00	Hz	to	0.01	±	0.01	Hz,	and	an	increase	in	input	resistance	from	1143	±	68	MΩ	to	1431	±	127	MΩ	(n=29)	(figure	4.6).	When	 comparing	 GE	 responses	 of	 fed	 and	 fasted	 groups,	 no	 statistical	significance	was	 observed	 in	 the	magnitude	 of	 responses,	measured	 in	 terms	 of	membrane	 potential,	 action	 potential	 firing	 rate	 and	 input	 resistance	 (see	 figure	4.6F).	 The	 increased	 input	 resistance	associated	with	glucose-induced	excitation	in	 the	 fasted	 state	 was	 accompanied	 by	 a	 reversal	 potential	 around	 -90	 mV.	Reversal	 potentials	 associated	 with	 excitatory	 responses	 to	 glucose	 varied	between	neurons	tested	here,	ranging	from	-63.00	mV	to	-95.00	mV	with	a	mean	of	-78.50	 ±	 2.14	 mV	 (n=20).	 This	 is	 indicative	 of	 the	 inhibition	 of	 a	 potassium	conductance	 by	 glucose	 under	 our	 recording	 conditions	 (figure	 4.4Biii).	 The	 GE	effect	 in	NPY	eGFP	neurons	persisted	 in	 the	presence	of	TTX	suggesting	activity-dependent	 synaptic	 transmission	 did	 not	 indirectly	 underpin	 this	 effect	 (n=6).	Bath	 application	 of	 the	 KATP	 channel	 blocker	 tolbutamide	 (200	 μM)	 induced	membrane	excitation	similar	to	that	observed	with	increased	extracellular	glucose.	Repolarization	 of	 the	 membrane	 potential	 in	 these	 neurons	 to	 pre-tolbutamide	levels	and	subsequent	application	of	5	mM	glucose	from	1	mM,	in	the	presence	of	tolbutamide,	 failed	 to	 induce	membrane	 excitation.	 Thus	 block	 of	 KATP	 channels	
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with	tolbutamide	was	sufficient	to	prevent	the	glucose-induced	excitation	of	NPY	eGFP	neurons	(n=4).	In	one	NPY	eGFP	neuron,	5	mM	glucose	application	induced	a	reversible	membrane	potential	depolarization,	whilst	subsequent	application	of	5	mM	 glucose	 in	 the	 presence	 of	 200	 μM	 tolbutamide	 induced	 membrane	hyperpolarization	 (n=1)	 (figure	 4.7A).	 Control	 membrane	 potential	 and	spontaneous	firing	rate	values	here	are	more	hyperpolarized	than	stated	in	section	4.2.1	as	membrane	potential	was	held	down	to	around	-50	mV	control	for	voltage-sensitive	conductances.		
4.2.5		 The	effects	of	adenosine	receptor	antagonists	on	glucose-induced	
responses	in	NPY	eGFP	neurons	To	probe	the	potential	role	for	non-neuronal	glia/tannycytes	in	glucose-sensing	by	NPY	neurons,	the	effect	of	adenosine	receptor	antagonists	were	tested	on	glucose-induced	responses,	adenosine	being	released	from	astroglia	directly,	or	produced	by	extracellular,	nucleotidase-dependent	catalysis	of	glia-derived	ATP.	Incubation	of	brain	slices	prepared	from	‘fasted’	animals,	 in	the	adenosine	A1	 receptor	 antagonist	 DPCPX	 (1	 μM),	 did	 not	 affect	 the	 percentage	 of	 glucose-induced	 inhibitions,	 relative	 to	 the	 control	 ‘fasted’	 population	 (34%	 vs.	 35%	respectively)	 but	 markedly	 decreased	 the	 percentage	 of	 excitations	 induced	 by	glucose	from	40%	in	control	to	24%	in	the	presence	of	DPCPX.	An	increase	in	the	percentage	of	non-responders	from	26%	to	41%	was	also	apparent	(n=29)	(figure	4.5C).	 Chi-square	 analysis	 did	 not	 reveal	 any	 significant	 response	 redistribution,	when	comparing	‘fasted’	to	‘fasted,	DPCPX’	(p=0.2189).	Incubation	of	brain	slices	prepared	from	‘fasted’	animals,	 in	the	adenosine	A2A	 receptor	 antagonist	 istradefylline	 (50	 nM)	 did	 not	 alter	 the	 percentage	 of	
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glucose-induced	 inhibitions,	 compared	 to	 the	 ‘fasted’	 control	 population,	 but	decreased	the	percentage	of	GE-NPY	neurons	from	40%	to	13%.	The	percentage	of	non-responders	 increased	 from	 26%	 to	 40%	 (n=23)	 (figure	 4.5D).	 Chi-square	analysis	 revealed	 significant	 response	 redistribution,	when	 comparing	 ‘fasted’	 to	‘fasted,	Istradefylline’	(p=0.0242).	Incubation	of	brain	slices	prepared	from	‘fasted’	animals,	 in	the	adenosine	A2B	 receptor	 antagonist	 PSB-603	 (100	 nM),	 slightly	 increased	 the	 percentage	 of	glucose-induced	 inhibitions,	 relative	 to	 the	 ‘fasted’	 control	population,	 from	34%	to	 35%,	 and	 slightly	 decreased	 the	 percentage	 of	 excitations	 induced	 by	 glucose	from	40%	 in	control	 to	35%	 in	 the	presence	of	PSB-603.	A	 small	 increase	 in	 the	percentage	of	non-responders	from	26%	to	30%	was	also	apparent	(n=20)	(figure	4.5E).	 Chi-square	 analysis	 did	 not	 reveal	 any	 significant	 response	 redistribution,	when	comparing	‘fasted’	to	‘fasted,	PSB-603’	(p=0.9115).	Incubation	of	brain	slices	prepared	from	‘fasted’	animals,	 in	the	adenosine	A3	 receptor	 antagonist	MRS	1523	 (300	nM),	 slightly	 increased	 the	percentage	of	glucose-induced	 inhibitions,	 relative	 to	 the	 ‘fasted’	 control	population,	 from	34%	to	36%,	 and	notably	decreased	 the	percentage	of	 excitations	 induced	by	 glucose	from	 40%	 in	 control	 to	 23%	 in	 the	 presence	 of	 MRS	 1523.	 An	 increase	 in	 the	percentage	of	non-responders	from	26%	to	41%	was	also	apparent	(n=22)	(figure	4.5F).	 Chi-square	 analysis	 did	 not	 reveal	 any	 significant	 response	 redistribution,	when	comparing	‘fasted’	to	‘fasted,	MRS	1523’	(p=0.2649).	
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4.2.6		 The	effects	of	ghrelin	on	NPY	eGFP	neurons	in	fed	and	fasted	
conditions	NPY/AgRP	neurons	from	both	‘fed	5	mM	glucose’	and	‘fasted	1	mM	glucose’	groups	were	sensitive	to	bath	application	of	3nM,	10nM	and	30nM	ghrelin,	with	excitation	associated	 with	 an	 increased	 action	 potential,	 firing	 rate	 and	 input	 resistance	(Figure	4.10).		In	 the	 ‘Fed	 5	 mM	 glucose’	 NPY	 eGFP	 neurons,	 ghrelin	 induced	 a	concentration-dependent	 excitation	 whereby	 40%	 of	 NPY	 eGFP	 neurons	 were	excited	by	3	nM,	60%	by	10	nM	and	75%	by	30	nM	(n=15,15,16	respectively).	In	 the	 ‘fasted	 1	 mM	 glucose’	 NPY	 eGFP	 neurons,	 ghrelin	 induced	 a	concentration-dependent	excitation	whereby	42%	were	excited	by	3	nM,	66%	by	10	nM	and	70%	%	by	30	nM	(n=33,	33,	23	respectively)	(figure	4.10).		In	 the	 fed	 group,	 ghrelin-induced	depolarization	 amounted	 to	4.10	±	0.77	mV,	 3.37	 ±	 0.42	 mV	 and	 4.27	 ±	 0.94	 mV	 in	 the	 presence	 of	 3,	 10	 and	 30	 nM	respectively.	 The	 corresponding	 values	 for	 the	 fasted	 group	 amounted	 to	 3.96	 ±	0.72	mV,	5.01	±	1.12	mV	and	7.30	±	1.76	mV	in	the	presence	of	3,	10	and	30	nM	respectively.		In	the	fed	group	ghrelin-induced	excitation	was	associated	with	an	increase	in	action	potential	firing	rate	and	amounted	to	0.29	±	0.12	Hz,	0.30	±	0.14	Hz	and	0.16	 ±	 0.16	 Hz	 in	 the	 presence	 of	 3,	 10	 and	 30	 nM	 ghrelin,	 respectively.	 The	corresponding	values	for	the	fasted	group	amounted	to	0.05	±	0.03	Hz,	0.20	±	0.09	Hz	and	0.45	±	0.28	Hz	in	the	presence	of	3,	10	and	30	nM	respectively.		Ghrelin-induced	depolarization	was	associated	with	in	increase	in	neuronal	input	resistance	in	the	fed	population	amounting	to	an	increase	of	196	±	131	MΩ,	119	±	121	MΩ	and	56	±	74	MΩ	in	the	presence	of	3,	10	and	30	nM	respectively.	The	
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corresponding	values	for	the	fasted	group	amounted	to	264	±	223	MΩ,	541	±	421	MΩ	and	1446	±	409	MΩ	in	the	presence	of	3,	10	and	30	nM	respectively.	When	comparing	the	magnitude	of	ghrelin-induced	excitation	in	NPY	eGFP	neurons	of	fed	and	fasted	animals,	no	significant	difference	in	membrane	potential	change	 or	 firing	 rate	 change	 was	 observed	 between	 groups.	 Numbers	 are	summarized	 in	 figures	4.9Bi	and	4.9Bii.	However,	when	comparing	the	change	 in	input	resistance	associated	with	ghrelin-induced	excitation,	NPY	eGFP	neurons	of	the	‘fasted	1	mM	glucose’	group	displayed	a	significantly	greater	increase	in	input	resistance	 in	 response	 30	 nM	 ghrelin,	 compared	 to	 neurons	 of	 the	 ‘fed	 5	 mM	glucose’	group	in	the	presence	of	30	nM	ghrelin	(1446	±	409	MΩ	vs.	56	±	74,	n=3	and	4	respectively,	p=<0.05,	2-way	ANOVA).		
4.2.7		 Ionic	mechanism	underlying	ghrelin-induced	excitation	of	NPY	eGFP	
neurons	in	fasted	conditions	Bath	 application	 of	 the	 KATP	 channel	 blocker	 tolbutamide	 (200	 μM)	 induced	membrane	 excitation	 similar	 to	 that	 observed	 with	 ghrelin	 bath	 application.	Repolarization	 of	 the	 membrane	 potential	 in	 these	 neurons	 to	 pre-tolbutamide	levels	 and	 subsequent	 application	 of	 100	 nM	 ghrelin,	 in	 the	 presence	 of	tolbutamide,	 failed	 to	 induce	membrane	 excitation.	 Thus	 block	 of	 KATP	 channels	with	 tolbutamide	was	sufficient	 to	prevent	 the	ghrelin-induced	excitation	of	NPY	eGFP	 neurons	 (n=6)	 (figure	 4.8A).	 The	 ghrelin-induced	 excitation	 of	 NPY/AgRP	neurons	can	be	reversed	by	lowering	the	extracellular	glucose	concentration	(n=1)	(figure	4.7B).		
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4.2.8		 Effects	of	ghrelin	on	glucose	inhibited	and	glucose	excited	eGFP	
neurons		There	 is	 a	 subpopulation	 of	 NPY	 eGFP	 neurons	 that	 are	 excited	 by	 ghrelin,	 are	glucose	 excited	 and	 express	 KATP	 channels	 (figure	 4.11A).	 There	 is	 also	 a	subpopulation	of	NPY	eGFP	neurons	 that	are	excited	by	ghrelin,	 are	 inhibited	by	glucose,	and	expresses	KATP	channels	(figure	4.11B).	Of	ghrelin-excited	NPY	eGFP	neurons	 from	 fasted	 animals,	 37%	 are	 GE,	 37%	 are	 GI	 whilst	 26%	 are	 glucose	insensitive	 (n=19).	 Of	 ghrelin-excited	 NPY	 eGFP	 neurons	 from	 animals	 fed	 ad	
libitum,	33%	are	GE,	50%	are	GI	and	17%	are	glucose	insensitive	(n=6).		
4.3		 Discussion	The	principle	findings	of	this	study	were:	1. NPY	 neurons	 demonstrate	 a	 remarkable	 energy-status-dependent	functional	plasticity	whereby	fasting	and	low	ambient	glucose	levels	recruit	GE	 neurons.	 This	 is	 the	 first	 report	 of	 NPY-GE	 neurons,	 with	 previous	studies	suggesting	NPY	neurons	to	be	exclusively	GI.	NPY-GE	neurons	may	be	 recruited	 from	 previously	 non-glucose	 sensing	 NPY	 neurons,	 and	may	also	be	recruited	 through	 the	switching	of	GI	 to	GE.	Although	a	 trend	was	detected	 towards	 this	 effect	 (p=0.0783),	 no	 significant	 difference	 was	observed	between	the	glucose	response	distribution	of	fed	and	fasted	NPY	neurons.	2. Glucose-induced	 excitation	 in	 NPY	 neurons	 is	 mediated	 via	 an	 ATP-sensitive	 potassium	 channel-dependent	 mechanism,	 whereas	 glucose-induced	 inhibition	 is	mediated	 via	multiple	mechanisms,	 possibly	 via	 the	activation	of	chloride	and/or	potassium	conductances.	
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3. A	 role	 for	 adenosine	 in	 mediating	 the	 glucose-induced	 excitation	 of	 NPY	neurons	is	also	suggested,	via	A2A	receptors,	and	possibly	also	via	adenosine	A1,	 and	A3	 receptors.	 The	neuronal/non-neuronal	 origins	 of	 this	 response	remain	to	be	determined.	4. Ghrelin	induced	a	concentration-dependent	excitation	in	both	NPY-GE	and	NPY-GI	 neurons,	 and	 the	 responsiveness	 to	 ghrelin	 was	 enhanced	 in	 the	fasted	state.	5. In	 fasted	 states,	 the	 ghrelin-induced	 excitation	 of	NPY	neurons	 (including	NPY-GE	neurons)	was	mediated	via	the	block	of	KATP	channels.		6. These	data	suggest	that	in	the	fasted	state,	glucose	and	ghrelin	converge	on	a	common	signal	transduction	endpoint;	the	KATP	channel.	This	indicates	an	important	 relationship	 between	 glucose	 and	 ghrelin	 at	 NPY-GE	 neurons.	This	 may	 from	 a	 mechanism	 by	 which	 in	 states	 of	 hunger,	 glucose	 and	ghrelin	may	work	synergistically	 to	drive	 increased	 food	 intake	 to	restore	depleted	 glucose	 levels.	 Thus	 NPY-GE	 neurons	 may	 adopt	 a	 reward-like	phenotype	to	drive	food	intake	whereas	the	function	of	NPY-GI	neurons	is	likely	to	suppress	food	intake	upon	store	repletion.	Nevertheless	these	data	represents	 a	 previously	 unrecognized	 and	 potentially	 vital	 functional	adaptation	 for	survival	 in	NPY	neurons,	and	also	presents	a	novel	role	 for	glucose	sensing	in	the	melanocortin	system.		
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4.3.1		 NPY/AgRP	neuron	firing	rate	is	sensitive	to	extracellular	glucose	
concentration	and	feeding	state	At	 first	 glance,	 results	 presented	 here	 do	 not	 appear	 to	 fit	 with	 our	 current	understanding	of	the	orexigenic	NPY	neuron.	Here,	I	present	results	demonstrating	that	in	vitro,	NPY	eGFP	neurons	have	a	significantly	elevated	input	resistance	and	action	potential	firing	rate	when	taken	from	mice	fed	ad	libitum	and	incubated	in	5	mM	 glucose,	 compared	 to	 NPY	 eGFP	 neurons	 of	 brain	 slices	 taken	 from	 ‘fasted’	mice,	 incubated	 in	 1	 mM	 glucose.	 Elevated	 input	 resistance	 could	 underpin	high(er)	frequency	discharge	however	increased	EPSPs	could	also	be	the	cause	of	elevated	NPY	eGFP	neuron	firing	rate.	Undoubtedly	 these	 activity	 levels	 are	 not	 representative	 of	 arcuate	 NPY	neuron	activity	in	vivo,	as	in	situ	neuronal	activity	will	be	subject	to	neuronal	and	hormonal	stimulation,	variables	 that	are	not	present	when	neurons	are	recorded	from	during	brain	 slice	 electrophysiological	 experiments.	 These	data	 allow	us	 to	generate	 a	 deeper	 understanding	 of	 NPY	 neuron	 information	 processing	 at	 the	molecular	and	cellular	levels.	Here,	I	propose	that	the	increased	firing	rate	and	input	resistance	observed	
in	vitro	in	relatively	positive	energy	states	is	the	result	of	increased	glucose	uptake	and	metabolism,	elevated	ATP/ADP	ratio,	 inhibited	KATP	channels	and	membrane	depolarization.		Previous	 in	vitro	slice	electrophysiology	has	described	NPY/AgRP	neurons	to	 elevate	 their	 electrical	 activity	 in	 vitro	 following	 a	 fast	 (Takahashi	 and	 Cone,	2005).	 However	 this	 and	 other	 work	 describes	 neurons	 from	 brain	 slices	incubated	in	10	mM	glucose	post-fast.	I	suggest	the	elevated	firing	rate	observed	in	previous	studies	is	due	to	an	acute	response	to	glucose,	rather	than	an	effect	of	the	
	 110	
food	 deprivation.	 Consistent	with	 this	 hypothesis	 is	 the	 observation	 that	 fasting	increases	the	percentage	of	GE	NPY/AgRP	neurons.	It	is	my	contention	that	in	their	publication,	 Takahashi	 and	 Cone	 are	 mistaking	 a	 glucose	 excitation	 for	 a	 fast-induced	activity	increase.		
4.3.2		 Fasting-induced	reorganization	of	glucose	sensing	in	the	arcuate	
NPY/AgRP	neuron	population	Fasting	 increased	 the	 percentage	 of	 glucose-sensing	NPY	 neurons	 in	 the	 ARH.	 A	greater	degree	of	plasticity	was	observed	in	the	subpopulation	of	GE	neurons,	with	the	 percentage	 of	 glucose-induced	 excitations	 rising	 by	 15%,	 from	 25%	 in	 fed	conditions	 to	 40%	 in	 fasted	 conditions	 (figure	 4.5).	 Conversely,	 the	 fasting	increased	the	percentage	of	NPY-GI	neurons	by	5%,	from	29%	to	34%.		This	fast-induced	increase	in	the	proportion	of	NPY-GE	neurons	in	the	ARH	could	underlie	a	short-lived	positive	feedback	loop,	wherein	post-fast	consumption	of	 carbohydrate	promotes	 further	 feeding	 through	elevated	NPY	neuron	activity.	This	acute	excitatory	response	to	elevated	central	glucose	may	then	be	supplanted	by	 lower	 frequency	 NPY	 neuron	 electrical	 activity,	 when	 long-term	 signals	indicative	of	a	positive	energy	status	are	transduced	by	NPY	neurons.		
4.3.3		 Mechanism	of	glucose-induced	excitation	of	NPY	neurons	The	 glucose-induced	 excitation	 of	 NPY	 neurons	 was	 via	 the	 inhibition	 of	 KATP	channels.	 In	 the	 fasted	 state,	 glucose-induced	 excitation	 was	 associated	 with	increased	neuronal	input	resistance	and	reversal	potential	around	-90	mV.	This,	in	addition	 to	 the	 sensitivity	 of	 the	 GE	 response	 to	 the	 KATP	 channel	 blocker	tolbutamide	confirms	ATP-sensitive	potassium	channels	as	the	signal	transduction	
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endpoint	mediating	the	excitatory	effects	of	glucose	observed	here.	KATP	channels	are	 expressed	 in	 arcuate	NPY/AgRP	neurons	 (van	den	Top	et	 al.,	 2007).	Glucose	sensing	 experiments	 conducted	 in	 the	 presence	 of	 TTX,	 confirm	 the	 glucose-induced	 excitation	 of	 NPY	 neurons	 to	 be	 direct,	 not	 via	 increased	 excitatory	afferent	neuronal	 innervation.	 In	many	instances,	 the	glucose-induced	membrane	response	 was	 not	 reversible	 upon	 5	 mM	 glucose	 washout	 from	 the	 recording	chamber.	 As	 such	 the	 preferred	 experimental	 design	 for	 signal	 transduction	characterization	 -	 of	 repeating	 the	 experiment	 in	 the	 presence	 of	 receptor	antagonists	 –	 was	 deemed	 unreliable,	 namely	 too	 vulnerable	 to	 false	 positive	results.	 As	 such	 the	 experimental	 design	 was	 adapted	 to	 assess	 the	 glucose	response	 distribution	 of	 NPY	 neurons	 after	 incubation	 in	 receptor	 antagonists	prior	 to	 recording.	 These	 experimental	 response	 distributions	 would	 then	 be	compared	with	control	data.	Incubation	of	brain	slices	 in	adenosine	receptor	antagonists	decreased	the	percentage	of	NPY-GE	neurons	but	had	 little	or	no	affect	upon	 the	proportion	of	NPY-GI	 neurons.	 Whole-cell	 recordings	 taken	 from	 brain	 slices	 of	 fasted	 mice	demonstrate	 that	 antagonism	of	 adenosine	 receptors	A1,	A2A,	A2B	 and	A3	 reduces	the	 percentage	 of	 NPY-GE	 neurons	 from	 40%	 to	 24%,	 13%,	 35%	 and	 23%	respectively.	 This	 data	 indicates	 that	 the	 glucose-induced	 excitation	 of	 NPY	neurons	 is	 via	 A1,	 A3	 and	 A2A	 receptors,	 and	 perhaps	 to	 a	 lesser	 degree	 by	 A2B	receptors.		Further	work	is	required	to	investigate	the	neuronal	or	non-neuronal	origin	of	adenosine	mediating	glucose	sensing	in	NPY-GE	neurons.	A	potential	source	of	adenosine	 in	 the	 arcuate	 nucleus	 is	 astrocytes.	 Previous	 studies	 have	 concluded	that	 increased	astrocytic	activity	 is	associated	with	a	reduction	of	ghrelin	evoked	
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feeding	whilst	A1	receptor	antagonism	or	astrocyte	inhibition	potentiates	ghrelin-induced	 food	 intake	 (Yang	 et	 al.,	 2015).	 This	 study	 found	 no	 effect	 of	 astrocytic	activation	or	A1	receptor	inhibition	on	post-fast	refeeding.	The	study	by	Yang	et	al	would	suggest	A1	receptors	to	negatively	regulate	AgRP	neuron	activity,	whereas	data	presented	here	indicates	that	A1	receptors	transduce	excitatory	signals	in	NPY	neurons.		KATP	channel	activation	as	a	result	of	adenosine	A1	receptor	activation	has	been	identified	as	a	mechanism	of	hippocampal	ischemic	tolerance	(Heurteaux	et	al.,	1995).	The	inhibition	of	hypothalamic	KATP	channels	by	A1	receptor	activation	is	yet	to	be	definitively	demonstrated.	Previous	reports	have	linked	A2A	receptors	to	KATP	channels	via	protein	kinase	A	(PKA)	(Kleppisch	and	Nelson,	1995,	Tang	et	al.,	1999),	however	these	studies	found	A2A	activation	linked	to	channel	activation	and	neuronal	 hyperpolarization,	 rather	 than	 the	 KATP	 inhibition	 and	 neuronal	depolarization,	observed	here.			
4.3.4		 Mechanism	of	glucose-induced	inhibition	of	NPY	neurons	The	 mechanisms	 of	 glucose-induced	 inhibition	 observed	 here	 appeared	 to	 be	heterogeneous	in	nature,	with	reversal	potentials	indicating	multiple	mechanisms	including	 potassium	 and	 chloride	 conductance	 activation.	 This	 heterogeneity	 of	inhibitory	mechanisms	is	consistent	with	previous	reports	of	multiple	mechanisms	(Oomura	et	al.,	1974,	Fioramonti	et	al.,	2007,	Burdakov	and	Gonzalez,	2009,	Jordan	et	al.,	2010,	Canabal	et	al.,	2007).		Fast-induced	plasticity	was	observed	in	the	GI	subpopulation	of	NPY/AgRP	neurons	 of	 the	 ARH,	 albeit	 to	 a	 lesser	 degree	 than	 the	 GE	 subpopulation.	 Here	fasting	increased	the	percentage	of	GI	neurons	from	29%	to	34%.		
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Data	presented	here	does	not	 implicate	 adenosine	 receptors	 in	mediating	the	glucose-induced	inhibition	of	arcuate	NPY	neurons.	A	1%	increase	(from	34%	to	 35%)	 in	 glucose-induced	 inhibitions	 was	 observed	 in	 glucose	 sensing	experiments	conducted	on	NPY	neurons	in	the	presence	of	either	the	adenosine	A1	receptor	antagonist	DPCPX	or	the	adenosine	A2B	receptor	antagonist	PSB-603.	No	change	 in	 the	 percentage	 of	 NPY-GI	 neurons	 was	 observed	 in	 glucose	 sensing	experiments	 conducted	 in	 the	presence	of	 the	adenosine	A2A	 receptor	antagonist	istradefylline.	The	largest	-	but	still	modest	–	increase	in	the	percentage	of	NPY-GI	neurons	was	observed	in	whole-cell	glucose-sensing	experiments	conducted	in	the	presence	of	the	adenosine	A3	receptor	antagonist	MRS	1523.	Here	the	percentage	of	NPY-GI	 neurons	 rose	 by	 2%,	 from	34%	 in	 fasted	 conditions	 to	 36%	 in	 fasted	conditions,	with	the	A3	receptor	antagonist.	This	suggests	that	the	glucose-induced	inhibition	 of	 NPY	 neurons	 in	 the	 ARH	 is	 via	 adenosine	 receptor-independent	mechanisms.			
4.3.5		 The	mechanism	of	fast-induced	reorganization		Experiments	 presented	 here	 do	 not	 concussively	 prove	 the	 mechanism	 of	 fast-induced	 reorganization	 of	 NPY	 neurons.	 However	 they	 do	 demonstrate	 that	adenosine,	and/or	adenosine	receptor	subtypes	are	required	for	the	fast-induced	recruitment	 of	 glucose-excited	 NPY	 neurons.	 Mechanisms	 of	 plasticity	 could	involve	 increased	 ATP	 release,	 increased	 extracellular	 ectonucleotidase	 activity,	increased	adenosine	receptor	expression,	increased	uncoupling	protein-2	(UCP-2)-dependent	mitochondrial	fusion	/	fission,	changes	in	AMPK	or	PI3K	signaling	and	undoubtedly	 many	 more	 possibilities	 (Coppola	 et	 al.,	 2007,	 Toda	 et	 al.,	 2016).	
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Among	 further	 work	 required	 is	 the	 characterization	 of	 NPY	 neuron	 adenosine	receptor	expression	in	fed	and	fasted	conditions.		
	
4.3.7		 NPY-GI	and	NPY-GE	neuron	excitation	by	ghrelin	is	KATP	channel-
dependent	In	whole-cell	recordings	taken	from	brain	slices	of	fasted	animals,	bath	application	of	 the	 KATP	 channel	 blocker	 tolbutamide	 was	 sufficient	 to	 prevent	 NPY	 neuron	membrane	 depolarization	 by	 ghrelin.	 This	 in	 addition	 to	 the	 increased	 input	resistance	 and	 reversal	 potential	 around	 -90	 mV	 associated	 with	 the	 ghrelin-induced	 membrane	 excitation	 in	 the	 presence	 of	 TTX	 confirms	 the	 excitatory	actions	 of	 ghrelin	 on	NPY	neurons	 to	 be	 direct,	 and	not	 via	 increased	 excitatory	afferent	neuron	innervation.		 Ghrelin	 induced	 excitation	 observed	 in	 whole	 cell	 recordings	 taken	 from	brain	 slices	 of	 animals	 fed	 ad	 libitum	 were	 also	 associated	 with	 increases	 in	neuronal	 input	 resistance	 and	 reversal	 potentials	 around	 -90	 mV.	 However	 the	30nM	ghrelin-induced	excitation	of	NPY	neurons	in	the	fasted	state	was	associated	with	a	significantly	greater	input	resistance	elevation,	relative	to	recordings	taken	from	brain	slices	of	fed	animals	(Δ	966	±	373	vs.	Δ	56	±	74	MΩ,	Figure	4.10	Aiv).	The	 ability	 of	 ghrelin	 to	 induce	 large	 increases	 in	 input	 resistance	 in	 the	 fasted	state	 may	 be	 the	 result	 of	 increased	 basal	 KATP	 channel	 activity	 under	 these	conditions.		 Ghrelin	excited	both	NPY-GI	and	NPY-GE	neurons	from	both	fed	and	fasted	animals.	 As	 both	 ghrelin	 and	 glucose	 induce	 membrane	 depolarization	 of	 NPY	neurons	 via	 KATP	 channel	 inhibition,	 it	 follows	 that	 the	 signaling	 of	 one	 these	metabolic	 factors	 will	 affect	 the	 signaling	 of	 the	 other.	 In	 the	 case	 of	 ghrelin-
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sensitive	NPY-GE	neurons,	glucose	and	ghrelin	may	work	synergistically	post-fast	to	 increase	 the	 acute	 refeeding	 response.	 Conversely	 glucose	 sensing	 in	 ghrelin	sensitive	NPY-GI	neurons	may	work	have	an	antagonistic	relationship	with	ghrelin	orexigenic	ghrelin	signaling,	functioning	to	suppress	food	intake	once	food	intake	has	resorted	a	positive	energy	status.	Here	we	propose	that	glucose	‘sets	the	gain’	for	 hormonal	 signaling,	 in	 NPY/AgRP	 neurons,	 and	 presumably	 other	 neuronal	populations.			
4.3.8		 The	convergence	of	glucose	and	ghrelin	signaling	Previous	 work	 has	 demonstrated	 the	 convergence	 of	 PI3K	 signaling	 and	 KATP	channel	 ATP	 sensitivity	 (Shyng	 and	 Nichols,	 1998).	 Here,	 PIP3	 stabilizes	 KATP	channel	open	state	and	prevents	channel	inhibition	by	ATP,	reducing	channel	ATP	sensitivity	 by	 orders	 of	 magnitude.	 Multiple	 hormones	 –	 including	 insulin	 and	leptin	 -	 converge	 on	 the	 PI3K	 pathway,	 and	modulation	 of	 cytoplasmic	 inositide	concentrations	will	affect	KATP	channel	opens	state	and	ATP	sensitivity.		Increased	AMPK	signaling	has	been	shown	to	stimulate	PI3K	signaling	(Tao	et	 al.,	 2010).	 Fast-induced	 AMPK	 activity	 would	 elevate	 PI3K,	 opening	 KATP	channels.	 Subsequent	 ghrelin	 application	 would	 rapidly	 inhibit	 PI3K	 activity,	causing	a	profound	reduction	in	KATP	channel	open	probability.	The	relative	change	in	KATP	channel	open	probability	(before	ghrelin	vs.	after	ghrelin)	would	be	greater	than	 that	 from	 ghrelin	 application	 in	 a	 fed	 (low	 AMPK	 activity)	 state.	 This	mechanism	 could	 explain	 the	 greater	 change	of	 input	 resistance	 observed	 in	 the	‘fasted	1	mM’	ghrelin	dose	response.	An	implication	of	this	finding	is	that	ghrelin	sensitivity	 in	vivo	will	be	diminished	 in	 individuals	with	elevated	central	 glucose	levels,	such	as	obese	and	diabetic	individuals.	Increased	hormone	sensitivity	could	
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potentially	 be	 achieved	 in	 these	 individuals	 by	 lowering	 central	 glucose	concentrations.																																											
	 117	
Figure	 4.1:	 NPY/AgRP	 neuron	 membrane	 potential,	 firing	 rate	 and	 input	
resistance	 is	 affected	 by	 extracellular	 glucose	 concentration	 and	 feeding	
state	
A:	Representative	current	clamp	trace	of	an	NPY/AgRP	neuron	from	a	‘fed’	mouse,	with	brain	slices	 incubated	 in	aCSF	containing	5	mM	glucose	(mean	spontaneous	firing	rate:	2.18	±	0.24	Hz	(mean	±	SEM),	n=70).	
B:	 Representative	 current	 clamp	 trace	 of	 an	 NPY/AgRP	 neuron	 from	 a	 ‘fasted’	mouse,	 with	 brain	 slices	 incubated	 in	 aCSF	 containing	 1	 mM	 glucose	 (mean	spontaneous	firing	rate:1.61	±	0.11	Hz,	n=211).	
C:	Representative	current	clamp	trace	of	an	NPY/AgRP	neuron	from	a	‘fed’	mouse,	with	brain	slices	 incubated	 in	aCSF	containing	1	mM	glucose	(mean	spontaneous	firing	rate:1.33	±	0.14	Hz,	n=41).														
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Figure	 4.2:	 NPY/AgRP	 neuron	 membrane	 potential,	 firing	 rate	 and	 input	
resistance	 is	modulated	by	extracellular	glucose	 concentration	and	 feeding	
state	
A:	Bar	chart	summarizing	the	mean	membrane	potential	of	neuronal	populations	represented	in	1A,	1B	and	1C	(fasted,	1	mM	glucose;	-41.04	±	0.57	mV,	Fed	1	mM	glucose;	-38.68	±	0.63	mV,	Fed	5	mM	glucose;	-39.60	±	0.84	mV).	
B:	 Bar	 chart	 summarizing	 the	 mean	 spontaneous	 action	 potential	 firing	 rate	 of	neuronal	population	represented	in	1A,	1B	and	1C	 (fasted,	1	mM	glucose;	1.61	±	0.11	Hz,	 Fed	1	mM	glucose;	 1.33	±	 0.14	Hz,	 Fed	5	mM	glucose;	 2.18	±	 0.24	Hz).	(Fasted	1	mM	vs.	Fed	5	mM,	p=	<0.05;	Fed	1	mM	vs.	Fed	5	mM,	p=<0.05,	2-way	ANOVA	with	post-hoc	Bonferroni	test)	
C:	 Bar	 chart	 summarizing	 the	 mean	 input	 resistance	 of	 neuronal	 populations	represented	 in	1A,	1B	 and	1C	 (Fed	 5	 mM	 glucose;	 1827	 ±	 132	MΩ,	 Fed	 1	 mM	Glucose;	1680	±	136	MΩ,	Fasted	1	mM	Glucose;	1538	±	66	MΩ.	(Fasted	1	mM	vs.	Fed	5	mM,	p=	<0.05,	2-way	ANOVA	with	post-hoc	Bonferroni	test)			
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Figure	4.3:	Glucose-Inhibited	NPY-eGFP	neurons	
A:	 A	 representative	 current-clamp	 recording	 taken	 from	 an	 NPY-eGFP	 neuron	showing	 glucose-induced	 inhibition.	 Briefly	 increasing	 extracellular	 glucose	induced	a	reversible	membrane	hyperpolarization.	
Bi:	 Superimposed	 sweeps	 of	 a	 current	 clamp	 recording	 taken	 from	 a	 glucose-inhibited	NPY	eGFP	neuron,	 showing	 the	membrane	 current-voltage	 relationship	in	1	mM	glucose	aCSF.	
Bii:	 Superimposed	 sweeps	 of	 a	 current	 clamp	 recording	 taken	 the	 same	 glucose	inhibited	 NPY	 eGFP	 neuron	 shown	 in	Bi.	 Sweeps	 show	 the	 membrane	 current-voltage	relationship	in	the	presence	of	5	mM	glucose	aCSF.	
Biii:	 Representative	 current-voltage	 relationship	 plots	 of	 glucose-induced	inhibition.	 Note	 the	 decreased	 slope	 of	 the	 membrane	 response	 to	 current	injection	 and	 reversal	 potential	 around	 -70	 mV.	 Taken	 together	 these	 indicate	membrane	 hyperpolarization	 via	 the	 activation	 of	 a	 chloride	 conductance,	 and	decreased	neuronal	input	resistance.	
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Figure	4.4:	Glucose-Excited	NPY-eGFP	neurons	
A:	 A	 representative	 current-clamp	 recording	 taken	 from	 an	 NPY-eGFP	 neuron	showing	glucose-induced	excitation.	Increasing	extracellular	glucose	concentration	from	 1	 mM	 to	 5	 mM	 induced	 membrane	 depolarization	 and	 increased	 action	potential	firing	frequency.	
Bi:	 Superimposed	 sweeps	 of	 a	 current	 clamp	 recording	 taken	 from	 a	 glucose-excited	NPY	eGFP	neuron,	showing	the	membrane	current-voltage	relationship	in	1	mM	glucose	aCSF.	
Bii:	 Superimposed	 sweeps	 of	 a	 current	 clamp	 recording	 taken	 from	 the	 same	glucose	 excited	 NPY	 eGFP	 neuron	 shown	 in	 Bi.	 Sweeps	 show	 the	 membrane	current-voltage	relationship	in	the	presence	of	5	mM	glucose	aCSF.	
Biii:	Representative	current-voltage	relationship	plots	of	glucose	excitation.	Note	the	 increased	 slope	 of	 the	membrane	 response	 to	 current	 injection	 and	 reversal	potential	around	-90	mV.	Taken	together	these	indicate	membrane	depolarization	via	 the	 inhibition	 of	 a	 potassium	 conductance,	 and	 increased	 neuronal	 input	resistance.			
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Figure	 4.5:	 Fasting-induced	 reorganization	 of	 glucose	 sensing	 in	 the	
NPY/AgRP	neurons	of	the	ARH:	Effects	of	adenosine	receptor	antagonists	
A:	Pie	chart	showing	the	response	distribution	of	NPY	eGFP	neurons	from	mice	fed	
ad	 libitum	 prior	 to	 culling.	 Increasing	 extracellular	 glucose	 concentration	 from	1	mM	 to	 5	 mM	 caused	 membrane	 excitation	 in	 26%	 of	 neurons,	 membrane	inhibition	in	29%	of	neurons,	whilst	46%	of	neurons	did	not	respond	(n=35).	
B:	 Pie	 chart	 showing	 the	 response	 distribution	 of	NPY	 eGFP	 neurons	 from	mice	subjected	 to	 an	 18-hour	 fast	 prior	 to	 culling.	 Increasing	 extracellular	 glucose	concentration	from	1	mM	to	5	mM	caused	membrane	excitation	in	40%	of	neurons,	membrane	 inhibition	 in	34%	of	neurons,	whilst	26%	of	neurons	did	not	respond	(n=73).	
C:	Pie	chart	showing	the	response	distribution	of	NPY	eGFP	neurons	incubated	in	the	adenosine	A1	receptor	antagonist	DPCPX	(1	μM),	from	mice	subjected	to	an	18-hour	 fast	 prior	 to	 culling.	 	 Increasing	 extracellular	 glucose	 concentration	 from	1	mM	 to	 5	 mM	 caused	 membrane	 excitation	 in	 24%	 of	 neurons,	 membrane	inhibition	in	35%	of	neurons,	whilst	41%	of	neurons	did	not	respond	(n=29).	
D:	Pie	chart	showing	the	response	distribution	of	NPY	eGFP	neurons	incubated	in	the	adenosine	A2A	receptor	antagonist	Istradefylline	(50	nM),	from	mice	subjected	to	an	18-hour	fast	prior	to	culling.	 	Increasing	extracellular	glucose	concentration	from	1	mM	to	5	mM	caused	membrane	excitation	 in	13%	of	neurons,	membrane	inhibition	in	34%	of	neurons,	whilst	52%	of	neurons	did	not	respond	(n=23).	
E:	Pie	chart	showing	the	response	distribution	of	NPY	eGFP	neurons	incubated	in	the	adenosine	A2B	receptor	antagonist	PSB-603	(100	nM),	from	mice	subjected	to	an	 18-hour	 fast	 prior	 to	 culling.	 Increasing	 extracellular	 glucose	 concentration	
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from	1	mM	to	5	mM	caused	membrane	excitation	 in	35%	of	neurons,	membrane	inhibition	in	35%	of	neurons,	whilst	30%	of	neurons	did	not	respond		(n=20).	
F:	Pie	chart	showing	the	response	distribution	of	NPY	eGFP	neurons	incubated	in	the	adenosine	A3	receptor	antagonist	MRS	1523	(300	nM),	from	mice	subjected	to	an	 18-hour	 fast	 prior	 to	 culling.	 Increasing	 extracellular	 glucose	 concentration	from	1	mM	to	5	mM	caused	membrane	excitation	 in	23%	of	neurons,	membrane	inhibition	in	36%	of	neurons,	whilst	41%	of	neurons	did	not	respond		(n=22).	
G:	 Table	 summarizing	 the	 p-values	 resulting	 from	 Chi-square	 analysis	 of	population	data	displayed	in	A	–	F.																
	
	
A.	Fed	
B.	Fasted	
D.	Fasted,	Istradefylline	(A2A)		
C.	Fasted,	DPCPX	(A1)	
F.	Fasted,	MRS	1523	(A3)	
E.	Fasted,	PSB-603	(A2B)	
Figure	4.5		
(n=36)
Inhibition 29%
Excitation 26%
No Response 46 %
(n=73)
Inhibition 34%
Excitation 40%
No Response 26%
(n=29)
Inhibition 35%
Excitation 24%
No Response 41%
(n=23)
Inhibition 34%
Excitation 13%
No Response 52%
(n=20)
Inhibition 35%
Excitation 35%
No Response 30%
(n=22)
Inhibition 36%
Excitation 23%
No Response 41%
Popula'on	Comparison		 p	
Fed	Vs.	Fasted	 0.0783	
Fasted	Vs.	DPCPX	 0.2189	
Fasted	Vs.	Istradefylline		 0.0242	
Fasted	Vs.	PSP-603	 0.9115	
Fasted	Vs.	MRS	1523	 0.2649	
G.		
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Figure	 4.6:	Magnitude	 of	 glucose-induced	 responses	 in	 NPY	 neurons	 in	 fed	
and	fasted	states	
A:	 Bar	 chart	 outlining	 the	 mean	 change	 in	 membrane	 potential	 of	 the	 glucose-induced	inhibition	of	NPY	eGFP	neurons.	Data	is	from	animals	fed	ad	libitum	prior	to	culling	and	from	animal	subjected	to	an	18-hour	fast	prior	to	culling.	Of	glucose-induced	 inhibitions	 recorded	 from	 mouse	 tissue	 prepared	 from	 fed	 animals,	neurons	were	hyperpolarized	-6.66	±	1.63	mV	from	a	mean	control	level	of	-52.73	±	 1.54	mV	 to	 a	 peak	 of	 -59.39	 ±	 1.76	mV	 (n=10)	 (p=0.003).	 Of	 glucose-induced	inhibitions	 recorded	 from	 mouse	 tissue	 prepared	 from	 fasted	 animals,	 neurons	were	hyperpolarized	by	-6.26	±	0.87	mV	from	a	mean	control	level	of	-49.79	±	1.41	mV	to	a	peak	of	-55.90	±	1.73	mV	(n=17)	(p=0.000002),	(paired	students	t-test).	
B:	 Bar	 chart	 outlining	 the	mean	 change	 in	 neuronal	 input	 resistance	 associated	with	 glucose-induced	 inhibition	 of	 NPY	 eGFP	 neurons.	 Data	 is	 from	 neurons	 of	glucose-induced	inhibition	in	NPY	eGFP	neurons	from	animals	fed	ad	libitum	prior	to	culling	and	from	animal	subjected	to	an	18-hour	fast	prior	to	culling.	Of	glucose-induced	 inhibitions	 observed	 in	 the	 ‘fed’	 state,	 neuronal	 input	 resistance	 fell	 by	785	±	355	MΩ	from	a	mean	control	level	of	1759	±	318	MΩ	to	a	peak	of	1410	±	342	MΩ	(n=6)	(p=0.090).	In	the	‘fasted’	state,	neuronal	input	resistance	associated	with	glucose-induced	inhibition	fell	by	308	MΩ	±	143	MΩ	from	a	mean	control	level	of	1559	±	165	MΩ	to	a	peak	of	1150	±	174	MΩ	(n=14)	(p=0.049),	(paired	students	t-test).	
C:	 Bar	 chart	 outlining	 the	 mean	 change	 in	 membrane	 potential	 of	 the	 glucose-induced	excitation	of	NPY	eGFP	neurons.	Data	is	from	animals	fed	ad	libitum	prior	to	 culling	 and	 from	 animal	 subjected	 to	 an	 18-hour	 fast	 prior	 to	 culling.	 Of	 the	glucose-induced	 excitatory	 responses	 observed	 in	 the	 ‘fed’	 state,	 neurons	 were	
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depolarized	by	5.13	mV	±	1.00	from	a	mean	control	level	of	-48.94	±	2.46	mV	to	a	new	peak	of	 -43.80	±	2.78	mV	(n=6)	 (p=0.001).	Of	 ‘fasted’	excitations,	NPY	eGFP	neurons	were	depolarized	by	4.65	±	0.52	mV	from	a	mean	control	level	of	-49.07	±	1.44	mV	 to	a	peak	of	 -44.12	±	1.32	mV	(n=12)	 (p=0.0000001;	paired	 students	 t-test).	
D:	Bar	chart	outlining	the	mean	change	in	neuronal	input	resistance	of	the	glucose-induced	 excitation	 of	 NPY	 eGFP	 neurons.	 Data	 is	 from	 neurons	 of	 glucose	excitation	 in	NPY	eGFP	neurons	 from	animals	 fed	ad	libitum	 prior	 to	 culling	and	from	animal	subjected	 to	an	18-hour	 fast	prior	 to	culling.	Of	 the	glucose-induced	excitatory	 responses	 observed	 in	 the	 ‘fed’	 state,	 neuronal	 input	 resistance	decreased	by	188	±	234	MΩ	from	a	mean	control	level	of	1668	±	291	MΩ	to	a	peak	of	1263	±	213	MΩ	(n=6)	(p=0.459).	Of	‘fasted’	excitation,	neuronal	input	resistance	increased	by	398	±	249	MΩ	from	a	mean	control	level	of	1143	±	68	MΩ	to	a	peak	of	1431	±	127	MΩ	(n=12)	(p=0.138),	(paired	students	t-test).	
E:	 Table	 comparing	 the	 magnitude	 of	 glucose-induced	 inhibitions	 in	 ‘fed’	 and	‘fasted’	groups.	Measured	in	terms	of	change	in	membrane	potential	(mV),	action	potential	 firing	 rate	 (Hz)	 and	 neuronal	 input	 resistance	 (MΩ).	 Statistical	 values	expressed	are	results	of	unpaired	students	t-test.	
F:	 Table	 comparing	 the	 magnitude	 of	 glucose-induced	 excitations	 in	 ‘fed’	 and	‘fasted’	groups.	Measured	in	terms	of	change	in	membrane	potential	(mV),	action	potential	 firing	rate	(Hz)	and	neuronal	 input	resistance	(MΩ).	P	values	expressed	are	results	of	unpaired	students	t-test.				
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Figure	 4.7:	 KATP	 channels	 mediate	 the	 glucose-induced	 excitation	 of	 NPY	
eGFP	neurons	
A:	 Current-clamp	 recording	 taken	 from	 an	 NPY-eGFP	 neuron.	 Increasing	extracellular	 glucose	 concentration	 from	 1	 mM	 to	 5	 mM	 induced	 membrane	depolarization.	 Subsequent	 washout	 of	 glucose	 and	 application	 of	 200	 µM	tolbutamide	 mimicked	 and	 blocked	 the	 depolarizing	 response	 induced	 by	 D-glucose	(n=4).	In	one	NPY	eGFP	neuron	(shown),	blocking	KATP-dependent	glucose-induced	 excitation	 revealed	 a	 glucose-induced	 inhibition.	 Arrow	 indicates	 the	point	 in	 peak	 response	 to	 tolbutamide	 at	 which	 neuron	membrane	 voltage	 was	clamped	 back	 to	 the	 pre-response	 resting	 level	 by	 manual	 constant	 current	injection.		
B:	Plot	of	current-voltage	relationship	of	neuron	shown	in	A,	in	1mM	glucose	and	in	5	mM	extracellular	glucose.	Note	the	increased	slope	of	the	membrane	response	to	 current	 injection	 and	 reversal	 potential	 around	 -70	mV.	However,	 as	 glucose-induced	 excitation	 can	mask	 simultaneous	 glucose-induced	 inhibitory	 responses,	attempts	 to	 extrapolate	 reversal	 potentials	 may	 have	 been	 confounded	 by	 the	simultaneous	activation	of	another,	opposing	conductance.	
C:	Plot	of	current-voltage	relationship	of	neuron	shown	in	A.	Plots	of	IVs	in	1mM	glucose,	 1	mM	 glucose	 and	 tolbutamide	 and	 5	mM	 and	 tolbutamide	 are	 shown.	Note	increased	slope	of	the	membrane	response	to	current	injection,	and	reversal	around	-90	mV	upon	tolbutamide	application.	Also	note	the	decreased	slope	in	the	membrane	 response	 to	 current	 injection	 upon	 5	 mM	 glucose	 application	 in	 the	presence	of	 tolbutamide.	Here	an	extrapolated	 reversal	potential	 around	 -70	mV	indicates	 membrane	 hyperpolarization	 via	 the	 activation	 of	 a	 chloride	conductance.	
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Figure	 4.8:	 KATP	 channels	 mediate	 ghrelin-induced	 excitation	 of	 NPY	 eGFP	
neurons	
A:	 Current-clamp	 recording	 taken	 from	 a	 NPY-eGFP	 neuron.	 Bath	 application	 of	100	nM	ghrelin-induced	reversible	membrane	depolarization	and	increased	action	potential	 firing	 rate.	 This	 effect	 of	 ghrelin	 was	 mimicked	 and	 blocked	 by	 bath	application	of	200μM	tolbutamide.	Arrow	indicates	the	point	 in	peak	response	to	tolbutamide	 at	 which	 neuron	 membrane	 voltage	 was	 clamped	 back	 to	 the	 pre-response	resting	level	by	manual	constant	current	injection.		
Bi:	 Superimposed	 sweeps	 of	 a	 current	 clamp	 recording	 taken	 from	 a	 ghrelin-sensitive	NPY	eGFP	neuron	showing	 the	current-voltage	relationship	before	bath	application	of	100	nM	ghrelin.	
Bii:	Superimposed	sweeps	of	a	current	clamp	recording	taken	the	same	NPY	eGFP	neuron	shown	in	Bi.	Sweeps	show	the	membrane	current-voltage	relationship	 in	the	presence	of	100	nM	ghrelin.		
C:	Current-clamp	recording	 taken	 from	NPY-eGFP	neuron.	Bath	application	of	10	nM	 ghrelin-induced	 membrane	 depolarization.	 Subsequent	 decrease	 of	extracellular	 glucose	 concentration	 from	 5	 mM	 to	 1	 mM	 induces	 membrane	hyperpolarization	and	the	reversal	of	the	ghrelin-induced	excitation.	
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Figure	4.9:	The	excitatory	effect	of	ghrelin	on	NPY	eGFP	neurons	is	amplified	
in	low	glucose	conditions	
A:	 Current	 clamp	 recording	 take	 from	 NPY	 eGFP	 neuron,	 from	 a	 mouse	 fed	 ad	
libitum	 prior	 to	 culling,	 with	 brain	 slices	 incubated	 in	 aCSF	 containing	 5	 mM	glucose.	 Bath	 application	 of	 100	 nM	 ghrelin	 caused	 a	 reversible	 membrane	depolarization	and	increase	in	action	potential	firing	frequency.	
B:	Current	clamp	recording	take	from	a	NPY	eGFP	neuron,	from	a	mouse	subjected	to	an	18-hour	fast	prior	to	culling,	with	brain	slices	incubated	in	aCSF	containing	1	mM	 glucose.	 Bath	 application	 of	 100	 nM	 ghrelin,	 in	 the	 presence	 of	 1	 μM	 TTX	induces	 a	 reversible	 membrane	 depolarization.	 At	 peak	 response,	 membrane	hyperpolarization	 through	 constant	 negative	 current	 injection	 revealed	subthreshold	 membrane	 potential	 oscillations	 (shown	 in	 expanded	 timescale;	bottom	panel).	
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Figure	 4.10:	 The	 excitatory	 effect	 of	 ghrelin	 on	 NPY	 eGFP	 neurons	 is	
amplified	in	low	glucose	conditions	
Ai:	 Graph	 summarizing	 the	 percentage	 of	 NPY-eGFP	 neurons	 sensitive	 to	 bath	application	 of	 ghrelin	 at	 concentrations	 of	 3,	 10	 and	 30	 nM	 in	 the	 following	conditions:	 Fed,	 5	 mM	 glucose	 group;	 40%	 (n=15),	 60%	 (n=15),	 75%	 (n=16);	Fasted,	 1	 mM	 glucose	 group:	 42.4%	 (n=33),	 65.5%	 (n=33),	 69.6%	 (n=23)	(Control/wash	vs.	ghrelin).	
Aii:	Graph	summarizing	the	mean	change	in	membrane	potential	induced	by	bath	application	of	ghrelin	at	3,	10	and	30	nM	(Data	summarized	in	Bi).	
Aiii:	 Graph	 summarizing	 the	 mean	 change	 action	 potential	 firing	 frequency	induced	 by	 bath	 application	 of	 ghrelin	 at	 3,	 10	 and	 30	 nM	 (Data	 summarized	 in	
Bii).	
Aiv	 Graph	 summarizing	 the	 mean	 change	 in	 input	 resistance	 induced	 by	 bath	application	of	ghrelin	at	3,	10	and	30	nM	(Data	summarized	in	Biii).	
Bi:	Table	summarizing	data	shown	in	Ai.	
Bii:	Table	summarizing	data	shown	in	Aii.	
Biii:	Table	summarizing	data	shown	in	Aiii.	
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Figure	4.11:	Ghrelin	excites	both	glucose	 inhibited	and	glucose	excited	NPY	
eGFP	neurons	
A:	 Current	 clamp	 recording	 taken	 from	 a	 NPY	 eGFP	 neuron	 from	 a	 mouse	subjected	 to	 an	18	hour	 fast	prior	 to	 culling.	Bath	 application	of	100	nM	ghrelin	induced	membrane	depolarization	and	increased	action	potential	firing	rate.	After	ghrelin	 washout	 from	 the	 recording	 chamber	 and	 membrane	 repolarization,	increasing	 extracellular	 glucose	 concentration	 from	 1	 mM	 to	 5	 mM	 induced	membrane	depolarization	and	an	 increase	 in	 action	potential	 firing	 rate.	 Further	membrane	 excitation	 was	 induced	 by	 subsequent	 bath	 application	 of	 200μM	tolbutamide,	 the	 latter	 confirming	 the	 expression	 of	 functional	 KATP	 channels	 in	this	neuron.	
B:	 Current	 clamp	 recording	 taken	 from	 a	 NPY	 eGFP	 neuron	 from	 a	 mouse	subjected	 to	 an	18	hour	 fast	prior	 to	 culling.	Bath	 application	of	100	nM	ghrelin	induced	membrane	depolarization	and	increased	action	potential	firing	rate.	After	ghrelin	 washout	 from	 the	 recording	 chamber	 and	 membrane	 repolarization,	increasing	 extracellular	 glucose	 concentration	 from	 1	 mM	 to	 5	 mM	 induced	membrane	 hyperpolarization.	 Membrane	 excitation	 by	 subsequent	 bath	application	 of	 200μM	 tolbutamide	 confirmed	 the	 expression	 of	 functional	 KATP	channels	in	this	neuron.	
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Chapter	5:	The	contribution	of	
TCPTP,	PTP1B	and	PI3-kinase	to	
insulin	signaling	in	POMC	neurons	
	
5.1		 Introduction	Obesity	 is	 increasing	 in	 prevalence,	 especially	 in	 western	 societies.	 Intervention	strategies	 aimed	 at	 reducing	 appetite	 and	 increasing	 energy	 expenditure	 would	reduce	 death	 attributed	 to	 obesity-related	 diseases.	 Increased	 fat	 mass	 is	associated	 with	 a	 number	 of	 co-morbidities	 including	 cardiovascular	 disease,	cancer	 and	 type-2	 diabetes	mellitus	 (T2DM).	 In	 2016,	 1	 in	 11	 adults	worldwide	were	affected	by	diabetes	and	between	1980	and	2014,	the	prevalence	of	diabetes	rose	 to	 from	 108	million	 to	 422	million	 (WHO,	 2016).	 	 Elevated	 blood	 sugar	 is	linked	to	3.7	million	deaths	annually	(WHO,	2016).	T2DM	reduces	life	expectancy	by	7	years,	increases	the	risk	of	cardiovascular	disease,	peripheral	artery	disease,	retinopathy,	nephropathy	and	neuropathy	(NICE,	2015).	The	underlying	metabolic	disorders	of	T2DM	are	insulin	insensitivity	and	insulin	deficiency	(NICE,	2015).		Insulin	 is	 secreted	 from	pancreatic	β-cells	 in	 response	 to	 elevated	plasma	glucose	 (Rorsman	 and	 Braun,	 2013).	 The	 insulin	 receptor	 (IR)	 is	 a	 hormone-activated	protein	tyrosine	kinase,	expressed	ubiquitously	in	all	mammalian	tissues	(Desbuquois	 et	 al.,	 1993).	 Insulin-IR	 binding	 initiates	 insulin	 receptor	 substrate	(IRS)	 tyrosine	 residue	phosphorylation	and	 signal	 transduction	 (Watanabe	et	 al.,	1998).	Functional	peripheral	 and	central	 insulin	 signaling	 is	 required	 for	normal	glucose	 homeostasis	 (Plum	 et	 al.,	 2006a).	 Peripheral	 organs	 mediate	 the	physiological	 effects	 of	 insulin	 on	 blood	 glucose.	 The	 liver	 and	 kidneys	 regulate	plasma	 glucose	 through	 glycogenesis	 and	 gluconeogenesis	whilst	 glucose	 uptake	
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by	 muscle	 and	 adipose	 tissue	 is	 also	 critical	 to	 glucose	 homeostasis	 (Patti	 and	Kahn,	 1998).	 Elevated	 plasma	 insulin	 decreases	 hepatic	 glycogenolysis	 and	gluconeogenesis	 whilst	 also	 increasing	 glucose	 uptake	 to	 fat	 and	 muscle	 tissue.	Central	 insulin	 signaling	 affects	 glucose	 homeostasis	 through	 the	 regulation	 of	hepatic	glucose	production,	appetite	and	energy	expenditure	(Pocai	et	al.,	2005).	Insulin	elicits	significant	physiological	effects	through	signaling	in	neurons	of	 the	 arcuate	 nucleus	 of	 the	 hypothalamus	 (ARH),	 including	 neuropeptide	Y/agouti-related	 peptide	 (NPY/AgRP)	 and	 proopiomelanocortin/	 cocaine	 and	amphetamine-regulated	 transcript	 (POMC/CART)	 neurons	 (Dodd	 et	 al.,	 2015,	Konner	et	al.,	2007).	POMC	neurons	of	 the	ARH	are	sensitive	 to	both	 insulin	and	leptin	 (Cowley	 et	 al.,	 2001,	 Qiu	 et	 al.,	 2014,	 Williams	 et	 al.,	 2010).	 Leptin	 and	insulin	 signaling	 in	 POMC	 neurons	 increases	 brown	 adipose	 tissue	 (BAT)	thermogenesis	and	also	converts	white	adipose	tissue	(WAT)	to	BAT.	BAT	is	a	key	effector	of	energy	expenditure;	it	is	highly	metabolic,	dense	with	mitochondria	and	the	BAT-specific	protein,	uncoupling	protein-1	(UCP-1)	(Dodd	et	al.,	2015).	UCP-1	uncouples	 fatty	 acid	 oxidation	 and	 ATP	 production	 by	 catalyzing	 ATP	 synthase-independent	 proton	 transport	 across	 the	 inner	mitochondrial	membrane	 (Rosen	and	Spiegelman,	2014).	Increased	UCP-1	activity	increases	BAT	thermogenesis	and	energy	expenditure	(Rosen	and	Spiegelman,	2014).	The	attenuation	of	 leptin	and	insulin	signal	transduction	blunts	these	effects	(Dodd	et	al.,	2015).		POMC	 neurons	 of	 the	 ARH	 are	 anorexigenic,	 with	 increased	 electrical	activity	 promoting	 satiety	 and	 increasing	 energy	 expenditure	 via	 elevated	αMSH	release	 onto	 second	 order	 neurons,	 including	 those	 in	 the	 PVH	 (Huszar	 et	 al.,	1997).	Insulin	exerts	inhibitory	effects	on	some	POMC	neurons,	whilst	on	others	it	induces	 membrane	 excitation	 (Williams	 et	 al.,	 2010,	 Qiu	 et	 al.,	 2014).	 Insulin	
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excites	a	subpopulation	of	POMC	neurons	via	transient	receptor	potential	channel	(TRPC)	 activation	 (Qiu	 et	 al.,	 2014).	 The	 proportion	 of	 insulin-inhibited	 POMC	neurons	 varies	 greatly	 and	 has	 been	 reported	 to	 be	 25%,	 50%,	 and	 80%	 of	 the	population	(Choudhury	et	al.,	2005,	Claret	et	al.,	2007,	Williams	et	al.,	2010).	POMC	neurons	 express	 functional	 KATP	 channels	 and	 insulin	 has	 been	 shown	 to	 inhibit	arcuate	neurons	via	a	KATP	channel	and	PI3K-dependent	mechanism	(Spanswick	et	al.,	 2000,	 Claret	 et	 al.,	 2007,	 Plum	 et	 al.,	 2006b).	 Both	 TRPC	 and	 KATP	 channel	activation	 is	 dependent	 upon	 PI3K	 signal	 transduction:	 Increased	 POMC	 PI3K	activity	 has	 been	 associated	 with	 elevated	 KATP	 channel	 activation,	 and	 obesity	(Plum	 et	 al.,	 2006b).	 The	 PI3K	 inhibitor	 wortmannin	 has	 been	 shown	 to	 block	insulin-induced	POMC	neuron	excitation	(Qiu	et	al.,	2014).		Insulin	signal	 transduction	(see	Figure	1.2)	 is	 initiated	by	 the	binding	and	activation	of	the	IR,	initiating	IRS2	phosphorylation.	IRS2	recruits	PI3K,	increasing	intracellular	PIP3	concentration.	PI3K	activates	KATP	channels	in	arcuate	NPY/AgRP	and	 POMC	 neurons,	 and	 also	 activates	 TRPC	 channels	 in	 POMC	 neurons	(Spanswick	 et	 al.,	 2000,	 Williams	 et	 al.,	 2010,	 Qiu	 et	 al.,	 2014).	 Increased	 PIP3	activates	 the	serine/threonine	protein	kinase	AKT,	which	phosphorylates	FOX01,	increasing	POMC	expression,	promoting	the	anorexigenic	axis	of	the	melanocortin	system.	 Central	 insulin-IRS-PI3K	 signaling	 is	 required	 for	 normal	 energy	homeostasis.	Knock-out	or	 inhibition	of	hypothalamic	 insulin	 signaling	 results	 in	obesity,	 insulin	 resistance	 and	 impaired	 gonadotroph	 secretion,	whilst	 increased	hypothalamic	PI3K	 signaling	 enhances	 central	 glucose	 sensitivity	 (Bruning	 et	 al.,	2000,	Kubota	et	al.,	2004,	Gelling	et	al.,	2006).		The	 protein	 tyrosine	 phosphatases,	 T-cell	 protein	 tyrosine	 phosphatase	(TCPTP)	and	protein	 tyrosine	phosphatase	1B	 (PTP1B),	 attenuate	central	 insulin	
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signaling	and	are	expressed	in	distinct	and	overlapping	subpopulations	of	arcuate	POMC	neurons	(Zhang	et	al.,	2015).	PTP1B	is	expressed	in	75%	of	arcuate	POMC	neurons,	with	highest	POMC	expression	in	the	central	and	caudal	ARH	(Dodd	et	al.,	2015).	TCPTP	is	expressed	in	40%	of	ARH	POMC	neurons,	with	increased	POMC-TCPTP	localization	in	the	rostral	ARH	(Dodd	et	al.,	2015).	PTP1B	dephosphorylates	Y1162	and	Y1163	of	the	IR	(Zhang	et	al.,	2015).	Hypothalamic	PTP1B	knockdown	reduces	food	intake	and	body	weight	and	is	protective	against	obesity	(Picardi	et	al.,	 2008,	 Goldstein,	 2002).	 However,	 specific	 PTP1B	 knockout	 in	 arcuate	 POMC	neurons	 does	 not	 affect	 insulin	 signaling	 and	 energy	 homeostasis	 (Dodd	 et	 al.,	2015).	TCPTP	also	dephosphorylates	Y1162	and	Y1163	of	the	IR,	and	knockout	of	this	phosphatase	in	ARH	POMC	neurons	increases	AKT-induced	POMC	expression,	and	improves	glucose	homeostasis	(Dodd	et	al.,	2015,	Galic	et	al.,	2003).		 Intact	 PI3K	 signal	 transduction	 is	 required	 for	 insulin	 to	 affect	 arcuate	POMC	neuron	electrical	activity,	and	TCPTP	is	recognized	as	a	negative	regulator	of	insulin	signaling.	The	aims	of	this	study	were	to	use	the	visualized	whole-cell	patch	clamp	 technique	 to	determine	 the	 effects	 of	TCPTP	and	PI3K	activity	 on	 insulin-induced	changes	in	electrical	activity	of	POMC	neuron	
	
5.2		 Results	
5.2.1		 The	effects	of	insulin	on	POMC	eGFP	neurons	
Whole-cell	 recordings	 were	 obtained	 from	 53	 POMC	 eGFP	 neurons	 in	hypothalamic	brain	slices	prepared	from	POMC	eGFP	transgenic	mice.	Application	of	 100	nM	 insulin	 induced	 membrane	 depolarization	 and/or	 an	 increase	 in	spontaneous	 action	 potential	 firing	 rate	 in	 9.4%	 (n=5)	 of	 recorded	 neurons;	
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membrane	 hyperpolarization	 in	 51.0%	 (n=27)	 of	 recorded	 neurons,	 and	 the	remaining	39.6%	(n=21)	of	neurons	did	not	respond	to	bath	application	of	100	nM	insulin	(Figure	5.1A).		
Insulin	 induced	 a	mean	 peak	 amplitude	 depolarization	 of	 6.29	 ±	 1.74	mV	from	 a	 mean	 resting	 potential	 of	 −44.39	 ±	 2.27	mV	 to	 a	 new	 steady-state	membrane	 potential	 of	 −38.11	 ±	 1.74	mV	 (p=0.023,	 n=5).	 Insulin-induced	excitation	was	associated	with	an	increase	in	firing	rate	from	a	mean	control	basal	level	of	0.79	±	0.35	Hz	to	1.35	±	0.57	Hz	in	the	presence	of	insulin	(p=0.093,	n=5),	Spontaneous	firing	rate	in	the	presence	of	insulin	amounted	to	173.2	±	22.3	%	of	activity	observed	in	control	conditions	(n=3).	Insulin	 induced	 a	 mean	 peak	 amplitude	 membrane	 hyperpolarization	 of	2.58	 ±	 0.45	mV:	 from	 a	 mean	 resting	 potential	 of	 −41.04	 ±	 0.97	 mV	 to	 a	 new	steady-state	membrane	potential	of	−43.70	±	1.40	mV	(p=0.00001,	n=27).	Insulin-induced	 inhibition	 was	 associated	 with	 a	 reduction	 in	 firing	 rate	 from	 a	 mean	control	 basal	 level	 of	 0.90	±	0.20	Hz	 to	0.16	±	0.06	Hz	 in	 the	presence	of	 insulin	(p=0.00007,	n	=	27).	Spontaneous	firing	rate	in	the	presence	of	 insulin	amounted	to	21.2	±	4.8	%	of	activity	observed	in	control	conditions	(n=15).		
5.2.2		 The	effects	of	insulin	on	POMC-eGFP	neurons,	in	the	presence	of	a	
TCPTP	inhibitor	
Whole-cell	 recordings	 were	 obtained	 from	 58	 POMC	 eGFP	 neurons,	 with	 the	TCPTP	inhibitor	 ‘Compound	8’	 included	in	the	pipette	solution	at	a	concentration	of	 20	 nM.	 Compound	 8	 is	 a	menthoxyacetic	 acid	 derivative	 (Zhang	 et	 al.,	 2009).	Bath	application	of	100	nM	insulin	was	performed	at	least	15	minutes	after	whole-
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cell	access	was	achieved.	Here,	 insulin	 induced	membrane	depolarization	and/or	an	increase	in	spontaneous	action	potential	firing	rate	in	32.7%	(n=19)	of	recorded	neurons;	membrane	hyperpolarization	 in	 12.1%	 (n=7)	 of	 recorded	neurons,	 and	the	remaining	55.2%	(n=32)	of	neurons	did	not	respond	to	bath	application	of	100	nM	insulin	(Figure	5.1B).		
Insulin	 induced	 a	mean	 peak	 amplitude	 depolarization	 of	 5.91	 ±	 0.79	mV	from	 a	 mean	 resting	 potential	 of	 −48.25	 ±	 1.60	mV	 to	 a	 new	 steady-state	membrane	 potential	 of	 −42.33	 ±	 1.20	mV	 (p=0.0000007,	 n=19).	 Insulin-induced	excitation	was	associated	with	an	increase	in	firing	rate	from	a	mean	control	basal	level	of	0.51	±	0.21	Hz	to	0.81	±	0.27	Hz	in	the	presence	of	insulin	(p=0.094,	n=19).	Of	neurons	firing	in	control	conditions,	spontaneous	firing	rate	in	the	presence	of	insulin	amounted	to	160	%	of	activity	observed	in	control	conditions	(n=10).	Insulin	induced	a	mean	peak	amplitude	hyperpolarization	of	4.00	±	0.50	mV	from	 a	 mean	 resting	 potential	 of	 −46.98	 ±	 3.89	mV	 to	 a	 new	 steady-state	membrane	 potential	 of	 −50.98	 ±	 4.22	mV	 (p=0.0002,	 n=7).	 Insulin-induced	inhibition	was	associated	with	a	reduction	in	firing	rate	from	a	mean	control	basal	level	of	0.11	±	0.09	Hz	to	0.01	±	0.00	Hz	in	the	presence	of	insulin	(p=0.27,	n=7).	Of	neurons	 firing	 in	 control	 conditions	 spontaneous	 firing	 rate	 in	 the	 presence	 of	insulin	amounted	to	7.4	±	2.6	%	of	activity	observed	in	control	conditions	(n=2).		
5.2.3		 The	effects	of	insulin	on	POMC	neurons	lacking	TCPTP		Whole-cell	 recordings	 were	 obtained	 from	 33	 POMC	 Z/EG	 TCPT	 lox/lox	 neurons.	Application	 of	 100	nM	 insulin	 induced	 membrane	 depolarization	 and/or	 an	increase	 in	 spontaneous	action	potential	 firing	 rate	 in	36.4%	(n=12)	of	 recorded	neurons,	membrane	hyperpolarization	in	36.4%	(n=12)	of	recorded	neurons,	and	
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the	remaining	27.2%	(n=9)	of	neurons	did	not	respond	to	bath	application	of	100	nM	insulin	(Figure	5.1C).		Insulin	 induced	 a	mean	 peak	 amplitude	 depolarization	 of	 4.24	 ±	 0.67	mV	from	 a	 mean	 resting	 potential	 of	 −42.11	 ±	 1.84	mV	 to	 a	 new	 steady-state	membrane	potential	of	−37.87	±	1.66	mV	(p=0.00006).	Insulin-induced	excitation	was	associated	with	an	 increase	 in	 firing	 rate	 from	a	mean	control	basal	 level	of	0.35	±	0.19	Hz	to	0.79	±	0.39	Hz	in	the	presence	of	insulin	(p=0.14;	n	=	12;	paired	students	 t-test).	 Spontaneous	 firing	 rate	 in	 the	 presence	 of	 insulin	 amounted	 to	366.6	±	113.9	%	of	activity	observed	in	control	conditions	(n=6).	Insulin	induced	a	mean	peak	amplitude	hyperpolarization	of	3.75	±	0.89	mV	from	 a	 mean	 resting	 potential	 of	 −43.04	 ±	 1.77	mV	 to	 a	 new	 steady-state	membrane	 potential	 of	 −46.78	 ±	 2.30	mV	 (p=0.001).	 Insulin-induced	 inhibition	was	associated	with	a	 reduction	 in	 firing	 rate	 from	a	mean	control	basal	 level	of	0.32	±	0.15	Hz	to	0.05	±	0.03	Hz	in	the	presence	of	insulin	(p=0.058;	n	=	12;	paired	students	 t-test).	 Spontaneous	 firing	 rate	 in	 the	 presence	 of	 insulin	 amounted	 to	11.2	±	4.1	%	of	activity	observed	in	control	conditions	(n=6).	
	
5.2.4		 The	effects	of	inhibition	of	PI3kinase	on	insulin-induced	responses	in	
POMC	eGFP	neurons	
Whole-cell	recordings	were	obtained	from	58	POMC	eGFP	neurons.	Application	of	100	nM	insulin	was	preceded	by	bath	application	of	the	PI3K	inhibitor	LY294002	(10μM).	 Insulin	 induced	 membrane	 depolarization	 and/or	 an	 increase	 in	spontaneous	 action	 potential	 firing	 rate	 in	 36.6%	 (n=21)	 of	 recorded	 neurons,	membrane	 hyperpolarization	 in	 11.6%	 (n=7)	 of	 recorded	 neurons,	 and	 the	
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remaining	 51.6%	 (n=30)	 of	 neurons	 did	 not	 respond	 to	 100	 nM	 insulin	 (Figure	5.1).		
Insulin	 induced	 a	mean	 peak	 amplitude	 depolarization	 of	 4.04	 ±	 0.39	mV	from	 a	 mean	 resting	 potential	 of	 −45.38	 ±	 0.67	mV	 to	 a	 new	 steady-state	membrane	potential	of	−41.34	±	0.68	mV	(p=0.00001).	Insulin-induced	excitation	was	associated	with	an	 increase	 in	 firing	 rate	 from	a	mean	control	basal	 level	of	0.72	±	0.13	Hz	to	1.03	±	0.19	Hz	in	the	presence	of	insulin	(n	=	22,	p=0.89;	paired	students	 t-test).	 Spontaneous	 firing	 rate	 in	 the	 presence	 of	 insulin	 amounted	 to	115.7	±	17.7	%	of	activity	observed	in	control	conditions	(n=18).	Insulin	 induced	 a	 mean	 peak	 amplitude	 membrane	 hyperpolarization	 of	3.60	±	1.22	mV	from	a	mean	resting	potential	of	−39.76	±	3.60	mV	to	a	new	steady-state	 membrane	 potential	 of	 −43.35	 ±	 4.75	mV	 (p=0.008).	 Insulin-induced	inhibition	was	associated	with	a	reduction	in	firing	rate	from	a	mean	control	basal	level	of	0.40	±	0.17	Hz	to	0.07	±	0.07	Hz	in	the	presence	of	insulin	(n	=	7,	p=0.055;	paired	 students	 t-test).	 Spontaneous	 firing	 rate	 in	 the	 presence	 of	 insulin	amounted	to	5.6	±	5.6	%	of	activity	observed	in	control	conditions	(n=4).		
5.3		 Discussion	Here	I	show	an	increased	proportion	of	insulin-induced	excitations	when	TCPTP	is	inhibited	 or	 knocked	 out,	 or	 when	 PI3K	 is	 inhibited,	 compared	 to	 POMC	 eGFP	controls.	 I	 also	 show	 that	 the	 magnitude	 of	 the	 insulin-induced	 excitation	 is	significantly	 increased	 in	 the	 presence	 of	 a	 TCPTP	 inhibitor,	 relative	 to	 insulin-induced	 excitations	 in	 the	 presence	 of	 a	 PI3K	 inhibitor.	 Here,	 the	 response	distribution	of	insulin’s	effect	on	POMC	EGFP	neurons	was	found	to	be	significantly	different	to	the	effect	of	insulin	in	the	presence	of	a	TCPTP	inhibitor	(p=<0.0001),	
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the	effect	of	insulin	on	POMC	Z/EG	neurons	lacking	TCPTP	(p=0.0095)	and	POMC	EGFP	 neurons	 in	 the	 presence	 of	 a	 PI3K	 inhibitor	 (p=<0.0001).	 The	 insulin	response	distribution	of	 the	TCPTP	 inhibitor	and	PI3K	 inhibitor	groups	were	not	statistically	 different	 (p=0.9041).	 Response	 distributions	 of	 the	 TCPTP	 inhibitor	and	TCPTP	knockout	groups	were	found	to	be	significantly	different	(p=0.008).		Taken	 together,	 this	 data	 indicates	 that	TCPTP	attenuates	 insulin-induced	excitation	of	POMC	neurons.	This	data	is	generally	in	agreement	with	physiological	studies	 that	 demonstrated	 attenuation	 of	 insulin	 signaling	 by	 TCPTP	 in	 vivo	(Tiganis,	2013).	 	Thus	TCPTP	has	an	 important	role	 in	mediating	 insulin-induced	excitation	in	POMC	neurons.		 Previous	studies	have	suggested	Insulin	depolarizes	arcuate	POMC	neurons	via	 the	 PI3K-dependent	 activation	 of	 TRPC	 channels	 (Qiu	 et	 al.,	 2014).	 TCPTP	dephosphorylates	 Y1162	 and	 Y1163	 residues	 of	 the	 IR	 (Galic	 et	 al.,	 2003),	downstream	effects	of	which	are	the	reduced	phosphorylation	of	IRS2	and	reduced	activation	of	PI3K.	 	Thus,	disinhibition	of	PI3K	signaling,	via	 inhibition	of	TCPTP,	may	 promote	 POMC	neuron	 excitation	 via	 TRPC	 channels.	 This	 notion	 is	 further	supported	by	the	observations	here	of	the	significantly	elevated	magnitude	of	the	excitatory	 membrane	 potential	 response	 to	 insulin,	 in	 the	 presence	 of	 a	 TCPTP	inhibitor,	relative	to	a	PI3K	inhibitor.	These	data	indicate	that	the	inhibition	of	TCPTP	in	arcuate	POMC	neurons	promotes	 an	 increased	 proportion	 of	 insulin-induced	 excitations	 possibly	 via	disinhibition	 of	 the	 IR-PI3K-TRPC	 pathway.	 The	 larger	 proportion	 of	 insulin-induced	 inhibitions	observed	 in	 the	control	POMC	population,	compared	 to	eGFP	plus	TCPTP	inhibitor	population	suggests	that	TCPTP	signaling	promotes	insulin-induced	inhibition	of	POMC	neurons.	Paradoxically	the	similarity	between	TCPTP	
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and	 PI3K	 inhibitor	 group	 response	 distributions	 would	 suggest	 that	 the	 same	insulin	 response	 distribution	 can	 be	 generated	 through	 both	 the	 inhibition	 and	disinhibition	 of	 PI3K	 signaling.	 Previous	 work	 has	 demonstrated	 KATP	 channel	activation	 to	 result	 from	 elevated	 intracellular	 PIP3	 (Harvey	 et	 al.,	 2000).	Presumably	 PI3K	 inhibition	 would	 decrease	 cytosolic	 PIP3,	 whilst	 TCPTP	inhibition	would	increase	intracellular	PIP3.	How	blocking	TCPTP	and	PI3-kinase	results	in	a	similar	population	and	distribution	of	insulin-sensitive	POMC	neurons	is	 currently	 unclear.	 	 However,	 as	 indicated	 above,	 increased	 excitation	 through	disinhibition	of	PI3-kinase	 could	explain	 increased	excitation	whilst	 inhibition	of	PI3-kinase	could	promote	insulin-induced	excitation	by	suppressing	a	PI-3-kinase-dependent	inhibition	that	effectively	masks	concomitant	excitation.		Such	a	notion	is	 supported	 here	 by	 observations	 that	 PI3-kinase	 inhibition	 alone	 induced	depolarization,	 suggesting	 a	 tonic	 inhibitory	 drive	 via	 PI3	 kinase	 exists	 in	 some	POMC	neurons.	 	Furthermore,	PI3	kinase	has	been	clearly	shown	to	activate	KATP	channels	 in	 pancreatic	 beta	 cells	 (Khan	 et	 al.,	 2001)	 and	 hypothalamic	 neurons	(Spanswick	et	al.,	2000)	including	POMC	(Plum	et	al.,	2006b).		PI3-kinase	can	also	be	 activated	 via	 many	 routes	 other	 than	 tyrosine	 kinase-dependent	 pathways	including	 via	 G-protein	 coupled	 receptors,	 for	 example	 adenosine	 A2	 and	 A3	receptors	 (Gavi	 et	 al.,	 2006).	 Thus,	 the	 reduced	 incidence	 of	 insulin-induced	inhibitions	 in	 the	PI3K	 inhibitor	population	 is	explainable	 in	 that	neurons	are	no	longer	 competent	 of	 KATP	 channel	 activation	 and	 membrane	 hyperpolarization.	One	final	point	worthy	of	note	is	the	fact	that	the	selectivity	of	the	TCPTP	inhibitor	may	 be	 questionable,	 although	 introducing	 the	 inhibitor	 via	 the	 patch	 pipette	enabled	drug	application	at	a	reported	selective	concentration.	The	fact	that	some	inhibitions	 remain	 in	 the	 PI3K	 inhibitor	 group	 also	 suggests	 PI3K-independent	
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mechanisms	may	 contribute	 to	 insulin-induced	hyperpolarization	 in	 some	POMC	neurons.			TCPTP	and	PI3K	inhibitor	groups	have	comparable	proportions	of	 insulin-induced	 inhibitory	 responses	 in	 POMC	 neurons.	 However	 the	 TCPTP	 knockout	population	had	a	notably	higher	proportion	of	 insulin	 inhibited	neurons	and	 less	insulin-insensitive	neurons.	These	observations	may	be	indicative	of	the	presence	of	redundant	compensatory	mechanisms	arising	in	POMC	neurons,	in	response	to	TCPTP	knockout.		POMC	 neurons	 can	 be	 hyperpolarized	 via	 a	 PI3K-KATP	 channel-dependent	mechanism	 (Plum	 et	 al.,	 2006b).	 Increased	 PI3K	 activity	 is	 associated	 with	activated	 KATP	 channels	 and	 membrane	 hyperpolarization.	 Therefore	 one	 could	hypothesize	 that	 the	 control	 population	 would	 have	 the	 smallest	 percentage	 of	insulin-inhibited	 neurons	 due	 to	 TCPTP	 attenuation	 of	 PI3K	 signaling.	 However	this	 is	 not	 the	 case.	 A	 smaller	 proportion	 of	 POMC	 neurons	 are	 inhibited	 in	 the	TCPTP	knockout	compared	to	control	and	to	a	greater	degree	in	the	presence	of	a	TCPTP	or	PI3K	inhibitor.	Thus	TCPTP	also	appears	important	fro	insulin-induced	inhibition,	at	least	in	a	subpopulation	of	POMC	neurons	These	 results	 indicate	 that	 TCPTP	 can	 drive	 inhibitory	 insulin	 signaling	through	 the	 attenuation	 of	 PI3K	 signaling.	 Blocking	 the	 ability	 of	 TCPTP	 to	attenuate	signaling	gives	rise	to	a	greater	proportion	of	insulin	excited	and	smaller	proportion	 of	 insulin-inhibited	 POMC	 neurons.	 This	 net	 increase	 in	 membrane	excitation	 is	 associated	 with	 increased	 innervation	 of	 the	 sympathetic	 nervous	system	 (SNS)	 by	 POMC	 neurons,	 measured	 in	 terms	 of	 BAT	 thermogenesis	 and	increased	browning	of	white	adipose	tissue	(Dodd	et	al.,	2015).		
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Blocking	 the	 effects	 of	 TCPTP	 at	 these	 neurons	 generates	 an	 increase	 in	excitatory	output.	A	net	increase	in	the	electrical	activity	of	arcuate	POMC	neurons	is	 associated	 with	 reduced	 food	 intake,	 elevated	 energy	 expenditure	 and	 the	reduction	of	adiposity	(Claret	et	al.,	2007,	Zhan	et	al.,	2013).	Insulin	acts	at	POMC	neurons	 to	 increase	energy	expenditure	by	promoting	 the	 conversion	of	WAT	 to	BAT,	in	addition	to	increasing	BAT	thermogenesis,	an	effect	enhanced	by	the	knock	out	 of	 PTP1B	 and	 TCPTP	 (Dodd	 et	 al.,	 2015).	 POMC	 neuron	 specific	 TCPTP	knockout	 has	 been	 shown	 to	 increase	 PI3K-pAKT	 signaling.	 In	 vivo	 Inhibition	 of	TCPTP	 with	 the	 selective	 inhibitor	 used	 in	 electrophysiological	 experiments	outlined	here	and	described	by	Zhang	et	al.,	results	in	a	2.5	fold	increase	in	POMC	mRNA	 expression	 (Dodd	 et	 al.,	 2015,	 Zhang	 et	 al.,	 2009).	 	 Thus,	 data	 described	here,	at	least	in	part,	agree	with	physiological	observations	made	in	vivo.		One	final	point	worthy	of	note	here	is	the	heterogeneity	of	insulin-induced	responses.		This	almost	 certainly	 reflects	 heterogeneity	 of	 POMC	 neuronal	 function	 (Sohn	 and	Williams,	 2012)	 in	 relation	 to	 functional	 anatomical	 organization,	 target	 neuron,	organ	and	behavioral	output.	 	Future	work	would	benefit	from	identifying	insulin	responses	 in	 relation	 to	 target	 organ	 and	 function	 to	 fully	 understand	 the	heterogeneity	of	 insulin-induced	responses	 in	these	neurons	and	their	associated	signal	transduction	pathways.	In	summary,	data	presented	here	provide	insight	of	the	 mechanisms	 by	 which	 insulin-dependent	 signaling	 regulates	 POMC	 neurons	and	how	future	pharmaceuticals	could	attenuate	obesity,	through	the	inhibition	of	POMC	 protein	 tyrosine	 phosphatases,	 and	 the	 disinhibition	 of	 insulin	 signal	transduction.	However	it	must	be	noted	that	TCPTP	expression	is	ubiquitous,	with	especially	 high	 expression	 found	 in	 hematopoietic	 tissue	 (Ibarra-Sanchez	 et	 al.,	2001).	As	such,	the	effects	on	food	intake	and	energy	expenditure	are	unlikely	to	
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the	 only	 impact	 of	 phosphatase	 manipulation.	 Furthermore,	 current	pharmacological	 agents	 -	 such	 as	 Compound	 8	 used	 here	 -	 although	 effective	 at	nanomolar	concentrations,	also	 inhibit	other	phosphatases	 	 -	 such	as	PTP1B	–	at	the	same	order	of	magnitude	concentration.	There	is	a	need	for	more	specific	and	selective	pharmacological	agents.																																							
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Figure	5.1:	Distribution	of	 insulin-induced	responses	 in	POMC	neurons	and	
the	effects	of	TCPTP	and	PI3K	inhibition	
A:	 Pie	 chart	 summarizing	 POMC	 eGFP	 neuron	 responses	 to	 bath	 application	 of	insulin	 (100nM).	51.0%	of	neurons	were	 inhibited	by	 insulin;	9.4%	were	excited	by	insulin	and	in	39%	of	neurons,	no	membrane	response	was	detected	(n=53).	
B:	 Pie	 chart	 summarizing	 POMC	 eGFP	 neuron	 responses	 to	 bath	 application	 of	insulin	 (100nM)	 in	 the	presence	of	a	 selective	TCPTP	 inhibitor,	Compound	8	 (20	nM),	 introduced	 from	 the	 patch	 pipette.	 12.1%	 of	 neurons	 were	 inhibited	 by	insulin,	 32.7%	were	 excited	 by	 insulin	 and	 in	 55.2%	 of	 neurons,	 no	 membrane	response	was	detected	(n=58).	
C:	 Pie	 chart	 summarizing	 the	 effects	 of	 insulin	 (100nM),	 applied	 by	 bath	application,	 in	 hypothalamic	 slices	 prepared	 from	 POMC	 Z/EG	 TCPTP	 knockout	transgenic	 mice.	 Under	 these	 conditions,	 TCPTP	 was	 selectively	 knocked-out	 of	POMC	neurons.	 	36.4%	of	neurons	were	inhibited	by	insulin,	36.4%	were	excited	by	insulin	and	27%	did	not	respond	to	this	hormone.		
D:	 Pie	 chart	 summarizing	 POMC	 eGFP	 neuron	 responses	 to	 bath	 application	 of	insulin	(100nM)	following	inhibition	of	PI3K	by	incubating	hypothalamic	slices	in	the	PI3K	inhibitor	LY294002	(10μM).	11.66%	of	neurons	were	excited	by	insulin,	36.66%	 of	 neurons	 were	 inhibited	 by	 insulin	 and	 51.66%	 of	 neurons	 did	 not	respond	to	insulin	in	the	presence	of	LY294002	(10μM).	
E.	Table	summarizing	comparative	analysis	of	population	data	shown	in	A	–	D.	p-values	shown	are	the	result	of	Chi-square	population	analysis.	
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Popula'on	Comparison	 p	
POMC	EGFP	Vs.	TCPTP	Inhibitor	 <0.0001
POMC	EGFP	Vs.	POMC	Z/EG	TCPTP	lox/lox	 0.0095	
POMC	EGFP	Vs.	LY294002	 <0.0001
TCPTP	Inhibitor	Vs.	LY294002	 0.9041	
TCPTP	Inhibitor	Vs.	POMC	Z/EG	TCPTP	lox/lox	 0.008	
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Figure	5.2:	Magnitude	of	insulin-induced	POMC	neuron	membrane	responses	
A:	Bar	 chart	 summarizing	 the	mean	membrane	potential	 change	 to	 insulin	 in	 all	four	 experimental	 groups.	 Both	 insulin-induced	 inhibition	 and	 insulin-induced	excitation	 are	 shown.	 Of	 POMC	 eGFP	 neurons	 tested,	 mean	 insulin-induced	membrane	depolarization	was	6.29	±	1.74	mV	(n=5),	whilst	mean	insulin-induced	membrane	hyperpolarization	was	2.58	±	0.45	mV	(n=27).	Of	POMC	eGFP	neurons	tested	 in	 the	presence	of	a	TCPTP	 inhibitor,	mean	 insulin-induced	depolarization	was	 found	 to	 be	 5.91	 ±	 0.79	mV	 (n=19),	 whilst	 mean	 insulin-induced	hyperpolarization	was	4.00	±	0.50	mV	(n=7).	Of	POMC	Z/EG	TCPTP	lox/lox	neurons,	mean	 insulin-induced	 depolarization	 was	 4.24	 ±	 0.67	mV	 (n=12),	 whilst	 mean	insulin-induced	 hyperpolarization	 was	 3.75	 ±	 0.89	mV	 (n=12).	 Of	 POMC	 eGFP	neurons	 tested	 in	 the	 presence	 of	 a	 PI3K	 inhibitor,	 mean	 insulin-induced	membrane	depolarization	was	4.04	±	0.39	mV	(n=22),	whilst	mean	insulin-induced	membrane	 hyperpolarization	 was	 3.60-±	 1.22	mV	 (n=7).	 Of	 insulin-induced	membrane	 depolarisations,	 those	 of	 the	 TCPTP	 inhibitor	 population	 were	 of	 a	significantly	greater	magnitude	 than	 those	of	 the	PI3K	 inhibitor	 (p=<0.05,	2-way	ANOVA).	
B:	 Bar	 chart	 summarizing	 the	mean	 percentage	 decrease	 in	 spontaneous	 action	potential	 firing	 rate,	 of	 inhibitory	 responses	 from	 all	 four	 experimental	 groups	(with	 control	 as	 100%).	 Of	 insulin-inhibited	 POMC	 eGFP	 neurons	 tested,	 action	potential	 firing	 rate	 in	 the	 presence	 of	 insulin	was	 21.2	 ±	 4.8	%	 that	 of	 control	levels	(n=15).	Of	insulin-inhibited	POMC	eGFP	neurons	tested	in	the	presence	of	a	TCPTP	inhibitor,	action	potential	firing	rate	in	the	presence	of	insulin	was	7.4	±	2.6	%	 that	 of	 control	 levels	 (n=2).	 Of	 insulin-inhibited	 POMC	 Z/EG	 TCPTP	 lox/lox	neurons	tested,	action	potential	firing	rate	in	the	presence	of	insulin	was	11.2	±	4.1	
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%	that	of	control	 levels	 (n=6).	Of	 insulin-inhibited	POMC	eGFP	neurons	 tested	 in	the	 presence	 of	 a	 PI3K	 inhibitor,	 action	 potential	 firing	 rate	 in	 the	 presence	 of	insulin	was	5.6	±	5.6	%	that	of	control	levels	(n=4).	
C:	 Bar	 chart	 summarizing	 the	 mean	 percentage	 increase	 in	 spontaneous	 action	potential	 firing	 rate,	 of	 excitatory	 responses	 from	 all	 four	 experimental	 groups	(with	 control	 as	 100%).	 Of	 insulin-excited	 POMC	 eGFP	 neurons	 tested,	 action	potential	 firing	rate	in	the	presence	of	 insulin	was	173.2	±	22.3	%	that	of	control	levels	 (n=3).	 Of	 insulin-excited	 POMC	 eGFP	 neurons	 tested	 in	 the	 presence	 of	 a	TCPTP	inhibitor,	action	potential	firing	rate	in	the	presence	of	insulin	was	923.3	±	678.5	%	that	of	control	 levels	(n=10).	Of	 insulin-excited	POMC	Z/EG	TCPTP	 lox/lox	neurons	tested,	action	potential	 firing	rate	in	the	presence	of	 insulin	was	366.6	±	113.9	%	that	of	control	levels	(n=6).	Of	insulin-excited	POMC	eGFP	neurons	tested	in	 the	presence	of	a	PI3K	 inhibitor,	action	potential	 firing	rate	 in	 the	presence	of	insulin	was	115.7	±	17.7	%	that	of	control	levels	(n=18).												
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Figure	5.3:	POMC	eGFP	neurons	are	insulin-inhibited	and	insulin-excited	
A:	 Samples	 of	 a	 continuous	 current-clamp	 recording	 of	 a	 POMC	 eGFP	 neuron,	showing	 insulin	 induced	 membrane	 depolarization	 and	 an	 increase	 in	 action	potential	firing	rate.	Right	panel;	samples	of	the	record	from	A	shown	on	a	faster	time-base	to	highlight	increased	firing	rate	in	the	presence	of	insulin	compared	to	control	pre-insulin	bath	application.	
B:	 Samples	 of	 a	 continuous	 current-clamp	 recording	 of	 a	 POMC	 eGFP	 neuron,	showing	 insulin	 induced	a	 reversible	membrane	hyperpolarization	and	cessation	of	action	potential	firing.																	
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Figure	5.4:	TCPTP-inhibited	POMC	eGFP	neurons	have	insulin-inhibited	and	
insulin-excited	subpopulations	
A:	Samples	of	a	continuous	current-clamp	recording	of	a	POMC	eGFP	neuron	with	the	selective	TCPTP	inhibitor	compound	8	(20	nM)	‘loaded’	into	the	patch	pipette.	Insulin-induced	membrane	 depolarization	 and	 increase	 in	 action	 potential	 firing	rate.	
B:	Samples	of	a	continuous	current-clamp	recording	of	a	POMC	eGFP	neuron	with	the	 selective	 TCPTP	 inhibitor	 ‘loaded’	 into	 the	 patch	 pipette.	 Insulin	 induced	 a	partially	reversible	membrane	hyperpolarization	and	reduction	in	action	potential	firing	rate	under	these	recording	conditions.		
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Figure	 5.5:	 Insulin-induced	 excitation	 and	 inhibition	 in	 POMC	 Z/EG	 TCPTP	
knockout	transgenic	mice	in	which	TCPTP	was	selectively	knocked-out	from	
POMC	neurons	
A:	 Samples	of	a	 continuous	current-clamp	recording	of	a	POMC	Z/EG	TCPT	 lox/lox	neuron	showing	insulin	induced	reversible	membrane	depolarization.	
B:	 Samples	of	a	 continuous	current-clamp	recording	of	a	POMC	Z/EG	TCPT	 lox/lox	neuron,	 showing	 insulin	 induced	membrane	 hyperpolarization	 and	 reduction	 of	action	potential	firing	rate.	
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Figure	5.6:	 Insulin	 induced	 excitation	 in	POMC	eGFP	neurons,	 incubated	 in	
the	PI3K	inhibitor	LY294002		
A:	 Samples	 of	 a	 continuous	 current-clamp	 recording	 of	 a	 POMC	 eGFP	 neuron	showing	 the	PI3K	 inhibitor	LY294002	(10μM)	 induced	membrane	depolarization	associated	with	an	increase	in	spontaneous	firing	rate.	
B:	Samples	of	the	same	continuous	current-clamp	recording	as	that	shown	in	A.			In	the	 presence	 of	 the	 PI3K	 inhibitor	 LY294002	 (10μM),	 insulin	 induced	 a	 further	increase	in	spontaneous	firing	rate.			
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Chapter	6:	Effects	of	leptin	on	leptin	
receptor-expressing	neurons	in	the	
dorsomedial	hypothalamus		
6.1		 Introduction	In	2008	 the	World	Health	Organization	 (WHO)	reported	 that	worldwide,	35%	of	adults	 were	 overweight,	 of	 these,	 10%	 of	 men	 and	 14%	 of	 women	 were	 obese	(Bastien	et	al.,	2014).	An	individual	is	considered	obese	if	their	BMI	exceeds	30.	A	BMI	of	30	is	representative	of	a	person	standing	5	feet	and	10	inches	high	(178	cm)	and	weighing	 97.7	 Kg.	 BMI	 is	 calculated	 as	 body	weight	 (kg)	 divided	 by	 height2	(m2)	 (Must	 et	 al.,	 1999).	 Obesity	 is	 a	 disease	 of	 significantly	 elevated	 fat	 mass,	however	 elevated	 adiposity	 does	 not	 kill	 directly.	 Secondary,	 obesity-associated	diseases	 cause	morbidity	 and	mortality.	 These	 diseases	 include	 type	 II	 diabetes,	osteoporosis,	 cancer	 and	 cardiovascular	disease.	The	 incidence	of	 cardiovascular	diseases	 including	 hypertension	 is	 significantly	 increased	 in	 obese	 populations	(Must	et	al.,	1999,	Bastien	et	al.,	2014).	Cardiovascular	diseases	are	the	number	1	cause	 of	 death	 globally	 and	 it	 has	 been	 estimated	 that	 as	 much	 as	 70%	 of	cardiovascular	 disease	 is	 associated	 with	 elevated	 fat	 mass.	 Hypertension	 is	 a	major	risk	factor	for	stroke,	myocardial	infarction,	heart	failure	and	renal	disease.	In	 2000	 it	 was	 estimated	 that	 24%	 of	 the	 adult	 population	 in	 the	 USA	 were	hypertensive	or	taking	medication	to	reduce	blood	pressure	(Carretero	and	Oparil,	2000).	 In	 addition	 to	 obesity,	 risk	 factors	 for	 hypertension	 include	 insulin	resistance,	 high	 alcohol	 and	 or	 salt	 consumption,	 aging	 and	 stress,	 and	 in	many	cases,	risk	factors	are	additive	(Cutler,	1996,	Luft,	1998,	Sever	and	Poulter,	1989).	In	 humans,	 clinical	 hypertension	 is	 defined	 as	 blood	 pressure	 exceeding	 140	
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mmHg	 systolic	 and	 90	 mmHg	 diastolic	 (140/90	 mmHg),	 whilst	 a	 normal	 blood	pressure	sits	around	120/80	mmHg	(Carretero	and	Oparil,	2000).		In	1950,	Jackson	Laboratory	scientists	reported	mice	that	quickly	gained	fat	mass	 from	birth,	with	obese	adult	mice	weighing	as	much	as	 three	 times	 that	of	age-matched	 controls	 (Ingalls	 et	 al.,	 1950).	 Breeding	 of	 heterozygotic	 mice	generated	 a	 lean/obese	 ratio	 of	 3	 to	 1	 indicating	 the	 phenotype	 was	 due	 to	 a	recessive	 gene	 mutation	 (Furney	 et	 al.,	 2006).	 This	 gene	 was	 named	 the	 obese	gene,	 and	 to	 it	 was	 designated	 the	 symbol	 ob	 (Ingalls	 et	 al.,	 1950).	 Parabiosis	experiments,	wherein	obese	mice	rapidly	lost	weight	when	conjoined	to	lean	mice,	indicated	 the	 product	 of	 the	 ob	 gene	 to	 be	 a	 circulatory	 factor,	 negatively	regulating	energy	homeostasis	(Coleman,	1978).	Coleman	identified	another	strain	of	 mice,	 with	 an	 identical	 obese	 phenotype,	 also	 due	 to	 an	 autosomal	 recessive	mutation.	 Here,	 parabiosis	 experiments	 of	 obese	 and	 lean	 mice	 with	 connected	circulation	resulted	in	starvation	of	the	lean	animal	due	to	cessation	of	food	intake,	but	 no	 weight	 loss	 in	 the	 obese	 mouse	 (Coleman,	 1973).	 The	 etiology	 of	 the	metabolic	 disorder	 was	 concluded	 to	 be	 distinct	 from	 that	 of	 ob	 mice	 and	 the	mutation	 was	 named	 diabetic,	 or	 db.	 It	 was	 later	 discovered	 that	 the	 db	 gene	encoded	the	leptin	receptor	(Coleman,	1973,	Tartaglia	et	al.,	1995).	In	1994	the	mouse	ob	gene	and	its	human	homologue	were	cloned	(Zhang	et	 al.,	 1994).	The	 sequenced	protein	was	highly	 conserved,	 localized	 to	white	 fat	and	 had	 an	 N-terminus	 signal	 sequence	 indicating	 that	 it	 was	 secreted	 from	adipocytes	(Tsuchiya	et	al.,	2003,	Zhang	et	al.,	1994).	Leptin	is	a	16kDa,	167	amino	acid	 protein,	 secreted	 from	white	 adipose	 cells	 into	 the	 plasma	 in	 proportion	 to	body	 fat	mass.	 In	obesity,	circulatory	 leptin	 levels	are	as	high	as	10	times	that	of	lean	 mice	 (Maffei	 et	 al.,	 1995,	 Zhang	 et	 al.,	 1994).	 Leptin	 receptors	 (LepR)	 are	
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expressed	ubiquitously	in	virtually	all	tissues	and	high	expression	levels	are	found	in	multiple	central	nervous	system	(CNS)	regions	(Tune	and	Considine,	2007).	To	date,	six	LepRs	have	been	identified	(ObRa	through	ObRf),	and	they	belong	to	the	class-I	 cytokine	 receptor	 family	 (Scott	 et	 al.,	 2009).	 ObRa	 receptors	 have	 been	attributed	 to	 the	 trafficking	of	 leptin	 into	 the	brain.	ObRb	receptors	are	 the	only	LepR	to	effectively	couple	to	signal	 transduction	cascades,	 including	Janus	kinase	2/	 signal	 transducer	 and	 activator	 of	 transcription	 3	 (JAK2/STAT3),	 mitogen-activated	protein	kinase	(MAPK)	and	phosphoinositide	3-kinase	(PI3K)	pathways,	and	are	thus	thought	to	be	the	only	LepRs	that	mediate	the	physiological	outputs	of	leptin	 signaling	 (Hileman	 et	 al.,	 2002,	 Fruhbeck,	 2006).	 ObRb	 is	 expressed	 in	multiple	hypothalamic	nuclei	critical	to	energy	homeostasis,	including	the	arcuate	nucleus	 of	 the	 hypothalamus	 (ARH),	 lateral	 hypothalamus	 (LH),	 ventromedial	hypothalamus	 (VMH)	 and	 dorsomedial	 hypothalamus	 (DMH)	 (Scott	 et	 al.,	 2009,	Minokoshi	et	al.,	1999,	Leinninger	et	al.,	2009).	Leptin	 signaling	 in	 the	 hypothalamus	 excites	 anorexigenic	 neurons	 and	inhibits	 orexigenic	 neurons	 (with	 the	 exception	 of	 a	 population	 of	 leptin-excited	NPY	 neurons	 in	 the	 DMH	 (Lee	 et	 al.,	 2013)),	 eliciting	 increases	 in	 energy	expenditure	 and	 reductions	 in	 food	 intake	 (Cowley	 et	 al.,	 2001,	 Cone,	 2005).	 In	doing	 so	 an	 increase	 in	body	 fat	mass	will	 exert	negative	 feedback	on	 the	brain,	preventing	 excessive	weight	 gain	 (Maffei	 et	 al.,	 1995).	 In	 obesity,	 leptin	 loses	 its	ability	to	signal	in	the	ARH,	and	similarly	loses	its	ability	to	elicit	its	anorexigenic	effects;	 this	 is	 termed	 leptin	 resistance	 (Enriori,	 2007).	 Intracerebroventricular	(ICV)	 administration	 of	 leptin	 to	 obese	 animals,	 although	 capable	 of	 generating	acute	 reductions	 in	 food	 intake	 and	 weight	 loss,	 is	 unable	 to	 elicit	 sustained	reductions	in	adiposity	(Enriori	et	al.,	2007).	
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The	 long	 form	of	 the	LepR,	ObRb	 is	 structurally	 associated	 to	 JAK2.	ObRb	activation	initiates	JAK2	autophosphorylation.	pJAK2	then	phosphorylates	tyrosine	(Y)	 985,	 Y1077	 and	 Y1138	 on	 the	 ObRb.	 Phosphorylated	 Y1138	 results	 in	 the	phosphorylation	of	cytoplasmic	STAT3,	which	then	translocates	to	the	nucleus	to	regulate	 transcription.	 Y985	 phosphorylation	 stimulates	 the	 MAPK	 pathway	 via	SHP2.	 PI3K	 signaling	 is	 also	 stimulated	 via	 JAK2-mediated	 phosphorylation	 of	IRS2.	 Leptin	 also	 activates	 the	 PI3K	 pathway	 activation,	 affecting	 neuronal	electrical	activity	through	ion	channel	regulation.	For	example	PIP3	activates	ATP-sensitive	 potassium	 (KATP)	 channels	 in	 neuropeptide	 Y/agouti-related	 peptide	(NPY/AgRP)	 neurons	 whilst	 PI3K	 stimulated	 phospholipase-C	 (PLC)	 activates	transient	receptor	potential	channels	(TRPC)	in	proopiomelanocortin/	cocaine	and	amphetamine	 -	 regulated	 transcript	 (POMC/CART)	 neurons	 (Niswender	 and	Schwartz,	2003,	Qiu	et	al.,	2010).		 The	etiology	of	the	leptin	resistance	that	develops	in	obesity	is	two-fold,	1:	BBB	leptin	trafficking	becomes	saturated	in	obesity	resulting	in	low	central	leptin	concentrations	relative	 to	plasma	 levels	 (Banks,	1996).	2:	Central	desensitization	to	 leptin;	 proposed	mechanisms	 underlying	 central	 leptin	 resistance	 include	 the	inhibition	 of	 leptin	 signal	 transduction	 by	 the	 protein	 tyrosine	 phosphatases	protein	tyrosine	phosphatase	1B	(PTP1B)	and	T-cell	protein	tyrosine	phosphatase	(TCPTP),	 expressed	 in	 hypothalamic	 neurons	 (Zhang	 et	 al.,	 2015).	 PTP1B	attenuates	 leptin	 signaling	 by	 dephosphorylating	 Y1007	 and	 Y1008	 in	 the	 JAK2	activation	loop	of	the	ObRb	(Bence	et	al.,	2006).	PTP1B	knock	out	in	neurons	and	glia	 generates	 diet-induced	 obese	 (DIO)-resistant	 mice,	 with	 increased	 central	leptin	 sensitivity	 and	 elevated	 energy	 expenditure	 (Bence	 et	 al.,	 2006).	 TCPTP	inhibits	 leptin	 signaling	 via	 dephosphorylating	 nuclear	 pSTAT3,	 curtailing	 its	
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ability	 to	 regulate	 gene	 expression.	 Knockout	 of	 neuronal	 TCPTP	 elevates	 POMC	and	 reduces	 AgRP	 mRNA	 expression	 (Loh	 et	 al.,	 2011).	 SOCS3	 also	 negatively	regulates	 leptin	 signaling	by	dephosphorylating	 JAK2,	 reducing	STAT,	MAPK	and	PI3K	signal	transduction	(Bjorbaek	et	al.,	1999).	Mice	lacking	neuronal	SOCS3	are	DIO	resistant	(Kievit	et	al.,	2006).	In	 the	 arcuate	 nucleus	 of	 the	 hypothalamus	 (ARH),	 both	 NPY/AgRP	 and	POMC/CART	neurons	express	 leptin	receptors	(Spanswick	et	al.,	1997,	Cowley	et	al.,	 2001).	 Orexigenic	 NPY/AgRP	 neurons	 are	 hyperpolarized	 by	 increased	extracellular	 leptin	 via	 the	 activation	 of	 KATP	 channels	 (Spanswick	 et	 al.,	 1997).	Anorexigenic	 POMC/CART	 neurons	 are	 depolarized	 by	 leptin	 through	 two	mechanisms;	 (a)	 direct	 excitation	 via	 the	 activation	 of	 a	 non-selective	 cation	channel	 (NSCC)	and	 (b)	POMC/CART	neuron	disinhibition	via	NPY/AgRP	neuron	hyperpolarization	and	 reduction	of	GABAergic	 transmission	 (Cowley	et	 al.,	 2001,	Qiu	et	al.,	2010).		Leptin	 elicits	 much	 of	 its	 physiological	 effects	 through	 the	 regulation	 of	sympathetic	 output,	 in	 part	 through	 the	melanocortin	 system;	 increasing	 brown	adipose	 tissue	 (BAT)	 thermogenesis,	 blood	 pressure	 (BP)	 and	 heart	 rate	 (HR)	(Enriori	et	al.,	2007,	Simonds	et	al.,	2014).	Melanocortin	agonists	increase	BP	and	HR	in	both	lean	and	HFD	mice	whilst	antagonists	decrease	BP	(Enriori	et	al.,	2007,	da	 Silva	 et	 al.,	 2006,	 da	 Silva	 et	 al.,	 2004).	 However	 some	 leptin-mediated	sympathetic	nerve	activity	(SNA)	would	appear	to	be	melanocortin-independent	as	BAT	temperature	elevations	are	still	observed	in	obese	MC4	KO	mice	(Enriori	et	al.,	2011).		Leptin	 resistance	develops	 in	 the	ARH	of	obese	mammals,	however	LepR-expressing	neurons	 in	other	hypothalamic	nuclei	remain	 leptin-sensitive	(Enriori	
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et	 al.,	 2011,	Rezai-Zadeh	et	 al.,	 2014).	 Local	 injection	of	 leptin	 into	 the	VMH	and	DMH	elevates	blood	pressure	and	heart	 rate	 in	vivo.	DMH	neurons	project	 to	 the	paraventricular	nucleus	of	the	hypothalamus	(PVH),	raphe	pallidus	nucleus	(RPa)	and	rostral	ventrolateral	medulla	(RVLM),	all	premotor	nuclei,	directly	regulating	sympathetic	 tone	 (Cao	 and	 Morrison,	 2003,	 Horiuchi	 et	 al.,	 2004).	 DMH-RPa	efferents	 regulate	 leptin-induced	 BAT	 thermogenesis	 (Zhang	 et	 al.,	 2011).	 DMH-RVLM	 efferents	 regulate	 BP	 (Horiuchi	 et	 al.,	 2006).	 To	 date,	 a	 thorough	characterization	of	the	molecular,	pharmacological	and	electrophysiological	profile	of	LepR-expressing	DMH	neurons	has	not	been	performed.	The	DMH	is	known	to	be	 a	 critical	 hypothalamic	 nucleus,	 regulating	 physiological	 processes	 including	stress,	 circadian	 rhythm,	 food	 intake,	 energy	 expenditure	 and	 cardiovascular	function	 (Bernardis,	1972,	Coolen	et	al.,	1996,	Gallo,	1981,	 Inglefield	et	al.,	1994,	Keim	and	Shekhar,	1996,	Bellinger	et	al.,	1976,	Enriori	et	al.,	2011).	The	 aims	 of	 this	 study	 are	 to	 use	 the	 visualized	 whole-cell	 patch	 clamp	technique	 to	 characterize	 the	 electrophysiological	 properties	 of	 leptin	 receptor-expressing	 neurons	 in	 the	 DMH	 of	 a	 transgenic	 LepR-YFP	 mouse.	 I	 aimed	 to	determine	 the	 electrophysiological	 effects	 of	 leptin	 and	 the	 mechanism(s)	 by	which	leptin	affects	the	electrical	activity	of	this	neuronal	population.		
6.2	 	Results	
6.2.1		 Leptin-induced	depolarization	of	LepR-expressing	neurons	in	the	
DMH	
Whole-cell	 recordings	 were	 obtained	 from	 34	 DMH	 neurons	 expressing	 LepR.	Application	 of	 100	nM	 leptin	 induced	 membrane	 depolarization	 and/or	 an	
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increase	in	spontaneous	action	potential	firing	rate	in	38.2%	of	recorded	neurons	(n=13,	 see	 figure	 6.1A),	 membrane	 hyperpolarization	 in	 14.7%	 of	 recorded	neurons	(n=5;	see	figure	6.4A)	and	the	remaining	47.1%	(n=16)	of	neurons	did	not	respond	to	bath	application	of	100	nM	leptin.		
Leptin	induced	a	mean	peak	amplitude	depolarization	of	4.9	±	1.0	mV	from	a	 mean	 resting	 potential	 of	 −49.9	 ±	 3.1	mV	 to	 a	 new	 steady-state	 membrane	potential	of	−45.0	±	2.7	mV	(p	=	0.0004).	Leptin-induced	excitation	was	associated	with	an	increase	in	firing	rate	from	a	mean	control	basal	level	of	0.48	±	0.28	Hz	to	0.64	±	0.34	Hz	 in	 the	presence	of	 leptin	 (n	=	5),	 effects	 that	were	at	 least	 in	part	reversible	after	washout	of	 leptin	(p	=	0.59).	 In	 two	neurons,	 leptin	 induced	sub-	and	 suprathreshold	 oscillations	 in	 membrane	 potential	 (Figure	 6.2).	 Voltage-current	 relations,	 generated	 in	 response	 to	 a	 range	 of	 depolarizing	 and	hyperpolarizing	 rectangular-wave	 current	 pulses	 (−150	 to	+100	pA,	 1,000	ms	duration)	revealed	that	leptin-induced	excitation	was	principally	associated	with	a	trend	for	a	decrease	(p	=	0.86)	in	neuronal	input	resistance	from	841	±	111	MΩ	in	the	absence	to	743	±	138	MΩ	in	the	presence	of	leptin.	Plots	of	the	voltage-current	relations	 revealed	 extrapolated	 reversal	 potentials	 for	 leptin-induced	 excitation	around	 −35	mV	 (Figure	 6.1E).	 Taken	 together,	 these	 data	 suggest	 that	 leptin-induced	excitation	is	mediated	via	activation	of	a	non-selective	cation	conductance.	In	addition	 to	 these	effects	on	membrane	 input	 conductance,	 leptin	also	 induced	modulation	 of	 intrinsic	 subthreshold	 active	 conductance	 in	 a	 subpopulation	 of	DMH	neurons.	 In	DMH	neurons,	membrane	depolarization	 from	negative	holding	potentials	 (<	 −65	mV)	 or	 rebound	 depolarization	 at	 the	 offset	 of	 the	membrane	response	 to	 hyperpolarization	 from	 potentials	 close	 to	 resting	 potential	 (−45	 to	−50	mV)	evoked	a	transient	depolarizing	potential	consistent	with	activation	of	a	
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low-threshold	T-type	calcium	conductance.	In	the	presence	of	leptin,	this	potential	was	prolonged	(Figures	6.1B,	C	and	D),	the	half-time	to	decay	increasing	from	132	±	59	ms	 in	 the	 absence	 to	179	±	61	ms	 in	 the	presence	of	 leptin.	These	data	 are	consistent	with	leptin	modulating	intrinsic	active	conductances	in	a	subpopulation	of	DMH	neurons.		
In	 addition	 to	 these	 postsynaptic	 effects,	 leptin	 induced	 an	 increase	 in	spontaneous	excitatory	postsynaptic	potentials	(EPSPs)	in	a	subpopulation	(n	=	2)	of	DMH	neurons	(Figure	6.3).	The	mean	frequency	of	spontaneous	EPSPs	increased	from	0.07	±	0.02	Hz	to	0.31	±	0.11	Hz	in	the	presence	of	leptin.	These	EPSPs	could	be	 of	 sufficient	magnitude	 to	 reach	 threshold	 for	 firing,	 suggesting	 that	 indirect	presynaptic	 effects	 of	leptin	 on	 DMH	 neurons	 can	 contribute	 to	 leptin-induced	increases	in	neuronal	excitability.	
	
6.2.2		 Leptin-induced	hyperpolarization	of	DMH	LepR-expressing	neurons	
Application	of	100	nM	leptin	induced	membrane	hyperpolarization		(Figure	6.4A)	and/or	a	decrease	in	spontaneous	action	potential	firing	rate	in	14.7%	of	recorded	neurons	(n=5).	Leptin	induced	a	mean	peak	amplitude	hyperpolarization	of	-15.5	±	2.3	mV	 from	 a	 mean	 resting	 potential	 of	 −46.4	 ±	 3.0	mV	 to	 a	 new	 steady-state	membrane	potential	of	−61.9	±	3.3	mV	(p	=	0.0009).	Leptin-induced	inhibition	was	associated	with	a	decrease	and	abolition	of	spontaneous	 	 firing	rate	from	a	mean	control	basal	level	of	0.30	±	0.30	Hz	to	0.00	±	0.00	Hz	in	the	presence	of	leptin	(n	=	5).	Voltage-current	relations,	generated	in	response	to	a	range	of	depolarizing	and	hyperpolarizing	 rectangular-wave	 current	 pulses	 (−150	 to	+100	pA,	 1,000	ms	duration)	revealed	that	leptin-induced	inhibition	was	principally	associated	with	a		
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significant	decrease	(p	=	0.005)	in	neuronal	input	resistance	from	962	±	125	MΩ	in	the	absence	to	421	±	67	MΩ	in	the	presence	of	leptin	(Figure	6.4B	and	C).	Plots	of	the	 voltage-current	 relations	 revealed	 reversal	 potentials	 for	 leptin-induced	inhibition	around	−90	mV	(Figure	6.4D).	Taken	 together,	 these	data	 suggest	 that	leptin-induced	inhibition	is	mediated	via	activation	of	a	potassium	conductance.	
	
6.2.3		 Differential	active	conductance	expression	in	DMN	neurons	
In	 experiments	 described	 here,	 voltage-dependent	 conductance	 expression	 was	determined	 during	 voltage-current	 relations	 experiments,	 whereby	 a	 range	 of	hyperpolarizing	and	depolarizing	square-phase	current	pulses	were	 injected	 into	the	 neuron	 of	 interest,	 at	 equal	 integers.	 	 Here,	 transient	 outward	 rectification	(ITOR)	was	observed	as	a	delayed	return	to	rest	at	the	offset	of	membrane	response	to	negative	current	injection.	Low-threshold	t-type	calcium	conductances	(IT)	were	observed	as	transient	membrane	depolarization	from	negative	holding	potentials	(<	−65	mV)	or	transient	depolarization	at	the	offset	of	the	membrane	response	to	hyperpolarization	 from	 potentials	 close	 to	 resting	 potential	 (−45	 to	 −50	mV).	Instantaneous	 or	 anomalous	 inward	 rectification	 (IAN)	 was	 observed	 as	 voltage-dependent	 decrease	 in	membrane	 response	 and	 decrease	 in	 input	 resistance	 to	negative	 current	 injection	 at	 membrane	 potentials	 greater	 than	 around	 -75mV.	Hyperpolarization-activated	non-selective	cation	conductances	(IH)	were	observed	as	a	time-	and	voltage-dependent	repolarization	of	the	membrane	potential	during	the	membrane	response	to	negative	current	injection	and	a	rebound	excitation	at	the	offset	of	the	response	to	hyperpolarising	current	injection	(see	Fig	6.4).	Of	the	leptin	excited	neurons	23%	(n=3)	of	neurons	expressed	ITR,	54%	(n=7)	expressed	
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IT,	8%	expressed	IAN	(n=1)	and	15%	expressed	IH	(n=2).		Of	leptin	inhibited	neurons	60%	 expressed	 ITR,	 60%	 (n=3)	 expressed	 IT,	 40%	 (n=3)	 expressed	 IAN	 and	 40%	(n=2)	 expressed	 IH.	 Of	 non-responsive	 neurons	 50%	 (n=8)	 expressed	 ITOR,	 44%	(n=7)	expressed	IT,	44%	(n=7)	expressed	IAN	and	25%	(n=4)	expressed	IH	(Figure	6.5A).	No	 significant	difference	 in	 active	 conductance	profile	was	 found	between	leptin-excited,	 leptin-inhibited	 and	 no	 response	 groups	when	 analysed	with	 Chi-squared	tests.	
	
6.3		 Discussion	
6.3.1	 	Leptin-induced	excitation	of	DMH	LepR-expressing	neurons	
Here	I	show	leptin	to	depolarize	a	population	of	LepR-expressing	DMH	neurons	via	the	 activation	 of	 a	 non-selective	 cation	 conductance,	 consistent	 with	 previous	research	 examining	 the	 mechanism	 of	 leptin-induced	 depolarization	 of	 arcuate	POMC	neurons	(Cowley	et	al.,	2001,	Qiu	et	al.,	2010).		
Increased	 EPSP	 frequency	 in	 a	 subset	 of	 DMH	 LepR-expressing	 neurons	indicates	 the	 existence	 of	 leptin-sensitive	 excitatory	 afferent	 neurons.	 DMH	neurons	receive	afferent	innervation	from	other	CNS	areas	including	the	forebrain	and	brainstem	in	addition	to	local	inputs	from	other	hypothalamic	nuclei	including	the	ARH	and	PVH	and	probably	other	DMH	neurons	themselves	(Chou	et	al.,	2003,	Bagnol	et	al.,	1999,	Thompson	and	Swanson,	1998).	Consistency	of	leptin-induced	EPSP	 rise	 time	 kinetics	 in	 these	 experiments	may	 indicate	 but	 does	 not	 confirm	that	elevated	EPSP	frequency	 is	due	to	 the	activation	of	spatially	restricted	 input	and	 most	 likely	 from	 a	 common	 source	 or	 origin.	 Further	 work	 is	 required	 to	
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identify	the	source	of	these	inputs	and	whether	leptin	effects	are	mediated	at	the	level	 of	 the	 presynaptic	 terminal	 or	 elsewhere	 in	 the	 presynaptic	 network.	 The	neuroanatomical	location	of	this	leptin-excited/disinhibited	afferent	neuron	could	be	within	the	DMH	and	may	be	indicative	of	reciprocal	connectivity	between	LepR	neurons	of	the	DMH.	Cholera	toxin	B	(CTB)	retrograde	tracing	studies	would	be	a	valuable	 tool	 to	 investigate	 the	 molecular	 identity	 of	 afferent	 neurons	 in	 this	network	(Llewellyn-Smith	et	al.,	1990).	
In	a	subpopulation	of	leptin-excited	neurons,	oscillatory	membrane	activity	was	 induced	 and	was	 associated	 with	 the	modulation	 of	 a	 low	 threshold	 t-type	calcium	 conductance.	 T-type	 calcium	 conductances	 have	 been	 described	 as	necessary	for	pacemaker-like	activity	in	other	hypothalamic	neurons	(van	den	Top	et	 al.,	 2004).	 Burst-firing	 activity	 patterns	 have	 been	 suggested	 to	 mediate	increased	 peptide	 release	 relative	 to	 tonic	 firing	 (Poulain	 and	Wakerley,	 1982).	Leptin-induced	oscillatory	activity	was	associated	with	a	prolonged	t-type	calcium	conductance.	 Whether	 this	 effect	 was	 mediated	 via	 a	 direct	 effect	 on	 T-type	calcium	 conductance	 biophysical	 properties	 and	 properties	 of	activation/inactivation	 requires	 clarification.	 	 Other	 possible	 mechanisms	 that	could	account	for	this	are	inhibition	of	calcium-activated	potassium	conductances,	activated	by	 calcium	 influx	via	 the	T-type	 channels.	 Subsequent	 activation	of	 the	calcium	 activated	 potassium	 conductance	 could	 curtail	 T-type	 calcium	conductance	 activity.	 Thus,	 leptin-induced	 inhibition	 of	 a	 calcium-activated	potassium	 conductance	 could	 indirectly	 result	 in	 prolonged	 T-type-mediated	activity.		Again,	further	studies	are	required	to	clarify	this	mechanism	of	action	of	leptin.		
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6.3.2		 Leptin-induced	inhibition	of	DMH	LepR-expressing	neurons	
Of	DMH	LepR	neurons	tested,	14.7%	were	inhibited	by	leptin,	via	the	activation	of	a	 potassium	 conductance.	 This	 is	 consistent	 with	 the	 mechanism	 of	 NPY/AgRP	neuron	hyperpolarization	by	 leptin	 in	the	ARH	and	other	hypothalamic	neurones	where	 leptin	 inhibits	 cells	 via	 activation	 of	 ATP-sensitive	 potassium	 channels	(Spanswick	 et	 al.,	 1997).	 However	 as	 I	 did	 not	 use	 sulphonamides	 in	 a	pharmacological	 characterization	 of	 the	 specific	 potassium	 channels	 involved,	further	 work	 is	 therefore	 required	 to	 determine	 whether	 leptin	 inhibits	 these	neurons	via	KATP	channels.	The	physiological	function	of	this	population	of	leptin-inhibited	DMH	 neurons	 is	 unclear,	 but	 retrograde	 and	 anterograde	 tracing	 from	these	neurons	or	trans-synaptic	viral	 tracing	from	identified	target	organs	would	be	worthwhile	pursuing	to	identify	the	functional	significance	of	these	neurons.		If	cellular	 mechanisms	 of	 leptin	 resistance	 differentially	 affect	 signal	 transduction	pathways,	 further	 work	 would	 do	 well	 to	 determine	 if	 in	 obesity,	 any	 change	occurs	 in	 the	 percentage	 of	 leptin-excited-leptin-inhibited	 and	 leptin-insensitive	DMH	LepR	neurons.		
	
6.3.3		 Response	distribution	
Ostensibly	 the	 physiological	 effect	 of	 activation	 of	 leptin-excited	 neurons	 in	 the	DMH	 is	 the	 elevation	 of	 BAT	 thermogenesis,	 BP	 and	 HR	 (Enriori	 et	 al.,	 2011,	Simonds	et	al.,	2014).	Future	work	will	undoubtedly	focus	on	the	signal	integration	at	 PVH,	 RPa	 and	 RVLM	 neurons	 in	 order	 to	 gain	 a	 deeper	 understanding	 of	 the	neurocircuitry	 involved	 in	 the	 regulation	 of	 sympathetic	 output.	 It	 would	 be	 of	interest	 to	 determine	 the	 physiological	 significance	 of	 leptin-inhibited	 DMH	
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neurons;	 anterograde	and	 trans-synaptic	viral-tracing	 studies	would	be	useful	 to	determine	 the	 targets	 of	 these	 neurons.	 DMH-LepR	 neurons	 express	 the	 ObRb	receptor,	 which	 is	 the	 only	 leptin	 receptor	 coupled	 to	 signal	 transduction	pathways.	Whether	the	lack	of	electrophysiological	responsiveness	reported	here	is	representative	of	leptin-insensitive	neurons	is	yet	to	be	determined.	In	47.1%	of	neurons	 tested	 here,	 the	 absence	 of	 electrophysiological	 response	 to	 leptin	 does	not	 confirm	 leptin	 insensitivity.	 It	 may	 be	 that	 the	 leptin-induced	 effects	 are	delayed	 and	 due	 to	 time	 constraints	 attached	 to	 whole	 cell	 recording,	 we	 are	unable	 to	 observe	 effects.	 Alternatively	 in	 these	 neurons,	 leptin-effects	 could	involve	STA3-mediated	gene	expression	changes,	rather	than	PI3K	signalling	that	likely	underlies	both	the	excitation	and	inhibitions	observed	in	other	hypothalamic	neurons	 (Mesaros	 et	 al.,	 2008,	 Plum	 et	 al.,	 2006b).	 As	 the	 LepRb-CreYFP	mouse	model	 has	 not	 yet	 been	 demonstrated	 to	 express	 false	 positive	 YFP	 neurons,	 it	would	 appear	 more	 likely	 that	 ostensible	 leptin	 insensitivity	 is	 due	 to	 either	experimental	time	constrains	or	signal	transduction	with	a	purely	transcriptional	endpoint.	
	
6.3.4	 	Differential	active	conductance	expression	
Voltage-sensitive	 subthreshold	 active	 conductances	 inherent	 to	 DMH-LepR	neurons	included	ITR,	IIH,	IIT	and	IAN.	Voltage-sensitive	conductances	affect	neuronal	processing	 of	 afferent	 synaptic	 inputs	 as	well	 as	 regulating	membrane	potential,	action	 potential	 firing	 rate	 and	 firing	 pattern.	 ITR	 is	 observed	 as	 a	 delay	 in	 the	return	 to	 rest	 immediately	 following	 the	 removal	 of	 membrane	 response	 to	negative	 current	 injection.	 In	 other	 neuron	 populations	 ITR	 has	 been	 shown	 to	
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regulate	firing	frequency	by	delaying	membrane	depolarization	and	are	activated	during	 the	 afterhyperpolarisation	 potential	 (AHP),	 following	 an	 action	 potential	(AP)	(Whyment	et	al.,	2011).	IT	is	observed	as	a	rebound	depolarization	following	the	removal	of	membrane	response	to	negative	square-phase	current	injection	or	as	a	transient	depolarization	following	depolarization	from	a	hyperpolarized	state.	
IIT	is	required	for	the	generation	of	pacemaker-like	activity	in	other	hypothalamic	neurons	(van	den	Top	et	al.,	2004).	Similarly	in	this	study,	cells	expressing	T-type	conductance	 could	 be	 induced	 to	 oscillate	 in	 the	 presence	 of	 leptin	 suggesting	some	DMN	neurons	can	act	as	conditional	pacemakers,	conditional	on	the	presence	of	leptin,	and	underlie	and	drive	pacemaker-like	activity.	IH	is	observed	as	a	time-	and	voltage-dependent	depolarization	 following	 the	 injection	of	negative	 square-phase	 current.	 IH	 has	 been	 shown	 to	 be	 required	 for	 rhythmic	 firing	 in	 other	neuronal	populations	and	can	generate	membrane	depolarization,	following	IPSP-mediated	membrane	hyperpolarization	(Maccaferri	and	McBain,	1996,	McCormick	and	Pape,	1990).	IAN	is	observed	as	an	instantaneous	reduction	in	membrane	input	resistance	 following	hyperpolarization	 to	potentials	more	negative	 than	around	-75mV.	This	membrane	conductance	can	contribute	to	resting	neuronal	membrane	potential	 and	 input	 resistance,	 for	 example	 as	 exemplified	 by	 medium	 spiny	neurons	 (MSN)	 in	 the	 striatum	 (Mermelstein	 et	 al.,	 1998).	 It	 has	 also	 been	suggested	to	function	to	prevent	cells	becoming	too	hyperpolarized	and	maintain	neurons	within	 a	 functional	 operational	window.	 	 The	 inward	 rectifier	 family	 of	potassium	channels	 is	an	extensive	group	made	up	of	7	families	and	includes	the	weakly	 rectifying	 ATP-sensitive	 potassium	 channels	 and	 g-protein	 coupled	inwardly	 rectifying	 subfamily	 (Hibino	 et	 al.,	 2010).	 	 The	 effects	 of	 many	neurotransmitters	 can	 be	 mediated	 through	 the	 modulation	 of	 IAN	 properties.	
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These	include	5-HT,	a	transmitter	important	in	the	regulation	of	stress,	the	role	of	5-HT	 in	 the	 control	 of	 BP	 and	 HR	 at	 these	 DMH	 neurons	 is	 worth	 investigating	(Horiuchi	et	al.,	2006,	Lambe	and	Aghajanian,	2001,	Chaouloff	et	al.,	1999).		
Although	not	statistically	significant	when	compared	to	 leptin-inhibited	or	no	 responders,	 we	 observed	 a	 distinct	 profile	 of	 subthreshold	 voltage-sensitive	active	 conductances	 in	 leptin	 excited	 DMH	 neurons	 tested	 here.	 Conversely,	profiles	 of	 conductances	 expressed	 in	 leptin-inhibited	 and	 leptin-insensitive	neurons	 were	 relatively	 similar.	 Here	 we	 find	 that	 the	 greatest	 predictor	 of	 a	leptin-excited	 neuron	 is	 the	 absence	 of	 IAN	 and	 ITR.	 Although	 IT	 conductance	modulation	was	associated	with	leptin-induced	excitation,	a	similar	percentage	of	both	inhibited	and	insensitive	DMH	neurons	express	IT.	Thus,	these	properties	are	not	predictive	of	a	leptin-excited	DMH	neuron.	However	the	homogeneity	in	terms	of	%	ITOR	expression	between	groups	may	indicate	that	the	majority	of	DMH	LepR	neurons	are	competent	for	leptin-excitation,	and	that	acute	application	of	leptin	is	insufficient	 to	 generate	 increases	 in	 firing	 rate.	 Studies	 in	 obese	 animals	 should	further	this	work.	
Populations	 of	 leptin	 inhibited	 and	 non-responsive	 neurons	 exhibited	 a	similar	 profile	 of	 active	 conductances.	 There	 was	 a	 notably	 low	 percentage	 of	leptin-excited	 neurons	 expressing	 ITOR	 and	 IAN,	 indicating	 that	 these	 potassium	conductances	are	not	necessarily	 involved	 in	 the	excitatory	effect	of	 leptin	 in	 the	DMH,	consistent	with	I/V	relationships	of	these	neurons	indicating	the	activation	of	a	non-selective	cation	conductance	as	mediating	the	leptin-induced	excitation	of	these	 neurons.	 However,	 upon	 inspection	 of	 active	 conductance	 expression,	 the	absence	of	 ITOR	would	appear	 to	be	 the	best	predictor	of	 leptin	excitation,	 rather	
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than	IH	and	IT	conductances.	Finally,	the	extensive	differential	expression	of	these	active	 conductances	 between	 DMN	 neurons	 argues	 strongly	 for	 this	 population	being	heterogeneous	in	electrophysiological	properties.	 	Further	work	combining	retrograde	 labelling	 from	 known	 target	 areas	 with	 electrophysiological,	morphological	and	chemical	phenotype	profiling	is	needed	to	fully	understand	the	functional	and	topographic	significance	of	this	heterogeneity.	
	
6.3.5		 Physiological	significance	of	leptin-excited	LepR-expressing	DMH	
neurons	
My	research	examining	the	electrophysiological	characteristics	of	LepR	neurons	in	the	mouse	 DMH	 has	 contributed	 to	 a	 publication	 investigating	 the	 physiological	significance	 of	 leptin-excited	 DMH	 neurons	 in	 obesity-associated	 hypertension	(Simonds	 et	 al.,	 2014).	 This	 work	 outlines	 the	 physiological	 significance	 of	increased	 leptin-DMH	 signalling	 in	 obesity.	 Results	 generated	 here	 describe	obesity	 to	be	associated	with	elevated	plasma	 leptin,	HR	and	BP.	 Increased	BP	 is	not	observed	in	in	ob/ob	or	db/db	mice	and	increased	cardiovascular	parameters	can	be	reversed	with	leptin	antagonists	injected	into	DMH.	Additional	evidence	is	provided	 by	 the	 use	 of	 engineered	 pharmacologically	 selective	 chimeric	 ion	channels	 to	 hyperpolarize	 LepR	 neurons	 in	 vivo,	 this	 being	 associated	 with	reductions	in	BP.	Conversely	the	depolarization	of	these	neurons	in	vivo	increases	BP.	Human	data	supports	the	hypothesis	that	leptin	increases	BP	as	leptin	deficient	adults	have	reduced	BP,	regardless	of	extreme	obesity.		
Future	 studies	 should	 determine	 the	 molecular	 profile	 of	 DMH	 LepR	neurons,	 and	 investigate	 the	 physiological	 significance	 of	 leptin-inhibited	 and	
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leptin-insensitive	 neurons	 described	 here.	 Further	 study	 of	 LepR	 DMH	 neurons	may	uncover	potential	target	for	antihypertensive	drugs.	
	
6.3.6	 	Leptin	resistance		
In	 obesity,	 neurons	 of	 the	 ARH	 develop	 leptin	 resistance	 (Enriori	 et	 al.,	 2007).	Work	outlined	in	chapter	3	of	this	thesis	would	support	the	notion	of	reduced	KATP	channel-dependent	 signalling	 in	 high	 extracellular	 glucose	 conditions.	 Elevated	central	glucose	concentrations,	as	 is	 the	case	 in	obesity	and	diabetes,	 leads	 to	an	elevated	neuronal	ATP/ADP	ratio	and	the	closure	of	KATP	channels.	 In	NPY/AgRP	and	 POMC/CART	 neurons,	 both	 leptin	 and	 insulin	 hyperpolarize	 membrane	potential	via	the	activation	of	KATP	channels	(Spanswick	et	al.,	1997).	Further	work	is	required	to	investigate	the	hypothesis,	but	elevated	central	glucose	may	prevent	leptin	and	insulin	signalling	via	this	mechanism.	Arcuate	POMC/CART	neurons	are	excited	 by	 leptin	 via	 a	 TRPC	 channel	 (Qiu	 et	 al.,	 2010);	 this	 in	 addition	 to	NPY/AgRP	 neuron	 hyperpolarization	 promotes	 MC4	 release,	 MC4R	 agonism,	reduced	 food	 intake,	 increased	 hepatic	 gluconeogenesis	 and	 increased	 energy	expenditure.	 Perhaps	 glucose-induced	NPY/AgRP	neuron	KATP	 channel	 closure	 is	sufficiently	strong	that	it	prevents	channel	opening	by	insulin	and/or	leptin.	In	this	case	 increased	 AgRP-mediated	 MC4R	 antagonism	 would	 prevent	 optimal	melanocortin	agonism	and	its	associated	physiological	affects.	 Indeed,	DMH	LepR	neurons	do	not	develop	leptin	resistance	in	obesity.	Perhaps	this	is	reflective	of	a	non	KATP-dependent	mechanism	or	 efferent	 neuron	 innervation.	 Further	work	 is	required	to	test	this	hypothesis.	
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Figure	6.1:	A	subpopulation	of	DMH	LepR-expressing	neurons	are	excited	by	
leptin	
A:	 Samples	 of	 a	 continuous	whole-cell	 recording	 taken	 from	 DMH	 LepR	 neuron	showing	 an	 increase	 in	 spontaneous	 action	 potential	 firing	 rate	 following	 bath	application	of	100	nM	leptin.		
B:	Samples	of	a	continuous	whole-cell	recording	showing	superimposed	responses	to	 rectangular-wave	 current	 injection:	 the	 current-voltage	 relationship	of	 a	DMH	LepR	neuron	in	control	conditions.	
C:	 same	neuron	 as	B	 showing	 the	 voltage-current	 relations	 taken	 at	 the	 peak	 of	leptin-induced	excitation.	
D:	Superimposed	current-voltage	relations	of	neuron	shown	in	A,	B	and	C	before	and	in	the	presence	of	leptin.	Note	the	prolonged	transient	rebound	depolarization	at	the	offset	of	membrane	response	to	negative	current	injection	in	the	presence	of	leptin	compared	to	control	(in	red).	
E:	Plot	of	current	voltage	relations	shown	in	B	and	C.	Note	the	decrease	in	slope	of	the	 voltage-current	 relations	 in	 the	 presence	 of	 leptin	 and	 extrapolated	 reversal	potential	 around	 -30	 mV.	 Taken	 together	 these	 data	 indicate	 a	 decrease	 in	neuronal	input	resistance	and	the	activation	of	a	non-selective	cation	conductance.						
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Figure	6.2:	A	subpopulation	of	DMH	LepR-expressing	neurons	are	excited	by	
leptin	
A:	Samples	of	a	continuous	whole-cell	current	clamp	recording	taken	from	a	DMH	LepR	 neuron	 in	 which	 membrane	 potential	 oscillations	 were	 induced	 by	 bath	application	of	100	nM	leptin.	
B:	 1	 highlights	membrane	 activity	 from	A	 before	 leptin	 application,	2	 highlights	membrane	 oscillations	 on	 an	 extended	 time	 scale	 and	3	 shown	 the	 abolition	 of	membrane	oscillations	by	membrane	hyperpolarization.																		
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Figure	6.3:	Indirect	excitation	of	DMH	LepR	neurons	by	leptin		
A:	 Current-camp	 recording	 of	 a	 DMH	 LepR	 neuron	 showing	 membrane	depolarization	and	increased	frequency	of	EPSPs	in	the	presence	of	100	nM	leptin.	
B:	Extracts	of	the	current	clamp	recording	shown	in	A,	before	leptin	application,	on	an	expanded	time	base.	
C:	Extracts	of	 the	current	 clamp	recording	shown	 in	A,	 in	 the	presence	of	 leptin,	shown,	on	an	expanded	time	base,	highlighting	the	increased	frequency	of	EPSPs.	Shown	 in	 lower	 panel	 are	 superimposed	 EPSPs.	 Note	 the	 consistent	 rise	 times,	indicating	a	likely	single	origin	of	excitatory	synaptic	potentials.																	
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Figure	6.4:	A	subpopulation	of	DMH	LepR	neurons	are	inhibited	by	leptin	
A:	 Samples	 of	 a	 continuous	 whole-cell	 current	 clamp	 recording	 of	 a	 DMH	 LepR	neuron,	showing	bath	application	of	leptin	induced	a	membrane	hyperpolarization,	reversible	upon	washout	of	the	peptide.		
B:	 Same	neuron	as	A	 showing	samples	of	a	 continuous	whole-cell	 current	 clamp	recording	and	superimposed	membrane	potential	 responses	 to	rectangular-wave	current	injection	in	control,	before	leptin	application.	
C:	 Same	neuron	as	A	 and	B	 showing	current-voltage	relations	 in	 the	presence	of	leptin.		This	data	was	obtained	at	the	point	in	the	record	indicated	by	*	in	A.	
D:	Plot	of	current-voltage	relations	shown	in	B	and	C.	Note	the	decrease	in	slope	of	the	 voltage-current	 relations	 in	 the	 presence	 of	 leptin	 and	 reversal	 potential	around	 -90	mV.	Taken	 together	 these	data	 indicate	a	decrease	 in	neuronal	 input	resistance	and	the	activation	of	a	potassium	conductance.	
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Figure	6.5:	Differential	expression	of	subthreshold	active	conductances	in	
LepR-expressing	DMH	neurons	
A:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	ostensibly	lacking	any	subthreshold	active	conductance	expression.	
B:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	a	low	threshold	T-type	calcium	conductance	(IT),	observed	as	an	overshoot	in	membrane	potential	following	the	offset	of	membrane	hyperpolarization	and	in	response	to	the	highest	depolarizing	pulse	tested	here.	
C:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	a	hyperpolarization-activated	non-selective	cation	conductance	IH,	observed	as	a	time-	and	voltage-dependent	reduction	in	neuron	input	resistance,	upon	membrane	hyperpolarization	and	a	rebound	depolarization	at	the	offset	of	the	response	to	current	injection.	
D:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	transient	outward	rectification	(ITOR),	observed	as	a	delayed	return	to	resting	membrane	potential	and	action	potential	firing	following	the	offset	of	membrane	hyperpolarization.	
E:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	both	ITOR,	observed	here	as	a	delay	in	reaching	threshold	of	the	membrane	response	to	depolarizing	current	injection	from	a	relatively	negative	resting	potential		
F:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	instantaneous	anomalous	inward	rectification	(IAN)	and	IT.	IAN	is	observed	as	an	immediate	or	instantaneous	reduction	in	neuronal	input	resistance	upon	membrane	hyperpolarization	to	negative	membrane	potentials.	
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G:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	IAN	and	ITOR.		
H:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	IH	and	ITOR.		
I:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	IH	and	IT.	
J:	Samples	of	a	continuous	whole-cell	current	clamp	recording	of	a	DMH	LepR	neuron,	expressing	IAN,	and	ITOR.																			
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Figure	 6.6:	Differential	 subthreshold	 active	 and	 passive	 properties	 of	DMH	
LepR	neurons	and	the	effects	of	leptin	
A:	 Pie	 chart	 illustrating	 the	 response	distribution	 of	DMH	LepR	neurons	 to	 bath	application	 of	 100	 nM	 leptin.	 In	 47.1%	 of	 neurons,	 bath	 application	 of	 100	 nM	leptin	does	not	alter	membrane	excitability.	In	14.7%	of	neurons,	leptin	application	induced	 an	 inhibitory	 response	 whilst	 in	 38.2%	 of	 DMH	 LepR	 neurons	 bath	application	of	leptin	induced	membrane	excitation	(n=34)	
B:	Bar	chart	 illustrating	the	differential	expression	profile	of	active	conductances	expressed	 in	 leptin-inhibited,	 leptin-excited	 and	 leptin-insensitive	 DMH	 LepR	neurons.		
C:	Table	 summarizing	 the	 statistical	 analysis	 of	 data	 shown	 in	B.	p	 values	 are	of	Chi-square	statistical	tests.														
Figure	6.6		
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Chapter	7:	Electrophysiological	and	
pharmacological	profile	of	
Gonadotropin	Inhibitory	hormone-
expressing	neurons	of	the	rat	in	vitro		
7.1	 	Introduction	Reproductive	function	is	critical	to	the	survival	of	any	species.	For	mammals	 it	 is	closely	controlled	by	an	interacting	signaling	matrix	of	hypothalamic,	pituitary	and	gonadal	 hormones.	 The	 hypothalamic	 pituitary	 gonadal	 (HPG)	 axis	 consists	 of	multiple	 negative	 feedback	 loops,	 coordinating	 the	 pattern	 of	 the	 estrus	 (or	menstrual)	cycle.	Three	distinct	hypothalamic	neuronal	populations	are	key	regulators	of	the	reproductive	axis;	gonadotrophin-releasing	hormone	(GnRH)	neurons,	kisspeptin	neurons,	and	gonadotropin-inhibitory	hormone	(GnIH)	neurons.	The	GnRH	neuron	is	the	key	stimulator	of	luteinizing	hormone	(LH)	and	follicle-stimulating	hormone	(FSH)	secretion	from	the	pituitary	(Amoss	et	al.,	1971,	Matsuo	et	al.,	1971,	Schally	et	al.,	1971).	GnIH	and	kisspeptin	neurons	are	afferent	to	GnRH	neurons,	and	exert	significant	 influence	 over	 GnRH	 neuron	 excitability.	 Unlike	 GnRH	 neurons,	 both	kisspeptin	 and	 GnIH	 neurons	 express	 sex	 steroid	 receptors	 (Smith	 et	 al.,	 2006,	Soga	 et	 al.,	 2014).	 A	 cartoon	 of	 the	 hypothalamic	 neuronal	 network,	 key	 to	reproductive	and	metabolic	function	is	outlined	in	figure	7.1.	Kisspeptin	 neurons	 express	 the	 estrogen	 receptor	 ERα	 and	 are	 a	 conduit	through	which	estrogen	excites	GnRH	neurons	and	 initiates	 the	preovulatory	LH	surge	 (Smith	 et	 al.,	 2006,	Wintermantel	 et	 al.,	 2006).	 Kisspeptin	 neurons	 of	 the	arcuate	 nucleus	 of	 the	 hypothalamus	 (ARH)	 coexpress	 neurokinin	 B	 and	
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dynorphin	and	are	termed	KNDy	neurons	(Cheng	et	al.,	2010).	In	addition	to	ERα,	KNDy	 neurons	 express	 the	 progesterone	 receptor	 (Foradori	 et	 al.,	 2002).	Kisspeptin	signaling	 is	 required	 for	normal	 sexual	development	and	 function	 (de	Roux	et	al.,	2003).	Kisspeptin	acts	centrally,	stimulating	gonadotroph	secretion	via	actions	at	GnRH	neuron	GPR54	receptors,	rather	than	via	release	into	hypophysial	portal	blood	(Messager	et	al.,	2005,	Smith	et	al.,	2008,	Han	et	al.,	2005,	Irwig	et	al.,	2004).	 Function-specific	 subpopulations	 of	 kisspeptin	 neurons	 exist.	 Not	 all	kisspeptin	 neurons	 express	 ERα	 and	 kisspeptin	 neurons	 of	 the	 Anteroventral	periventricular	nucleus	 (AVPV)	 increase	 their	activity	 in	 the	preovulatory	period	whilst	 the	 opposite	 is	 true	 for	 KNDy	 neurons	 (Smith,	 2009).	 Ostensibly,	 some	kisspeptin	 neurons	 integrate	 reproductive	 and	 metabolic	 signals,	 indicated	 by	observations	 that	 kisspeptin	 neurons	 have	 reciprocal	 connections	 with	neuropeptide-Y/agouti-related	 peptide	 (NPY/AgRP)	 and	 proopiomelanocortin/	cocaine	 and	 amphetamine-regulated	 transcript	 (POMC/CART)	 neurons,	 and	 are	sensitive	to	the	adipokine	leptin	(Backholer	et	al.,	2010).		GnIH	is	a	hypothalamic	peptide	that	exerts	an	 inhibitory	tone	on	pituitary	gonadotroph	secretion	(Tsutsui	et	al.,	2000).	 In	mammals,	 two	GnIH	variants	are	translated;	 GnIH-related	 peptide	 (RP)-1	 and	 GnIH-RP-3	 (Tsutsui	 et	 al.,	 2010).	 In	the	rat,	GnIH	is	produced	within	neurons	of	the	dorsomedial	hypothalamus	(DMH)	and	 tuberomamillary	 nucleus	 (TMN)	 (Johnson	 et	 al.,	 2007).	 	 Extrahypothalamic	GnIH	neuron	projection	fibers	are	found	throughout	the	amygdala,	bed	nucleus	of	the	stria	terminalis	(BnST),	septal	nuclei	and	the	paraventricular	thalamic	nucleus	(PVT)	(Johnson	et	al.,	2007).	GnIH	projections	within	the	hypothalamus	include	the	medial	preoptic	area	(MPOA)	and	to	other	neurons	within	the	DMH	(Johnson	et	al.,	2007).	 In	 the	 rat	 75%	of	GnIH	projections	 in	 the	MPOA	have	been	 shown	 to	 co-
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localize	with	GnRH	cell	bodies	whilst	in	sheep	and	primates	GnIH	immunoreactive	terminals	have	been	observed	in	the	neurosecretory	zone	of	the	median	eminence	(Clarke	et	al.,	2008,	Ubuka	et	al.,	2009a,	Ubuka	et	al.,	2009b,	Johnson	et	al.,	2007),	some	of	these	projection	targets	are	highlighted	in	figure	7.2.	The	 lack	 of	 interspecies	 consistency	 in	 GnIH	 neuron	 projection	 sites	suggests	 a	 degree	 of	 variation	 in	 the	 specific	 regulatory	 mechanisms	 of	gonadotropin	secretion.	GnIH	 is	 the	endogenous	agonist	of	 the	GPR147	receptor,	expressed	 in	 both	 the	 gonads	 and	 CNS	 (Ubuka	 et	 al.,	 2013).	 	 In	 the	 ovine	 brain,	GPR147	 is	 expressed	 in	 the	 suprachiasmatic	 nucleus,	 supraoptic	 nucleus,	periventricular	 nucleus	 and	 the	 pars	 tuberalis	 of	 the	 anterior	 pituitary	 (Clarke,	2011).	In	the	Siberian	hamster	over	85%	of	GnRH-expressing	neurons	in	the	POA	express	GPR147	(Ubuka	et	al.,	2012).	In	the	mouse,	application	of	GnIH-3	has	been	found	 to	 inhibit	 a	 subset	 of	 GnRH	 neurons	 (Ducret	 et	 al.,	 2009).	 Wu	 et	 al.	demonstrated	 the	 inhibitory	 mechanism	 of	 GnIH	 at	 GnRH	 neurons	 to	 be	 via	potassium	conductance	activation	(Wu	et	al.,	2009).	Stress	 is	 a	 known	 negative	 regulator	 of	 reproductive	 function	 and	 sexual	behavior,	 as	 such	 the	 hypothalamic-pituitary-adrenal	 (HPA)	 axis	 exerts	 an	inhibitory	 influence	 upon	 the	 HPG	 axis.	 Quail	 GnIH	 neurons	 express	 α2A-adrenoreceptor	 mRNA	 and	 norepinephrine	 has	 been	 demonstrated	 to	 increase	GnIH	 secretion	 in	 vitro	 (Tobari	 et	 al.,	 2014).	 Central	 administration	 of	glucocorticoids	suppresses	plasma	LH	whist	hypothalamic	corticotropin-releasing	hormone	(CRH)	reduces	plasma	GnRH	and	LH	in	vivo	(Petraglia	et	al.,	1987,	Rivier	et	al.,	1986,	Dubey	and	Plant,	1985,	Sakakura	et	al.,	1975).	CRH	receptor-1	(CRH-R1)	and	the	glucocorticoid	receptor	(GCR)	are	expressed	on	12.8	±	1.1%	and	53.1	±	11.4%	 of	 rat	 GnIH	 neurons	 respectively	 (Kirby	 et	 al.,	 2009).	 GnIH	 mRNA	
	 200	
expression	is	elevated	upon	both	acute	(2.3	±	0.3	fold)	and	chronic	(1.8	±	0.1	fold)	immobilization	stress;	an	effect	that	can	be	prevented	by	adrenalectomy	(Kirby	et	al.,	 2009).	 In	 rats,	 genetic	 knockdown	 of	 GnIH	 can	 prevent	 stress-induced	reproductive	dysfunction,	suggesting	that	these	neurons	are	key	regulators	of	the	reproductive	axis	(Geraghty	et	al.,	2015).	Stress	 and	 glucocorticoids	 are	 known	 to	 regulate	 the	 central	 serotonergic	system.	5-HT	1A,	1D,	1F,	2A,	2B,	3A,	5A,	5B,	6	and	7	receptors	(but	not	2C,	3B	or	4)	are	expressed	on	all	GnIH	neurons	and	the	selective	serotonin	reuptake	inhibitor	(SSRI)	 citalopram	 can	 cause	 sexual	 dysfunction	 (de	 Jong	 et	 al.,	 2005,	 Soga	 et	 al.,	2010).	Citalopram	treatment	is	associated	with	reduced	GnRH	and	elevated	GnIH	mRNA	expression	 (Soga	et	 al.,	 2010,	Prasad	et	 al.,	 2015).	These	data	 suggest	 the	central	 serotonergic	 system	 to	exert	an	excitatory	effect	upon	GnIH	neurons	and	an	inhibitory	tone	upon	the	HPG	axis.		The	 aim	 of	 this	 study	 was	 to	 use	 the	 visualized	 whole-cell	 patch	 clamp	technique	 to	 characterize	 the	 electrophysiological	 properties	 of	GnIH	neurons	 in	the	GnIH-EGFP	rat.	Herein	I	 investigate	the	intrinsic	membrane	and	extrinsic	fast	synaptic	 properties	 of	 GnIH	 neurons,	 and	 the	 membrane	 receptor	 profile	 of	 a	number	 of	 putative	 GnIH-regulating	 neurotransmitters,	 including	 noradrenaline,	5-HT,	ghrelin	and	TRH.	These	studies	highlight	the	importance	of	mechanisms	that	regulate	the	electrical	excitability	and	output	of	GnIH	neurons.			
7.2		 Results	
7.2.1		 Electrophysiological	profile	of	GnIH	neurons	A	total	of	32	GnIH	neurons	within	 the	DMH	were	recorded	 from	and	 included	 in	this	 study.	 Whole-cell	 current	 clamp	 recordings	 revealed	 a	 mean	 resting	
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membrane	potential	of	-39.54	±	0.74	mV	(range:	-32.6	to	-52.6	mV),	a	spontaneous	firing	rate	of	0.92	±	0.19	Hz	(range;	0	to	4.2	Hz),	input	resistance	of	1596	±	122	MΩ	(range	 691	 to	 3245	 MΩ),	 with	 25%	 (n=8)	 of	 neurons	 displaying	 an	 absence	 of	action	 potential	 firing	 at	 rest.	 Of	 female	 rats	 (n=17),	 whole-cell	 current	 clamp	recordings	 revealed	 a	 mean	 resting	 membrane	 potential	 of	 -40.48	 ±	 1.05	 mV,	whilst	mean	control	action	potential	firing	rate	was	0.79	±	0.19	Hz	and	basal	input	resistance	 was	 1469	 ±	 125	 MΩ.	 Of	 male	 rats	 (n=15),	 whole-cell	 current	 clamp	recordings	 revealed	 a	 mean	 resting	 membrane	 potential	 of	 -38.49	 ±	 1.00	 mV,	whilst	mean	control	action	potential	firing	rate	was	1.07	±	0.36	Hz	and	basal	input	resistance	was	1750	±	233	MΩ.	No	significant	difference	 in	membrane	potential,	firing	rate	or	input	resistance	was	observed	between	male	and	female	rats	(p=0.18,	0.49	and	0.25	respectively,	(Students	unpaired	t-test)).	The	estrus	phase	of	female	rats	was	not	determined	on	the	day	of	culling.		
7.2.2		 Sub-threshold	active	conductances	57%	 (n=18	 of	 32)	 of	 neurons	 expressed	 a	 Cs+	 (500μM)	 sensitive	hyperpolarization-activated	 non-selective	 cation	 conductance	 (IH)	 defined	 by	 a	delayed	 depolarizing	 sag	 in	 membrane	 potential	 at	 the	 peak	 of	 large	 amplitude	membrane	 hyperpolarizations	 evoked	 in	 response	 to	 negative	 current	 injection	(Figure	7.3A).		74%	 (n=24	 of	 32)	 of	 neurons	 expressed	 a	 Ni2+	 (1	 mM)	 sensitive	 rebound	depolarization	 observed	 at	 the	 break	 of	 the	 response	 to	 membrane	hyperpolarization,	 this	 being	 consistent	 with	 the	 activation	 of	 a	 T-type	 Ca2+	conductance.	91%	(n=29	of	32)	of	neurons	expressed	a	4-aminopyridimine	(1	mM)	sensitive	transient	outwardly	rectifying	K+	conductance	(ITOR)	defined	by	a	delayed	
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return	 to	 resting	 membrane	 potential	 at	 the	 break	 of	 the	 response	 to	hyperpolarizing	 current	 injection	 or	 as	 a	 delay	 in	 reaching	 threshold	 for	 action	potential	firing	in	response	to	depolarizing	current	injection	from	a	hyperpolarized	resting	potential	(Figure	7.3C).		
7.2.3		 Synaptic	inputs	Under	control	conditions,	both	excitatory	and	inhibitory	postsynaptic	events	were	detectable	(n=8	of	8),	(Figure	7.4).	At	rest,	spontaneous	EPSPs	were	observed	at	a	frequency	of	1.88	±	0.47	Hz.	EPSPs	were	sensitive	to	the	AMPA	receptor	antagonist	NBQX	(5	μM).	 	At	rest	spontaneous	IPSPs	were	observed	at	a	frequency	of	0.19	±	0.07	Hz	and	were	sensitive	to	 the	GABAA	receptor	antagonist	Bicuculine	(20	μM)	(Figure	7.4B).		
7.2.4		 Noradrenaline	depolarizes	GnIH	neurons		Bath	application	of	40	μM	noradrenaline	induced	membrane	depolarization	in	all	GnIH	 neurons	 tested	 (n=5)	 (Figures	 7.5	 and	 7.6).	 Noradrenaline	 induced	membrane	depolarization	from	a	mean	resting	potential	of	-46.90	±	2.19	mV	to	a	peak	membrane	potential	of	-45.84	±	3.12	mV.	Depolarization	was	associated	with	an	increase	in	action	potential	firing	rate,	from	0.40	±	0.19	Hz	at	rest,	to	a	peak	rate	of	0.68	±	0.41	Hz	in	the	presence	of	NA.	The	NA	induced	excitation	was	associated	with	a	reduction	 in	neuronal	 input	resistance	from	1230	±	196	MΩ	to	884	±	244	MΩ.	 	Following	washout	of	NA	from	the	recording	chamber,	membrane	potential,	firing	rate	and	input	resistance	returned	to	basal	levels.	The	NA-induced	excitation	persisted	 in	 the	 presence	 of	 1	 μM	 TTX	 (n=3)	 indicating	 a	 direct	 effect	 on	 the	postsynaptic	 membrane	 (Figure	 7.5B).	 I/V	 relationships	 plotted	 for	 this	 group	
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revealed	 an	 extrapolated	 reversal	 potential	 around	 0	 mV	 indicating	 that	 the	activation	 of	 a	 non-selective	 cation	 conductance	 most	 likely	 underpins	 this	response	to	NA	(Figure	7.6).		
7.2.5		 5-HT	induced	effects	on	GnIH	neurons	
7.2.5.1	Inhibition	15.8	%	(n=3	of	19)	of	neurons	were	inhibited	upon	bath	application	of	50	μM	5-HT,	observed	as	a	hyperpolarization	of	the	membrane	potential	from	a	mean	control	of	-48.08	 ±	 8.67	mV	 to	 peak	 inhibition	 of	 -55.27	 ±	 8.00	mV	 (p=0.032).	 This	 effect	persisted	in	the	presence	of	1	μM	TTX	(n=3)	and	was	associated	with	a	reduction	in	input	resistance	from	a	basal	level	of	1213	±	270	MΩ	to	a	peak	of	1021	±	124	MΩ	(p=0.415).	Current-voltage	relationships	plotted	for	this	group	revealed	a	reversal	potential	 of	 around	 -90	mV	 indicating	 the	 activation	 of	 a	 K+	 conductance	 (n=3)	(Figure	7.7	Biii).	 	 Furthermore	voltage-current	 relations	 in	 the	presence	of	 5-HT	revealed	a	rectification	at	negative	membrane	potentials	suggesting	5-HT-induced	inhibition	 at	 least	 in	 part	 involves	 the	 activation	 of	 an	 inwardly	 rectifying	potassium	conductance.		
7.2.5.2	Excitation	42.1	%	(n=8	of	19)	of	neurons	were	excited	upon	bath	application	of	5-HT	(Figure	7.7Ai)	Membrane	potential	depolarized	 from	a	baseline	of	 -47.45	±	1.52	mV	 to	a	peak	of	-41.68	±	1.73	mV	(p=0.001).	This	was	associated	with	a	decrease	in	input	resistance	from	a	baseline	of	912	±	229	MΩ	to	a	peak	of	862	±	209	MΩ	(p=0.163).	This	 effect	 persisted	 in	 the	presence	 of	 TTX	 (n=8).	 Current-voltage	 relationships	
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indicated	 that	 at	 least	 two	 mechanisms	 were	 involved	 in	 the	 5-HT-induced	excitation	 of	 GnIH	 neurons.	 Of	 the	 eight	 5-HT-induced	 excitations,	 five	 were	associated	 with	 a	 reduction	 in	 neuronal	 input	 resistance	 and	 reversal	 potential	around	0	mV.	Two	excitations	were	associated	with	an	increase	in	input	resistance	and	 reversal	 potential	 around	 -90	 mV.	 In	 the	 one	 remaining	 neuron,	 input	resistance	in	the	presence	of	5-HT	was	not	determined.	These	data	indicate	that	5-HT-induced	 excitation	 of	 GnIH	 neurons	 is	 via	 at	 least	 two	 mechanisms,	 the	inhibition	 of	 a	 potassium	 conductances	 and	 the	 activation	 of	 one	 or	 a	 cation	conductance.			
7.2.5.3	Biphasic	inhibitory/	excitatory	responses	42.1	 %	 (n=8	 of	 19)	 of	 neurons	 responded	 to	 5-HT	 with	 a	 biphasic	 response	observed	 as	 a	 transient	 inhibition	 followed	by	 a	 delayed	depolarization	 (Figures	7.7	and	7.8Aii).	5-HT	initially	induced	membrane	hyperpolarization	from	a	control	level	of	 -46.30	±	1.51	mV	to	 -56.17	±	3.65	mV	(p=0.005),	which	was	 followed	by	depolarization,	which	peaked	at	-39.53	±	1.17	mV	(p=0.0001	vs.	control).	Transient	membrane	hyperpolarization	was	 associated	with	 a	 decrease	 in	 input	 resistance	from	1665	±	287	MΩ	to	1213	±	261	MΩ	(p=0.16).	Subsequent	depolarization	was	associated	with	reduced	input	resistance	compared	to	control,	peaking	at	1027	±	333	MΩ	(p=0.51).		
7.2.5.4	Pharmacological	characterization	of	5-HT-induced	responses	in	GnIH	
neurons	A	combination	of	the	5-HT1A	receptor	antagonist	(S)-WAY	100135	(100	nM)	and	the	 5-HT1B	 receptor	 antagonists	 SB224289	 (10	 μM)	 reduced	 5-HT-induced	
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membrane	hyperpolarization	by	78%	in	GnIH	neurons.		Under	control	conditions,	5-HT	induced	a	membrane	hyperpolarization	of	-5.24	±	1.00	mV.	Subsequently	in	the	 presence	 of	 5-HT1A	 and	 5-HT1B	 receptor	 antagonists,	 5-HT	 induced	 a	membrane	hyperpolarization	of	-1.17	±	1.43	mV	(p=0.09)	(n=3)	(Paired	students	t-test).	 In	 one	 neuron,	 the	 5-HT7	 receptor	 antagonist	 SB-269970	 hydrochloride	(100nM)	reduced	5-HT	induced	depolarization	by	39%.	Under	control	conditions,	5-HT	 induced	 a	 membrane	 depolarization	 of	 7.75	 mV.	 Subsequently	 in	 the	presence	 of	 the	 5HT7	 receptor	 antagonist,	 5-HT	 induced	 a	 membrane	hyperpolarization	of	4.73	mV.	
	
7.2.6		 Thyrotropin-releasing	hormone	excites	GnIH	neurons	Bath	 application	 of	 400	 nM	 thyrotropin	 releasing	 hormone	 (TRH)	 induced	 an	excitation	 in	 all	 neurons	 tested	 (n=7)	 (Figures	 7.9	 and	 7.10)	 TRH	 induced	membrane	depolarization	from	a	resting	membrane	potential	of	-48.07	±	1.95	mV	to	a	peak	of	-33.43	±	1.19	mV	in	the	presence	of	TRH	(p=0.0001).	Action	potential	firing	 was	 induced	 in	 previously	 silent	 GnIH	 neurons	 reaching	 a	 peak	 firing	frequency	of	1.52	±	1.23	Hz	(p=0.03).	This	effect	persisted	in	the	presence	of	TTX	(n=3)	 (Figure	 7.9B)	 and	 TRH-induced	 depolarization	 of	 the	membrane	 potential	was	associated	with	a	reduction	in	input	resistance	from	1699	±	338	MΩ	to	1053	±	203	 MΩ	 at	 peak	 response	 (p=0.02).	 I/V	 relationships	 plotted	 for	 this	 group	revealed	an	extrapolated	reversal	potential	around	0	mV,	indicating	the	activation	of	 a	 non-selective	 cation	 conductance	 most	 likely	 underlies	 this	 effect	 of	 TRH	(Figure	7.10).	
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7.2.7		 Ghrelin	excites	GnIH	neurons		Bath	application	of	100	nM	ghrelin	induced	a	membrane	excitation	in	half	of	GnIH	neurons	 tested	 (4	 of	 8).	 Ghrelin-induced	 excitation	 was	 associated	 with	 a	membrane	potential	depolarization	from	-53.3	±	3.21	mV	to	a	peak	of	 -46.05	mV	(n=4)	(p=0.13)	(Figure	7.11).	This	effect	was	associated	with	an	increase	in	action	potential	firing	rate	from	0.46	±	0.33	Hz	to	a	peak	of	0.62	±	0.39	Hz	(p=0.15)	in	the	presence	of	ghrelin.	Membrane	depolarization	was	associated	with	an	increase	in	input	 resistance	 from	 a	 baseline	 of	 2348	 ±	 1002	MΩ	 to	 3347	 ±	 1723	MΩ	 in	 the	presence	 of	 ghrelin	 (p=0.15).	 I/V	 relationships	 plotted	 for	 this	 group	 revealed	 a	reversal	 potential	 of	 around	 -90	 mV,	 which	 under	 our	 recording	 conditions	 is	indicative	 of	 ghrelin	 inducing	 excitation	 via	 the	 closure	 of	 a	 resting	 potassium	conductance	(Figure	7.11B).		
7.2.8		 β-estradiol	and	corticosterone		400	nM	β-estradiol	was	 bath	 applied	 to	 5	GnIH	neurons,	without	 any	 ostensible	effect	on	membrane	potential,	action	potential	firing	frequency	or	input	resistance.	The	effect	 of	 corticosterone	 (400	nM)	upon	GnIH	neurons	was	 also	 investigated.	Here,	bath	application	of	corticosterone	to	4	GnIH	neurons	was	without	any	clear	effect	on	membrane	potential,	action	potential	firing	frequency	or	input	resistance.		
7.3	 	Discussion	
7.3.1		 Electrophysiological	properties	GnIH	 neuronal	 activity	 and	 ultimately	 peptide	 release	 can	 be	 modulated	 by	intrinsic	voltage-dependent	membrane	properties.	Active	conductances	modulate	
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the	 mechanisms	 by	 which	 neurons	 compute	 afferent	 inputs	 and	 generate	functional	 outputs	 partly	 through	 regulating	 the	 amplitude	 and	 time	 course	 of	post-synaptic	 currents	but	also	by	affecting	basic	membrane	characteristics	 such	as	 membrane	 potential,	 input	 resistance,	 action	 potential	 firing	 rate	 and	 firing	pattern	(Zhu	et	al.,	1999).	In	this	context,	these	parameters	ultimately	impact	GnIH	release,	GnRH	secretion,	and	the	tone	of	the	HPG	axis.	91%	of	GnIH	neurons	displayed	 transient	outward	rectification.	Transient	potassium	 conductances	 (ITR)	 are	 a	 conduit	 through	 which	 neurons	 delay	membrane	 depolarization,	 opposing	 excitation	 (Whyment	 et	 al.,	 2011).	 ITOR	 are	voltage-dependent	 conductances,	 and	 become	 activated	 during	 the	afterhyperpolarisation	 potential	 (AHP)	 that	 follows	 an	 action	 potential	 (AP),	delaying	 membrane	 depolarization	 and	 in	 doing	 so	 regulating	 action	 potential	firing	 frequency	 and	 firing	 pattern	 (Whyment	 et	 al.,	 2011,	 van	 den	 Top	 et	 al.,	2004).	 Modulation	 of	 this	 conductance	 by	 central	 and	 peripheral	 factors	 would	likely	influence	neuronal	firing	rate	and	GnIH	release.	74%	 of	 GnIH	 neurons	 tested	 expressed	 a	 Ni2+-sensitive	 low-threshold	 T-type	 Ca2+	 conductance.	 T-type	 calcium	 conductances	 are	 observed	 as	 a	 rebound	depolarization	 in	 response	 to	negative	current	 injection	and	are	required	 for	 the	generation	of	pacemaker-like	activity	in	other	hypothalamic	neuronal	populations	(van	 den	 Top	 et	 al.,	 2004).	 57%	 of	 GnIH	 neurons	 expressed	 a	 Cs+-sensitive	hyperpolarization-activated	 conductance	 (Ih).	 Ih	 has	 been	 demonstrated	 to	 be	required	 for	 rhythmic	 firing	 and	 pacemaker-like	 activity	 in	 other	 neuronal	populations	 (Maccaferri	 and	 McBain,	 1996,	 McCormick	 and	 Pape,	 1990).	 No	rhythmic	or	pacemaker-like	firing	was	observed	in	the	GnIH	neurons	tested	here.	However	 further	 experiments	 may	 clarify	 endogenous	 and	 exogenous	 factors	
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capable	 of	 generating	 this	 activity	 type,	 which	 may	 be	 required	 for	 significant	elevations	of	GnIH	secretion	from	these	neurons.	Active	 conductance	 expression	 was	 remarkably	 conserved	 amongst	 GnIH	neurons	tested	here.	Variations	in	active	conductance	expression	may	be	indicative	of	 functional	heterogeneity	within	 this	population	of	neurons.	No	sex	differences	were	observed	in	terms	of	active	conductance	expression	in	this	study.	It	remains	unclear	 as	 to	 whether	 these	 conductances	 are	 under	 temporal	 or	 steroidal	regulation.			
7.3.2		 Pharmacology	Here	we	demonstrate	 that	 rat	DMH	GnIH	neurons	 express	GABAA	 receptors	 and	AMPA	glutamate	receptors,	activated	at	rest	under	our	recording	conditions.	The	DMH	 is	 known	 to	 receive	 afferents	 from	 the	 telencephalon	 including	 the	 ventral	subiculum,	infralimbic	area	of	the	prefrontal	cortex,	lateral	septal	nucleus,	and	bed	nuclei	of	the	stria	terminalis	(Thompson	and	Swanson,	1998).	Brainstem	afferents	originate	in	the	periaqueductal	gray,	parabrachial	nucleus	(PBN),	and	ventrolateral	medulla	 (Thompson	 and	 Swanson,	 1998).	 Intrahypothalamic	 inputs	 are	 received	from	the	suprachiasmatic	nucleus	(SCN),	subparaventricular	zone	(SPZ),	VMH,	and	both	NPY/AgRP	and	POMC/CART	neurons	of	the	ARH	(Chou	et	al.,	2003,	Bagnol	et	al.,	 1999,	 Thompson	 and	 Swanson,	 1998).	 Local	 DMH	 glutamate/TRH	 neurons	could	be	a	source	of	glutamatergic	transmission	in	the	rat	(Chou	et	al.,	2003).	GnIH	neuron	sensitivity	to	TRH	would	suggest	this	to	be	likely.	DMH	neurons	are	known	to	 receive	GABAergic	afferents	 from	SCN	neurons	and	NPY/AgRP	neurons	of	 the	ARH	(Kalsbeek	et	al.,	1996,	Bellinger	et	al.,	1976,	Bagnol	et	al.,	1999).	It	is	evident	that	 there	are	a	multitude	of	neuronal	populations	 terminating	at	DMH	neurons,	
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and	 probably	 GnIH	 neurons.	 Cholera	 toxin	 B	 (CTB)	 retrograde	 tracing	 studies	would	be	a	valuable	tool	to	investigate	the	molecular	identity	of	afferent	neurons	in	this	network	(Llewellyn-Smith	et	al.,	1990).		
7.3.3		 Noradrenaline	Here	we	show	that	the	catecholamine	noradrenaline	directly	excites	GnIH	neurons	via	 the	 activation	 of	 a	 non-selective	 cation	 conductance,	 consistent	 with	 α1	adenoreceptor	 (AR)	 activation	 (Ishibashi	 et	 al.,	 2003).	 α1	 adrenoceptors	 are	expressed	in	the	rat	DMH	(Day	et	al.,	1997).	α-1B	receptors	are	also	expressed	in	rat	GnRH	neurons	(Hosny	and	Jennes,	1998)	and	α1	receptor	activation	has	been	shown	to	increase	LH	secretion	(Gearing	and	Terasawa,	1991,	Heaulme	and	Dray,	1984).	 These	 data	 indicate	 a	 complex	 integration	 of	 noradrenergic	 signals	upstream	 of	 gonadotroph	 secretion.	 Further	 work	 should	 further	 clarify	 the	influence	of	NA	and	NA	 receptor	 subtypes	on	 the	 electrophysiological	 activity	 of	these	neuronal	populations.	Quail	 GnIH	 neurons	 express	 α2A	 receptors	 and	 are	 innervated	 by	noradrenergic	 afferents	 (Tobari	 et	 al.,	 2014).	 This	 is	 associated	 with	 increased	noradrenergic	innervation	of	the	male	quail	PVH	following	the	viewing	of	a	female.	This	mechanism	has	been	proposed	to	mediate	the	decrease	in	plasma	T	observed	in	male	quail	following	visualization	of	a	female	(Delville	et	al.,	1984,	Cornil	et	al.,	2009).	 It	 is	 clear	 that	 noradrenergic	 innervation	 of	 GnIH	 neurons	 is	 conserved	between	 species.	 The	 DMH	 is	 well	 characterized	 as	 a	 hypothalamic	 nucleus	involved	in	stress	signal	integration.	In	non-mammalian	vertebrates	both	restraint	stress	 and	 central	 administration	 of	 corticotropin	 releasing	 hormone	 (CRH)	 and	corticosterone	 have	 been	 shown	 to	 elevate	 adrenaline,	 noradrenaline,	 dopamine	
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and	5-HT	tissue	concentration	in	the	DMH	(Lowry	et	al.,	2001).	Catecholaminergic	excitation	of	GnIH	neurons	may	represent	a	central	mechanism	by	which	the	HPA	axis	inhibits	gonadotroph	release	(Inglefield	et	al.,	1994,	Keim	and	Shekhar,	1996,	Bellinger	et	al.,	1976).			
7.3.4		 Serotonin		A	 significant	 degree	 of	 variation	 was	 observed	 in	 the	 5-HT	 responses	 of	 GnIH	neurons.	31.6%	were	inhibited,	26.3%	excited	and	42.1%	biphasic	responses.	This	differential	 responsiveness	may	 be	 indicative	 of	 functional	 heterogeneity	 within	the	 GnIH	 neuron	 population,	 or	 perhaps	 5-HT	 receptor	 expression	 in	 under	temporal	control,	and	the	proportion	of	excitations	and	inhibitions	changes	during	estrus.	 The	 diversity	 of	 5-HT-induced	 responses	 observed	 in	 these	 studies	 is	 no	doubt	 reflective	 of	 the	 complex	 profile	 of	 5-HT	 receptor	 expression	 on	 these	neurons.	 It	 has	 previously	 been	 demonstrated	 that	 all	 rat	 GnIH	 neurons	 contain	mRNA	for	multiple	5-HT	receptor	subtypes	1A,	1D,	1F,	2A,	2B,	3A,	5A,	5B,	6	and	7,	but	not	2C,	3B	or	4	(Soga	et	al.,	2010).	This	complexity	of	receptor	expression	may	account	 for	 the	 somewhat	 incomplete	 pharmacological	 characterization	 of	responses	reported	here.		Previous	research	into	the	effects	of	serotonin	on	the	HPG	axis	has	garnered	disparate	 results,	with	 some	 studies	 reporting	 5-HT	 to	 have	 a	 stimulatory	 effect	upon	gonadotroph,	whilst	others	have	observed	5-HT	to	exert	an	inhibitory	effect	upon	the	release	of	both	GnRH	and	LH	secretion	(Chen	et	al.,	1981,	Donnelly	and	Dailey,	1991,	Hery	et	al.,	1976,	Johnson	and	Crowley,	1986,	Vitale	et	al.,	1985,	Fink	et	 al.,	 1999,	 Gore	 and	 Terasawa,	 2001,	 Arendash	 and	 Gallo,	 1978,	 Lynch	 et	 al.,	1984,	Schneider	and	McCann,	1970).	
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Whilst	Gore	et	al	 found	5-HT	antagonists	to	 inhibit	LH	secretion,	 the	5-HT	receptor	agonist	quipazine	did	not	 increase	LH	pulse	amplitude	but	did	 induce	a	more	 erratic	 LH	 pulse	 pattern	 (Gore	 and	 Terasawa,	 2001).	 Perhaps	 this	 data,	 in	addition	 to	observations	of	 the	plethora	of	5-HT	receptor	subtypes	expressed	on	hypothalamic	 neurosecretory	 cells,	 implies	 a	 more	 intricate	 regulation	 of	gonadotroph	 release	 by	 5-HT.	 Considering	 serotonergic	 control	 of	 reproductive	function	as	either	‘on’	or	‘off’	is	presumably	too	reductive	to	be	helpful.	The	differential	effect	of	specific	5-HT	receptor	agonists	and	antagonists	on	gonadotroph	 secretion	 in	 vivo	 (and	 at	 different	 points	 of	 estrus)	 needs	 to	 be	determined	 in	 order	 for	 us	 to	 better	 understand	 the	 serotonergic	 control	 of	 the	HPG	axis.		
7.3.5	 	TRH	Here	we	demonstrate	that	TRH	reliably	depolarizes	GnIH	neurons	in	the	rat	via	the	activation	of	a	non-selective	cation	conductance.	This	is	consistent	with	activation	of	the	TRH-receptor	TRHR	(Gershengorn	and	Osman,	1996).	This	receptor	is	Gq/11-coupled,	and	ligand	binding	stimulates	phosphoinositide-specific	phospholipase	C,	which	 in	 turn	 increases	 intracellular	 IP3,	 DAG	 and	 calcium	 store	 mobilization	(Aragay	 et	 al.,	 1992,	 Hsieh	 and	 Martin,	 1992,	 Gershengorn	 and	 Osman,	 1996).	Further	 work	 to	 determine	 the	 specific	 TRHR	 subtype(s)	 expressed	 on	 GnIH	neuron	membranes	is	needed	to	characterize	this	population.	Previous	studies	have	shown	TRH	to	increase	prolactin	secretion	(Donnelly	and	Dailey,	1991),	and	also	increase	LH	and	FSH	secretion	in	humans	(Lamberts	et	al.,	1987,	Snyder	et	al.,	1984,	Kwekkeboom	et	al.,	1989).	Perhaps	TRH	excitation	of	GnIH	 neurons	 is	 indicative	 of	 a	 negative	 feedback	 mechanism,	 regulating	 the	
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degree	to	which	TRH	stimulates	gonadotroph	secretion.	Further	work	is	needed	to	clarify	this.	TRH	responsiveness	may	indicate	the	existence	of	a	PVN-GnIH	synaptic	contact,	 therefore	 it	 would	 be	 worthwhile	 for	 future	 studies	 to	 investigate	 the	effects	 of	 other	 PVH	 neuropeptides	 such	 as	 corticotropin-releasing	 hormone	(CRH),	 arginine	 vasopressin	 and	 oxytocin	 on	 the	 electrical	 activity	 of	 GnIH	neurons.		
7.3.6	 	Ghrelin	These	 studies	 demonstrate	 that	 ghrelin	 excites	 GnIH	 neurons	 through	 the	inhibition	 of	 a	 resting	 potassium	 conductance,	 this	 being	 similar	 to	 previous	reports	 of	 a	 direct	 effect	 of	 ghrelin	 upon	 the	 neuron,	 via	 binding	 to	 the	 growth	hormone	 secretagogue	 receptor	 (GHSR)	 and	 ATP-sensitive	 potassium	 (K+ATP)	channel	inhibition	(see	chapter	4	of	this	thesis)	(van	den	Top	et	al.,	2007).		These	results	suggest	a	cellular	mechanism	by	which	ghrelin	inhibits	GnRH	and	LH	pulse	 frequency	as	described	 in	previous	work	 (Fernandez-Fernandez	et	al.,	2004,	Lebrethon	et	al.,	2007).	It	also	provides	more	evidence	that	GnIH	neurons	exist	within	both	reproductive	and	feeding	circuitry	in	the	hypothalamus.	It	 is	 well	 known	 that	 the	 reproductive	 axis	 is	 inhibited	 during	 negative	 energy	states	 (Bronson,	 1986,	 Sisk	 and	Bronson,	 1986,	 Schneider	 et	 al.,	 2013).	 It	would	seem	 unsurprising	 that	 a	 peptide,	 with	 increased	 plasma	 concentrations	 during	negative	energy	states	would	exert	a	negative	effect	upon	the	HPG	axis,	however	perhaps	 it	 would	 be	 considered	 more	 appropriate	 for	 long-term	 signaling	hormones	such	as	 leptin	to	affect	GnIH	neuron	electrical	activity.	However	 leptin	did	not	result	in	membrane	depolarization	in	neurons	tested	here	despite	the	high	concentration	of	LepR	in	the	DMH	(Elmquist	et	al.,	1998).		
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Reports	 indicate	 that	GnIH	has	 an	 orexigenic	 effect	 in	vivo	with	 ICV	GnIH	stimulating	 food	 intake	 in	 rats	 and	 chicks	 (Johnson	et	 al.,	 2007,	Tachibana	et	 al.,	2005).	 	 GnIH	 has	 been	 shown	 to	 inhibit	 POMC	 neurons	 via	 the	 activation	 of	 a	potassium	 conductance	 (Fu	 and	 van	 den	Pol,	 2010).	 GnIH	 terminals	 are	 in	 close	apposition	 to	 ARH	 NPY/AgRP	 neurons,	 although	 there	 is	 not	 yet	 any	 direct	electrophysiological	 evidence	 demonstrating	 NPY	 neuron	 excitation,	 ICV	 GnIH	does	 increase	 arcuate	 NPY	mRNA	 expression	 (McConn	 et	 al.,	 2014,	 Jacobi	 et	 al.,	2013).	If	the	endpoint	of	ghrelin	signaling	in	these	neurons	is	KATP	channels,	it	may	be	 that	 the	 electrical	 excitability	 of	 the	 GnIH	 neuron	 is	 directly	 coupled	 to	 the	metabolic	state	of	the	organism,	introducing	another	mechanism	by	which	the	HPG	axis	is	modulated	by	central	homeostatic	factors.	This	 study	 looked	 into	 the	 effects	 of	 both	 estradiol	 and	 corticosterone	 on	GnIH	 neurons	 activity,	 with	 no	 ostensible	 effects	 observed.	 However	 this	 result	may	 be	 more	 indicative	 of	 time	 restrictions	 whist	 performing	 whole-cell	recordings.	Perhaps	steroids	regulate	GnIH	neuronal	excitability	over	durations	in	excess	of	those	we	were	able	to	study	here.	Additionally	these	steroids	are	cyclical	and	phasic	in	their	expression	levels,	as	are	their	receptors.	These	factors	were	not	accounted	 for	 in	 these	 experiments	 however	 they	 warrant	 investigation.	Nevertheless	 the	 absence	 of	 any	 clear	 corticosterone	 or	 estrogen	 indicates	 that	these	 hormones	 do	 not	 regulate	 electrical	 excitability	 directly	 and	 more	 likely	change	the	functional	operation	and	sensitivity	of	the	GnIH	circuit	through	changes	in	gene	expression	and	protein	synthesis	in	the	longer	term.		
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7.3.7		 Conclusions	These	 studies	 demonstrate	 the	 basal	 electrophysiological	 profile	 of	 rat	 GnIH	neurons,	 the	 pharmacology	 of	 afferent	 synaptic	 connections	 within	 the	hypothalamic	circuit	and	reveal	the	manner	by	which	they	respond	to	a	number	of	neurotransmitters	 and	 hormones	 allowing	 us	 to	 further	 contextualize	 the	 GnIH	neuron	within	 the	HPG	axis.	From	the	data	presented	here,	GnIH	neurons	would	appear	to	integrate	multiple	signals	including	stress	and	metabolic	secretagogues.	Observations	 that	 central	 factors	 known	 to	 stimulate	 GnRH	 and	 LH	 secretion	 in	
vivo	 also	 excite	 GnIH	 neurons	 suggests	 a	 highly	 complex	 central	 regulation	 of	gonadotroph	secretion,	that	should	be	investigated	further.	It	must	be	noted	that	a	significant	 caveat	 of	 this	 work	 is	 that	 the	 estrus	 phase	 of	 female	 rats	 was	 not	determined	on	the	day	of	culling	and	until	 this	sort	of	work	 is	performed	we	are	unable	 to	 associate	 electrophysiological	 characteristics	 to	 specific	 female	reproductive	functions.												
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Figure	7.1:	Functional	organization	of	the	hypothalamic	reproductive	circuit	Both	 GnIH	 and	 kisspeptin	 neuron	 project	 to	 GnRH	 neurons;	 kisspeptin	 neurons	send	additional	projections	to	arcuate	NPY	and	POMC	neurons.	This	connectivity	is	likely	 indicative	 of	 a	 neuronal	 circuit,	 linking	 metabolic	 energy	 status	 to	reproductive	function.	Adapted	from	(Fu	and	van	den	Pol,	2010).																					
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Figure	 7.2:	 GnIH	 neuron	 projection	 sites	 from	 the	 rat	 dorsomedial	
hypothalamus	Sagittal	 section	of	 an	 adult	mouse	brain	with	DMH	GnIH	neuron	projection	 sites	highlighted;	these	include	the	amygdala,	PVT,	BnST	and	MPOA.																						
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Figure	7.3:	Characteristic	electrophysiological	properties	of	GnIH	neurons	
A:	 Representative	 current-voltage	 relationship	 of	 a	 GnIH	 neuron	 recorded	 in	current-clamp	 mode.	 Here,	 superimposed	 sweeps	 show	 membrane	 potential	deflections	in	response	to	the	injection	of	square-wave	current	steps	of	decreasing	magnitude	and	constant	integer.	A	hyperpolarization-activated	cation	conductance	(IH)	is	expressed	by	this	neuron.	IH	is	observed	as	a	depolarizing	sag	in	the	larger	amplitude	hyperpolarizing	responses	to	negative	current	injection.		
B:	The	current-voltage	relationship	of	the	same	cell	as	shown	in	Ai,	in	the	presence	of	CsCl	(500μM),	which	blocked	 IH.	Note	 the	 linear	 relationship	 in	 the	membrane	response	to	hyperpolarizing	current	steps,	in	the	presence	of	CsCl.	
C:	The	current-voltage	relationship	of	a	GnIH	neuron	that	was	characterized	by	a	transient-outward	rectifying	conductance	(ITR).	In	this	instance	ITR	was	activated	in	response	 to	 depolarizing	 current	 pulses	 from	 a	 negative	 resting	 membrane	potential,	 and	 is	 seen	 as	 a	 delay	 in	 the	 neuron	 membrane	 potential	 reaching	threshold	 for	 firing.	 This	 conductance	 was	 sensitive	 to	 4-AP	 (1mM)	 (data	 not	shown).											
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Figure	7.4:	Synaptic	properties	of	GnIH	neurons	
A:	 Representative	 voltage	 clamp	 recording	 from	a	GnIH	neuron,	with	membrane	potential	 ‘clamped’	 at	 -60	mV.	 Upward	 deflections	 from	 the	 trace	 are	 inhibitory	postsynaptic	 currents	 (IPSCs)	 and	 downward	 deflections	 are	 excitatory	postsynaptic	currents	(EPSCs).		
B:	Voltage	clamp	recording	from	the	same	neuron	as	in	Bi	after	bath	application	of	NBQX	and	bicuculine,	blocking	AMPA	and	GABAA	membrane	currents	respectively.	Note	the	total	abolition	of	synaptic	currents.	
C:	 Superimposed	EPSPs	 from	Bi.	Note	 the	 similar	 rise-times	of	 the	post-synaptic	currents,	suggesting	a	common	spatial	origin	of	these	inputs.	
D:	 Superimposed	 EPSPs	 from	 a	 GnIH	 neuron	 voltage	 clamp	 recording.	 Note	 the	similar	 rise-times	 of	 the	 post-synaptic	 currents,	 suggesting	 a	 common	 spatial	origin	of	these	inputs.	
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Figure	 7.5:	 Noradrenaline	 excites	 GnIH	 neurons	 via	 a	 direct	 postsynaptic	
mechanism	of	action		
A:	 Current-clamp	 recording	 from	 a	 GnIH	 neuron.	 Bath	 application	 of	 40	 μM	noradrenaline	 (NA)	 induced	 a	 membrane	 depolarization	 that	 was	 sufficient	 to	reach	 threshold	 for	 action	 potential	 firing,	 an	 effect	 that	 was	 reversible	 upon	washout	of	NA.		
B:	 Noradrenaline-induced	 excitation	 persisted	 in	 the	 presence	 of	 1	 μM	 TTX,	 the	latter	 applied	 to	 eliminate	 activity	 dependent	 synaptic	 inputs	 and	 potential	indirect	effects	of	NA.	This	data	suggests	a	direct	postsynaptic	site	and	mechanism	of	action.	
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Figure	7.6:	Direct	excitation	of	GnIH	neurons	by	noradrenaline.		
A:	 Samples	 of	 a	 continuous	 record	 showing	 superimposed	 current	 clamp	recordings	of	the	current-voltage	relations	of	a	GnIH	neuron	in	control	conditions.	
B:	 Superimposed	 current	 clamp	 recording	 showing	 the	 current-voltage	relationship	of	the	same	neuron	as	in	A	during	the	peak	response	to	NA.		
C:	Plots	of	 the	current-voltage	relationships	shown	 in	A	 and	B.	Note	 the	reduced	slope	of	 the	membrane	potential	response	to	current	 injection	 in	the	presence	of	noradrenaline.	 Also	 note	 the	 extrapolated	 reversal	 potential	 around	 0	 mV,	indicating	 GnIH	 neuron	 NA-induced	 depolarization	 to	 be	 via	 the	 activation	 of	 a	non-selective	cation	conductance,	and	a	reduction	in	neuronal	input	resistance.	
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Figure	7.7:	Differential	effects	of	5-HT	on	GnIH	neurons		
Ai:	 Current	 clamp	 recording	 of	 a	 GnIH	 neuron.	 Bath	 application	 of	 50	 μM	 5-HT	induced	 a	 biphasic	 response,	 with	 an	 initial	 transient	 membrane	 potential	hyperpolarisation	 followed	 by	 a	 membrane	 depolarisation,	 associated	 with	 an	increase	in	action	potential	firing	rate.	These	effects	were	reversed	upon	washout	of	5-HT.	
	Aii:	The	same	neuron	as	 that	 shown	 in	Ai,	 in	 the	presence	of	1μM	TTX	 to	block	activity-dependent	 transmission	 and	 indirect	 effects	 of	 5-HT.	Bath	 application	 of	50	μM	5-HT	induced	a	primarily	inhibitory	response	with	the	excitatory	response	observed	previously	in	this	cell,	significantly	diminished.	
Bi:	 Superimposed	 current	 clamp	 recording	 showing	 the	 current-voltage	relationship	of	a	GnIH	neuron	in	control	conditions.	
Bii:	 Superimposed	 current	 clamp	 recording	 showing	 the	 current-voltage	relationship	 of	 same	 GnIH	 neuron	 shown	 in	 Bi,	 recorded	 at	 the	 peak	 of	 5-HT-induced	inhibition.	
Biii:	 The	 plots	 of	 current-voltage	 relationships	 shown	 in	 Bi	 and	 Bii.	 Note	 the	reduced	slope	of	the	membrane	response	to	current	injection	in	the	presence	of	5-HT	 and	 the	 distinct	 non-linear	 deviation	 (rectification)	 at	 more	 negative	membrane	 potentials.	 Also	 note	 the	 reduction	 in	 neuronal	 input	 resistance	 and	reversal	potential	 around	 -90	mV.	Taken	 together	 these	data	 indicate	 that	5-HT-induced	 GnIH	 neuron	 hyperpolarization	 is	 via	 the	 activation	 of	 a	 potassium	conductance,	most	likely	involving	an	inwardly	rectifying	potassium	conductance				
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Figure	7.8:	Differential	effects	of	5-HT	on	GnIH	neurons		
Ai	&	Aii:	Two	simultaneous	current-clamp	recordings	of	GnIH	neurons,	both	held	at	 a	 membrane	 potential	 of	 -50	 mV	 by	 injection	 of	 constant	 current.	 Bath	application	of	50	μM	5-HT	induced	a	membrane	depolarization	in	the	cell	shown	in	
Ai	and	biphasic	inhibition-excitation	in	the	cell	shown	in	Aii.	
B:	 Pie	 chart	 showing	 the	 proportion	 of	 GnIH	 neurons	 excited,	 inhibited	 and	responding	with	a	biphasic	 (inhibited-excited)	 response	 to	bath	application	of	5-HT.	Here,	42.1%	of	5-HT-induced	responses	were	biphasic,	15.8%	of	neurons	were	inhibited	whilst	the	remaining	42.1%	were	excited	(n=19).																		
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Figure	7.9:	TRH-induced	direct	post-synaptic	excitation	of	GnIH	neurons	
A:	 Samples	 of	 a	 continuous	 current	 clamp	 recording	 from	 a	 GnIH	 neuron.	 Bath	application	 of	 400	 nM	 TRH	 induced	 a	 reversible	 membrane	 depolarization	 and	increase	in	action	potential	firing	rate.		
B:	Current	clamp	recording	of	the	same	neuron	as	shown	in	A,	 in	the	presence	of	1μM	TTX.	TRH-induced	depolarization	persisted	in	the	presence	of	TTX	indicating	a	direct	post-synaptic	site	of	action.	Note	also	the	fall	in	amplitude	of	the	electronic	potentials	 (downward	 deflections	 of	 the	 record),	 evoked	 in	 response	 to	 regular	square-wave	 negative	 current	 pulses,	 indicating	 a	 reduction	 in	 neuronal	 input	resistance	underlies	TRH-induced	excitation.		
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Figure	7.10:	TRH-induced	direct	post-synaptic	excitation	of	GnIH	neurons		
A:	 Superimposed	 current	 clamp	 recordings	 showing	 the	 current-voltage	relationship	of	a	GnIH	neuron	in	control	conditions.	
B:	 Superimposed	 current	 clamp	 recording	 showing	 the	 current-voltage	relationship	of	 the	same	GnIH	neuron	shown	in	A,	 taken	at	 the	peak	of	 the	TRH-induced	excitation.	
C:	The	plots	of	current-voltage	relationships	shown	in	A	and	B.	Note	the	reduced	slope	of	the	membrane	response	to	current	injection	in	the	presence	of	TRH.	Also	note	 the	extrapolated	reversal	potential	around	0	mV.	Taken	together	 these	data	indicate	 that	 GnIH	 neuron	 TRH-induced	 depolarization	 is	 via	 the	 activation	 of	 a	non-selective	cation	conductances,	and	a	reduction	in	neuronal	input	resistance.															
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Figure	7.11:	Ghrelin	excites	GnIH	neurons.		
A:	Current	clamp	recording	taken	from	a	GnIH	neuron.	Bath	application	of	100	nM	ghrelin	induced	membrane	depolarization.		
B:	Plot	of	GnIH	neuron	current-voltage	relationships	 in	control	conditions	and	 in	the	 presence	 of	 100	 nM	 ghrelin.	 Note	 the	 increased	 slope	 of	 the	 membrane	response	 to	 current	 injection	 and	 reversal	 potential	 around	 -90	 mV.	 Taken	together	 these	 indicate	 membrane	 depolarization	 is	 via	 inhibition	 of	 a	 resting	potassium	conductance.																		
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Chapter	8:	Electrical	synaptic	
transmission	in	layer	1	cortical	
interneurons		
8.1		 Introduction	Gap-junctions	are	conduits	through	which	ions	and	metabolites	can	move	between	apposing	mammalian	cells,	including	neurons.	A	gap-junction	plaque	is	composed	of	a	number	of	intercellular	channels,	ranging	from	just	a	few	to	hundreds.		Each	of	these	intercellular	channels	is	made	up	of	two	hemichannels,	covalently	docked	to	one	another	via	their	extracellular	moieties	(Harris,	2001).	Each	hemichannel	is	a	hexamer	of	connexin	subunits	and	20	connexin	genes	have	been	identified	in	mice	(Sohl	 and	 Willecke,	 2004).	 In	 the	 central	 nervous	 system	 (CNS),	 11	 connexin	isoforms	 are	 differentially	 expressed	 in	 glia	 and	 neurons	 and	 throughout	development	 (Harris,	 2001).	 To	 date	 only	 connexin	 36	 (Cx36)	 has	 been	 clearly	identified	to	mediate	neuron-to-neuron	gap	junction	communication	(Bargiotas	et	al.,	2012,	Beaumont	and	Maccaferri,	2011).	Cx36	is	found	throughout	the	CNS	but	with	a	discrete	distribution	in	specific	cell	types.	Direct	electrotonic	coupling	and	electrical	 synaptic	 transmission	 has	 been	 demonstrated	 in	 the	 cerebral	 cortex,	hippocampus,	 locus	 coeruleus,	 suprachiasmatic	 nucleus,	 olfactory	 bulb,	 inferior	olive	and	spinal	cord	(Meier	and	Dermietzel,	2006,	Nolan	et	al.,	1999,	Galarreta	and	Hestrin,	 2001,	 Leznik	 and	 Llinas,	 2005,	 Long	 et	 al.,	 2005,	 Kosaka	 et	 al.,	 2005,	Fukuda	 and	 Kosaka,	 2000).	 It	 is	 becoming	 increasingly	 evident	 that	 electrical	synaptic	transmission	plays	a	more	widespread	role	in	CNS	information	processing	in	development	and	adulthood,	in	health	and	disease,	than	previously	recognized.	Whilst	 the	 precise	 role	 of	 these	 synapses	 is	 still	 far	 from	 clear,	 one	 function	 of	
	 238	
electrotonic	 coupling	 in	 neurons	 is	 to	 synchronize	 the	 electrical	 activity	 of	neuronal	networks	(Meier	and	Dermietzel,	2006,	Harris,	2001,	Leznik	and	Llinas,	2005,	Logan	et	al.,	1996).	Aberrant	 gap-junctional	 intercellular	 communication	 is	 associated	 with	 a	number	 of	 neurological	 diseases	 including	 cerebrovascular	 disease,	 Alzheimer’s	disease,	Parkinson’s	disease,	and	epilepsy	(Nakase	and	Naus,	2004).	Epilepsy	is	the	most	 common	 neurological	 disorder	 worldwide	 (Jacoby	 et	 al.,	 2005).	 Seizures	result	 from	 the	 aberrant	 spread	 of	 synchronized	 neuronal	 depolarization,	 either	spreading	within	a	CNS	structure,	or	throughout	the	entire	forebrain,	resulting	in	a	tonic-clonic	seizure	(Beghi,	2016).	Connexin-based	electrical	synapses	are	known	to	 synchronize	 electrical	 activity	 across	 neuronal	 networks	 and	 as	 such	 the	neuronal	gap	 junction	 is	a	potential	 target	 for	anti-epileptic	drugs	(Meldrum	and	Rogawski,	2007).	Specific	 pharmacological	 tools	 for	 experimental	 and	 therapeutic	manipulation	of	gap	junctions	are	still	lacking.	This	is	in	part	due	to	a	shortage	of	high	throughput	screening	protocols,	as	well	as	poor	knowledge	of	the	intricacies	and	idiosyncrasies	of	connexin	channel	structure	and	conformation,	irrespective	of	some	 successful	 crystallographic	 studies	 (Maeda	 et	 al.,	 2009).	 A	 number	 of	relatively	 non-specific	 gap-junction	 blockers	 are	 available.	 Carbenoxolone	 is	among	 the	most	widely	used	 (Juszczak	 and	Swiergiel,	 2009).	 Carbenoxolone	 is	 a	glycyrrhetinic	acid	derivative	used	as	a	non-specific	gap	junction	blocker	in	in	vitro	experiments,	 however	 it’s	mechanism	of	 action	at	 gap	 junctions	 remains	unclear	(Connors,	2012).	Major	drawbacks	of	the	use	of	carbenoxolone	in	experiments	are	off-target	effects.		In	addition	to	gap-junctions,	carbenoxolone	blocks	voltage	gated	Ca2+	channels,	P2X7	receptors,	NMDA,	and	GABAA	currents	(Connors,	2012,	Vessey	
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et	 al.,	 2004,	 Suadicani	 et	 al.,	 2006,	 Chepkova	 et	 al.,	 2008).	 Carbenoxolone	 also	stimulates	glucocorticoid	signaling,	elevating	cortisol	and	coritcosterone	levels	by	inhibiting	11-β	hydroxysteroid	dehydrogenase	(Juszczak	and	Swiergiel,	2009).	 In	addition	to	carbenoxolone,	quinine,	quinidine	and	mefloquine	are	commonly	used	gap-junction	blockers,	 however	none	 are	 selective	 for	 a	 single	 connexin	 isoform,	and	 all	 have	 off	 target	 effects,	 including	 well	 documented	 effects	 on	 other	 ion	channels	(Juszczak	and	Swiergiel,	2009).	Novel,	selective	gap	junction	blockers	are	required	for	a	thorough	and	accurate	characterization	of	gap-junction	functions	in	
vitro	and	in	vivo.	Tonabersat	 (SB-220453)	 and	 Carabersat	 (SB-204269)	 are	 structurally	related	 benzoylamino-benzopyran	 compounds	 that	 have	 been	 studied	 in	preclinical	 and	 clinical	 trials	 as	 potential	 antimigraine	 and	 anticonvulsant	therapeutics	(Dahlof	et	al.,	2009,	Goadsby	et	al.,	2009,	Hauge	et	al.,	2009,	Bradley	et	al.,	2001,	Parsons	et	al.,	2001,	Upton	et	al.,	1997,	Upton	and	Thompson,	2000).	Carabersat	is	an	effective	anticonvulsant	when	used	in	a	number	of	in	vivo	seizure	models,	 including	 the	 maximal	 electroshock	 seizure	 threshold	 (MEST)	 test,	 the	maximal	 electroshock	 (MES)	 test,	 and	 in	 a	 pentylenetetrazole	 (PTZ)	 infusion-evoked	 tonic	 extension	 seizure	 model	 (Upton	 et	 al.,	 1997).	 Treatment	 with	carabersat	is	not	associated	with	depressive	side	effects	(Upton	et	al.,	1997).	In	an	
in	vitro	model	of	hippocampal	seizure	induced	by	elevated	extracellular	potassium,	Carabersat	is	a	more	effective	anticonvulsant	than	carbamazepine	and	lamotrigine	(Upton	et	al.,	1997).	Data	indicates	that	the	mechanism	of	action	of	benzoylamino-benzopyran	compounds	on	epileptiform	activity	is	independent	of	sites	affected	by	current	 anticonvulsants	 including	 phenobarbitone,	 phenytoin,	 sodium	 valproate,	carbamazepine,	 diazepam,	 ethosuximide,	 lamotrigine,	 vigabatrin,	 gabapentin	 and	
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levetiracetam	(Herdon	et	al.,	1997).	Tonabersat	has	been	shown	to	reduce	cortical	spreading	 depression	 (CSD),	 inhibit	 nitric	 oxide	 release	 and	 antagonize	 gap	junction	 glia-neuron	 communication	 (Durham	 and	 Garrett,	 2009,	 Damodaram	 et	al.,	2009,	Read	et	al.,	2000).	The	effect	of	 these	compounds	on	neuron-to-neuron	gap-junctional	communication	 is	unknown	and	 is	of	significant	 interest	given	the	therapeutic	 potential	 of	 this	 compound	 family.	 Data	 may	 provide	 a	 definitive	explanation	of	the	mechanism(s)	of	anticonvulsant	action.	The	 International	 Federation	 of	 Societies	 for	 Electroencephalographers	(IFSECN)	 define	 epileptiform	 activity	 as	 “Distinctive	 waves	 or	 complexes,	
distinguished	 from	 background	 activity,	 and	 resembling	 those	 recorded	 in	 a	
proportion	 of	 human	 subjects	 suffering	 from	 epileptic	 disorders”	 (IFESCN,	 1974).	This	 activity,	 measured	 in	 vivo	 using	 the	 electroencephalogram	 (EEG),	 can	 be	replicated	 in	 vitro	 using	 whole-cell	 patch	 clamp	 recording	 techniques,	 and	 is	observed	 as	 aberrant	 depolarizing	potentials,	 synchronized	 throughout	 neuronal	populations	 (Kantrowitz	 et	 al.,	 2005,	 Bikson	 et	 al.,	 2002,	 Carlen	 et	 al.,	 2000).	Electrotonic	 coupling	 of	 neuronal	 networks	 facilitates	 the	 generation	 of	synchronous	activity	in	in	vitro	models	of	hippocampal	and	cortical	seizure	(Perez	Velazquez	 and	 Carlen,	 2000).	 Gap-junction	 blockers	 such	 as	 quinine,	 reduce	epileptiform	 activity	 in	 vitro,	 cortical	 seizure	 in	 vivo,	 and	 protect	 against	 PTZ-induced	seizure	(Srinivas	et	al.,	2001,	Bikson	et	al.,	2002,	Gajda	et	al.,	2005,	Nassiri-Asl	 et	 al.,	 2009).	 Conversely,	 some	 studies	 have	 concluded	 that	 gap-junctions	 do	not	 contribute	 significantly	 to	 synchronized	epileptiform	activity:	 In	vitro	studies	of	brain	slices	obtained	from	Cx36	knockout	mice,	demonstrate	that	synchronous	epileptiform	 activity	 can	 generated	 in	 response	 to	 Mg2+-free	 aCSF	 (Voss	 et	 al.,	2014).	This	activity	can	be	decoupled	by	the	application	of	either	the	anaesthetic	
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etomidate	 or	 carbenoxolone.	 Glycyrrhizic	 acid,	 a	 compound	 similar	 to	carbenoxolone	that	does	not	affect	gap	 junctions,	does	not	decouple	epileptiform	activity	(Voss	et	al.,	2014).	These	results	suggest	that	non-Cx36	gap	junctions	may	synchronize	 epileptiform	 activity,	 or	 that	 the	 antiepileptic	 actions	 of	carbenoxolone	 are	 not	 at	 all	 mediated	 via	 gap-junction	 inhibition	 (Voss	 et	 al.,	2014).	 Muddying	 the	 waters	 further	 -	 in	 terms	 of	 the	 role	 of	 gap-junctions	 and	epilepsy	-	is	data	indicating	that	electrical	synapses	are	actually	protective	against	seizure.	 Quinine	 and	 carbenoxolone	 have	 been	 found	 to	 exert	 a	 proconvulsive	effect	in	rat	cortical	slices,	increasing	both	the	frequency	and	amplitude	of	seizure-like	 events	 (Voss	 et	 al.,	 2009).	 Moreover	 Cx36	 knockout	 mice	 have	 a	 lower	threshold	 for	 PTZ-induced	 generalized	 tonic-clonic	 seizures,	 compared	 to	 wild-type	controls	(Jacobson	et	al.,	2010).	
	In	 vitro	 experimental	 models	 of	 epileptiform	 activity	 aim	 to	 closely	resemble	 the	 neuronal	 activity	 underlying	 epileptic	 phenomena.	 As	 such	 they	generally	concentrate	on	pathophysiological	neuronal	activity	within	hippocampal	and	cortical	networks;	two	neuroanatomical	structures	affected	by	epilepsy	in	vivo.	The	 rodent	 prefrontal	 cortex	 (PFC)	 consists	 of	 six	 layers.	 Layer	 1	 is	 the	 most	superficial,	and	contains	the	apical	dendrites	of	pyramidal	neurons	originating	 in	deeper	 cortical	 layers.	 The	 few	 cell	 bodies	 that	 exist	 in	 layer	 1	 include	neurogliaform	 interneurons	 that	 extend	 inhibitory	 projections	 to	 deeper	pyramidal	neurons	 (Puig	and	Gulledge,	2011).	Layers	2	and	3	 contain	pyramidal	neurons,	 fast	 spiking	 and	 non-fast	 spiking	 interneurons.	 Layers	 5	 and	 6	 contain	pyramidal	 neurons	 with	 large	 somata,	 relative	 to	 those	 originating	 in	 more	superficial	 layers.	 Also	 in	 layers	 5	 and	 6	 are	 several	 interneuron	 subtypes,	including	fast	spiking	and	non-fast	spiking	interneurons	(Puig	and	Gulledge,	2011).	
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The	prefrontal	cortex	is	innervated	by	serotonergic	fibers	originating	in	the	dorsal	and	median	raphe	(O'Hearn	and	Molliver,	1984,	Puig	and	Gulledge,	2011).	Fourteen	5-HT	receptor	subtypes	have	been	identified	(5-HT1A	through	5-HT7).	All	but	 one	 of	 the	 5-HT	 receptor	 subtypes	 are	 G-protein	 coupled	 receptors,	 the	exception	is	the	5-HT3	receptor	which	is	a	ligand-gated	ion	channel	(Derkach	et	al.,	1989).	Cortical	pyramidal	neurons	express	5-HT1A	and	5-HT2A	receptors	(Martin-Ruiz	et	al.,	2001,	Puig	et	al.,	2003,	Pompeiano	et	al.,	1992).	Unpublished	data	from	the	Spanswick	laboratory	also	indicates	the	expression	of	5HT2B,	5HT2C	and	5HT7	receptors	 on	 rat	 layer	 5	 pyramidal	 neurons,	 all	 of	 which	 contribute	 to	 the	excitatory	 effects	 of	 5-HT	 on	 prefrontal	 pyramidal	 neurons	 (unpublished	 data).	Cortical	 interneurons	 express	 5-HT1A,	 5-HT2A	 and	 5-HT3	 receptors	 (Puig	 and	Gulledge,	2011).	 In	cortical	 interneurons,	5-HT3	receptors	are	 found	coexpressed	with	 cholecystokinin	 (CCK)	 and	 calretinin	 (CR)	 but	 not	 parvalbumin	 (PV)	 or	somatostatin	 (SOM),	 and	 are	 preferentially	 expressed	 in	 layers	 2,	 3,	 5	 and	 6	(Morales	and	Bloom,	1997).	 In	cortical	CCK	and	CR	neurons,	 the	 inward	currents	gated	 by	 5-HT3	 receptors	 elicit	 rapid	membrane	 depolarization,	 and	 in	 doing	 so	modulate	GABAergic	output	and	the	activity	of	efferent	cortical	neurons	(Ferezou	et	al.,	2002).	5-HT3	receptors	are	widely	expressed	throughout	the	CNS	and	in	the	periphery	(Thompson	and	Lummis,	2007).	In	the	CNS,	in	addition	to	the	cortex,	5-HT3	 receptors	are	 found	 in	 the	hippocampus,	 entorhinal	 cortex,	 cingulate	 cortex,	amygdala,	 nucleus	 accumbens,	 substantia	 nigra	 ventral	 tegmental	 area	 and	hypothalamus	 (Thompson	 and	 Lummis,	 2007).	 5-HT3	 receptor	 antagonism	 has	been	proposed	as	a	potential	therapeutic	strategy	for	the	treatment	of	a	number	of	neurological	 diseases	 including	 anxiety,	 schizophrenia	 and	 bipolar	 disorder	(Niesler	et	al.,	2001,	Kelley	et	al.,	2003,	Thompson	and	Lummis,	2007).		
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In	the	cortex,	Cx36-dependent	electrotonic	coupling	is	ostensibly	exclusive	to	 interneuron	 networks	 (Galarreta	 and	 Hestrin,	 2002,	 Galarreta	 and	 Hestrin,	1999,	Lee	et	al.,	2014).	Layer	1	(L1)	of	 the	rat	somatosensory	cortex	contains	no	principal	 neurons.	 Here	 20%	 of	 GABAergic	 neurons	 contain	 CR/VIP/CCK/ChAT	whilst	 the	 remaining	neurons	are	positive	 for	α-actinin2	 (Ma	et	al.,	2011).	 In	L1,	49%	of	Cx36	positive	neurons	are	positive	for	α-actinin2,	whilst	in	L2	and	L3,	13%	of	Cx36	positive	neurons	are	α-actinin2	positive	(Ma	et	al.,	2011).	In	addition	to	α-actinin2	cell	bodies,	L1	contains	the	dendritic	arbors	of	principal	cells	originating	in	deeper	cortical	layers,	it	does	not	contain	pyramidal	cell	somata	(Vogt,	1991).		L1	 receives	 glutamatergic,	 GABAergic,	 noradrenergic	 and	 serotonergic	innervation	 (Llinas	 et	 al.,	 2002).	 Axons	 terminating	 in	 L1	 include	 thalamic	afferents	and	cortical	afferents	originating	in	L2	to	L6.	As	such,	L1	is	thought	of	as	a	site	of	cortical	and	thalamic	signal	 integration	(Llinas	et	al.,	2002,	Vogt,	1991).	 In	L1,	 networks	 of	 electrotonically	 coupled	 late	 spiking	 (LS)	 interneurons	 receive	glutamatergic	 innervation	 from	 L2	 and	 L3	 pyramidal	 neurons	 and	 have	 efferent	GABAergic	 connections	 with	 other	 GABAergic	 neurons	 of	 L1.	 In	 L1	 83%	 of	electrotonic	 coupling	 is	 between	 LS	 neurons	 (Chu	 et	 al.,	 2003).	 Electrical	stimulation	 of	 L1	 can	 evoke	EPSPs	 in	 L5	 pyramidal	 neuron	 apical	 dendrites	 and	evoke	 action	 potentials	 at	 the	 soma	 of	 L5	 principle	 neurons	 (Larkum	 and	 Zhu,	2002,	 Helmchen	 et	 al.,	 1999).	 A	 thorough	 functional	 characterization	 of	electronically	 coupled	 networks	 in	 L1	 of	 the	 cortex	 is	 yet	 to	 be	 completed.	However,	electrical	synapse-dependent	network	synchronization	may	be	critical	to	the	maintenance	GABAergic	tone	to	layer	5	pyramidal	cells.		The	 aims	 of	 this	 study	 were	 to	 characterize	 the	 electrophysiological	properties	of	electrotonically	coupled	interneurons	of	L1	of	the	cortex.	Investigate	
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the	effect	of	serotonin	(5-HT)	on	the	membrane	excitability	of	these	neurons	and	determine	the	utility	of	carbenoxolone,	tonabersat	and	carabersat	as	neuronal	gap	junction	modulators.	
	
8.2		 Results	Whole	cell	patch	clamp	recordings	were	obtained	from	25	pairs	of	electrotonically	coupled	interneurons	in	L1	of	the	adult	mouse	(>	6	weeks)	PFC.	These	neurons	had	a	mean	resting	membrane	potential	and	neuronal	input	resistance	of	-63.98	±	0.98	mV	 and	 570	 ±	 60	MΩ	 respectively.	 Of	 the	 50	 L1	 interneurons	 recorded,	 8	were	classified	as	fast	spiking	(FS),	and	42	were	classified	as	non-fast	spiking	(NFS).	FS	interneurons	 were	 defined	 by	 their	 ability	 to	 discharge	 rapidly	 at	 frequencies	between	 12	 and	 29	 Hz	 in	 response	 to	 a	 depolarizing	 current	 step,	 with	 little	obvious	spike	frequency	accommodation.	NFS	interneurons	were	characterized	by	slower	 frequencies	 of	 firing	 in	 response	 to	 depolarizing	 current	 injection,	 and	marked	 spike	 frequency	 accommodation.	 Simultaneous	 paired	 recordings	 were	obtained	from	>60	pairs	of	L1	interneurons.	Of	these,	direct	electrotonic	coupling	was	detected	between	25	pairs	and	the	latter	were	experimented	upon.		
8.2.1	 	Biophysical	properties	of	L1	electrical	synapses	A	pair	 of	 cells	were	 defined	 as	 electrotonically	 coupled	 by	 the	 demonstration	 of	direct	 current	 transfer	 between	 cells	 following	 injection	 of	 rectangular-wave	current	pulses	from	one	of	a	pair	(figure	8.2).	 	From	these	paired	recordings	and	injected	current	steps	quantification	of	membrane	properties	allowed	estimates	of	junctional	conductance	(gj),	using	a	model	in	which	each	neuron	was	represented	by	a	single	compartment	 joined	by	a	resistor	representing	the	electrical	synapse:	
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g12	=	R1k12	/	((R1R2)	(R1k12))	(see	Nolan	et	al.,	1999;	Logan	et	al.,	1996)	where	R1	 and	R2	 are	 input	 resistances	 of	 pre-	 and	postsynaptic	 cells,	 respectively,	 and	k12	 is	 the	 coupling	 coefficient.	 Using	 this	 approach,	 electrotonically	 coupled	interneurons	 originating	 in	 L1	 of	 the	 PFC	 recorded	 here	 had	 a	 mean	 coupling	coefficient	(cc)	of	0.07	±	0.01,	and	junctional	conductance	of	0.16	±0.01	nS	(n=25)	(figure	 8.5).	 In	 the	 majority	 of	 electrotonically	 coupled	 pairs	 recorded	 here	coupling	was	bidirectional	and	symmetrical	in	that	current	passed	equally	well	in	either	 direction	 (See	 table	 8.1).	 Any	 ostensible	 asymmetric	 junction	 rectification	can	 be	 explained	 as	 a	 product	 of	 unequal	 neuronal	 input	 resistance.	 Figure	 8.5C	demonstrates	 the	 negative	 correlation	 of	 junction	 symmetry	 to	 input	 resistance	asymmetry.	
	
8.2.2		 Interneuron	subtype	Of	 the	 25	 pairs	 of	 electrotonically	 coupled	 neurons	 discussed	 here,	 electrotonic	coupling	 between	 L1	 interneurons	was	 predominantly	 between	 non	 fast	 spiking	(NFS)	 interneurons	 (80%,	 n=20	 pairs),	with	 12%	of	 coupling	 observed	 between	two	fast	spiking	(FS)	neurons	(n=3	pairs)	and	8%	between	one	FS	neuron	and	one	NFS	neuron	(n=2	pairs)	(figure	8.5B).	
	
8.2.3		 Electrical	synaptic	transmission	and	low	pass	filters	Action	 potentials	 in	 one	 neuron,	 discharged	 in	 response	 to	 depolarizing	 current	injection,	evoked	simultaneous	oscillations	(spikelets)	in	the	neighboring	coupled	cell.	 These,	 'spikelets'	 or	 electrical	 postsynaptic	 potentials	 constituted	 low-pass	filtered	action	potentials	from	the	presynaptic	neuron,	the	rapid	spike	component	of	 the	 action	 potential	 being	 more	 markedly	 filtered	 than	 the	 subsequent	
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inhibitory	 afterhyperpolarisation	 (AHP).	 	 Thus,	 electrical	 postsynaptic	 potentials	were	 biphasic,	 with	 rapid	 depolarizing	 transients	 (electrical	 excitatory	postsynaptic	potentials	(eEPSPs))	 followed	by	electrical	 inhibitory	PSPs	(eIPSPs).		Examples	of	the	low	pass	filtering	properties	conferred	unto	FS	and	NFS	neurons	by	 gap-junctions	 are	 shown	 in	 figure	 8.3.	 Mean	 presynaptic	 action	 potential	 to	postsynaptic	spikelet	time-lag	was	2.04	±	0.20	ms	(n=12).		
	
8.2.4		 Dual	electrical	and	chemical	synaptic	transmission	in	L1	PFC	
interneurons	Electrical	 synaptic	 transmission	 was	 demonstrated	 by	 positive	 current	 injection	into	the	presynaptic	neuron	and	evoked	membrane	depolarization	and	discharge	of	a	train	of	action	potentials	in	the	presynaptic	neuron.	Simultaneous	membrane	depolarization	 was	 also	 observed	 in	 the	 postsynaptic	 neuron,	 with	 biphasic	membrane	 potential	 oscillations	 or	 ‘spikelets’	 observed	 in	 the	 postsynaptic	neuron.	 	 In	 4	 of	 25	 pairs,	 chemical	 postsynaptic	 currents	 were	 also	 observed	evoked	 in	 response	 to	presynaptic	 action	potential	 firing.	These	 electrotonically-coupled	 cells	were	 connected	 unidirectionally	with	 IPSPs	 only	 evoked	 by	 action	potential	firing	in	one	of	the	pair,	which	in	all	 instances	was	a	NFS	neuron	(n=4).		Inhibitory	postsynaptic	currents	(IPSCs)	and	potentials	(IPSPs)	were	observed	 in	response	 to	 depolarisation	 and	 action	 potential	 discharge	 in	 the	 presynaptic	neurone.		Chemical	IPSPs	and	IPSCs	manifest	with	a	simple	monophasic	waveform	characterised	by	a	relatively	rapid	rising	phase	followed	by	a	slower	decay,	unlike	their	 electrical	 counterparts.	 Bath	 application	 of	 the	 GABAA	 receptor	 antagonist	bicuculine	 (10-20mM)	blocked	 IPSPs	and	 IPSCs	 in	 all	neurones	 tested	 (n=2)	and	
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was	 without	 effect	 on	 the	 electrical	 postsynaptic	 currents,	 confirming	 dual	chemical	and	electrical	innervation	of	these	neurons	(figure	8.7).		
8.2.5		 Carbenoxolone	blocks	gap	junctions		The	 effects	 of	 the	putative	 gap	 junction	 and	hemichannel	 blocker	 carbenoxolone	were	 tested	 on	 electrotonic	 coupling	 between	 L1	 interneurons.	 Carbenoxolone	(100	 μM)	 suppressed	 electrotonic	 coupling	 between	 all	 cells	 tested	 (n=5	 pairs).	Carbenoxolone	 induced	 a	 mean	 peak	 reduction	 in	 neuronal	 coupling	 coefficient	from	0.11	±	0.04	 to	0.03	±	0.01	 (p=0.055)	 (Figure	8.6A).	 Junctional	 conductance	was	 reduced	 from	 a	 control	 value	 of	 0.23	 ±	 0.06	 nS	 to	 a	 peak	 of	 0.11	 ±	 0.02	(p=0.021)	 in	 the	presence	of	carbenoxolone	(Figure	8.6B).	However	 this	effect	of	carbenoxolone	was	associated	with	a	reduction	in	neuronal	input	resistance,	from	control	 levels	 of	 494	 ±	 67	 MΩ	 to	 a	 peak	 of	 260	 ±	 21	 MΩ	 in	 the	 presence	 of	carbenoxolone	 (p=0.008)	 (figures	 8.8	 and	 8.9)	 (n=10).	 This	 change	 in	 neuronal	input	 resistance	was	not	 consistent	with	 a	 block	 of	 ion	 channels,	 despite	 a	 clear	reduction	in	electrotonic	coupling.	Plots	of	current-voltage	relations	in	the	absence	and	 presence	 of	 carbenoxolone	 revealed	 a	 reversal	 potential	 around	 -60	 mV	(Figure	8.8C).	Taken	together	these	data	indicate	that	the	effects	of	carbenoxolone	on	these	neurons	is	in	part	a	product	of	gap-junction	blockade,	but	also	a	product	of	the	activation	of	a	chloride	conductance.	The	mean	peak	reduction	in	cc	and	JC	was	observed	around	16	minutes	after	 the	onset	of	application	of	carbenoxolone	(Figures	8.9A	and	8.9B),	whereas	the	mean	peak	reduction	in	input	resistance	was	observed	24	minutes	after	the	onset	of	bath	application	of	carbenoxolone	(Figure	8.9C).	Taken	 together,	 these	differences	 in	 the	 temporal	effects	of	 carbenoxolone	suggest	that	this	compound	targets	independent	signalling	pathways.	
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8.2.6		 Novel	gap	junction	blockers:	Effects	on	electrical	synaptic	
transmission	Carabersat	and	Tonabersat,	anticonvulsant	and	anti-migraine	agents,	respectively,	have	been	suggested	as	putative	gap-junction/	hemichannel	blockers	(Damodaram	et	al.,	2009,	Durham	and	Garrett,	2009).	Thus	we	investigated	the	effects	of	these	agents	 on	 electrotonically	 coupled	 PFC	 L1	 interneurons.	 Bath	 application	 of	Tonabersat	 (10	 μM)	 induced	 a	 mean	 peak	 reduction	 in	 neuronal	 coupling	coefficient	 from	 a	 control	 value	 of	 0.08	 ±	 0.02	 to	 0.07	 ±	 0.02	 (n=8	 pairs).	Subsequent	application	of	carabersat	further	reduced	cc	to	0.05	±	0.01	(n=8	pairs)	(Figures	8.12	and	8.13).	This	slight	reduction	in	coupling	coefficient	by	Tonabersat	corresponded	with	a	mean	peak	reduction	in	 junctional	conductance	from	0.26	±	0.05	 nS	 to	 0.22	 ±	 0.05	 nS	 (p=0.03)	 (n=8	 pairs).	 Subsequent	 application	 of	carabersat	further	reduced	the	junctional	conductance	to	0.17	±	0.04	(p=0.02	(vs.	control))	(Figures	8.12	and	8.13).	These	effects	of	Tonabersat	were	associated	with	a	mean	peak	increase	in	neuronal	input	resistance	from	392	±	40	MΩ	to	409	±	46	MΩ.	However,	subsequent	application	of	carabersat	reduced	mean	input	resistance	to	370	±	28.81	(n=12)	(Figures	8.12	and	8.13).			
8.2.7		 5-HT-induced	depolarization	of	fast	spiking	layer	2	interneurons	Bath	 application	 of	 5-HT	 (50	 μM)	 induced	 membrane	 depolarization	 in	 all	 FS	neurons	tested	(n=6).	5-HT-induced	depolarization	had	a	mean	peak	amplitude	of	6.7	±	1.8	mV,	from	a	mean	resting	potential	of	−48.7	±	1.4	mV	to	a	new	steady-state	membrane	potential	of	−42.0	±	1.9	mV	(p=0.014)	(n=6)	(figures	8.14	and	8.15).	5-HT-induced	 excitation	was	 associated	with	 an	 increase	 in	 action	 potential	 firing	
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rate	from	a	mean	control	level	of	0.02	±	0.01	Hz	to	1.54	±	0.90	Hz	in	the	presence	of	5-HT	(p=0.14)	 (Figures	8.14	and	8.15).	Voltage-current	relations,	generated	 in	response	to	a	range	of	depolarizing	and	hyperpolarizing	rectangular-wave	current	pulses	 (−250	 to	+100	pA,	 1,000	ms	 duration)	 revealed	 that	 5-HT-induced	excitation	was	principally	associated	with	a	trend	for	a	decrease	in	neuronal	input	resistance	from	a	mean	control	value	of	384	±	43	MΩ	to	a	peak	of	365	±	29	MΩ	in	the	presence	of	5-HT	(p=0.52)	(Figures	8.14	and	8.15).	Plots	of	the	voltage-current	relations	revealed	reversal	potentials	 for	5-HT-induced	excitation	around	-50	mV	(n=3)	 (figure	 8.13D),	 -90	 mV	 (n=2)	 and	 in	 one	 instance,	 5-HT-induced	 FS	interneuron	excitation	was	not	associated	with	any	clear	conductance	change.	 In	the	 case	 of	 excitations	 associated	 with	 a	 reversal	 potential	 of	 -90	 mV,	 input	resistance	 actually	 increased,	 from	 a	 control	 value	 of	 233	MΩ	 to	 287	MΩ	 at	 the	peak	of	excitation.	Taken	together,	these	data	suggest	that	5-HT-induced	excitation	is	mediated	via	either	the	activation	of	a	non-selective	cation	conductance	and	in	some	cells	the	inhibition	of	a	potassium	conductance.		
8.3		 Discussion	Data	presented	here	demonstrate	for	the	first	time	electrical	synaptic	transmission	between	 L1	 interneurons	 of	 the	 PFC.	 Furthermore	 these	 interneurons	 not	 only	communicate	 via	 direct	 electrical	 synaptic	 transmission,	 but	 also	 chemically,	utilizing	 GABA	 as	 a	 neurotransmitter.	 	 Thus,	 interneurons	 in	 L1	 of	 PFC	 show	similar	properties	to	those	described	for	layer	1	neurons	in	the	neocortex	(Chu	et	al.,	2003)	and	other	layers	in	various	regions	of	the	cortex	(Galarreta	and	Hestrin,	2002,	Simon	et	al.,	2005,	Tamas	et	al.,	2000).		
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8.3.1		 Biophysical	properties	of	L1	electrical	synapses	Electrotonic	coupling	between	L1	interneurons	in	the	PFC	was	demonstrated	in	25	pairs	 of	 cells.	 	 Coupling	 for	 the	main	 part	was	 bidirectional	 and	 symmetrical	 i.e.	current	 passed	 equally	 well	 in	 either	 direction	 regardless	 of	 which	 cell	 was	designated	pre-	or	post-synaptic.	Any	ostensible	rectification	could	be	explained	as	a	 result	of	differences	 in	neuronal	 input	 resistance	on	either	 side	of	 the	 junction	rather	than	a	rectifying	property	of	the	junction	itself.		The	mean	coupling	coefficient	of	electrotonically-coupled	neurons	recorded	here	was	0.07	±	0.01.	This	 is	 compared	 to	 a	 value	of	 0.09	±	0.06	observed	 in	α-actinin-positive	neurogliaform	neurons	of	the	rat	hippocampus	(Price	et	al.,	2005).		The	mean	 junctional	conductance	of	coupled	neurons	observed	 in	this	study	was	0.16	 ±0.01	 nS.	 This	 is	 somewhat	 weaker	 than	 coupling	 reported	 between	 other	rodent	 cortical	 interneuron	 populations.	 Of	 layer	 2/3	 basket	 cells	 of	 the	 rat	somatosensory	cortex,	mean	junctional	conductance	is	0.334	±	0.086	nS	(Tamas	et	al.,	2000),	whilst	murine	L5,	PV-positive	FS	interneurons	exhibit	a	mean	junctional	conductance	of	0.203	±	0.044	nS	(Galarreta	and	Hestrin,	2002).	The	mean	junctional	conductance	observed	here	was	0.16	±	0.01	nS.	If	one	assumes	 the	coupling	described	here	 is	mediated	via	Cx36	and	 the	mean	unitary	conductance	of	Cx36-based	gap	junctions	to	be	15	pS	(Harris,	2001),	and	assumes	that	under	 control	 conditions,	 gap	 junctions	 connecting	 layer	1	 interneurons	are	fully	 open,	 one	 can	 estimate	 that	 around	 10.66	 Cx36-based	 channels	 are	responsible	for	the	electrotonic	coupling	observed	here.	Conversely	if	the	number	of	connexin	channels	interconnecting	neurons	described	here	is	comparable	to	the	number	 between	 cortical	 PV-positive	 interneurons	 (150	 –	 380)	 (Fukuda	 and	Kosaka,	 2003),	 then	only	2.81%	 to	7.11%	of	 channels	 are	open	 at	 any	one	 time,	
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and	 this	 minority	 of	 open	 channels	 is	 responsible	 for	 the	 electrotonic	 coupling	observed.	An	ultrastructural	study	of	the	gap	junction	plaques	in	these	neurons	is	required	to	fully	address	this	issue.	
	
8.3.2		 Low-pass	filtering	by	gap	junctions	Of	neurons	recorded	in	layer	1,	electrotonic	coupling	was	most	commonly	detected	between	 non-fast	 spiking	 interneurons	 (80%),	 whilst	 coupling	 between	 fast	spiking	 interneurons	 was	 observed	 in	 12%	 of	 pairs	 recorded	 and	 coupling	between	fast	spiking	and	non-fast	spiking	interneurons	was	observed	between	8%	of	 cortical	 pairs.	 Previous	 studies	 have	 reported	 an	 absence	 of	 fast	 spiking	interneurons	 in	 layer	 1	 of	 the	 cortex	 (Puig	 et	 al.,	 2010)	 and	 coupling	 in	 the	neocortex	 layer	 1	 has	 previously	 been	 suggested	 mediated	 via	 late	 spiking	interneurons	(Chu	et	al.,	2003).	The	report	of	their	existence	in	 layer	1	here	may	simply	 be	 the	 result	 of	 a	 lack	 of	 a	 definitive	 anatomical	 boundary	 between	 the	superficial	edge	of	layer	two,	and	the	deep	border	of	layer	1.		Synchronized	discharge	of	action	potentials	in	fast	spiking	coupled	neurons	was	not	observed	in	these	experiments.	The	filtering	properties	of	the	gap	junction	truncated	 the	 action	 potentials	 of	 fast	 spiking	 interneurons	 to	 a	 greater	 degree	than	that	of	slow	spiking	interneurons,	reflecting	the	low-pass	filtering	properties	of	these	connections.	Synchronous	action	potential	firing	was	not	observed	under	control	 conditions	 in	 data	 presented	 here,	 I	 attribute	 this	 to	 action	 potential	waveform	rather	than	conductance	limitations	of	electrical	synapses.	Synchronous	firing	was	observed	 in	 a	pair	 of	 coupled	 interneurons	when	patch	pipettes	were	‘loaded’	 with	 cesium	 chloride	 (Figure	 8.4).	 CsCl	 has	 the	 effect	 of	 inhibiting	membrane	 potassium	 channels,	 broadening	 the	 action	 potential	 repolarization	
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phase.	Synchronous	firing	of	gap	junction	coupled	neurons	is	apparent	in	neurons	with	 broad,	 slow,	 relatively	 long	 duration	 action	 potentials	 such	 as	 sympathetic	preganglionic	neurons,	the	action	potentials	of	which	have	a	characteristic	calcium	shoulder,	making	them	ideal	for	transmission	across	an	electrical	synapse	(Nolan	et	al.,	1999).	The	function	of	neuronal	gap	junctions	between	cortical	interneurons	is	 yet	 to	 be	 determined,	 however	 unless	 yet-unknown	 endogenous	 factors	manipulate	 gap	 junction	open	 state	or	 action	potential	waveform,	 it	would	 seem	unlikely	that	their	primary	function	is	to	synchronize	discharge	of	individual	action	potentials	 in	 these	 neurons.	 However,	 in	 the	 event	 that	 rhythmic	 patterns	 of	activity,	 as	 seen	 in	 epileptiform-like	 patterns	 of	 activity,	 where	 bursts	 of	 action	potentials	 superimpose	 on	 slow	 depolarizing	 shifts,	 the	 coupling	 described	 here	would	and	indeed	does	contribute	to	synchronization	of	bursts	of	activity.				
8.3.3		 Electrical	and	chemical	synaptic	transmission	Electrotonically	 coupled	 NFS	 interneurons	 reported	 here	 have	 similar	electrophysiological	 characteristics	 to	 coupled	 α-actinin2-positive	 neurogliaform	neurons	of	the	hippocampal	CA1	area	(Price	et	al.,	2005)	and	layer	1	interneurons	reported	in	neocortex	of	rat	(Chu	et	al.,	2003).	In	the	study	by	Price	et	al.,	85%	of	neurons	 were	 electrotonically	 coupled	 and	 70%	 were	 connected	 by	 GABAergic	synapses.	 Similar	 recordings	 in	 the	 present	 study	 revealed	 chemical	 GABA-mediated	 synaptic	 interactions	 between	 electrotonically-coupled	 interneurons.	 It	must	 be	 noted	 that	 ostensible	 chemical	 transmission	 observed	 here	 did	 have	 a	remarkably	 high	 failure	 rate	 and	 as	 such	 data	 presented	 here	 (Figure	 8.7)	 is	 of	limited	value.	At	present	the	numbers	included	in	the	present	study	are	insufficient	to	 draw	 definitive	 conclusions	 regarding	 the	 extent	 of	 chemical	 interactions	
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between	 these	 electrically	 coupled	 cells	 and	 to	 relate	 circuit	 structure	 and	organization	 to	 function.	 More	 recordings	 from	 layer	 1	 pairs	 are	 needed	 to	determine	 fully	 the	 role	 of	 dual	 electrical	 and	 chemical	 communication	 between	these	 cells,	 although	 it	 is	 tempting	 to	 hypothesize	 that	 one	 function	 may	 be	 to	modulate	 the	 synchronization	 and	 timing	of	GABA	output	 commands	 from	 these	interneurons,	 in	 order	 to	 affect	 target	 pyramidal	 neuron	 output.	 	 Strength	 of	electrotonic	coupling	here	could	be	an	important	determinant	of	GABAergic	output	drive	and	could	constitute	an	important	form	of	synaptic	plasticity	regulating	this	output.	Although	 the	 filtering	 properties	 of	 electrical	 synapses	 ostensibly	 did	 not	drive	the	generation	of	synchronized	action	potential	discharge	in	these	neurons,	it	is	likely	that	they	would	increase	the	probability	of	synchronizing	activity	in	the	in	
vivo	situation.	 	Alternatively,	perhaps	gap	junctional	coupling	here	is	more	suited	to	 the	 electrotonic	 dissemination	 of	 slower	 events,	 such	 as	 GABAergic	 or	 other	chemical	 inputs.	 If	 this	 is	 indeed	 a	 function	 of	 coupling	 between	 cortical	interneurons,	 it	provides	a	mechanism	by	which	the	activity	and	input	resistance	of	 coupled	 networks	 could	 be	 modulated	 in	 vivo,	 affecting	 efferent	 pyramidal	function	and	cortical	output.	
	
8.3.4		 Fast	spiking	layer	2	interneurons	are	depolarized	by	5-HT	Here	I	show	that	5-HT	rapidly	and	reversible	depolarizes	fast	spiking	interneurons	of	 layer	 2	 of	 the	 prefrontal	 cortex.	 In	 experiments	 described	 here,	 membrane	depolarization	was	associated	with	either	a	reduction	of	neuronal	input	resistance	and	 reversal	 potential	 around	 -30	 mV,	 or	 an	 increase	 in	 input	 resistance	 and	reversal	potential	around	-90	mV.	The	former	is	consistent	with	the	activation	of	a	
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non-selective	cation	conductance,	whilst	the	latter	is	consistent	with	the	inhibition	of	 a	 potassium	 conductance.	 With	 the	 exception	 of	 5-HT3	 receptors,	 all	 5-HT	receptors	are	coupled	to	G-proteins.	Previous	studies	have	found	5-HT3	receptors	to	 be	 restricted	 to	 non-fast	 spiking	 interneurons,	 whist	 the	 excitation	 of	 fast	spiking	 interneurons	 by	 5-HT	 was	 mediated	 by	 5-HT2A	 receptors	 (Puig	 et	 al.,	2010).	 Further	 work	 is	 required	 to	 clarify	 the	 specific	 receptors	 mediating	 the	effects	of	5-HT,	as	described	in	the	present	study.		
8.3.5		 Rundown	of	coupling	following	patching	In	 the	 first	10	minutes	 following	 the	onset	of	dual	whole-cell	 recording,	a	steady	reduction	 in	 junctional	 conductance	 and	 coupling	 coefficient	was	 observed.	 This	may	be	reflect	dialysis	or	washout	of	cytoplasmic	 factors	that	affect	 the	gating	of	gap	junctions.	Washout	occurs	due	to	the	high	volume	of	pipette	solution	relative	to	neuronal	capacitance.	A	decrease	in	coupling	between	pairs	would	indicate	the	washout	of	a	positive	regulator	of	these	electrical	synapses,	or	the	introduction	of	a	negative	regulator	in	the	pipette	solution	itself.	Likely	mechanisms	for	this	change	in	gap	junction	properties	are	alterations	in	phosphorylation	state,	pH	or	calcium	binding	(Harris,	2001).		
8.3.6	 	Carbenoxolone	Here	 I	 show	 100μM	 carbenoxolone	 to	 significantly	 inhibit	 electrotonic	 coupling	between	 cortical	 interneurons,	 taking	 around	 16	 minutes	 to	 elicit	 peak	 gap	junction	block	(p=<0.05).	The	effect	and	time	course	of	carbenoxolone	gap	junction	block	 are	 consistent	 with	 previous	 reports	 (Verselis	 and	 Srinivas,	 2013).	 The	mechanism	 for	gap	 junction	block	by	carbenoxolone	has	not	been	confirmed	but	
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antagonism	through	connexin	dephosphorylation	has	been	suggested	(Guan	et	al.,	1996).	 Another	 suggested	 mechanism	 is	 via	 insertion	 into	 the	 membrane	 and	reduction	 in	 junctional	 conductance	 via	 connexin	 conformational	 change.	 This	 is	supported	by	observations	 that	other	 lipophilic	 compounds	 such	as	 testosterone	and	 estrogen	 also	 block	 gap	 junctions,	 however	 some	 steroids,	 such	 as	progesterone,	do	not	(Herve,	2002,	Bodendiek	and	Raman,	2010).	Many	 previous	 studies	 have	 demonstrated	 the	 generation	 of	 cortical	 and	hippocampal	epileptiform	activity	through	the	removal	of	Mg2+	from,	and	addition	of	 4-AP	 to	 aCSF	 (Lamsa	 and	 Kaila,	 1997,	 Ziburkus	 et	 al.,	 2006,	 Beaumont	 and	Maccaferri,	2011).	Previous	studies	have	shown	epileptiform	activity	to	rely	upon	depolarizing	 GABAergic	 transmission	 with	 gabazine	 application	 reducing	epileptiform	 activity	 (Kantrowitz	 et	 al.,	 2005,	 Zsiros	 et	 al.,	 2007).	 In	 these	experiments,	 bicuculine	 application	 did	 not	 have	 an	 inhibitory	 effect,	 instead	 it	increased	 event	 frequency.	 The	 synaptic	 pharmacology	 of	 induced	 cortical	epileptiform	 activity	 can	 be	 deconstructed	with	 the	 use	 of	 GABA	 and	 glutamate	receptor	 antagonists.	 Removing	 the	 GABAergic	 drive	 disinhibits	 the	 circuit,	increasing	the	frequency	of	epileptiform	events.	AMPA	receptor	blockade	inhibits	the	 network	 activity,	 reducing	 frequency	 of	 events	 whilst	 NMDA	 receptor	 block	eliminates	spontaneous	discharge	in	L1	neurons.		In	 the	 cortex	 electrical	 synapses	 would	 appear	 to	 exist	 predominantly	within	 interneuronal	 networks,	 although	 coupling	 between	 pyramidal	 cells	 has	been	reported	(Wang	et	al.,	2010).	Two	theses	could	be	put	forward	with	regards	to	 the	effect	of	 interneuronal	 coupling	on	epileptiform	activity:	 	 1.	 Interneuronal	gap	 junctions	 provide	 a	 conduit	 through	 which	 epileptiform	 activity	 can	 be	synchronized	 throughout	 vast	 neuronal	 networks,	 predisposing	 the	 network	 to	
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epileptigenesis.	2.	 Increased	synchronicity	of	GABAergic	neurons	coordinates	 the	inhibitory	 cortical	 drive,	 protecting	 against	 epileptiform	 activity.	 Results	 from	these	experiments	would	suggest	 that	blocking	gap	 junctions	does	 indeed	have	a	protective	 effect	 against	 cortical	 epileptiform	 activity.	 However	 due	 to	 the	 non-specific	nature	of	CBX,	I	cannot	be	sure	that	these	effects	are	due	to	those	on	gap	junctions	or	at	other	targets	within	the	network.		Here,	I	show	carbenoxolone	to	decouple	synchronous	epileptiform	activity	and	 block	 gap	 junctions.	 Whether	 antiepileptic	 effects	 observed	 are	 due	 to	 gap	junction	inhibition	or	via	the	gap	junction-independent	mechanisms	described	by	Beaumont	and	Maccaferri	is	unclear.	For	confirmation	either	way,	we	would	need	to	 perform	 control	 experiments	 on	 Cx36	 knockout	 mice	 (Beaumont	 and	Maccaferri,	2011).	 It	 is	clear	 from	my	experiments	that	carbenoxolone	 is	a	 ‘dirty’	pharmacological	tool.	In	addition	to	the	reduction	in	baseline	synaptic	noise	after	its	 application	and	elimination	of	 inward	 rectifying	 conductances	 (not	quantified	but	frequently	observed),	carbenoxolone	reliably	activated	chloride	conductances	in	these	experiments.		
8.3.7		 Tonabersat	and	Carabersat	Here	 I	 show	 both	 10	 μM	 Carabersat	 and	 of	 10	 μM	 Tonabersat	 are	 capable	 of	significantly	 inhibiting	 (p=<0.05)	 the	 conductance	 between	 L1	 cortical	interneurons,	 without	 significantly	 affecting	 input	 resistance.	 This	 is	 consistent	with	 the	 specific	 inhibition	 of	 gap	 junctional	 channels.	 These	 effects	 on	 L1	interneurons	 provide	 evidence	 that	 the	 anticonvulsant	 properties	 of	 these	benzoylamino-benzopyran	 compounds	 may	 be	 at	 least	 in	 part	 via	 gap	 junction	block,	 and	 not	 through	 actions	 at	 molecular	 sites	 targeted	 by	 other	 extant	antiepileptic	 compounds.	 This	 class	 of	 compound	may	 therefore	be	useful	 in	 the	
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treatment	of	medication-resistant	forms	of	epilepsy.	Conclusions	drawn	from	this	data	 set	 are	 nonetheless	 limited	 due	 to	 two	 caveats	 in	 particular.	 One;	 that	tonabersat	 and	 carabersat	were	 applied	 sequentially	without	 a	wash	period	 and	two;	 that	no	 time-control	 experiment	was	performed	 in	order	 to	account	 for	 the	rundown	of	electrotonic	coupling	observed	in	the	minutes	 immediately	following	the	onset	of	dual	whole-cell	recording.																																							
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Figure	8.1:	Basic	schematic	of	L1	interneuron	functional	organization	Subsets	of	L1	interneurons	express	Cx36	and	α-actinin	2.	L1	interneurons	release	GABA	 into	 other	 L1	 interneurons	 and	 onto	 distal	 dendritic	 tufts	 of	 pyramidal	neurons	originating	in	deep	cortical	layers.																																											
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Figure	8.2:	Electrotonic	coupling	between	layer	1	cortical	interneurons	
A:	An	example	of	electrotonic	coupling	between	two	non-fast	spiking	interneurons	in	 layer	 1	 of	 the	 prefrontal	 cortex.	 Left:	 injection	 of	 a	 range	 of	 hyperpolarizing	(downward)	 and	 depolarizing	 (upward)	 current	 pulses	 injected	 into	 one	 of	 a	simultaneously	 recorded	 pair	 of	 neurons	 evoked	 membrane	 responses	 in	 the	injected	 cell	 (top)	 and	 the	 simultaneously	 recorded	 cell	 (bottom).	 	 Right:	 The	injection	of	a	rectangular-wave	current	pulse	into	the	presynaptic	neuron,	evoked	a	 membrane	 potential	 change	 in	 both	 the	 presynaptic	 (top)	 and	 postsynaptic	(bottom)	neuron.	
B:	Differential	interference	contrast	(DIC)	photomicrograph	of	two	simultaneously	recorded	electrotonically	coupled	interneurons	of	layer	1	or	the	prefrontal	cortex,	taken	at	157.5-X	magnification.		
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Figure	8.3:	Layer	I	neuronal	electrical	synapses	act	as	low-pass	filters	
A:	 Electrotonically	 coupled	 non	 fast-spiking	 interneurons	 highlighting	 low	 pass	filtering	 of	 action	potentials	 across	 the	 gap	 junction.	Action	potentials	 evoked	 in	the	presynaptic	 neuron	 (black)	 are	detected	 in	 the	postsynaptic	 neuron	 (red)	 as	truncated	biphasic	membrane	potential	oscillations.	
B:	 Electrotonically	 coupled	 fast-spiking	 interneurons	 highlighting	 low	 pass	filtering	 of	 action	potentials	 across	 the	 gap	 junction.	Action	potentials	 evoked	 in	the	presynaptic	 neuron	 (black)	 are	detected	 in	 the	postsynaptic	 neuron	 (red)	 as	truncated	biphasic	membrane	potential	oscillations.		
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Figure	 8.4:	 Layer	 I	 interneuron-based	 electrical	 synapses	 act	 as	 low-pass	
filters;	 cesium	 chloride	 loading	 of	 cells	 facilitates	 synchronous	 action	
potential	firing		
A:	Current	clamp	recording	taken	from	an	electrotonically	coupled	pair	of	layer	1	interneurons,	with	CsCl	 included	 in	 the	patch	pipette	solution.	Note	synchronous	spontaneous	action	potential	firing	in	cell	1	(top)	and	cell	2	(bottom).	
B:	 Action	 potential	 and	membrane	 potential	 oscillation	 recorded	 from	 the	 same	neurons	 shown	 in	 A.	 Note	 the	 narrow	 waveform	 of	 ‘cell	 1’	 action	 potential	associated	with	asynchronous	discharge.	An	action	potential	is	not	evoked	in	‘cell	2’,	however	a	biphasic	membrane	potential	oscillation	is	observed.	
C:	Action	potential	and	membrane	potential	oscillation	of	the	neurons	shown	in	A.	Note	the	broad	waveform	of	 ‘cell	1’	action	potential	associated	with	synchronous	action	potential	discharge.			
	
	
	
	
	
	
	
	
	
	
	
Figure	8.4		
10	mV	
5	secon
ds	
Cell	1	 Cell	2	
A	
20	mV	
/	3	mV
	
10	ms	
Cell	1	
Cell	1	 Cell	2	
Cell	2	
B	
C	
	 266	
Figure	 8.5:	 Properties	 of	 electrical	 synaptic	 transmission	 between	
interneurons	of	layer	1	of	the	cortex	
Ai:	Bar	chart	showing	mean	coupling	coefficient	0.07	±	0.01	(n=25).	
Aii:	Bar	chart	showing	mean	junctional	conductance	0.16	±0.01	nS	(n=25).	
Aiii:	Bar	chart	showing	mean	neuronal	input	resistance	570	±	60	MΩ	(n=25).	
B:	 Electrotonic	 coupling	 is	 predominantly	 between	 non-fast	 spiking	 (NFS)	interneurons	(80%),	with	12%	of	coupling	observed	between	two	fast	spiking	(FS)	neurons	and	between	one	(8%)	FS	neuron	and	one	NFS	neuron	(total	n=25).	
C:	Graph	showing	normalized	Cell	2	 input	 resistance	against	Normalized	cell2	 to	cell	 1	 coupling	 coefficient,	 demonstrating	 the	 negative	 correlation	 between	 the	two.	 This	 graph	 highlights	 the	 directionality	 and	 symmetrical	 nature	 of	 layer	 1	based	 electrical	 synapses.	 Any	 ostensible	 channel	 rectification	 is	 a	 product	 of	differences	in	neuronal	input	resistance	on	either	side	of	the	junction.					
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Figure	 8.6:	 Summary	 of	 coupling	 coefficient	 and	 neuronal	 input	 resistance	
values	 for	 each	 electrotonically-coupled	 pair	 of	 cortical	 interneurons	
included	in	this	study	
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Figure	8.7:	Mixed	electrical	and	chemical	synaptic	transmission	
A:	Action	potentials	evoked	in	the	presynaptic	neuron	(top,	red)	were	detected	in	the	postsynaptic	neuron	(bottom,	red)	as	truncated	biphasic	membrane	potential	oscillations.	 The	 initial	 biphasic	 membrane	 oscillation	 is	 likely	 the	 result	 of	 a	combination	 of	 electrical	 synaptic	 transmission	 combined	 with	 chemical	GABAergic	 inhibitory	 synaptic	 transmission,	whereas	 subsequent	oscillations	are	mediated	by	electrical	synaptic	transmission	alone.	
B:	The	same	neuron	as	shown	in	A.	Presynaptic	neuron	(top)	recorded	in	current	clamp	 configuration,	 postsynaptic	 neuron	 (bottom)	 recorded	 in	 voltage-clamp	configuration,	 held	 at	 -50	 mV.	 Presynaptic	 action	 potentials	 can	 evoke	 an	inhibitory	postsynaptic	current	(IPSC)	in	the	postsynaptic	neuron.	
C:	The	same	neuron	as	shown	in	A	and	B.	Bath	application	of	the	GABAA	receptor	antagonist	bicuculine	(20µM),	inhibits	postsynaptic	IPSC’s,	induced	by	presynaptic	action	 potential	 firing.	 	 Note	 downward	 deflections	 shown	 in	 the	 bottom	 record	represent	spontaneous	EPSC’s.		
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Figure	 8.8:	 Carbenoxolone	 suppresses	 electrotonic	 coupling	 and	 induces	 a	
reduction	in	neuronal	input	resistance		
A:	A	pair	of	electrotonically	coupled	non-fast	spiking	interneurons	of	layer	1	of	the	cortex.	 Current	 injected	 into	 the	 presynaptic	 neuron	 (top)	 results	 in	 membrane	potential	change	in	both	the	presynaptic	and	the	postsynaptic	(bottom)	neurons.	
B:	 The	 same	 pair	 of	 electrotonically-coupled	 neurons	 as	 shown	 in	A,	 after	 bath	application	of	100μM	carbenoxolone.	Electrotonic	coupling	was	reduced,	shown	as	a	reduced	membrane	potential	change	in	the	postsynaptic	neuron,	in	response	to	current	injection	into	the	presynaptic	neuron.	
C:	Plot	of	current	voltage	relations	of	a	 layer	1	 interneuron	 in	control	conditions	and	 in	 the	 presence	 of	 100μM	 carbenoxolone.	 Note	 the	 decreased	 slope	 of	 the	membrane	 response	 to	 current	 injection	 in	 the	 presence	 of	 carbenoxolone,	indicating	a	decrease	of	neuronal	input	resistance.	Also	note	the	reversal	potential	around	 -70	 mV	 indicating	 the	 activation	 of	 a	 chloride	 conductance	 under	 our	recording	conditions.	
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Figure	 8.9:	 Carbenoxolone	 suppresses	 electrotonic	 coupling	 and	 induced	 a	
reduction	of	input	resistance	
A:	Carbenoxolone	reduces	the	neuronal	coupling	coefficient	(mean	peak	response	on	top	panel,	time	plot	on	bottom	panel),	from	a	mean	control	value	of	0.07	±	0.02	to	0.03	±	0.01	 in	 the	presence	of	100μM	carbenoxolone	 (n=10)	 (p=0.055;	paired	students	t-test).	
B:	 Carbenoxolone	 significantly	 reduces	 the	 neuronal	 junctional	 (mean	 peak	response	on	top	panel,	 time	plot	on	bottom	panel),	 from	a	mean	control	value	of	0.2	±	0.04	nS	 to	0.14	±	0.04	nS	 in	 the	presence	of	100μM	carbenoxolone	 (n=10)	(p=0.021;	paired	students	t-test).	
C:	Carbenoxolone	significantly	reduces	the	neuronal	 input	resistance	(mean	peak	response	on	top	panel,	 time	plot	on	bottom	panel),	 from	a	mean	control	value	of	383	 ±	 25	MΩ	 to	 239	 ±	 27	MΩ	 in	 the	 presence	 of	 100μM	 carbenoxolone	 (n=10)	(p=0.008;	Paired	students	t-test).	
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Figure	 8.10:	 Tonabersat	 and	 Carabersat	 inhibit	 electrotonic	 coupling	
between	cortical	interneurons	
A:	 Example	 of	 steady-state	 electrotonic	 coupling	 between	 a	 pair	 of	 layer	 1	interneurons.	With	 current	 transfer	 from	cell	 1	 to	 cell	 two	 (top	panel)	 and	 from	cell	two	to	cell	1	(bottom	panel).	
B:	 Electrotonic	 coupling	 between	 the	 same	 neurons	 shown	 in	 A,	 after	 bath	application	of	10μM	Tonabersat.	
C:	Electrotonic	coupling	between	the	same	neurons	shown	in	A	and	B,	after	bath	application	of	10μM	Carabersat.	
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Figure	 8.11:	 Tonabersat	 and	 Carabersat	 inhibit	 electrotonic	 coupling	
between	cortical	 interneurons.	 (Mean	peak	 inhibition;	 left	panel,	 time	plot;	
right	panel)	
Ai	 &	 Aii:	 Bath	 application	 of	 10	 μM	 Tonabersat	 reduced	 neuronal	 coupling	coefficient	 from	a	 control	 level	of	0.08	±	0.02	 to	a	peak	 inhibition	of	0.07	±	0.02	(p=0.402),	 subsequent	 bath	 application	 of	 10	 μM	 Carabersat	 further	 reduced	neuronal	 coupling	 coefficient	 to	 0.05	 ±	 0.01	 (p=0.080	 vs.	 control;	 n=16;	 Paired	students	t-test).	
Bi	 &	 Bii:	 Bath	 application	 of	 10	 μM	 tonabersat	 inhibits	 neuronal	 junctional	conductance	 from	 a	 mean	 control	 level	 of	 0.26	 ±	 0.05	 nS	 to	 0.22	 ±	 0.05	 nS	(p=0.032).	 Subsequent	 bath	 application	 of	 10	 μM	 Carabersat	 further	 reduced	junctional	 conductance	 to	 0.17	 ±	 0.04	 nS	 (p=0.022	 vs.	 control;	 n=16;	 Paired	students	t-test).	
Ci	&	Cii:	Bath	application	of	10	μM	Tonabersat	increased	neuronal	input	resistance	from	a	mean	control	 level	of	392	±	40	MΩ	 to	a	peak	of	409	±	46	MΩ	 (p=0.242).	Subsequent	application	of	10	μM	Carabersat	reduced	neuronal	input	resistance	to	370	±	28.81	(P=0.454;	n=16;	Paired	students	t-test).			
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Figure	8.12:	Layer	2	fast-spiking	interneurons	are	excited	by	5-HT	
A:	 Bath	 application	 of	 50	 μM	 5-HT	 induced	membrane	 excitation	 of	 layer	 2	 fast	spiking	interneurons.		
B:	 Superimposed	 current	 clamp	 recordings	 showing	 membrane	 current-voltage	relationship	of	a	fast	spiking	interneuron	before	5-HT	bath	application.	
C:	 Superimposed	 current	 clamp	 recordings	 showing	 membrane	 current-voltage	relationship	of	 the	 same	 fast	 spiking	 interneuron	 as	 shown	 in	B	 following	5-HT-induced	membrane	depolarization.	
D:	Plot	of	membrane	current-voltage	relationships	shown	in	figures	8.3B	and	8.3C.	Note	 the	 reduced	 slope	 of	 the	 membrane	 response	 to	 current	 injection	 in	 the	presence	of	5-HT	indicating	a	reduction	of	neuronal	input	resistance.	Also	note	the	reversal	potential	 around	 -30	mV.	Taken	 together	 these	data	are	 indicative	of	5-HT-induced	 activation	 of	 a	 non-selective	 cation	 conductance,	 consistent	 with	 5-HT3	receptor	activation.	
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Figure	8.13:	Layer	2	fast-spiking	interneurons	are	excited	by	5-HT	
A:	Bath	application	of	50	μM	5-HT	induced	a	mean	membrane	depolarization	of	6.7	±	 1.8	mV	 from	a	mean	 resting	potential	 of	 −48.7	±	1.4	mV	 to	 a	 new	 steady-state	membrane	potential	of	−42.0	±	1.9	mV	(p=0.014;	n=6;	Paired	students	t-test).	
B:	 Bath	 application	 of	 50	 μM	 5-HT	 increased	 action	 potential	 firing	 rate	 from	 a	mean	control	basal	level	of	0.02	±	0.01	Hz	to	1.54	±	0.90	Hz	in	the	presence	of	5-HT	(p=0.14;	n=6;	Paired	students	t-test).	
C:	 Fast	 spiking	 neuron	 excitation	 was	 associated	 with	 a	 reduction	 in	 the	 mean	neuronal	input	resistance	from	384	±	43	MΩ	in	control	conditions	to	365	±	29	MΩ	in	the	presence	of	5-HT	(p=0.522;	Paired	students	t-test).	
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Chapter	9:	General	Discussion		 	Multiple,	 distinct	 populations	 of	 hypothalamic	 neurons,	 defined	 in	 terms	 of	neuroanatomical	 location,	 chemical	 phenotype,	 molecular	 profile	 and	 efferent	target,	are	required	for	the	maintenance	of	normal	neurological	and	physiological	function.	 Work	 described	 here	 investigated	 the	 electrophysiological	 and	pharmacological	 profile	 of	 a	 number	 of	 hypothalamic	 neuronal	 populations,	yielding	 a	 deeper	 and	 broader	 understanding	 of	 their	 functional	 significance.	Hypothalamic	 neurons	 investigated	 here	 include	 neuropeptide-Y/agouti-related	peptide	 (NPY/AgRP)	 and	 proopiomelanocortin	 /	 cocaine	 and	 amphetamine-regulated	 transcript	 (POMC/CART)	 neurons	 of	 the	 arcuate	 nucleus	 of	 the	hypothalamus	 (ARH),	 leptin	 receptor	 (LepR)	 and	 gonadotropin	 inhibitory	hormone	 (GnIH)-expressing	 neurons	 of	 the	 dorsomedial	 hypothalamus	 (DMH).	Also	 explored	 in	 this	 thesis,	 are	 the	 electrophysiological	 characteristics	 of	electrotonically-coupled	 interneurons	 of	 the	 prefrontal	 cortex	 (PFC).	 This	 latter	work	 focused	 on	 neuron	 and	 network	 properties	 of	 coupled	 interneurons.	Additionally	 the	sensitivity	of	 these	neurons	 to	5-hydroxytryptamine	 (5-HT)	was	investigated,	as	were	the	effects	of	the	gap	junction	blocker	carbenoxolone	and	the	novel	 benzoylamino-benzopyran	 anticonvulsant	 compounds	 Tonabersat	 and	Carabersat.					
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9.1		 An	 electrophysiological	 characterization	 of	 NPY	 neurons	 of	 the	
hypothalmic	arcuate	nucleus	in	vitro	NPY/AgRP	neurons	of	the	ARH	are	known	to	have	an	important	physiological	role	in	the	regulation	of	food	intake,	body	weight	and	glucose	homeostasis	(Aponte	et	al.,	2011,	Hahn	et	al.,	1998,	Konner	et	al.,	2007,	Luquet	et	al.,	2005,	Muroya	et	al.,	1999,	 Takahashi	 and	 Cone,	 2005).	 These	 neurons	 are	 sensitive	 to	 a	 number	 of	metabolic	 signals	and	secretagogues,	 including	glucose,	 fatty	acids,	 insulin,	 leptin	and	ghrelin.	NPY/AgRP	neurons	compute	these	peripheral	physiological	signals,	in	addition	 to	 central	 afferent	 neurochemical	 signals,	 and	 generate	 functional	outputs,	 including	 driving	 food	 intake	 and	 influencing	 energy	 expenditure	(Belgardt	 et	 al.,	 2009,	 Hahn	 et	 al.,	 1998,	 Luquet	 et	 al.,	 2005,	 van	 den	 Top	 et	 al.,	2004,	Takahashi	and	Cone,	2005).	Neurosecretion	is	known	to	positively	correlate	with	 action	 potential	 firing	 frequency,	 the	 linearity	 of	 this	 relationship	 varying	between	neurons	and	depends	on	the	transmitter	or	peptide	in	question	(Brown	et	al.,	 2013).	 Within	 the	 in	 vivo	 context	 of	 the	 melanocortin	 system,	 low	 central	glucose	 and	 high	 central	 orexigen	 concentrations	 are	 known	 to	 elevate	 NPY	neuron	 firing	 rate,	 the	 output	 of	 which	 is	 NPY	 GABA	 and	 AgRP	 (Cowley	 et	 al.,	2001).	Ostensibly	GABA	primarily	functions	to	inhibit	POMC	neurons	whilst	AgRP	antagonizes	 MC4Rs	 at	 second	 order	 neurons.	 It	 is	 this	 neuronal	 output	 that	correlates	to	 functional	outputs	such	as	elevated	food	intake	and	reduced	energy	expenditure	 (Cone,	2005).	Here	multidisciplinary	 research	has	demonstrated	 the	physiological	effects	of	neuronal	firing	frequency	fluctuations.	This	study	represents	one	of	the	first	electrophysiological	characterizations	of	identified	NPY	neurons	in	positive	and	negative	energy	states.	Previous	studies	have	 used	 the	 ‘blind’	 whole-cell	 patch	 clamp	 technique	 to	 investigate	 the	 active	
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and	 passive	 electrophysiological	 properties	 of	 hypothalamic	 neurons,	 however	these	 studies	 have	 grouped	 neurons	 in	 terms	 of	 their	 neuroanatomical	 location	and/or	 voltage-sensitive	 conductance	 expression,	 rather	 that	 molecular	expression	 profile	 (Burdakov	 and	 Ashcroft,	 2002,	 Armstrong,	 1995,	 Tasker	 and	Dudek,	1991,	Stern,	2001,	Pennartz	et	al.,	1998,	Gonzalez	et	al.,	2012).	This	 investigation	 uncovered	 significant	 fed-state	 dependent	 changes	 in	passive	 and	 active	 membrane	 properties.	 NPY	 neurons	 of	 fasted	 animals,	 with	brain	slices	incubated	in	fasted	levels	of	glucose	(1	mM),	had	a	significantly	shorter	mean	action	potential	duration	-	both	when	measured	from	threshold	and	at	action	potential	 half-height	 –	 than	 NPY	 neurons	 of	 fed	 animals,	 with	 brain	 slices	incubated	in	1	mM	glucose-containing	aCSF.	A	reduced	action	potential	refractory	period,	resulting	 from	faster	action	potential	kinetics	could	theoretically	 increase	the	upper	 limits	of	neuronal	 firing	 frequency,	 and	 therefore	 could	be	a	means	of	influencing	 neurotransmitter	 release	 rate,	 however	 this	may	 be	 unlikely	 to	 have	any	 significant	 effect	 at	 the	 low	 frequencies	 observed	 here.	 This	 may	 be	 a	mechanism	 by	 which	 NPY	 neurons	 elevate	 NPY,	 AgRP	 and	 GABA	 release	 in	negative	energy	states.	Action	potential	firing	frequency,	membrane	potential	and	input	resistance	did	not	show	significant	state-dependent	variation.	However	this	could	reflect	the	small	sample	size	relative	to	that	discussed	in	Chapter	4	of	this	thesis.	In	 these	studies,	active	conductance	expression	displayed	a	degree	of	 fed-state-dependent	plasticity.	Of	particular	note	was	the	variation	in	the	expression	of	T-type	 calcium	 (IT),	 and	 hyperpolarization-activated	 non-selective	 cation	 (IH)	conductances.	 IT	 was	 identified	 most	 frequently	 in	 NPY	 neurons	 of	 fed	 mice,	incubated	 in	 5	 mM	 glucose-containing	 aCSF,	 and	 least	 frequently	 observed	 in	
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neurons	of	fasted	animals,	with	brain	slices	incubated	in	1	mM	glucose-containing	aCSF.	 Conversely,	 IH	 was	 identified	most	 frequently	 in	 the	 fasted	 1	 mM	 glucose	population	 and	 least	 frequently	 in	 slices	 reflecting	 the	 fed-state:	 5	mM	 glucose-containing	 population.	 Previous	 studies	 have	 linked	 IT	but	 not	 Ih	 to	 orexin	 and	ghrelin-induced	pacemaker-like	activity	 in	arcuate	NPY	neurons	 (van	den	Top	et	al.,	 2004).	 The	 increased	 expression	 of	 the	 Ih	 conductance	 in	 negative	 energy	states	 therefore	may	 have	 a	 critical	 role	 in	 generating	 and	 patterning	 activity	 of	NPY	 neurons	 in	 states	 of	 hunger	 and	 negative	 energy	 balance	 and	 thus	 driving	increased	 food	 intake.	 As	 IT	 is	 also	 implicated	 in	 pacemaker-like	 activity	 in	 NPY	neurons	in	fed	states	and	10mM	glucose	(van	den	Top	et	al.,	2004),	the	functional	significance	 of	 the	 differential	 expression	 of	 these	 conductances	 depending	 on	energy	status	is	unclear.	However,	given	that	the	biophysical	properties	of	Ih	and	
IT	 and	 their	 modes	 of	 activation	 -	 Ih	 being	 hyperpolarization	 activated	 versus	hyperpolarization-inactivated	 and	 depolarization-activated,	 as	 seen	 with	 T-type	conductances	 -	 differ,	 changes	 in	 expression	 of	 these	 conductances	 could	significantly	 modulate	 electrical	 excitability	 and	 computational	 capability	 of	neurons	 and	 thus	 modify	 neurotransmitter	 release.	 	 In	 relation	 to	 this	 point,	NPY/AgRP	 neuron-derived	 GABA	 NPY	 and	 AgRP	 clearly	 have	 differences	 in	function	 and	 can	 be	 differentially	 released,	 therefore	 a	 relationship	 between	neuron	electrical	coding	and	specific	chemical	release	would	seem	likely	(Krashes	et	 al.,	 2013).	 Further	work	would	 do	well	 to	 further	 investigate	 the	 relationship	between	 fed	 state,	 extracellular	 glucose	 and	 orexigen	 concentration,	 upon	 active	conductance	 expression	 and	 the	 functional	 significance	 of	 Ih	 and	T-type	 calcium	conductances	in	vivo	in	NPY	neurons.		
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9.2		 Energy	status-dependent	plasticity	of	arcuate	NPY	neurons	NPY	neurons	of	the	ARH	express	ATP-sensitive	potassium	(KATP)	channels,	and	are	sensitive	to	both	glucose	and	ghrelin	(van	den	Top	et	al.,	2004,	van	den	Top	et	al.,	2007,	Willesen	et	al.,	1999,	Muroya	et	al.,	1999).	To-date	NPY	neurons	have	been	characterized	 as	 exclusively	 glucose-inhibited,	 although	 the	 fundamental	 ionic	mechanisms	 underlying	 this	 response	 are	 unclear.	 	 Furthermore,	 the	 ability	 of	these	neurons	to	detect	changes	in	extracellular	glucose	in	different	physiological	states-	such	as	a	fasted	versus	fed,	-	has	never	been	explored.	In	experiments	discussed	here,	the	effect	of	increasing	extracellular	glucose	concentration	was	investigated	on	NPY	neurons	of	brain	slices	obtained	from	fed	and	fasted	animals.	Also	investigated	were	the	effects	of	ghrelin	on	NPY	neurons,	using	 in	 vitro	 conditions	 approximating	 the	 fed	 and	 fasted	 states	 found	 in	 vivo.	Action	potential	firing	frequency	and	neuronal	input	resistance	were	significantly	elevated	in	NPY	neurons	of	fed	mice,	with	brain	slices	incubated	in	5	mM	glucose	–containing	 aCSF,	 compared	 to	 neurons	 of	 fasted	mice,	with	 slices	 incubated	 in	 1	mM	glucose-containing	aCSF.	This	 is	the	first	report	of	elevated	electrical	activity	of	 NPY	 neurons	 in	 positive	 energy	 states.	 Previous	 in	 vitro	work	 has	 reported	elevated	NPY	electrical	activity	in	negative	energy	states,	which	is	possibly	due	to	the	use	of	supraphysiological	glucose	concentration	used	 in	aCSF	(Takahashi	and	Cone,	 2005,	 Burdakov	 and	 Gonzalez,	 2009).	 Other	 work	 has	 reported	 afferent,	excitatory	 PVH	 neurons	 to	 regulate	 energy-status-dependent	 NPY/AgRP	 output	(Krashes	 et	 al.,	 2014,	 Yang	 et	 al.,	 2011).	 Work	 described	 here	 unequivocally	supports	 the	 notion	 that	 NPY/AgRP	 neurons	 are	 intrinsic	 energy	 sensors,	 with	increased	 system	 computational	 power	 introduced	 by	 afferent	 NPY	 neuron	innervation.	
	 289	
The	reduced	electrical	activity	of	fasted	NPY	neurons	observed	here	is	likely	not	 representative	 of	 in	 vivo	 activity	 levels	 where	 NPY	 neurons	 are	 driven	 to	higher	 levels	 of	 excitability	 in	 fasted	hunger	 states.	 	 This	most	 likely	 reflects	 the	presence	of	other	factors	in	vivo,	such	as	ghrelin.	However	these	data	inform	us	of	the	manner	 in	which	energy	status-signals	are	 integrated	at	 the	 level	of	 the	NPY	neuron,	and	 the	critical	 role	of	KATP	channels	 -	open	when	glucose	 levels	are	 low	and	vice-versa.	 Future	work	would	do	well	 to	 bear	 this	 in	mind	when	designing	experiments	investigating	glucose-sensing	neurons.			These	 experiments	 also	 unveiled	 an	 increased	 proportion	 of	 glucose	responsive	(GR)	NPY	neurons	 in	brain	slices	of	mice	 fasted	 for	18-hours	prior	 to	culling,	relative	to	the	proportion	of	GR	neurons	observed	in	brain	slices	of	animals	fed	ad	 libitum.	 This	work	 is	 the	 first	 report	 of	 glucose	 excited	 (GE)	 arcuate	NPY	neurons,	which	have	previously	been	presumed	to	be	universally	glucose	inhibited	(GI)	(Burdakov	and	Gonzalez,	2009).	Fasting	increased	the	proportion	of	both	GE	and	GI	NPY	neurons,	 compared	 to	 a	 fed	 control,	 however	 the	 greatest	 degree	 of	plasticity	was	observed	 in	 the	GE	population.	The	GE	response	was	mediated	via	adenosine	 A1,	 A2A	 and	A3	 receptors,	 and	KATP	 channel	 inhibition,	whereas	 the	 GI	response	was	 via	 the	 activation	 of	 a	 chloride	 conductance.	 These	 data	 suggest	 a	physiological	 role	 for	 GE	 NPY	 neurons	 in	 post-fast	 refeeding,	 and	 future	 work	should	 focus	 on	 the	 physiological	 effects	 of	 NPY	 neuron	 adenosine	 receptor	antagonism.	 Interestingly,	 in	 one	 neuron	 tested,	 KATP	 channel	 antagonism	 was	capable	of	converting	a	glucose-induced	excitation	to	a	glucose-induced	inhibition.	This	data	indicates	that	there	exists	a	subpopulation	of	NPY	neurons	that	are	both	GE	and	GI	 competent	 and	 can	 shift	 depending	on	 fed	 and	glucose	 status.	 	 It	 also	suggests	 GE	 can	 be	 recruited	 from	 both	 previously	 non-glucose	 sensing	 NPY	
	 290	
populations	 and	 from	 GI	 populations.	 	 The	 functional	 significance	 of	 this	remarkable	 energy-status-dependent	 plasticity	 requires	 further	 study	 to	 fully	understand	 the	 functional	 and	physiological	 significance.	 In	vivo	 pharmacological	manipulation	of	this	could	be	of	therapeutic	benefit	to	metabolic	disorders.		 The	excitatory	effect	of	ghrelin	on	NPY	neurons	was	shown	 to	be	a	direct	post-synaptic	 action,	 via	 KATP	 channel	 inhibition.	 Ghrelin	 induces	 the	 greatest	excitatory	 effect	 upon	 NPY	 neurons,	 under	 fasted,	 low	 extracellular	 glucose	conditions.	 These	 data	 suggest	 that	 glucose	 ‘sets	 the	 gain’	 for	 ghrelin	 at	 NPY	neuron	membranes,	with	 low	 ambient	 glucose	 concentrations	 –	 as	 found	 during	fasting	conditions	–	amplifying	 the	orexigenic	effects	of	ghrelin,	whilst	 inevitably	reducing	 the	 physiological	 effect	 of	 KATP	 channel	 openers,	 such	 as	 leptin	 and	insulin.	 This	 data	 also	 suggest	 a	 synergistic	 relationship	 between	 ghrelin	 and	glucose	 in	 certain	 states	 of	 energy	 balance.	 	 For	 example,	 following	 a	 period	 of	hunger,	 or	 fasting	when	 glucose	 levels	 are	 low,	 an	 initial	 spike	 in	 glucose	 levels	with	 food	 intake	 may	 operate	 synergistically	 with	 ghrelin	 to	 drive	 further,	excessive	 food	 intake	 to	 maximize	 the	 opportunity	 to	 restore	 energy	 levels	following	fasting.	 	This	scenario	may	also	be	 important	 in	excess	 food	 intake	and	increased	 bodyweight	 that	 often	 follows	 calorie-restriction	 based	 diets.	 	 Further	work	is	required	to	clarify	this	suggestion.		
9.3		 The	 contribution	 of	 TCPTP	 and	 PTP1B	 and	 PI3-kinase	 to	 insulin	
signaling	in	POMC	neurons	POMC	 neurons	 of	 the	 ARH	 are	 sensitive	 to	 insulin,	 yet	 in	 obesity,	 hypothalamic	neurons	fail	to	respond	accordingly	to	changes	in	extracellular	insulin	(Williams	et	al.,	 2010,	Spanswick	et	 al.,	 2000).	 In	arcuate	POMC	neurons,	phosphoinositide	3-
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kinase	 (PI3K)–dependent	 insulin	 signal	 transduction	 promotes	 the	 browning	 of	white	adipose	 tissue	 (WAT),	and	elevates	energy	expenditure	 (Dodd	et	al.,	2015,	Qiu	et	al.,	2014).	Inhibition	of	PI3K-dependent	insulin	signal	transduction	by	T-cell	protein	 tyrosine	 phosphatase	 (TCPTP)	 is	 associated	 with	 obesity	 and	 type-2	diabetes	mellitus	(T2DM).	Conversely,	disinhibition	of	the	PI3K	pathway	-	through	TCPTP	 inhibition	 -	 is	 protective	 against	 metabolic	 disease	 (Zhang	 et	 al.,	 2015,	Tiganis,	 2013,	 Dodd	 et	 al.,	 2015,	 Loh	 et	 al.,	 2011).	 Hence	 we	 investigated	 the	neuronal,	 electrophysiological	 mechanisms	 underlying	 these	 physiological	phenomena.		 Whole-cell	 patch	 clamp	 experiments	 revealed	 that	 of	 arcuate	 POMC	neurons,	 insulin-excited,	 insulin-inhibited,	 and	 insulin-insensitive	 subpopulations	exist.	 Of	 the	 insulin-excited	 POMC	 subpopulation,	 a	 significantly	 greater	 insulin-induced	membrane	depolarization	was	observed	when	brain	slices	were	incubated	in	 a	 TCPTP	 inhibitor,	 relative	 to	 insulin-induced	 excitations	 observed	 in	 brain	slices	 incubated	in	a	PI3K	inhibitor.	These	results	concur	with	previous	research,	and	suggest	that	TCPTP	does	indeed	diminish	the	extent	to	which	insulin	is	able	to	depolarize	POMC	neurons,	and	promote	energy	expenditure.	Manipulation	of	this	pathway	may	be	a	viable	anti-obesity	strategy	and	hence	further	investigation	is	of	value.		 Comparison	 of	 the	 TCPTP	 inhibitor	 and	 control	 population	 indicates	 that	TCPTP	acts	to	impede	excitatory	insulin	signal	transduction,	whilst	also	promoting	the	 transduction	 of	 signals	 leading	 to	 POMC	 neuron	 hyperpolarization.	 A	comparison	 of	 the	 control	 population	 with	 the	 POMC	 neuron-specific	 TCPTP	knockout	 group	 also	 suggests	 that	 TCPTP	 acts	 to	 reduce	 excitatory	 signal	transduction.	Here,	 unlike	 the	TCPTP	 inhibitor	 population,	 over	 a	 third	 of	 POMC	
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neurons	 remain	 inhibited	 by	 insulin	 –	 compared	 to	 only	 around	 10%	 in	 the	inhibitor	 group.	Whether	 the	 TCPTP-inhibitor	 or	 the	 TCPTP-knockout	 is	 a	more	appropriate	 model	 is	 yet	 to	 be	 determined.	 Anomalies	 could	 be	 introduced	 in	either	 group,	 resulting	 from	 off	 target-effects	 of	 the	 TCPTP	 inhibitor,	 and	 from	compensatory	mechanisms	 arising	 in	 the	 TCPTP	 knockout	mouse	model.	 Future	research	should	look	in	to	this.	Finally,	when	comparing	the	control	population	of	POMC	 neurons	 to	 those	 of	 brain	 slices	 pretreated	with	 a	 PI3K	 inhibitor,	 results	indicate	 that	 PI3K-dependent	 insulin	 signaling	 in	 POMC	 neurons,	 differentially	promotes	 neuron	 hyperpolarization,	 over	 depolarization.	 This	 response	distribution	 is	 remarkably	 similar	 to	 that	 observed	 in	 the	 TCPTP	 inhibitor	population	 and	 the	 reason	 for	 this	 remains	 unclear.	 This	 result	 is	 ostensibly	paradoxical,	 with	 both	 inhibition	 and	 disinhibition	 of	 PI3K-dependent	 insulin	signaling	 promoting	 POMC	 neuron	 excitation.	 Of	 benefit	 to	 these	 experiments	would	 have	 been	 independent	 verification	 of	 phosphatase	 within	 neurons	recorded	from	in	electrophysiological	experiments.	Future	work	would	do	well	to	use	the	single-cell	polymerase	chain	reaction	(PCR)	technique	in	order	to	correlate	electrophysiological	data	with	a	definitive	molecular	analysis.		
9.4		 Effects	 of	 leptin	 on	 leptin	 receptor-expressing	 neurons	 in	 the	
dorsomedial	hypothalamus	The	dorsomedial	hypothalamus	(DMH)	is	a	hypothalamic	nucleus	known	to	exert	significant	 control	 over	 energy	 expenditure,	 in	 addition	 to	 blood	 pressure	 and	physiological	 responses	 to	 stress	 (Horiuchi	 et	 al.,	 2004,	 Enriori	 et	 al.,	 2011,	Guyenet,	 2006,	Horiuchi	 et	 al.,	 2006).	The	DMH	contains	 leptin	 receptor	 (LepR)-expressing	neurons	(Enriori	et	al.,	2011).	The	leptin-induced	excitation	in	38.2%	of	
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DMH	 LepR	 neurons,	 as	 observed	 here,	 correllates	with	 in	 vivo	experiments	 (not	presented	here)	demonstrating	that	activation	of	these	neurons	using	engineered,	pharmacologically-selective	chimeric	ion	channels	can	elevate	blood	pressure	and	heart	rate,	whilst	the	pharmacological	inhibition	of	these	neurons	has	the	opposite	effect	 (Simonds	 et	 al.,	 2014).	 This	 hypertensive	 physiological	 response	 to	hyperleptinemia	 underlies	 the	 high	 blood	 pressure	 associated	with	 obesity.	 The	evolutionary	 origin	 of	 leptin-induced	 energy	 expenditure	 is	 easy	 to	 explain;	 it	exerts	negative	feedback	upon	adipose	stores.	However	the	evolutionary	origin	of	the	hypertensive	effects	of	leptin	are	less	obvious.	Research	outlined	here	will	undoubtedly	lead	to	further	work,	investigating	the	 cardiovascular	 effects	 of	 DMH	 leptin	 signaling,	 in	 addition	 to	 revealing	potential	 targets	 for	 hypertension	 intervention	 strategies.	 	 Furthermore,	subpopulations	 of	 leptin	 receptor-expressing	 DMN	 neurons	 were	 inhibited	 by	leptin	 via	 activation	 of	 unidentified	 potassium	 channels,	 similar	 to	 previous	reports	of	 leptin	 inhibiting	hypothalamic	neurons	via	KATP	channels	 (Spanswick	et	 al.,	 1997).	 Further	 work	 is	 required	 to	 clarify	 the	 physiological	 role	 of	 these	DMN	neurons.			
9.5		 Electrophysiological	 and	 pharmacological	 profile	 of	 gonadotropin	
inhibitory	hormone-expressing	neurons	of	the	rat	in	vitro		Gonadotropin	 inhibitory	 hormone	 (GnIH)	 exerts	 a	 negative	 tone	 over	 the	hypothalamic-pituitary-gonadal	 (HPG)	 axis.	 Depending	 on	 the	 species,	 GnIH	inhibits	gonadotroph	secretion	either	through	release	into	the	hypophyseal	blood	or	 at	 gonadotropin-releasing	hormone	 (GnRH)-expressing	neurons	 (Clarke	 et	 al.,	2008,	Ducret	 et	 al.,	 2009).	 Stress-induced	 reproductive	dysfunction	 is	 associated	with	elevated	GnIH	expression	(Kirby	et	al.,	2009).			
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This	 is	 the	 first	 electrophysiological	 characterization	 of	 GnIH	 neurons	 in	any	 animal	model.	Whole-cell	 patch	 clamp	 experiments	 demonstrated	 that	 GnIH	neurons	 are	 sensitive	 to	 noradrenaline,	 thyrotropin	 releasing	 hormone	 (TRH),	ghrelin	 and	5-hydroxytryptamine	 (5-HT).	These	data	 indicate	 that	GnIH	neurons	integrate	 stress	 and	 orexigenic	 signals,	 and	 may	 be	 a	 critical	 hypothalamic	 link	between	stress,	reproductive	and	feeding	axes.	These	neurons	were	exclusively	excited	by	TRH,	ghrelin	and	noradrenaline,	whilst	 5-HT	 elicited	 inhibitory,	 excitatory	 and	 biphasic	 responses.	 A	pharmacological	characterization	of	the	contribution	of	5-HT	receptor	subtypes	to	the	 5-HT-induced	 membrane	 responses	 was	 attempted,	 however	 this	 proved	inconclusive	 at	 this	 point.	 This	 is	 likely	 due	 to	 the	 abundance	 of	 5-HT	 receptors	expressed	on	these	neurons,	as	reported	by	Soga	et	al.	(Soga	et	al.,	2010)	and	the	limited	 number	 of	 recordings	 in	 the	 present	 study.	 These	 data	 suggest	 that	metabolic	and	orexigenic	signals	are	integrated	into	the	HPG	axis,	at	the	level	of	the	GnIH	neuron,	inevitably	influencing	physiological	function.	Further	work	would	do	well	to	determine	the	physiological	significance	of	noradrenergic	and	serotonergic	GnIH	 neuron	 innervation.	 Some	 previous	 work	 has	 investigated	 this,	 but	 with	insufficient	 depth	 and	 rigor	 to	 determine	 GnIH	 neuron-specific	 contributions	 to	reproductive	function.		
9.6		 Electrical	 synaptic	 transmission	 in	 layer	 1	 cortical	 interneurons	 in	
vitro	Gap-junctions	are	intercellular	channels,	conduits	allowing	the	passage	of	ions	and	small	molecules.	 The	 fundamental	 subunit	 of	 the	 gap-junction	 is	 the	 connexin.	A	gap-junction	 plaque	 is	 made	 up	 of	 intercellular	 channels,	 each	 channel	 being	
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comprised	of	a	dimer	of	two	hemichannels,	and	each	hemichannel	is	a	hexamer	of	connexin	 subunits	 (Harris,	 2001).	 The	 connexin	 isoform	 Cx36	mediates	 neuron-neuron	 gap	 junctional	 coupling,	 and	 forms	 functional	 electrical	 synapses	throughout	the	mammalian	central	nervous	system	(CNS)	(Rozental	et	al.,	2000).			 Interneurons	of	the	mammalian	PFC	are	electrotonically	coupled	via	Cx36-based	 gap-junctions	 (Galarreta	 and	 Hestrin,	 1999,	 Galarreta	 and	 Hestrin,	 2001).	Aberrant	 electrotonic	 coupling	 is	 associated	 with	 a	 number	 of	 neurological	diseases	and	pathophysiological	phenomena	including	epilepsy,	migraine,	cortical	spreading	depression,	 and	glutamatergic	excitotoxicity	 (Bargiotas	et	 al.,	 2012,	de	Rivero	Vaccari	et	al.,	2007,	Durham	and	Garrett,	2009,	Gajda	et	al.,	2005).	As	such	gap-junctions	 are	 of	 interest	 as	 a	 potential	 therapeutic	 target	 for	 a	 number	 of	conditions,	including	epilepsy	(Meldrum	and	Rogawski,	2007).	Hence	I	performed	experiments	to	determine	the	electrophysiological	properties	of	coupled	neurons,	and	 the	 effects	 of	 novel	 benzoylamino-benzopyran	 compounds	 on	 electrotonic	coupling.	Additional	research	focused	on	the	effects	of	5-HT	on	FS	neurons	of	the	PFC.	 The	anti-convulsant	benzoylamino-benzopyran	compounds	tonabersat	and	carabersat	 inhibit	 electrotonic	 coupling	 between	 cortical	 interneurons,	 without	having	 significant	 effects	 upon	 neuronal	 input	 resistance,	 implying	 but	 not	confirming	 gap-junction-specific	 actions.	 These	 data	 indicate	 that	 these	compounds	 do	 indeed	 have,	 at	 least	 in	 part,	 a	 novel	 antiepileptic	mechanism	 of	action	via	an	effect	on	electrical	synapses.	Further	work	investigating	the	efficacy	of	 these	 gap-junction	 blockers,	 in	 epilepsy	 models	 that	 more	 closely	 mimic	 the	human	phenomenon,	would	be	of	value.		
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FS	 interneurons	 are	 sensitive	 to	 5-HT,	 and	 are	 depolarized	 via	 the	activation	 of	 a	 non-selective	 cation	 conductance,	 consistent	with	 5-HT3-receptor	activation.	 As	 the	 pharmacological	 manipulation	 of	 the	 cortical	 serotonergic	system	 is	 key	 to	 a	 number	 of	 therapeutics	 including	 antidepressant	 and	antipsychotic	 medication,	 this	 data	 may	 have	 implications	 for	 these	 fields	 of	research.		
9.7		 Conclusions	and	future	work	Key	 findings	 of	 studies	 discussed	 here	 amount	 to	 a	 deeper	 understanding	 of	hypothalamic	 neuron	 function.	 Experimental	 results	 presented	 in	 this	 thesis	include	 novel	 data	 revealing	 an	 energy-status-dependent	 plasticity	 within	 the	arcuate	NPY	neuron	population.	Additional	novel	findings	presented	here	include	the	 identification	 of	 a	 subpopulation	 of	 GE	 arcuate	 NPY	 neurons,	 and	 the	identification	 of	 a	 KATP	 channel-dependent	 mechanism	 of	 gain	 control	 over	hormone	 signal	 transduction	 in	 NPY	 neurons.	 This	 deeper	 understanding	 of	hypothalamic	cell	signaling	is	immediately	translational,	allowing	for	the	design	of	pharmacological	and	lifestyle	intervention	strategies	to	curtail	obesity.			 Other	 key	 findings	 of	 work	 presented	 in	 this	 thesis	 include	 the	quantification	 of	 the	 role	 of	 the	 protein	 tyrosine	 phosphatase	 TCPTP	 and	 PI3K-dependent	 insulin	 signaling	 in	 arcuate	 POMC	 neurons.	 The	 significance	 of	 this	work	is	a	deeper	understanding	of	neuronal	signal	transduction,	known	to	be	a	key	regulator	 of	 energy	 expenditure,	 which	 is	 of	 particular	 importance	 in	 research	focused	 on	 combating	 the	 global	 obesity	 epidemic.	 Future	 work	 should	 look	further	 into	 the	 effects	 of	 protein	 tyrosine	 phosphatases	 on	 central	 insulin	
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signaling	and	body	weight	management	and	 its	potential	as	a	 target	 for	diabetes	and	obesity	using	diet-induced	obese	models.		 Investigations	 of	 LepR	 neurons	 of	 the	 DMH	 revealed	 subpopulations	 of	leptin	 inhibited	 and	 leptin	 excited	 neurons.	 Of	 leptin-excited	 neurons,	 the	modulation	 of	 a	 T-type	 calcium	 conductance	 and	 the	 induction	 of	 oscillatory	membrane	 activity	 represent	 novel	 mechanisms	 of	 leptin-induced	 neuron	excitation.	This	mechanism	of	 excitation	 is	of	particular	 interest,	 as	 it	provides	a	potential	 target	 for	 centrally	 acting	 hypertensive	 medication.	 Future	 research	would	do	well	to	pursue	this	avenue	of	investigation.	Experiments	 performed	 on	 rat	 GnIH	 neurons	 represent	 the	 first	electrophysiological	 characterization	 of	 the	mammalian	 GnIH	 neuron.	 This	work	allows	us	 to	more	accurately	 contextualize	 the	GnIH	neuron	within	 the	HPG	and	HPA	axes,	in	addition	to	providing	us	with	a	deeper	appreciation	of	the	integration	of	neurohormonal	signals	 into	the	reproductive	axis,	and	vice-versa.	Future	work	should	further	elucidate	the	role	of	GnIH,	not	only	as	a	reproductive	regulator,	but	also	as	a	central	stress	and	central	orexigenic	signal.	Investigations	 of	 electrotonic	 coupling	 in	 the	 PFC	 outline	 the	 inhibitory	effects	of	benzoylamino-benzopyran	on	cortical	gap-junctions.	This	data	provides	a	potential	mechanism,	underlying	the	antiepileptic	properties	of	these	compounds.	Further	 work	 should	 continue	 to	 investigate	 the	 extent	 of	 the	 pharmaceutical	applications	 of	 these	 compounds.	 Also	 of	 note	 is	 the	 excitation	 of	 layer	 2	 FS	interneurons	by	5-HT,	via	a	non-selective	cation	conductance.	These	data	allow	us	to	 understand	 cortical	 network	 function	 to	 a	 deeper	 level,	 and	 is	 of	 particular	relevance	to	psychiatric-disorder	research.	
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